UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 20-F
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
for the fiscal year ended December 31, 2016
Commission File No. 0-28998
ELBIT SYSTEMS LTD.
(Exact name of registrant as specified in its charter and translation of registrant’s name into English)
Israel
(Jurisdiction of incorporation or organization)
Advanced Technology Center, Haifa 3100401, Israel
(Address of principal executive offices)
Joseph Gaspar
c/o Elbit Systems Ltd.
P.O. Box 539
Advanced Technology Center
Haifa 3100401
Israel
Tel: 972-4-831-6404
Fax: 972-4-831-6944
E-mail: j.gaspar@elbitsystems.com
(Name, telephone, e-mail and/or facsimile number and address of Company contact person)
Securities registered or to be registered pursuant to Section 12(b) of the Act:
Ordinary Shares, nominal value 1.0 New Israeli Shekels per share
(Title of Class)
The NASDAQ Global Select Market
(Name of each Exchange on which registered)
Securities registered or to be registered pursuant to Section 12(g) of the Act:
Not Applicable
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:
Not Applicable
Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of
the period covered by the annual report: 42,745,816 Ordinary Shares.
Indicate by check mark whether the registrant is a well-known seasoned issuer, as defined in Rule 405 of the
Securities Act.
If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports
pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Yes No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes No
Yes No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any,
every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this
chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such
files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer.
See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act (Check One).
Yes No
Large accelerated filer
Accelerated filer
Non-accelerated filer
Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included
in this filing.
U.S. GAAP
International Financial Reporting
Standards as issued by the International
Accounting Standards Board
Other
If “Other” has been checked in response to the previous question, indicate by check mark which financial statement
item the registrant has elected to follow.
Item 17 Item 18 No
If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2
of the Exchange Act).
Yes No
Table of Contents
General Disclosure Standards
Cautionary Statement with Respect to Forward-Looking Statements
Item 1.
Item 2.
Item 3.
Item 4.
Item 4A.
Item 5.
Item 6.
Item 7.
Item 8.
Item 9.
Item 10.
Item 11.
Item 12.
Item 13.
Item 14.
Item 15.
Item 16A.
Item 16B.
Item 16C.
Item 16D.
Item 16E.
Item 16F.
Item 16G.
Item 16H.
Item 17.
Item 18.
Item 19.
Identity of Directors, Senior Management and Advisers
Offer Statistics and Expected Timetable
Key Information
Information on the Company
Unresolved Staff Comments
Operating and Financial Review and Prospects
Directors, Senior Management and Employees.
Major Shareholders and Related Party Transactions
Financial Information.
The Offer and Listing
Additional Information
Quantitative and Qualitative Disclosures About Market Risk
Description of Securities Other than Equity Securities
Defaults, Dividend Arrearages and Delinquencies
Material Modifications to the Rights of Security Holders and Use of Proceeds.
Controls and Procedures
Audit Committee Financial Expert
Code of Ethics
Principal Accountant Fees and Services
Exemptions from the Listing Standards for Audit Committees
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
Change in Registrant’s Certifying Accountant
Corporate Governance
Mine Safety Disclosure
Financial Statements
Financial Statements
Exhibits
Page
1
1
2
2
3
12
27
28
48
63
64
65
66
81
83
83
83
83
84
84
84
85
85
85
85
85
85
85
86
General Disclosure Standards
PART I
The consolidated financial statements of Elbit Systems Ltd. (Elbit Systems) included in this annual report on Form 20-
F are prepared in accordance with United States generally accepted accounting principles (U.S. GAAP). Unless otherwise
indicated, all financial information contained in this annual report is presented in U.S. dollars. References in this annual report
to the “Company”, “we”, “our”, “us” and terms of similar meaning refer to Elbit Systems and our subsidiaries unless the
context requires otherwise.
The name "ELBIT SYSTEMS," and our logo, brand, product, service and process names appearing in this document,
are the trademarks of the Company or our affiliated companies. All other brand, product, service and process names appearing
in this document are the trademarks of their respective holders and appear for informational purposes only. Reference to or use
of any third party mark, product, service or process name herein does not imply any recommendation, approval, affiliation or
sponsorship of that or any other mark, product, service or process name. Nothing contained herein shall be construed as
conferring by implication, estoppel or otherwise any license or right under any patent, copyright, trademark or other intellectual
property right of the Company or any of our affiliated companies.
Cautionary Statement with Respect to Forward-Looking Statements
This annual report on Form 20-F contains forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements
relate to our current plans, estimates, strategies, goals and beliefs and as such do not relate to historical or current fact.
Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of
1995, as amended.
Forward-looking statements contained herein generally are identified by the words “believe”, “project”, “expect”,
“will likely result”, “strategy”, “plan”, “may”, “should”, “will”, “would”, “will be”, “will continue”, “will likely result” and
similar expressions, and the negatives thereof. Forward-looking statements are based on management’s current expectations,
estimates, projections and assumptions, are not guarantees of future performance and involve certain risks and uncertainties, the
outcomes of which cannot be predicted. Therefore, actual future results, performance and trends may differ materially from
these forward-looking statements due to a variety of factors, including, without limitation:
•
the scope and length of customer contracts;
• governmental regulations and approvals;
•
changes in governmental budgeting priorities;
• general market, political and economic conditions in the countries in which we operate or sell, including
Israel and the United States among others;
• differences in anticipated and actual program performance, including the ability to perform under long-
term fixed-price contracts;
•
the impact on our backlog from export restrictions by the Government of Israel;
• our ability to protect our proprietary information and avoid, withstand and/or recover from cyber attacks on
our systems;
•
the effect of competitive products, technology and pricing;
• our ability to attract, incentivize and retain key employees;
1
•
changes in applicable tax rates;
•
fluctuations in foreign currency exchange rates;
•
inventory write-downs and possible liabilities to customers from program cancellations due to political
relations between Israel and countries where our customers may be located; and
•
the outcome of legal and/or regulatory proceedings.
The factors listed above are not all-inclusive, and further information about risks and other factors that may affect our
future performance is contained in this annual report on Form 20-F. All forward-looking statements speak only as of the date of
this annual report. We expressly disclaim any obligation to update or review any forward-looking statements, whether as a
result of new information, future events or otherwise, except as may be required by applicable law.
Item 1.
Identity of Directors, Senior Management and Advisers.
Information not required in annual report on Form 20-F.
Item 2.
Offer Statistics and Expected Timetable.
Information not required in annual report on Form 20-F.
2
Item 3.
Key Information.
Selected Financial Data
The following selected consolidated financial data of the Company as of and for the years ended December 31,
2012, 2013, 2014, 2015 and 2016 are derived from our audited consolidated financial statements, including our audited
consolidated financial statements as of December 31, 2015 and 2016, and for each of the years ended December 31, 2014, 2015
and 2016, which appear in Item 18 in this annual report on Form 20-F. You should read the audited consolidated financial
statements appearing in Item 18 together with the selected financial data set forth below. (For non-GAAP financial data see
Item 5. Operating and Financial Review and Prospects – Non-GAAP Financial Data.)
Years Ended December 31,
(U.S. dollars in millions, except for per share amounts)
2016
2014
2012
2015
2013
$ 2,888.6 $ 2,925.2 $ 2,958.2 $ 3,107.6 $ 3,260.2
2,300.6
959.6
255.8
271.0
151.4
(17.6 )
660.6
299.0
(23.7 )
4.0
279.2
(45.6 )
5.2
238.8
—
238.8
(1.9 )
236.9
2,100.3
824.9
220.5
235.5
129.5
—
585.5
239.4
(37.3 )
0.9
203.0
25.3
13.0
190.7
0.7
191.4
(8.0 )
183.4 $
2,210.5
897.1
243.4
239.4
145.7
—
628.5
268.6
(20.2 )
0.2
248.6
46.2
4.5
206.9
—
206.9
(4.4 )
202.5 $
2,072.7
815.9
233.4
241.9
137.5
—
612.8
203.1
(26.1 )
0.1
177.1
17.1
11.2
171.2
(0.6 )
170.6
(2.6 )
168.0 $
2,133.2
825.0
228.0
216.5
139.6
(6.0 )
578.1
246.9
(47.5 )
0.1
199.5
25.6
5.5
179.4
—
179.4
(8.4 )
171.0 $
$
$
$
$
$
3.99 $
(0.01 )
3.98 $
4.34 $
0.01
4.35 $
4.01 $
—
4.01 $
4.74 $
—
4.74 $
3.98 $
(0.01 )
3.97 $
4.33 $
0.01
4.34 $
4.01 $
—
4.01 $
4.74 $
—
4.74 $
5.54
—
5.54
5.54
—
5.54
Income Statement Data:
Revenues
Cost of revenues
Gross profit
Research and development expenses, net
Marketing and selling expenses
General and administrative expenses
Gain from changes in holdings
Total operating expenses
Operating income
Financial expenses, net
Other income, net
Income before taxes on income
Taxes on income
Equity in net earnings of affiliated companies and partnerships
Net income from continuing operations, net
Income (loss) from discontinued operations, net
Net income
Less: net income (loss) attributable to non-controlling interests
Income attributable to Elbit Systems’ shareholders
Earnings per share:
Basic net earnings per share
Continuing operations
Discontinued operations
Total
Diluted net earnings per share
Continuing operations
Discontinued operations
Total
3
As of December 31,
(U.S. dollars in millions, except for per share amounts)
2016
2014
2012
2015
2013
Balance Sheet Data:
Cash, cash equivalents, short-term bank deposits and
marketable securities
Working capital
Long-term deposits, marketable securities and other
receivables
Long-term trade and unbilled receivables
Property, plant and equipment, net
Total assets
Long-term debt
Series A Notes, net of current maturities
Capital stock
Elbit Systems shareholders’ equity
Non-controlling interests
Total equity
$
$
265
375
$
265
561
$
306
626
$
332
645
19
230
501
3,811
174
409
249
1,017
34
1,051
53
243
481
3,933
224
378
268
1,177
17
1,194
18
213
442
4,021
221
294
272
1,227
12
1,239
16
152
450
4,124
166
227
274
1,391
8
1,399
245
527
16
190
474
4,352
—
171
274
1,560
7
1,567
Number of outstanding ordinary shares of NIS 1 par value
(in thousands)
Dividends paid per ordinary share with respect to the
applicable year
41,882
42,587
42,685
42,730
42,746
$
1.20
$
1.20
$
1.28
$
1.44
$
1.60
Risk Factors
General Risks Related to Our Business and Market
Our revenues depend on a continued level of government business. We derive most of our revenues directly or
indirectly from government agencies, mainly the Israeli Ministry of Defense (IMOD), the U.S. Department of Defense (DoD)
and authorities of various countries, pursuant to contracts awarded to us under defense and homeland security-related
programs. The funding of these programs could be reduced or eliminated due to numerous factors, including geo-political
events and macro-economic conditions that are beyond our control. Reduction or elimination of government spending under
our contracts would cause a negative effect on our revenues, results of operations, cash flow and financial condition.
Certain of our contracts may be terminated for convenience of the customer. Our contracts with governments
often contain provisions permitting termination for convenience of the customer. Our subcontracts with non-governmental
prime contractors sometimes contain similar provisions permitting termination for the convenience of the prime contractors. In
a minority of contracts with such customers, an early termination for convenience would not entitle us to reimbursement for a
proportionate share of our fee or profit for work still in progress.
We depend on governmental approval of our exports. Our international sales, as well as our international
procurement of skilled human resources, technology and components, depend largely on export license approvals from the
governments of Israel, the U.S. and other countries. If we fail to obtain material approvals in the future, or if material approvals
previously obtained are revoked or expire and are not renewed, our ability to sell our products and services to overseas
customers and our ability to obtain goods and services essential to our business could be interrupted, resulting in a material
adverse effect on our business, revenues, assets, liabilities and results of operations. (See Item 4. Information on the Company –
Governmental Regulation.)
4
We are subject to procurement and anti-bribery rules and regulations. We are required to comply with
government contracting rules and regulations relating to, among other things, cost accounting, anti-bribery and procurement
integrity, which increase our performance and compliance costs. (See Item 4. Information on the Company – Governmental
Regulation.) Failure to comply with these rules and regulations could result in the modification, termination or reduction of the
value of our contracts, the assessment of penalties and fines, or suspension or debarment from government contracting or
subcontracting for a period of time, all of which could negatively impact our results of operations and financial condition. We
are engaged in activities in certain markets considered to be high risk from an anti-bribery compliance perspective, and
investigations by government agencies in the anti-bribery area have been more prevalent.
We face other risks in our international operations. We derive a significant portion of our revenues from
international sales. Changes in international, political, economic or geographic events could cause significant reductions in our
revenues, which could harm our business, financial condition and results of operations. In addition to the other risks from
international operations set forth elsewhere in these Risk Factors, some of the risks of doing business internationally include
imposition of tariffs and other trade barriers and restrictions, political and economic instability in the countries of our customers
and suppliers, changes in diplomatic and trade relationships and increasing instances of terrorism worldwide. Some of these
risks may be affected by Israel’s overall political situation. (See “Risks Related to Our Israeli Operations” below.)
Funding obligations to our pension plans could reduce our liquidity. Funding obligations for certain of our
pension plans are impacted by the performance of the financial markets and interest rates. When interest rates are low, or if the
financial markets do not provide expected returns, we may be required to make additional contributions to these pension plans.
Volatility in the equity markets or actuarial changes in mortality tables can change our estimate of future pension plan
contribution requirements. (See Item 18. Financial Statements – Notes 2(S) and 17.)
We face currency exchange risks. We generate a substantial amount of our revenues in currencies other than the
U.S. dollar (our financial reporting currency), mainly New Israeli Shekels (NIS), Great Britain Pounds (GBP), Euros, Brazilian
reals, Australian dollars and Indian rupees, and we incur a substantial amount of our expenses in currencies other than the U.S.
dollar, mainly NIS. To the extent we derive our revenues or incur our expenses in currencies other than the U.S. dollar, we are
subject to exchange rate fluctuations between the U.S. dollar and such other currencies. For example, we could be negatively
affected by exchange rate changes during the period from the date we submit a price proposal until the date of contract award or
until the date(s) of payment. Certain currency derivatives we use to hedge against exchange rate fluctuations may not fully
protect against sharp exchange rate fluctuations over short time periods. In addition, our international operations expose us to
the risks of price controls, restrictions on the conversion or repatriation of currencies, or even devaluations or hyperinflation in
the case of currencies issued by countries with unstable economies. All of these currency-related risks could have a material
adverse effect on our financial condition and financial results. (See below “Risks Related to Our Israeli Operations – Changes
in the U.S. Dollar – NIS Exchange Rate” and Item 5. Operating and Financial Review and Prospects – Impact of Inflation and
Exchange Rates.)
We operate in a competitive industry. The markets in which we participate are highly competitive and
characterized by technological change. If we are unable to improve existing systems and products and develop new systems and
technologies in order to meet evolving customer demands, our business could be adversely affected. In addition, our
competitors could introduce new products with innovative capabilities, which could adversely affect our business. We compete
with many large and mid-tier defense contractors on the basis of system performance, cost, overall value, delivery and
reputation. Many of these competitors are larger and have greater resources than us, and therefore may be better positioned to
take advantage of economies of scale and develop new technologies. Some of these competitors are also our suppliers in some
programs.
Due to consolidation in our industry, we are more likely to compete with certain potential customers. As the
number of companies in the defense industry has decreased in recent years, the market share of some prime contractors has
increased. Some of these companies are vertically integrated with in-house capabilities similar to ours in certain areas. Thus, at
times we could be seeking business from certain of these prime contractors, while at other times we could be in competition
with some of them. Failure to maintain good business relations with these major contractors could negatively impact our
business.
5
We face risks of cost overruns in fixed-price contracts. Most of our contracts are fixed-price contracts, under
which we generally assume the risk that increased or unexpected costs may reduce profits or generate a loss. The risk of
adverse effects on our financial performance from such increased or unexpected costs can be particularly significant under a
fixed-price contracts for which we recognize profit or loss on a “percentage-of-completion” basis, and for which changes in
estimated gross profit/loss are recorded on a "cumulative catch-up basis." (See Item 5. Operating and Financial Review and
Prospects – General – Critical Accounting Policies and Estimates – Revenue Recognition and Item 18. Financial Statements -
Note 2(T) (Significant Accounting Polities - Revenue Recognition).) The costs most likely to fluctuate under our fixed price
contracts relate to internal design and engineering efforts. However, we do not believe changes in the market costs of
particular commodities that may be used in the production of our products are likely to present a material risk to our costs. To
the extent we underestimate the costs to be incurred in any fixed-price contract, we could experience a loss on the contract,
which would have a negative effect on our results of operations, financial position and cash flow.
We face fluctuations in revenues and profit margins. Our revenues may fluctuate between periods due to
changes in pricing, sales volume or project mix. Moreover, because certain of our project revenues are recognized upon
achievement of performance milestones, we may experience significant fluctuations in year-to-year and quarter-to-quarter
financial results. Similarly, our profit margin may vary significantly during the course of a project as a result of changes in
estimated project gross profits that are recorded in results of operations on a cumulative catch-up basis pursuant to the
percentage-of-completion accounting method. (See Item 5. Operating and Financial Review and Prospects – General – Critical
Accounting Policies and Estimates – Revenue Recognition and Item 18. Financial Statements - Note 2(T) (Significant
Accounting Polities - Revenue Recognition).) As a result, our financial results for prior periods may not provide a reliable
indicator of our future results.
Our backlog of projects under contract is subject to unexpected adjustments, delays in payments and
cancellations. Our backlog includes revenue we expect to record in the future from signed contracts and certain other
commitments. Many projects may remain in our backlog for an extended period of time because of the size or long-term nature
of the contract. In addition, from time to time, for reasons beyond our control (including economic conditions or customer
needs), projects are delayed, scaled back, stopped or cancelled, or the customer delays making payments, which may adversely
affect the revenue, profit and cash flow that we ultimately receive from contracts reflected in our backlog.
We may experience production delays or liability if suppliers fail to make compliant or timely deliveries. The
manufacturing process for some of our products largely consists of the assembly, integration and testing of purchased
components. Some components are available from a small number of suppliers, and in a few cases a single source. If a supplier
stops delivery of such components, finding another source could result in added cost and manufacturing delays. Moreover, if
our subcontractors fail to meet their design, delivery schedule or other obligations we could be held liable by our customers,
and we may be unable to obtain full or partial recovery from our subcontractors for those liabilities. The foregoing risks could
have a material adverse effect on our operating results.
We may be affected by failures of our prime contractors. We often act as a subcontractor, and a failure of our
prime contractor to meet its obligations may affect our ability to receive payments under our subcontract.
Undetected problems in our products could impair our financial results and give rise to potential product
liability claims. If there are defects in the design, production or testing of our or our subcontractors’ products and systems,
including our products sold for public safety purposes in the homeland security area, we could face substantial repair,
replacement or service costs, potential liability and damage to our reputation. In addition, we must comply with regulations
and practices to prevent the use of parts and components that are considered as counterfeit or that violate third party intellectual
property rights. We may not be able to obtain product liability or other insurance to fully cover such risks, and our efforts to
implement appropriate design, testing and manufacturing processes for our products or systems may not be sufficient to prevent
such occurrences, which could have a material adverse effect on our business, results of operations and financial condition.
Our future success depends on our ability to develop new offerings and technologies. The markets we serve are
characterized by rapid changes in technologies and evolving industry standards. In addition, some of our systems and products
are installed on platforms that may have a limited life or become obsolete. Unless we develop new offerings or enhance our
existing offerings we may be susceptible to loss of market share resulting from the introduction of new or enhanced offerings
by competitors. Accordingly, our future success will require that we:
6
•
•
identify emerging technological trends;
identify additional uses for our existing technology to address customer needs;
• develop and maintain competitive products and services;
•
add innovative solutions that differentiate our offerings from those of our competitors;
• bring solutions to the market quickly at cost-effective prices;
• develop working prototypes as a condition to receiving contract awards; and
•
structure our business, through joint ventures, teaming agreements and other forms of alliances, to reflect the
competitive environment.
We will need to invest significant financial resources to pursue these goals, and there can be no assurance that
adequate financial resources will continue to be available to us for these purposes. We may experience difficulties that delay or
prevent our development, introduction and marketing of new or enhanced offerings, and such new or enhanced offerings may
not achieve adequate market acceptance. Moreover, new technologies or changes in industry standards or customer
requirements could render our offerings obsolete or unmarketable. Any new offerings and technologies are likely to involve
costs and risks relating to design changes, the need for additional capital and new production tools, satisfaction of customer
specifications, adherence to delivery schedules, specific contract requirements, supplier performance, customer performance
and our ability to predict program costs. New products may lack sufficient demand or experience technological problems or
production delays. Our customers frequently require demonstration of working prototypes prior to awarding contracts for new
programs or require short delivery schedules which may cause us to purchase long-lead items or material in advance of
receiving the contract award. Moreover, due to the design complexity of our products, we may experience delays in developing
and introducing new products. Such delays could result in increased costs and development efforts, deflect resources from
other projects or increase the risk that our competitors may develop competing technologies that gain market acceptance in
advance of our products. If we fail in our new product development efforts, or our products or services fail to achieve market
acceptance more rapidly than the products or services of our competitors, our ability to obtain new contracts could be
negatively impacted. Any of the foregoing costs and risks could have a material adverse impact on our business, results of
operations, financial condition and cash flows.
Our business depends on proprietary technology that may be infringed. Many of our systems and products
depend on our proprietary technology for their success. Like other technology-oriented companies, we rely on a combination of
patents, trade secrets, copyrights and trademarks, together with non-disclosure agreements, confidentiality provisions in sales,
procurement, employment and other agreements and technical measures to establish and protect proprietary rights in our
products. Our ability to successfully protect our technology may be limited because:
•
intellectual property laws in certain jurisdictions may be relatively ineffective;
• detecting infringements and enforcing proprietary rights may divert management’s attention and company
resources;
•
contractual measures such as non-disclosure agreements and confidentiality provisions may afford only
limited protection;
• our patents may expire, thus providing competitors access to the applicable technology;
•
competitors may independently develop products that are substantially equivalent or superior to our products
or circumvent our intellectual property rights; and
•
competitors may register patents in technologies relevant to our business areas.
In addition, various parties may assert infringement claims against us. The cost of defending against infringement
claims could be significant, regardless of whether the claims are valid. If we are not successful in defending such claims, we
may be prevented from the use or sale of certain of our products, liable for damages and required to obtain licenses, which may
not be available on reasonable terms, any of which may have a material adverse impact on our business, results of operation or
financial condition.
7
A security breach or disruption or failure in a computer system could adversely affect us. Our operations
depend on the continued and secure functioning of our computer and communications systems and the protection of
information stored in computer databases maintained by us and, in certain circumstance, by third parties. Such systems and
databases are subject to breach, damage, disruption or failure from, among other things, cyber attacks and other unauthorized
intrusions, power losses, telecommunications failures, earthquakes, fires and other natural disasters.
We have been subject to attempted cyber attacks and face ongoing threats to our computer and communications
systems and databases of unauthorized access, computer hackers, computer viruses, malicious code, cyber crime, organized
cyber attacks and other security problems and system disruptions. In particular, we may be targeted by experienced computer
programmers and hackers (including those sponsored by foreign governments) who may attempt to penetrate our cyber security
defenses and damage or disrupt our computer and communications systems and misappropriate or compromise our intellectual
property or other confidential information or that of our customers. We devote significant resources to maintain and upgrade
the security of our systems and databases. However, despite our efforts to secure our systems and databases, events of this
nature may still result in system failures, loss of intellectual property and interruptions in our operations, which could have a
material adverse effect on our business, financial condition and results of operations.
We sometimes have risks relating to financing for our programs. A number of our major projects require us to
arrange, or to provide, guarantees in connection with the customer’s financing of the project. These include commitments by us
as well as guarantees provided by financial institutions relating to advance payments received from customers. Customers
typically have the right to drawdown against advance payment guarantees if we were to default under the applicable contract.
In addition, some customers require that the payment period under the contract be extended for a number of years, sometimes
beyond the period of contract performance. We may face difficulties in issuing guarantees or providing financing for our
programs, including in cases where a customer encounters impaired ability to continue to comply with extended payment terms.
Moreover, if we are required to provide significant financing for our programs, this could result in increased leverage on our
balance sheet. (See Item 4. Information on the Company – Financing Terms.)
We are subject to buy-back obligations. A number of our international programs require us to meet “buy-back”
obligations. (See Item 5. Operating and Financial Review and Prospects – Off Balance Sheet Transactions.) Should we, or the
local companies we contract with, be unable to meet such obligations we may be subject to contractual penalties, and our
chances of receiving further business from the applicable customers could be reduced or, in certain cases, eliminated.
We sometimes participate in risk-sharing contracts. We sometimes participate in “risk-sharing” type contracts, in
which our non-recurring costs, and in some cases costs that are capitalized as pre-contract costs, are only recoverable if there is
a sufficient level of sales for the applicable product, which level of sales typically is not guaranteed. If sales do not occur at the
level anticipated, we may not be able to recover our non-recurring costs under the contract.
We would be adversely affected if we are unable to retain key employees. Our success depends in part on key
management, scientific and technical personnel and our continuing ability to attract and retain highly qualified personnel. There
is competition for the services of such personnel. The loss of the services of key personnel, and the failure to attract highly
qualified personnel in the future, may have a negative impact on our business. Moreover, our competitors may hire and gain
access to the expertise of our former employees.
Our effective tax rate may be subject to fluctuations. Our worldwide effective tax rate could fluctuate as a result
of several factors, many of which are outside of our control, including: (i) changes in the mix of revenues and income we derive
from the jurisdictions where we operate which have different statutory tax rates; (ii) amendments to tax laws and regulations,
and changes in interpretations in the jurisdictions where we operate, including possible corporate tax reform in the U.S., Israel
or other countries; and (iii) tax assessments, or any related tax interest or penalties that could significantly affect our income tax
expense for the period in which the settlements take place. In addition, as we operate in multiple jurisdictions throughout the
world, our tax returns are periodically audited or subject to review by both domestic and foreign authorities. Increases in our
effective tax rates from the above factors could have a material adverse effect on our financial results and cash flows.
The Organization for Economic Cooperation and Development has recently introduced the base erosion and profit
shifting (BEPS) project. The BEPS project contemplates changes to numerous international tax principles, as well as national
tax incentives, and these changes, if adopted by individual countries, could adversely affect our provision for income taxes.
8
We may face labor relations disputes or not be able to amend collective bargaining agreements in a timely manner.
We are party to collective bargaining agreements that cover a substantial number of our employees, which number could
increase as a result of future acquisitions of companies. We have faced and may face future attempts to unionize additional parts
of our organization. Disputes with trade unions or other labor relations difficulties, as well as failure to timely amend or extend
collective bargaining agreements, could lead to worker disputes, slow-downs, strikes and other measures, which could
negatively impact our results of operations.
We face acquisition and integration risks. From time to time we make equity or asset acquisitions and
investments in companies and technology ventures. (See Item 4. Information on the Company – Mergers, Acquisitions and
Divestitures.) Such acquisitions involve risks and uncertainties such as:
• our pre-acquisition due diligence may fail to identify material risks;
• acquisitions may result in significant additional unanticipated costs associated with price adjustments or write-
downs;
• we may not integrate newly-acquired businesses and operations in an efficient and cost-effective manner;
• we may fail to achieve the strategic objectives, cost savings and other benefits expected from acquisitions;
• the technologies acquired may not prove to be those needed to be successful in our markets or may not have
adequate intellectual property rights protection;
• we may assume significant liabilities that exceed the enforceability or other limitations of applicable
indemnification provisions, if any, or the financial resources of any indemnifying parties, including indemnity
for regulatory compliance issues, such as anti-corruption and environmental compliance, that may result in
our incurring successor liability;
• we may fail to retain key employees of the acquired businesses;
• the attention of senior management may be diverted from our existing operations; and
• certain of our newly acquired operating subsidiaries in various countries could be subject to more restrictive
regulations by the local authorities after our acquisition, including regulations relating to foreign ownership of,
and export authorizations for, local companies.
Our acquisitions are subject to governmental approvals. Most countries require local governmental approval of
acquisitions of domestic defense businesses, which approval may be denied, or subject to unfavorable conditions, if the local
government determines the acquisition is not in its national interest. We may also be unable to obtain antitrust approvals for
certain acquisitions as our operations expand. Failure to obtain such governmental approvals could negatively impact our future
business and prospects.
Our share price may be volatile and may decline. Numerous factors, some of which are beyond our control and
unrelated to our operating performance or prospects, may cause the market price of our ordinary shares to fluctuate
significantly. Factors affecting market price include, but are not limited to: (i) variations in our operating results and ability to
achieve our key business targets; (ii) sales or purchases of large blocks of stock; (iii) changes in securities analysts’ earnings
estimates or recommendations; (iv) differences between reported results and those expected by investors and securities
analysts; and (v) changes in our business including announcements of new contracts by us or by our competitors. In addition,
we could be subject to securities class action litigation following periods of volatility in the market price of our ordinary shares.
Other general factors and market conditions that could affect our stock price include changes in: (i) the market’s
perception of our business; (ii) the businesses, earnings estimates or market perceptions of our competitors or customers; (iii)
the outlook for the defense and homeland security industries; (iv) general market or economic conditions unrelated to our
performance; (v) the legislative or regulatory environment; (vi) government defense spending or appropriations; (vii) military
or defense activities worldwide; (viii) the level of national or international hostilities; and (ix) the general geo-political
environment.
9
Being a foreign private issuer exempts us from certain SEC requirements. As a foreign private issuer within the
meaning of rules promulgated under the U.S. Securities and Exchange Act of 1934 (the Exchange Act), we are exempt from
certain Exchange Act rules and requirements that apply to U.S. public companies, including: (i) the requirement to file with the
SEC quarterly reports on Form 10-Q and current reports on Form 8-K; (ii) rules regulating the solicitation of proxies in
connection with shareholder meetings; (iii) Regulation FD prohibiting selective disclosures of material information; and (iv)
rules requiring insiders to disclose stock ownership and trading activities and establishing liability for profits realized from
“short-swing” trading transactions (i.e., a purchase and sale, or sale and purchase, of the issuer’s equity securities within less
than six months). Therefore certain protections and information generally available to investors with respect to public
companies organized in the U.S., may not be available in the same manner.
We have a major shareholder with significant influence over certain matters requiring shareholder approval.
Federmann Enterprises Ltd. (FEL) owns approximately 46% of our ordinary shares, directly and indirectly. Therefore, subject
to shareholder approval special majority requirements under the Companies Law and our Articles of Association, FEL may
have significant influence over the outcome of certain matters requiring shareholder approval, including the election of
directors who are not External Directors. Michael Federmann, who serves as the chair of our board of directors, is the
controlling shareholder of the entities that own FEL, and he is also the chair of the board and the chief executive officer of FEL.
Therefore, Mr. Federmann controls, directly and indirectly, the vote of ordinary shares owned by FEL. (See below - Item 6.
Directors, Senior Management and Employees - Board Practices - Appointment of Directors and - External Directors and Item
10. Additional Information - Approval of Certain Transactions and - Provisions Relating to Major Shareholders).
We have risks related to our issuance of Series A Notes under an Israeli debt offering. We face various risks
relating to our issuance of Series A Notes (the Notes). (See Items 5. Operating and Financial Review and Prospects - Liquidity
and Capital Resources - Israeli Debt Offering.) This includes the risk that we may not be able to maintain in the future the
rating level assigned to the Notes.
We have risks related to the inherent limitations of internal control systems. Despite our internal control
measures, we may still be subject to financial reporting errors or even fraud, which may not be detected. A control system, no
matter how well conceived and operated, can provide only reasonable, not absolute assurance that its objectives are met. In
addition, the design of a control system must reflect the fact that there are resource constraints, and the benefit of controls must
be relative to their costs. These inherent limitations include the realities that judgments in decision-making can be faulty and
that breakdowns can occur because of simple error or mistake. Further, controls can be circumvented by individual acts, by
collusion of two or more persons or by management override of the controls. Over time, a control may be inadequate because
of changes in conditions or the degree of compliance with applicable policies or procedures may deteriorate. (See Item 15.
Controls and Procedures.)
Risks Related to Our Israeli Operations
Conditions in Israel may affect our operations. Political, economic and military conditions in Israel and the
Middle East directly affect our operations. Since the establishment of the State of Israel, a number of armed conflicts have
taken place between Israel and its Arab neighbors. An ongoing state of hostility, varying in degree and intensity has caused
security and economic problems for Israel. We cannot predict whether or when such armed conflicts or other hostilities may
occur or the extent to which such events may impact us. For a number of years there have been continuing hostilities between
Israel and the Palestinians. This includes hostilities with the Islamic movement Hamas in the Gaza Strip, which have adversely
affected the peace process and at times resulted in armed conflicts. Such hostilities have negatively influenced Israel’s
economy as well as impaired Israel's relationships with several other countries. Israel also faces threats from Hezbollah
militants in Lebanon, from ISIS and rebel forces in Syria, and from various other countries in the Middle East region, including
the government of Iran, which is believed to be developing nuclear weapons and influences extremists groups such as Hamas
and Hezbollah. Moreover, some of Israel's neighboring countries have recently undergone or are undergoing significant
political changes. These political, economic and military conditions in Israel could have a material adverse effect on our
business, financial condition, results of operations and future growth.
Political relations could limit our ability to sell or buy internationally. We could be adversely affected by the
interruption or reduction of trade between Israel and its trading partners. Some countries, companies and organizations continue
to participate in a boycott of Israeli firms and others doing business with Israel, as well as with Israeli companies or with
Israeli-owned companies operating in other countries. Also, over the past several years there have been calls in various
countries and international organizations to reduce trade with Israel. Foreign government defense export policies towards Israel
could also make it more difficult for us to obtain the export authorizations necessary for our activities. See above “General
Risks Related to Our Business and Market.” There can be no assurance that restrictive laws, policies or practices directed
towards Israel or Israeli businesses will not have an adverse impact on our business.
10
Reduction in Israeli government spending or changes in priorities for defense products may adversely affect
our earnings. The Israeli government may reduce its expenditures for defense items or change its defense priorities in the
coming years. In addition, the Israeli defense budget may be adversely affected if there is a reduction in U.S. foreign military
assistance. See above "General Risks Related to Our Business and Market." Any of the foregoing circumstances could have an
adverse effect on our operations.
Israel’s economy may become unstable. From time to time Israel’s economy may experience inflation or
deflation, low foreign exchange reserves, fluctuations in world commodity prices, military conflicts and civil unrest. For these
and other reasons, in the past the government of Israel has intervened in the economy employing fiscal and monetary policies,
import duties, foreign currency restrictions, controls of wages, prices and foreign currency exchange rates and regulations
regarding the lending limits of Israeli banks to companies considered to be in an affiliated group. The Israeli government has
periodically changed its policies in these areas. Reoccurrence of previous destabilizing factors could make it more difficult for
us to operate our business as we have in the past and could adversely affect our business.
Israeli government programs and tax benefits may be terminated or reduced in the future. We participate in
programs of the Israel Innovation Authority and the Israel Investment Center, for which we receive tax and other benefits as
well as funding for the development of technologies and products. (See Item 4. Information on the Company – Conditions in
Israel – Israel Innovation Authority and Investment Center Funding.) If we fail to comply with the conditions applicable to
these programs, we may be required to pay additional taxes and penalties or make refunds and may be denied future benefits.
From time to time, the government of Israel has discussed reducing or eliminating the benefits available under these programs,
and therefore these benefits may not be available in the future at their current levels or at all.
Israeli law regulates acquisition of a controlling interest in Israeli defense industries. Israeli legislation
regarding the domestic defense industry requires Israeli government approval of an acquisition of a 25% or more equity interest
(or a smaller percentage that constitutes a “controlling interest”) in companies such as Elbit Systems. Such approval may be
subject to additional conditions relating to transfers of ownership. This could limit the ability of a potential purchaser to acquire
a significant interest in our shares. (See Item 4. Information on the Company – Governmental Regulation – Approval of Israeli
Defense Acquisitions.)
Israel has stringent export control regulations. Israeli law regulates the export of defense products and systems
and “dual use” items (items that are typically sold in the commercial market but that may also be used in the defense market). If
government approvals required under these laws and regulations are not obtained, or if authorizations previously granted are
not renewed or canceled, our ability to export our products from Israel could be negatively impacted, thus causing a reduction
in our revenues and a potential material negative impact on our financial results. (See Item 4. Information on the Company –
Governmental Regulation – Israeli Export Regulations.)
We may rely on certain Israel “home country” corporate governance practices which may not afford
stockholders the same protection afforded to shareholders of U.S. companies. As a foreign private issuer for purposes of U.S.
securities laws, Nasdaq rules allow us to follow certain Israeli “home country” corporate governance practices in lieu of the
corresponding Nasdaq corporate governance rules. In the event we elect to adopt such home country practices, shareholders
may not have the same level of rights or protections in certain matters as those of shareholders of U.S. domestic companies.
(See above "General Risks Related to Our Business and Market".)
Many of our employees and some of our officers are obligated to perform military reserve duty in Israel.
Generally, Israeli adult male and certain female citizens and permanent residents are obligated to perform annual military
reserve duty up to a specified age. They also may be called to active duty at any time under emergency circumstances, which
could have a disruptive impact on our workforce.
It may be difficult to enforce a non-Israeli judgment against us, our officers and directors. We are incorporated
in Israel. Our executive officers and directors and our outside auditors are not residents of the United States, and a substantial
portion of our assets and the assets of these persons are located outside the United States. Therefore, it may be difficult for an
investor, or any other person or entity, to enforce against us or any of those persons in an Israeli court a U.S. court judgment
based on the civil liability provisions of the U.S. federal securities laws. It may also be difficult to effect service of process on
these persons in the United States. Additionally, it may be difficult for an investor, or any other person or entity, to enforce civil
liabilities under U.S. federal securities laws in original actions filed in Israel. (See below – Item 4. Information on the Company
– Conditions in Israel – Enforcement of Judgments.)
11
Item 4.
Information on the Company.
Business Overview
Major Activities
We are an international high technology company engaged in a wide range of programs throughout
the world. We develop and supply a broad portfolio of airborne, land and naval systems and products for defense,
homeland security and commercial applications. Our systems and products are installed on new platforms, and
we also perform comprehensive platform modernization programs. In addition, we provide a range of support
services.
Our major activities include:
• military aircraft and helicopter systems;
• helmet mounted systems;
•
commercial aviation systems and aerostructures;
• unmanned aircraft systems and unmanned surface vessels;
•
•
•
•
•
electro-optic and countermeasures systems;
land vehicle systems;
command, control, communications, computer and intelligence (C4I) systems;
electronic warfare and signal intelligence systems;
cyber and intelligence systems; and
• various commercial activities.
Many of these major activities have a number of common and related elements. Therefore, certain of
our subsidiaries, divisions or other operating units often jointly conduct marketing, research and development,
manufacturing, performance of programs, sales and after sales support among these major activities.
Principal Market Environment
We operate primarily in the defense and homeland security arenas. There have been recent increased
budgetary allocations in these areas in the U.S. and certain European countries, as well as reduced budgetary
allocations in certain Latin American and other countries. The nature of military and homeland security actions in
recent years, including low intensity conflicts and ongoing terrorist activities, as well as budgetary pressures to
focus on leaner but more technically advanced forces, have caused a shift in the defense and homeland security
priorities for many of our major customers. As a result we believe there is a continued demand in the areas of C4I
systems, intelligence, surveillance and reconnaissance (ISR) systems, network centric information systems,
intelligence gathering systems, border and perimeter security systems, unmanned aircraft systems (UAS),
unmanned surface vessels (USVs), remote controlled systems, cyber-defense systems, space and satellite based
defense capabilities and homeland security solutions. There is also a continuing demand for cost effective logistic
support and training and simulation services. We believe our synergistic “one-company” approach of finding
solutions that combine elements of our various activities positions us to meet evolving customer requirements in
many of these areas.
We tailor and adapt our technologies, integration skills, market knowledge and operationally-proven
systems to each customer’s individual requirements in both existing and new platforms. By upgrading existing
platforms with advanced technologies, we provide customers with cost-effective solutions, and our customers are
able to improve their technological and operational capabilities within limited budgets. We are experienced in
providing “systems of systems”, which enables us to provide overall solutions in a range of areas to meet our
customers’ comprehensive defense, homeland security and safety needs.
12
Company History
Our predecessor Elbit Ltd. was incorporated in Israel in 1966 as Elbit Computers Ltd. Elbit Systems
was formed in 1996, as part of the Elbit Ltd. corporate demerger, under which Elbit Ltd.’s defense related assets
and business were spun-off to us.
Elbit Systems Ltd. is a corporation domiciled and incorporated in Israel where we operate in
accordance with the provisions of the Israeli Companies Law – 1999 (the Companies Law).
Trading Symbols and Address
Our shares are traded on the Nasdaq Global Select Market (Nasdaq), under the symbol “ESLT”, and
on the Tel-Aviv Stock Exchange (TASE).
Our main offices are in the Advanced Technology Center, Haifa 3100401, Israel, and our main
telephone number at that address is (972-77-2945315) . Our website home page is www.elbitsystems.com. We
make our website content available for informational purposes only. It should not be relied upon for investment
purposes, nor is it incorporated by reference in this annual report on Form 20-F.
Our principal offices in the United States are the headquarters of Elbit Systems of America, LLC at
4700 Marine Creek Parkway, Fort Worth, Texas 76179-6969, and the main telephone number at that address is
817-234-6799.
Revenues
In recent years we have achieved the highest level of defense-related revenues of any Israeli-based
company. The table below shows our consolidated revenues by major areas of operations for the years ended
December 31, 2014, 2015 and 2016:
2014
2015
(U.S. dollars in millions)
2016
Airborne systems
C4ISR systems
Land systems
Electro-optic systems
Other (mainly non-defense engineering and production services)
Total
$
$
1,198 $
1,118
275
265
102
2,958 $
1,226 $
995
559
232
96
3,108 $
1,242
1,221
408
276
113
3,260
The following table provides our consolidated revenues by geographic region, expressed as a
percentage of total revenues for the years ended December 31, 2014, 2015 and 2016:
Israel
North America
Europe
Asia-Pacific
Latin America
Others
2014
22%
28%
2016
2015
(U.S. dollars in millions)
20%
27%
22%
25%
16%
18%
15%
2%
16%
26%
10%
1%
20%
25%
6%
2%
13
Subsidiary Organizational Structure
Our beneficial ownership interest in our major subsidiaries and investees is set forth in Exhibit 8 to
this annual report. Our equity and voting interests in these entities are the same as our beneficial ownership
interests.
Below is a general description of our major subsidiaries, each of which is wholly-owned. We also have
other smaller subsidiaries and investee companies in Israel, Europe, North America, South America and Asia-Pacific
that conduct marketing, engineering manufacturing, logistic support and other activities, principally in the subsidiary’s
local market.
Elbit Systems of America
Elbit Systems of America, LLC (Elbit Systems of America), a Delaware limited liability company,
and its subsidiaries provide products and systems solutions focusing on U.S. military, homeland security, medical
instrumentation and commercial aviation customers. Elbit Systems of America and its subsidiaries have
operational facilities in Fort Worth, Texas, San Antonio, Texas, Merrimack, New Hampshire, Talladega, Alabama
and Boca Raton, Florida. Elbit Systems of America also has a 50% interest in a joint venture with Rockwell
Collins Inc., which is engaged in the area of helmet mounted display systems for fixed-wing military and para-
military aircraft.
Elbit Systems of America acts as a contractor for U.S. Foreign Military Financing (FMF) and
Foreign Military Sales (FMS) programs. (See below “Governmental Regulations – Foreign Military Financing.”)
Each of Elbit Systems of America’s major operational facilities has engineering and manufacturing capabilities.
Elbit Systems of America’s facilities in Alabama and Texas have significant maintenance and repair capabilities.
(See below “Manufacturing” and “Customer Satisfaction and Quality Assurance.”)
Elbit Systems of America, Elbit Systems and intermediate Delaware holding company subsidiaries
are parties to a Special Security Agreement (SSA) with the DoD. The SSA provides the framework for controls
and procedures to protect classified information, controlled unclassified information and export controlled data.
The SSA allows the Elbit Systems of America companies to participate in classified U.S. government programs
even though, due to their ownership by Elbit Systems, the Elbit Systems of America companies are considered to
be under the control of a non-U.S. interest. Under the SSA, a Government Security Committee of Elbit Systems of
America’s board of directors was permanently established to supervise and monitor compliance with Elbit
Systems of America’s export control and national security requirements. The SSA also requires Elbit Systems of
America’s board of directors to include outside directors who have no other affiliation with the Company. Elbit
Systems of America’s board of directors also includes an officer of Elbit Systems of America and up to two inside
directors, who have other affiliations with the Company. The SSA requires outside directors and officers of the
Elbit Systems of America companies who are directors, and certain other senior officers, to be U.S. resident
citizens and eligible for DoD personal security clearances.
Elop. Based in Rehovot, Israel, Elbit Systems Electro-Optics Elop Ltd. (Elop) designs, engineers,
manufactures and supports a wide range of electro-optic systems and products mainly for defense, space and
homeland security applications for customers worldwide.
ESLC. Headquartered in Netanya, Israel, Elbit Systems Land and C4I Ltd. (ESLC) is engaged in the
worldwide market for land-based systems and products for military vehicles, artillery and mortar systems, C4I
systems and communications systems and equipment.
Elisra. Based in Holon, Israel, Elbit Systems EW and SIGINT – Elisra Ltd. (Elisra) provides a wide
range of electronic warfare (EW) systems, signal intelligence (SIGINT) systems and C4ISR technological
solutions for the worldwide market.
CYBERBIT. Based in Raanana, Israel, CYBERBIT Ltd. (CYBERBIT) provides a range of solutions
in the areas of intelligence monitoring and lawful interception, investigation and knowledge management, open
source intelligence (OSINT), tactical SIGINT interception, cyber security and cyber training and simulation for
defense, homeland security and commercial customers, including financial enterprises, national critical
infrastructures, heavy industries, national cyber security organizations, military organizations, law enforcement
organizations and intelligence agencies.
14
Merger, Acquisitions and Divestitures
Part of our growth strategy includes our continued activity in mergers and acquisitions and joint
ventures with respect to businesses, assets and complementary technologies both in Israel and internationally. The
Company’s structure enables us to benefit from the synergy of our overall capabilities while at the same time
focus on local requirements.
During 2016 and the beginning of 2017, we continued to invest resources in these activities. In
addition, during this time period we continued the process of divesting non-core assets in Israel and certain other
countries. See Item 18. Financial Statements - Notes 1(D) and 6(B). We continue to actively pursue acquisition
and investment opportunities that meet our strategic goals and acquisition criteria in key markets.
During 2016, we participated as a potential purchaser in the tender process administered by the
Israeli government for the sale of most of the assets of IMI Systems (formerly Israel Military Industries Ltd.) As
of the date of this annual report, we are the sole remaining bidder in the tender. However, the tender process is
currently being reviewed by the Israeli government, and there is no assurance that we will ultimately be able to
complete the acquisition contemplated by the tender.
Current Business Operations
We generally operate and manage the major activities described below in an interrelated manner and
on a project-oriented basis. This means that contracts are frequently performed by more than one operating
subsidiary or division within the Company, on the basis of the multiple skills and available resources that may be
needed or appropriate for the contract. Thus, the involvement of a particular operating subsidiary or division in the
performance of a contract is not a function of management’s review of such subsidiary's or division's operating
results for purposes of allocation of resources within the Company.
Military Aircraft and Helicopter Systems
We supply advanced airborne systems and products to leading military aircraft manufacturers and
end users designed to enhance operational capabilities and extend aircraft life cycles. Our airborne systems
provide a range of solutions from a single sensor to an entire cockpit avionics suite. We integrate our systems on
fixed and rotary-wing, eastern and western, new and mature aircraft. Under our aircraft and helicopter upgrade
programs, we integrate advanced electronic, communication, navigation, electro-optic and EW systems. We
support life cycle extension of our customers’ fleets and supply logistic support services for airborne platforms,
including repair and maintenance centers, spare parts, training and operation of flight schools.
Our military fixed-wing aircraft and helicopter systems and products include a broad range of
avionic systems, such as integrated flight deck systems, mission management computers, displays, digital maps
and digital recorders. Our portfolio also includes airborne electro-optic systems such as head-up displays,
airborne intelligence gathering systems, precision guidance systems, aircraft structural components and a range of
aircraft tactical, virtual, appended and embedded trainers and simulators.
The customers and end users for our military fixed-wing aircraft and helicopter programs include a
wide range of air forces and other governmental defense and homeland security forces worldwide, as well as
major fixed-wing aircraft and helicopter manufacturers.
15
Helmet Mounted Systems
We design and supply advanced helmet mounted systems (HMS), including helmet mounted
displays for fixed-wing aircraft and rotary aircraft pilots. These systems and displays include tracking and display
systems for day and night flying. Our systems measure the pilot’s line-of-sight, slave applicable systems to the
target, identify target location and bring displays to the pilot’s eye level. We supply our HMS as part of our
upgrade programs and on a stand-alone basis. Through our 50% joint venture with Rockwell Collins (see above
“Subsidiary Organizational Structure – Elbit Systems of America”), we are a leader in HMS for fighter aircraft.
We are engaged in a range of programs for HMS for fixed-wing aircraft and helicopters. Customers
and end users for our HMS include numerous air forces and other governmental defense and homeland security
forces worldwide, as well as aircraft and helicopter manufacturers.
Commercial Aviation Systems and Aerostructures
We provide a range of systems and products for the commercial and business aviation market. These
systems and products include vision-based cockpit systems, other avionics systems, electrical systems and
aerostructure products. Our commercial avionics systems are employed on fixed-wing aircraft and commercial
helicopters. Our aerostructure products are installed on commercial aircraft.
Our portfolio of systems in the commercial aviation area includes vision-based cockpit systems, full
avionic suites for commercial helicopters, air data test equipment and air data processor/sensor systems and flight
instrumentation for the general avionics market, and aerostructure products such as pressurized and non-
pressurized doors, composite beans and winglets. Customers for our commercial and business aviation systems
and products and aerostructures products include major aircraft manufacturers and aircraft operators around the
world.
UAS (Unmanned Aircraft Systems) and USVs (Unmanned Surface Vessels)
We design and supply integrated UAS for a range of applications and UAS training systems with
capabilities to simulate payload performance, malfunctions and ground control station operation. We design and
supply command and control ground station elements, engines, data links, stabilized electro-optic payloads and
electronic intelligence (ELINT) and communications intelligence (COMINT) payloads that can be adapted for
various types of UAS. Our UAS technology has also been applied to our USV activities, where we are developing
USVs for a range of naval applications. We perform development, supply, lease and support services and training
activities relating to UAS and USVs. Customers for our UAS and USVs include armed forces and other
governmental and non-governmental organizations around the world.
Electro-Optic and Countermeasures Systems
We design and manufacture electro-optic-based solutions for space, air, land and sea applications.
Our electro-optic products include laser and thermal imaging systems, head-up displays, countermeasure systems
and ISR systems, including payloads for space, airborne, naval and land-based missions. Our products in this area
also include ground integrated sights and homeland security solutions. We are one of the few companies in the
world that has engineering capability and facilities in-house in all major areas of electro-optics. Also, in the space
area, we maintain in-house Israel’s national space electro-optics infrastructure.
Our portfolio of electro-optic systems and products includes forward looking infrared (FLIR)
systems for night observation, laser range-finders and laser radars, stabilized payloads, electro-optic-based ISR
systems and directional IR countermeasure (DIRCM) systems. We also supply panchromatic and multi-spectral
cameras and telescopes for space applications. In the homeland security area our electro-optic products and
systems include surveillance systems, "safe city" projects, facility perimeter security products, electronic fences,
fiber optic intrusion detection systems and transportation protection systems. Our customers include armed forces
of numerous governments, major defense contractors, homeland security agencies, critical infrastructure
authorities and owners of VIP aircraft.
16
Land Vehicle Systems
We upgrade and modernize tanks, other combat vehicles and artillery platforms, both as a prime
contractor and as a systems supplier to leading platform manufacturers. Our land vehicle and platform solutions
cover the entire combat vehicle spectrum, from complete modernization, to system supply to maintenance depots
and life cycle support services. Our systems are operational on a full range of tracked and wheeled combat
vehicles including main battle tanks, medium and light tanks, light armored vehicles, armored personnel carriers,
wheeled vehicles and artillery platforms. We offer a range of artillery and mortar solutions. We also develop and
supply unmanned ground vehicles and robotic devices for a variety of land based missions. In addition, we supply
training systems for tanks and fighting vehicles.
Our portfolio of systems and products for land vehicles includes fire control systems, electric gun
and turret drive systems, laser warning and threat detection systems, manned and unmanned turrets, remote
controlled weapon stations (for land and naval platforms), unmanned ground vehicles, combat vehicle C4I
systems, targeting systems, artillery gun and mortar systems, mortar ammunition, driver thermal vision systems,
life support systems, auxiliary power units and hydraulic systems. We are engaged in land vehicle systems
programs, from comprehensive vehicle modernization programs, to stand-alone system supply to vehicle
manufacturers to life cycle support programs. Customers for our land vehicle systems include armed forces and
homeland security agencies, as well as major military vehicle manufacturers around the world.
C4I Systems
We provide network-centric compatible solutions for land-based C4I systems ranging from target
acquisition, to battle management to communication systems. We supply our advanced land-based C4I systems as
part of turn-key solutions as well as on a stand-alone basis. Our solutions cater to all types of land combatant and
homeland security forces and first responders, and can be integrated into military and other types of vehicles.
Providing comprehensive net-centric solutions for low intensity conflicts and counter-terror activities, our systems
connect intelligence data to combat and homeland security forces via C4I networks and mobile command and
control posts and support “terrain dominance”. Our integrated infantry systems provide infantry units with C4ISR,
field intelligence, urban warfare and peacekeeping capabilities. We also have access to a full range of radio and
military communications solutions.
Our portfolio of systems and products in the land C4I area includes Digital Army "system of
systems" for net-centric operational effectiveness and connectivity throughout all land forces echelons. Our
portfolio also includes battle management systems, artillery C4I systems, observation and ground reconnaissance
systems, enhanced tactical computers and ruggedized personal data assistants, software design kits for mapping
capabilities, ground smart display units, military IT systems and tactical battle company training systems. Our
ground communications portfolio includes HF, VHF and UHF radio and communication systems and products,
software defined radios, integrated radio communication systems, satellite-on-the-move solutions and tactical
radio power amplifiers. Our radio and communications portfolio enables deployment of a full military network for
the complete range of scenarios and terrain. In the homeland security area, we supply integrated and coastal
border C4I surveillance systems, broadband communication systems, cyber protection systems, border control
systems, "safe city" systems and homeland security and emergency response training and simulation systems. We
perform programs under which we provide a range of C4I battle management systems, soldier mounted systems
and radio and communications systems with land-based applications. Our customers include ground forces and
governmental agencies worldwide.
EW and SIGINT Systems
We supply multi-spectral EW self-protection suites and systems for airborne, ground and naval
platforms, including advanced electronic countermeasure (ECM) systems for radar, missiles and communication
and electronic support measure (ESM) solutions, including missile warning systems, laser warning systems and
radar warning receivers. We also furnish SIGINT systems, including ELINT, COMINT and direction finding
systems, designed for air, ground and naval platforms and applications.
17
Our portfolio in the EW and SIGINT areas includes protection, intelligence and communications
solutions for air, ground and naval applications. We offer EW self-protection suites, including radio frequency,
radar warning receivers and laser warning systems, for all airborne platform types. We also offer IR-based missile
warning systems for advanced combat aircraft as well as for other fixed-wing and rotor platforms. In addition, we
provide ESM for threat identification. We also provide SIGINT systems for tactical and strategic intelligence
gathering including ELINT and ECM for naval, ground and airborne applications, COMINT and communication
jamming systems, counter improvised explosive devices jamming systems for ground forces and cyber protection
capabilities. We also supply radar solutions, data links and video dissemination systems and search and rescue
systems for pilots and rescue teams. In addition, we develop command and control systems and simulators for
anti-ballistic missiles. Customers for our EW, SIGINT and COMINT systems include governmental armed forces
and homeland security agencies as well as major defense contractors.
Cyber and Intelligence Systems
Our governmental and commercial cyber security systems and intelligence systems activities are led
by CYBERBIT. Our cyber-security solutions enable enterprises to rapidly detect advanced cyber threats, protect
critical infrastructures, automate security operations center workflows and train cyber security staff. Our solutions
utilize machine learning, Big Data and continuous technology advancements. Customers include a range of
commercial, financial and industrial enterprises.
Our intelligence solutions for law enforcement and national security agencies address the entire
intelligence cycle including collection, processing, analysis and visualization, providing law enforcement
agencies, intelligence organizations and SIGINT agencies with a full spectrum of intelligence capabilities.
Various Commercial Activities
We engage in an increasing range of technologies for commercial applications and activities. Our
current commercial activities, in addition to the activities described under “Commercial Aviation Systems and
Aerostructures”, "Cyber and Intelligence Systems" and elsewhere above, include, among others, medical
diagnostic equipment, automotive night vision enhancement equipment, smart glasses for sports applications and
super capacitor energy sources and fuel cells for transportation applications.
Property, Plant and Equipment
Facilities Owned or Leased by the Company
Israel(1)
U.S.(2)
Other Countries(3)
Owned
Leased
2,161,000 square feet
633,854 square feet
2,281,000 square feet
671,200 square feet
891,000 square feet
453,000 square feet
(1)
(2)
(3)
Includes offices, development and engineering facilities, manufacturing facilities, maintenance
facilities, hangar facilities and landing strips in various locations in Israel.
Includes mainly offices, development and engineering facilities, manufacturing facilities and
maintenance facilities of Elbit Systems of America, primarily in Texas, New Hampshire, Florida,
Alabama and Virginia. The facilities in Texas, New Hampshire and Alabama are located on owned
land totaling approximately 129 acres. 318,570 square feet of the leased facilities are sublet to a third
party. In addition, there is a 942,344 square foot ground lease, of which 629,910 square feet are
sublet to a third party.
Includes offices, design and engineering facilities and manufacturing facilities in Europe, Latin
America and Asia-Pacific.
Recent Investment in Facilities. Over the last two years the average annual net investment in our
facilities, including land and buildings, equipment, machinery and vehicles, amounted to approximately $112
million. We believe that our current facilities are adequate for our operations as now conducted.
18
Governmental Regulation
Government Contracting Regulations. We operate under laws, regulations, administrative rules and
other legal requirements governing defense and other government contracts, mainly in Israel and the United
States. Some of these legal requirements carry major penalty provisions for non-compliance, including
disqualification from participating in future contracts. In addition, our participation in governmental procurement
processes in Israel, the United States and other countries is subject to specific regulations governing the conduct
of the process of procuring defense and homeland security contracts.
Israeli Export Regulations. Israel’s defense export policy regulates the sale of a number of our
systems and products. Current Israeli policy encourages exports to approved customers of defense systems and
products such as ours, as long as the export is consistent with Israeli government policy. Subject to certain
exemptions, a license is required to initiate marketing activities. We also must receive a specific export license for
defense related hardware, software and technology exported from Israel. Israeli law also regulates export of “dual
use” items (items that are typically sold in the commercial market but that also may be used in the defense
market). In 2016 more than 50% of our revenue was derived from exports subject to Israeli export regulations.
U.S. and Other Export Regulations. Elbit Systems of America’s export of defense and dual use
products, as well as military technical data and technical services to Israel and other countries is subject to
applicable approvals of the U.S. government under the U.S. International Traffic in Arms Regulations (ITAR) and
the U.S. Export Administration Regulations (EAR). Such approvals are typically in the form of an export license,
and for defense technology or services in the form of a technical assistance agreement (TAA). Other U.S.
companies wishing to export defense products or military related services and technology to our Israeli and other
non-U.S. entities are also required to obtain such export licenses and TAAs. Such approvals apply to U.S. origin
data required by our non-U.S. entities to perform work for U.S. programs. Licenses are also required for Israeli
nationals assigned to work in defense-related technical areas at our U.S. affiliated companies. An application for
an export license or a TAA requires disclosure of the intended sales of the product and the use of the technology.
Pursuant to export control reform initiatives in the U.S., a greater part of Elbit Systems of America’s and our U.S.
suppliers' activities are becoming subject to control under the EAR. The U.S. government may deny an export
authorization if it determines that a transaction is counter to U.S. policy or national security. Other governments’
export regulations also affect our business from time to time, particularly with respect to end user restrictions of
our suppliers’ governments.
Approval of Israeli Defense Acquisitions
The Israeli Defense Entities Law (Protection of Defense Interests) establishes conditions for the
approval of an acquisition or transfer of control of an entity that is determined to be an Israeli “defense entity”
under the terms of the law. Designation as a “defense entity” is to occur through an order to be issued jointly by
the Israeli Prime Minister, Defense Minister and Economy Minister. Although no such orders have been issued as
of the date of this annual report on Form 20-F, it is assumed that Elbit Systems and most of our Israeli subsidiaries
will be designated as “defense entities” under the law and that the Israeli Government will issue such an order
regarding our applicable Israeli companies. Under separate regulations, Elbit Systems and our major Israeli
subsidiaries have been designated as “defense entities” by the Defense Minister with respect to Israeli law
governing various aspects of defense security arrangements.
Orders to be issued under the Israeli Defense Entities Law will also establish other conditions and
restrictions. It is anticipated that in the case of a publicly traded company such as Elbit Systems, Israeli
government approval will be required for acquisition of 25% or more of the voting securities or a smaller
percentage of shares that grant “means of control.” Means of control for purposes of the law include the right to
control the vote at a shareholders’ meeting or to appoint a director. Orders relating to defense entities are also
anticipated to, among other matters: (1) impose restrictions on the ability of non-Israeli resident citizens to hold
“means of control” or to be able to “substantially influence” defense entities; (2) require that senior officers of
defense entities have appropriate Israeli security clearances; (3) require that a defense entity’s headquarters be in
Israel; and (4) subject a defense entity’s entering into international joint ventures and transferring certain
technology to the approval of the IMOD.
19
Approval of U.S. and Other Defense Acquisitions. Many countries in addition to Israel also require
governmental approval of acquisitions of local defense companies or assets by foreign entities. Mergers and
acquisitions of defense related businesses in the U.S. are subject to the Foreign Investment and National Security
Act (FINSA). Under FINSA, our acquisitions of defense related businesses in the U.S. require review, and in
some cases approval, by the Committee on Foreign Investment in the United States.
“Buy American” Laws. The U.S. “Buy American” laws impose price differentials or prohibitions on
procurement of products purchased under U.S. government programs. The price differentials or prohibitions apply
to products that are not made in the United States or that do not contain U.S. components making up at least 50%
of the total cost of all components in the product. However, a Memorandum of Agreement between the United
States and Israeli governments waives the Buy American laws for specified products, including most of the
products currently sold in the United States by Elbit Systems and our Israeli subsidiaries.
Foreign Military Financing (FMF). Elbit Systems of America participates in United States FMF
programs. These programs require countries, including Israel, receiving military aid from the United States to use
the funds to purchase products containing mainly U.S. origin components. In most cases, subcontracting under
FMF contracts to non-U.S. entities is not permitted. As a consequence, Elbit Systems of America generally either
performs FMF contracts itself or subcontracts with U.S. suppliers. The U.S. government may authorize the IMOD
to utilize a portion of the FMF budget under the United States Subcontracting Procurement (USSP) channel. In
such cases, companies such as Elbit Systems or our Israeli subsidiaries, who are acting as the Israeli prime
contractor to the IMOD under the NIS funded portion of an IMOD program, are authorized to negotiate and enter
into a subcontract directly with a U.S. supplier. However, payment of the funds under a USSP channel subcontract
is administered by the IMOD Purchasing Mission to the U.S. Elbit Systems of America also participates in U.S.
Foreign Military Sales (FMS) programs.
Procurement Regulations. Solicitations for procurements by governmental purchasing agencies in
Israel, the United States and other countries are governed by laws, regulations and procedures relating to
procurement integrity, including avoiding conflicts of interest, corruption, human trafficking and conflict minerals
in the procurement process. Such regulations also include provisions relating to information assurance and for the
avoidance of counterfeit parts in the supply chain.
Anti-Bribery Regulations. We conduct operations in a number of markets that are considered high
risk from an anti-bribery compliance perspective. Laws and regulations such as the Israel Penal Code, the
Organization for Economic Cooperation and Development (OECD) Convention on Combating Bribery of Foreign
Public Officials in International Business Transactions, the U.S. Foreign Corrupt Practices Act, the U.K. Bribery
Act and corresponding legislation in other countries, prohibit providing personal benefits or bribes to government
officials in connection with the governmental procurement process. Israeli defense exporters, such as Elbit
Systems, are required to maintain an anti-bribery compliance program, including specific procedures, record
keeping and training.
Audit Regulations. The IMOD audits our books and records relating to its contracts with us. Our
books and records and other aspects of projects related to U.S. defense contracts are subject to audit by U.S.
government audit agencies. Such audits review compliance with government contracting cost accounting and
other applicable standards. If discrepancies are found this could result in a downward adjustment of the applicable
contract’s price. Some other customers have similar rights under specific contract provisions.
Antitrust Laws. Antitrust laws and regulations in Israel, the United States and other countries often
require governmental approvals for transactions that are considered to limit competition. Such transactions may
include the formation of joint venture entities, cooperative agreements for specific programs or areas, as well as
mergers and acquisitions.
Civil Aviation Regulations. Several of the products sold by Company entities for commercial
aviation applications are subject to flight safety and airworthiness standards of the U.S. Federal Aviation
Administration (FAA) and similar civil aviation authorities in Israel, Europe and other countries.
Federal Drug Administration Regulations. Medical products designed and manufactured by Elbit
Systems of America’s Medical Instruments – KMC Systems business unit are subject to U.S. Federal Drug
Administration (FDA) regulations.
20
Environmental, Health and Safety Regulations. We are subject to a variety of environmental,
health and safety laws and regulations in the jurisdictions in which we have operations. This includes regulations
relating to air, water and ground contamination, hazardous waste disposal and other areas with a potential
environmental or safety impact.
Buy-Back
As part of their standard contractual requirements for defense programs, several of our customers
include “buy-back” or “offset” provisions. These provisions are typically obligations to make, or to facilitate third
parties to make, various specified transactions in the customer’s country, such as procurement of defense and
commercial products, investment in the local economy and transfer of know-how. (For further information about
buy-back obligations, see Item 5. Operating and Financial Review and Prospects – Off-Balance Sheet
Transactions.)
Financing Terms
Types of Financing. There are several types of financing terms applicable to our defense contracts.
In some cases, we receive progress payments related to our progress in performing the contract. Sometimes we
receive advances from the customer at the beginning, or during the course, of the project, and sometimes we also
receive milestone payments for achievement of specific milestones. In some programs we extend credit to the
customer, sometimes based on receipt of guarantees or other security. In other situations work is performed before
receipt of the payment, which means that we finance all or part of the project’s costs for various periods of time.
Financing arrangements may extend beyond the term of the contract’s performance. When we believe it is
necessary, we seek to protect all or part of our financial exposure by letters of credit, insurance or other measures,
although in some cases such measures may not be available.
Advance Payment Guarantees. In some cases where we receive advances prior to incurring contract
costs or making deliveries, the customer may require guarantees against advances paid. These guarantees are
issued either by financial institutions or by us. We have received substantial advances from customers under some
of our contracts. In certain circumstances, such as if a contract is canceled for default and there has been an
advance or progress payment, we may be required to return payments to the customer as provided in the specific
guarantee. As part of the guarantees we provide to receive progress payments or advance payments, some of our
customers require us to transfer to them title in inventory acquired with such payments. (See Item 5. Operating
and Financial Review and Prospects – General – Long-Term Arrangements and Commitments – Bank and Other
Financial Institution Guarantees.)
Performance Guarantees. A number of projects require us to provide performance guarantees in an
amount equal to a percentage of the contract price. In certain cases we also provide guarantees related to the
performance of buy-back obligations. Some of our contracts contain clauses that impose penalties or reduce the
amount payable to us if there is a delay or failure in performing in accordance with the contract or the completion
of a phase of work, including in some cases during the warranty period. These types of guarantees may remain in
effect for a period of time after completion of deliveries under the contract. Such guarantees are customary in
defense transactions, and we provide them in the normal course of our business. (See Item 5. Operating and
Financial Review and Prospects – General – Long-Term Arrangements and Commitments – Bank and Other
Financial Institution Guarantees.)
Private Finance Initiatives (PFI). Some of our projects operate under PFI financing arrangements
where we provide long-term financing arrangements or facilities, with the repayment generally made based on the
project’s cash flow. PFI projects can be structured in several ways. PFI projects may require us to pledge project-
related equity and enter into relatively complex financial and other agreements. Such financing is usually medium
or long-term and may be raised either through banks or institutional lenders and carries various financial risks and
exposures. In addition, PFI projects may require us to draw upon our equity base and borrowing capacities and
may significantly affect our liquidity and increase our financial leverage. In recent years we were involved in
several PFI-type projects in Israel, and we expect to participate in future PFI contracts both in Israel and other
countries.
21
Intellectual Property
Patents, Trademarks and Trade Secrets. We own hundreds of living patent families including
patents and applications registered or filed in Israel, the United States, the European Patent Office and other
countries. We also hold dozens of living trademark families relating to specific products. A significant part of our
intellectual property assets relates to unique applications of advanced software-based technologies, development
processes and production technologies. Some of these applications are protected by patents and others are
considered as our trade secrets and proprietary information. We take a number of measures to safeguard our
intellectual property against infringement as well as to avoid infringement of other parties’ intellectual property.
(For risks related to our intellectual property see Item 3. Key Information – Risk Factors – General Risks Related
to Our Business and Market.)
Governmental Customers’ Rights in Data. The IMOD usually retains specific rights to technologies
and inventions resulting from our performance under contracts for end use by the IMOD or the IDF. This
generally includes the right to disclose the information to third parties, including other defense contractors that
may be our competitors. Consistent with common practice in the defense industry, approximately 25% of our
revenues in 2016 was dependent on products incorporating technology that a government customer may disclose
to third parties. When the IMOD funds research and development, it usually acquires rights to data and
inventions. We often may retain a non-exclusive license for such inventions. The Israeli government usually is
entitled to receive royalties on export sales in relation to sales resulting from government financed development.
However, if only the product is purchased without development effort, we normally retain the principal rights to
the technology. Sales of our products to the U.S. government and some other customers are subject to similar
conditions. Subject to applicable law, regulations and contract requirements, we attempt to maintain our
intellectual property rights and provide customers with the right to use the technology only for the specific project
under contract.
Licensing. There are relatively few cases where we manufacture under license. Such licenses
typically apply to the use of technologies that are the result of collaboration with academic institutions or where
we are manufacturing another company’s product in accordance with that company’s specifications. In such cases,
the licensor typically is entitled to royalties or other types of compensation. In some cases where we have
acquired business lines we obtain a royalty free license to use the applicable technology for specified applications.
Occasionally, we license parts of our intellectual property to customers as part of the requirements of a particular
contract. We also sometimes license technology to other companies for specific purposes or markets, such as the
right to use certain of our intellectual property relating to our training and simulation systems.
Research and Development
We invest in research and development (R&D) according to a long-term plan based on estimated
market needs. Our R&D efforts focus on anticipating operational needs of our customers, achieving reduced time
to market and increasing affordability. We emphasize improving existing systems and products and developing
new ones using emerging or existing technologies.
Our R&D projects relate to defense, homeland security and commercial applications. We perform
R&D projects to produce new systems for the IMOD and other customers. These projects give us the opportunity
to develop and test emerging technologies. We develop tools for fast prototyping for both the design and
development process. Fast prototyping permits the operational team members to effectively specify requirements
and to automatically transfer them into software code. We also are engaged in long-term investments in science
and technology infrastructure and building blocks, often in collaboration with academic bodies. We employ
thousands of software, hardware and systems engineers. In addition, most of our program and business line
managers have engineering backgrounds. More than 50% of our total workforce is engaged in research,
development and engineering.
Our companies in Israel have collectively been awarded the Israel Defense Prize eleven times,
recognizing extraordinary contributions to defense technological innovations.
22
Our customers, the Israel Innovation Authority in the Ministry of Economy and Industry (formerly
Office of Chief Scientist) and other R&D granting authorities sometimes participate in our R&D funding. We also
invest in our research and development activities. This investment is in accordance with our strategy and plan of
operations. The table below shows amounts we invested in R&D activities for the years ended December 31,
2014, 2015 and 2016.
Total Investment
Less Participation*
Net Investment
2014
2015
2016
(U.S. dollars in millions)
267.7 $
(39.7 )
228.0 $
277.8 $
(34.4 )
243.4 $
291.8
(36.0 )
255.8
$
$
* See above – “Government Rights in Data” and see below – “Conditions in Israel – Israel Innovation
Authority and Investment Center Funding.”
Manufacturing
We manufacture and assemble our systems and products at our operational facilities in Israel, the
U.S., Europe, Brazil and Australia and at the facilities of certain of our subsidiaries in other countries. These
facilities contain warehouses, electronic manufacturing areas, mechanical workshops, final assembly and test
stations with test equipment. We also have supporting infrastructure including fully automated surface mount
technology lines and clean rooms for electro-optic components, solid state components integration, environmental
testing and final testing, including space simulation and thermal chambers. We also have computerized logistics
systems for managing manufacturing and material supply. A number of our manufacturing activities are provided
on a shared services basis by several of our in-house centers of excellence.
We also manufacture and assemble composite materials, metal parts and machinery. One of our
Israeli subsidiaries has a high technology semiconductor manufacturing facility where it performs electronic
integration and assembly of thermal imaging detectors and laser diodes. We also manufacture and repair test
equipment.
We manufacture commercial avionics and aircraft components, as well as perform maintenance,
repair and overhaul at our U.S. FAA registered facilities in the U.S., Europe and Israel. We also manufacture
medical equipment at U.S. FDA registered facilities in the U.S.
Environmental Compliance
As part of overall Company policy, we are committed to environmental, health and safety standards
in all aspects of our operations. This includes all regulatory requirements as well as ISO 14001 compliance. We
also conduct a number of measures on an ongoing basis to promote environmentally friendly operational
practices, including measures to reduce electrical, fuel and water consumption. There are no material
environmental issues that affect the Company’s use of our facilities. See also "Social Sustainability" below.
Seasonality
Although revenues may sometimes increase towards the end of a fiscal year, no material portion of
the Company’s business is considered to be seasonal. The timing of revenue recognition is based on several
factors. (See Item 5. Operating and Financial Review and Prospects – General – Critical Accounting Policies and
Estimates – Revenue Recognition.)
23
Purchasing and Raw Materials
We conduct purchasing activities at most of our operational facilities. A number of purchasing and
related support and logistic services are performed on a shared services basis by central service providers in the
Company for various Company units and entities. We generally are not dependent on single sources of supply. We
manage our inventory according to project requirements. In some projects, specific major subcontractors are
designated by the customer. Raw materials used by us are generally available from a range of suppliers
internationally, and the prices of such materials are generally not subject to significant volatility. We monitor the
on-time delivery and the quality of our contractors and encourage them to continuously improve their
performance. We also require our suppliers to adhere to our Supplier Code of Conduct and to comply with a range
of procurement standards, including those relating to the avoidance of counterfeit parts and conflict minerals.
Customer Satisfaction and Quality Assurance
We invest in continuous improvement of processes, with emphasis on prevention of deficiencies, to
ensure customer satisfaction throughout all stages of our operations. This includes development, design,
integration, manufacturing and services for software and hardware, for the range of our systems and products. Our
quality teams are involved in assuring compliance with processes and administrating quality plans. These
activities begin at the pre-contract stage and continue through the customer’s acceptance of the product or
services.
We also use project management methods such as Kaizen and Lean and are enhancing and
expanding such processes on an ongoing basis. Our processes are based on a cutting edge tool case and CAD-
CAM tools. This infrastructure, together with well defined development methodology and management tools,
assists us in providing high quality and on-time implementation of projects. We are in the process of implementing
a "One-ERP" (enterprise resource planning) system, with a goal of consolidating uniform best practices for quality
and operations across the organization.
All Israeli operational sites are certified for one or more of the following: ISO-9001, ISO-90003 for
software, AS9100 (certified for revision C), AS9115 for software, ISO-14001, OHSAS 18001, FAA Part 145 and
European Aviation Safety Agency (EASA) Part 145 for maintaining civil products and Part 21 G for production of
civil products. Representatives of our customers generally test our products before acceptance. A number of our
customers have authorized us to conduct acceptance testing of our products on their behalf.
Quality certifications applicable to defense products of Elbit Systems of America’s operating units
include certifications for CMMI Level 3 of the SEI, ISO-9001, AS9100 (certified for revision C) and compliance
with NATO AQAP requirements. In the area of commercial aviation Elbit Systems of America’s operating units
hold EASA certification as well as a variety of FAA certifications including FAA Part 21 approval and FAA Part
145 approved repair stations. In the medical equipment area, Elbit Systems of America is certified for ISO
13485:2003, is registered with the FDA as a GMP manufacturer and is FDA compliant with Quality Systems
Regulations 21 CFR Parts 820, 803 and 806.
Service and Warranty
We instruct our customers on the proper maintenance of our systems and products. In addition, we
often offer training and provide equipment to assist our customers in performing their own maintenance. When
required, support may be provided by a local support team or by specialists sent from our facilities. We also
provide performance based logistics services.
We generally offer a one or two-year warranty for our systems and products following delivery to, or
installation by, the customer. In some cases we offer longer warranty periods. We accrue for warranty obligations
specifically determined for each project based on our experience and engineering estimates. These accruals are
intended to cover post-delivery functionality and operating issues for which we are responsible under the
applicable contract.
24
Marketing and Sales
We actively take the initiative in identifying the individual needs of our customers throughout the
world. We then focus our research and development activities on systems designed to provide tailored solutions to
those needs. We often provide demonstrations of prototypes and existing systems to potential customers.
We market our systems and products either as a prime contractor or as a subcontractor to various
governments and defense and homeland security contractors worldwide. In Israel, we sell our military systems
and products mainly to the IMOD, which procures all equipment for the IDF. A number of marketing related
support services are provided on a central shared services basis to various units in the Company. Marketing our
systems, products and services in other parts of the world is supported by subsidiaries, joint ventures and
representatives.
In the U.S., generally Elbit Systems of America leads our sales and marketing activities from its
facilities throughout the U.S. Elbit Systems of America operates under a Special Security Agreement that allows it
and its subsidiaries to work on certain classified U.S. government programs. See above “Subsidiary
Organizational Structure – Elbit Systems of America.” Our subsidiaries in other countries typically lead the
marketing activities in their home countries, often assisted by marketing and business development personnel
based in Israel.
Over the past several years, we have entered into cooperation agreements with defense contractors,
platform manufacturers and other companies in Israel, the United States, Europe, Latin America, Asia-Pacific and
certain other key markets. These agreements provide for joint participation in marketing and performance of a
range of projects around the world. In other situations, we actively pursue business opportunities as either a prime
contractor or a subcontractor, usually together with local companies. Often we enter into cooperation agreements
with other companies for such opportunities.
Competition
We operate in a competitive environment for most of our projects, systems and products.
Competition is based on product and program performance, price, reputation, reliability, life cycle costs, overall
value to the customer, responsiveness to customer requirements and the ability to respond to rapid changes in
technology. In addition, our competitive position sometimes is affected by specific requirements in particular
markets.
Continuing consolidation in the defense industry has affected competition. In addition, many major
prime contractors are increasing their in-house capabilities. These factors have decreased the number but
increased the relative size and resources of our competitors. We adapt to market conditions by adjusting our
business strategy to changing market conditions.
Competitors in the sale of some of our products to the government of Israel include IAI and Rafael
among others. From time to time we also cooperate with some of our competitors on specific projects. Outside of
Israel, we compete in a number of areas with major international defense and homeland security contractors
principally from the United States, Europe and Israel. Our main competitors include divisions and subsidiaries of
Boeing, Lockheed Martin, Northrop Grumman, Raytheon, General Dynamics, BAE Systems, Rockwell Collins,
L-3 Communications, Thales, Airbus, Leonardo, Saab, Harris, Textron, FLIR Systems, Orbital ATK,
AeroVironment, Rhode and Schwartz, Rheinmetall, Kongsberg, Safran, Aselsan, Bharat Electronics, Cubic and
Verint. Many of these competitors have greater financial, marketing and other resources than ours. We also
compete in the worldwide defense and homeland security markets with numerous smaller companies. In addition,
we compete with a range of companies in the commercial avionics market. In certain cases we also engage in
strategic cooperative activities with some of our competitors.
Overall, we believe we are able to compete on the basis of our systems development and
technological expertise, our systems’ operationally-proven performance and our policy of offering customers
overall solutions to technological, operational and financial needs.
25
Major Customers
Sometimes, our revenues from an individual customer account for more than 10% of our revenues in
a specific year. Our only such customer during the last three years was the IMOD, which accounted for 18% in
2014, 17% in 2015 and 18% in 2016.
Ethics
We conduct our business activities and develop Company policies based on a firm commitment to
ethical practices. In addition to our Code of Conduct (see Item 16.B) and compliance with applicable laws and
regulations, we have an active Company-wide ethics compliance program, incorporating policies and procedures.
This includes the anti-bribery area where we have a policy of zero tolerance for corruption. Our compliance
program also includes ongoing training and enforcement. We also expect our supply chain to follow ethical
practices. Our Code of Conduct, Anti-Bribery Compliance Policy and Supplier Code of Conduct are published on
our website www.elbitsystems.com. We are active in a number of international organizations relating to ethics
and compliance.
Social Sustainability
We place importance on sustainability and social responsibility to the communities in which we live
and work. This is consistent with our policy of emphasizing ethical business practices. Our policy encourages the
voluntary efforts of our Company entities and employees who donate their time and efforts in the support of
members of our communities who are in need. In this regard, we place priority on initiatives to promote
educational advancement in less developed communities, particularly in the technology sectors. We also promote
numerous other community support activities, including involvement on a national level in major charitable
organizations in Israel and the U.S. We place emphasis on best practices in corporate governance, ethical conduct
and fair employment practices. We also pursue continuous improvement of our operations from an environmental
perspective and have a policy of combating human trafficking and avoiding the use of "conflict minerals" in our
supply chain. These activities support our involvement as active members in leading sustainability and ethics
organizations. We periodically publish a Sustainability Report, available on our website, detailing our activities in
the areas of corporate responsibility, ethics, environmental initiatives and community-related activities.
Conditions in Israel
Political, Military and Economic Risks. Our operations in Israel are subject to several potential
political, military and economic risks. (See Item 3. Key Information – Risk Factors – Risks Related to Our Israeli
Operations.)
Trade Agreements. Israel is a member of the United Nations, the International Monetary Fund, the
International Bank for Reconstruction and Development and the International Finance Corporation. Israel also is a
party to the General Agreement on Tariffs and Trade, which provides for reciprocal lowering of trade barriers
among its members. In addition, Israel has been granted preferences under the Generalized System of Preferences
from several countries. These preferences allow Israel to export products covered by such programs either duty-
free or at reduced tariffs.
Israel Innovation Authority and Investment Center Funding. The government of Israel, through
the Israel Innovation Authority (IIA) in the Ministry of Economy and Industry (formerly the Office of the Chief
Scientist) and the Israel Investment Center (the Investment Center), encourages research and development projects
oriented towards export products and participates in the funding of such projects as well as company investments
in manufacturing infrastructures. Our Israeli companies receiving IIA funding for development of products usually
pay the Israeli government a royalty at various rates and such financing is typically subject to a number of
conditions. (See Item 5. Operating and Financial Review and Prospects – Long-Term Arrangements and
Commitments – Government Funding of Development.) Separate Israeli government consent is required to
transfer to third parties technologies developed through projects in which the government participates in the
funding of the development effort. The Investment Center promotes Israeli export products and increased
industrialization of peripheral areas through investment in industrial infrastructure. The Investment Center either
provides grants for qualified projects or provides tax benefits for qualified industrial investments by Israeli
companies.
26
Israeli Labor Laws. Our employees in Israel are subject to Israeli labor laws. Some employees are
also affected by some provisions of collective bargaining agreements between the Histadrut – General Federation
of Labor in Israel and the Coordination Bureau of Economic Organizations, which includes the Industrialists’
Association. These labor laws and collective bargaining provisions mainly concern the length of the work day,
minimum daily wages for professional workers, insurance for work-related accidents, procedures for dismissing
certain employees, determination of severance pay, employment of “manpower” employees and other conditions
of employment.
Severance Pay. Under Israeli law, our Israeli companies are required to make severance payments to
terminated Israeli employees, other than in some cases of termination for cause. The severance reserve is
calculated based on the employee’s last salary and period of employment. A portion of the severance pay and
pension obligation is covered by payment of premiums to insurance companies under approved plans and to
pension funds. The deposits presented in the balance sheet include profits accumulated to the balance sheet date.
The amounts deposited may be withdrawn only after fulfillment of the obligations under the Israeli laws relating
to severance pay. However, Elbit Systems and our Israeli subsidiaries have entered into agreements with some of
our employees implementing Section 14 of the Severance Payment Law, which agreements relate to the treatment
of severance pay. (See Item 18. Financial Statements – Note 2(R).)
National Insurance Institute. Israeli employees and employers are required to pay predetermined
sums to the National Insurance Institute, which is similar to the U.S. Social Security Administration. These
amounts also include payments for national health insurance. As of December 31, 2016, the payments to the
National Insurance Institute were equal to approximately 19.5% of wages, subject to a cap if an employee’s
monthly wages exceed a specified amount. The employee contributes approximately 61.5%, and the employer
contributes approximately 38.5%.
Enforcement of Judgments
Israeli courts may enforce U.S. and other foreign jurisdiction final executory judgments for
liquidated amounts in civil matters, obtained after due process before a court of competent jurisdiction. This
enforcement is made according to the private international law rules currently applicable in Israel, which
recognize and enforce similar Israeli judgments, provided that:
•
•
•
•
adequate service of process has been made and the defendant has had a reasonable opportunity
to be heard;
the judgment and its enforcement are not contrary to the law, public policy, security or
sovereignty of the State of Israel;
the judgment was not obtained by fraud and does not conflict with any other valid judgment in
the same matter between the same parties;
an action between the same parties in the same matter is not pending in any Israeli court at the
time the lawsuit is instituted in the foreign court; and
•
the judgment is no longer subject to a right of appeal.
Foreign judgments enforced by Israeli courts generally will be payable in Israeli currency. The usual
practice in Israel in an action to recover an amount in a non-Israeli currency is for the Israeli court to provide for
payment of the equivalent amount in Israeli currency at the exchange rate in effect on the judgment date. Under
existing Israeli law, a foreign judgment payable in foreign currency may be paid in Israeli currency at the foreign
currency’s exchange rate on the payment date or in foreign currency. Until collection, an Israeli court judgment
stated in Israeli currency will ordinarily be linked to the Israeli Consumer Price Index (CPI) plus interest at the
annual rate (set by Israeli regulations) in effect at that time. Judgment creditors must bear the risk of unfavorable
exchange rates.
Item 4A.
Unresolved Staff Comments.
None.
27
Item 5.
Operating and Financial Review and Prospects.
The following discussion and analysis should be read together with our audited consolidated financial statements
and notes appearing in Item 18 below.
General
Critical Accounting Policies and Estimates
Our significant accounting policies are described in Item 18. Financial Statements – Note 2.
Our results of operations and financial condition are based on our consolidated financial statements, which are
presented in conformity with United States generally accepted accounting principles (U.S. GAAP). The preparation of the
consolidated financial statements requires management to select accounting policies as well as estimates and assumptions and
to make judgments that involve the accounting policies described below that affect the amounts reported in the consolidated
financial statements. Significant changes in assumptions and/or conditions and changes in our critical accounting policies could
materially impact our operating results and financial condition.
We believe our most critical accounting policies relate to:
• Revenue Recognition.
• Business Combinations.
•
Impairment of Long-Lived Assets and Goodwill.
• Useful Lives of Long-Lived Assets.
•
Income Taxes.
• Stock-Based Compensation Expense.
Revenue Recognition
We generate revenues principally from fixed-price long-term contracts involving the design, development,
manufacture and integration of defense electronic systems and products. In addition, to a lesser extent, we provide non-defense
systems and products as well as support and services for our systems and products.
Revenues from long-term contracts are recognized primarily using the Financial Accounting Standards Board
(FASB), Accounting Standards Codification (ASC) ASC 605-35 “Construction-Type and Production-Type Contracts” (ASC
605-35) according to which we recognize revenues on the percentage-of-completion basis.
The percentage-of-completion method of accounting requires management to estimate the cost and gross profit
margin for each individual contract. Estimated gross profit or loss from long-term contracts may change due to changes in
estimates resulting from differences between actual performance and original estimated forecasts. Such changes in estimated
gross profit are recorded in results of operations when they are reasonably determinable by management, on a cumulative catch-
up basis. Anticipated losses on contracts are charged to earnings when determined to be probable.
In certain circumstances, sales under short-term fixed-price production type contracts or sale of products are
accounted for in accordance with the SEC’s Staff Accounting Bulletin (SAB) No. 104, “Revenue Recognition in Financial
Statements” (SAB 104), and recognized when all the following criteria are met: persuasive evidence of an arrangement exists,
delivery has occurred, the seller’s price to the buyer is fixed or determinable, no further obligation exists and collectability is
reasonably assured.
28
In cases where the contract involves the delivery of products and performance of services, or other obligations, we
follow the guidelines specified in ASC 605-25. “Multiple-Element Arrangements”, in order to allocate the contract
consideration between the identified different elements using the relative selling price method to allocate the entire arrangement
consideration. The selling price of each element would be allocated by using a hierarchy of: (i) Vendor Specific Objective
Evidence (VSOE); (ii) third-party evidence of the selling price for that element; or (iii) estimated selling price for individual
elements of an arrangement when VSOE or third-party evidence of the selling price is unavailable.
Service revenues include contracts primarily for the provision of supplies or services other than associated with
design, development or manufacturing and production activities. It may be a stand-alone service contract or a service element,
which was separated from the design, development or production contract according to the criteria established in ASC 605-25.
Our service contracts primarily include operation contracts, outsourcing-type arrangements, maintenance contracts, training,
installation service contracts, etc. Revenue from services were less than 10% of consolidated revenues in each of the fiscal
years 2014, 2015 and 2016. (For additional information see Item 18. Financial Statements - Notes 2(T) and 2(AE) (ASU 2014-
09.)
Business Combinations
In accordance with ASC 805 “Business Combinations”, we allocate the purchase price of acquired companies to
the tangible and intangible assets acquired and liabilities assumed, as well as to IPR&D and contingent consideration, and non-
controlling interest, based on their estimated fair values. Such valuations require management to make significant estimates and
assumptions, especially with respect to intangible assets. (See Item 18. Financial Statements - Note 2(E) for additional
information.)
We engage third-party appraisal firms to assist management in determining the fair values of certain assets
acquired and liabilities assumed. Estimating the fair value of certain assets acquired and liabilities assumed requires judgment
and often involves the use of significant estimates and assumptions, mainly with respect to intangible assets. Management
makes estimates of fair value based upon market participants’ assumptions believed to be reasonable. These estimates are based
on historical experience and information obtained from the management of the acquired companies, and although they are
deemed to be consistent with market participants’ highest and best use of the assets in the principal or most advantageous
market, they are inherently uncertain. While there are a number of different methods for estimating the value of intangible
assets acquired, the primary method used is the discounted cash flow approach. Some of the more significant estimates and
assumptions inherent in the discounted cash flow approach include projected future cash flows, including their timing, a
discount rate reflecting the risk inherent in the future cash flows and a terminal growth rate. We also estimate the expected
useful lives of the intangible assets, which requires judgment and can impact our results of operations. Unanticipated events and
circumstances may occur that may affect the accuracy or validity of such assumptions, estimates or actual results.
To the extent intangible assets are assigned longer useful lives, there may be less amortization expense recorded in
a given period. Because we operate in industries which are extremely competitive, the value of our intangible assets and their
respective useful lives are exposed to future adverse changes, which can result in an impairment charge to our results of
operations.
Impairment of Long-Lived Assets and Goodwill
Our long-lived assets, including identifiable property, plant and equipment and intangible assets, are reviewed for
impairment in accordance with ASC 360-10-35 “Property, Plant and Equipment Subsequent Measurement” whenever events or
changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be
held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to
be generated by the asset. If an asset is determined to be impaired, the impairment to be recognized is measured by the amount
by which the carrying amount of the asset exceeds its fair value. Fair value of non-financial assets is determined based on
market participant assumptions. For each of the years ended December 31, 2014, 2015 and 2016, no material impairment of
long-lived assets was identified. (See Item 18. Financial Statements - Note 2(P) for additional information.)
Goodwill represents the excess of the cost of acquired businesses over the fair values of the assets acquired net of
liabilities assumed. Goodwill is not amortized, but is instead tested for impairment at least annually (or more frequently if
impairment indicators arise).
29
We review goodwill for impairment on an annual basis and whenever events or changes in circumstances indicate
the carrying value of goodwill may not be recoverable. Such events or circumstances could include significant changes in the
business climate of our industry, operating performance indicators, competition or sale or disposal of a portion of a reporting
unit. The assessment is performed at the reporting unit level. Our annual testing date for all reporting units is December 31.
Performing the goodwill impairment test requires judgment, including how we define reporting units and
determine their fair value. We consider a component of our business to be a reporting unit if it constitutes a business for which
discrete financial information is available and management regularly reviews the operating results of that component. We
estimate the fair value of each reporting unit using a discounted cash flow methodology that requires significant judgment.
Forecasts of future cash flows are based on our best estimate of future sales and operating costs, based primarily on existing
backlog, expected future contracts, contracts with suppliers, labor agreements and general market conditions. We prepare cash
flow projections for each reporting unit using a five-year forecast of cash flows and a terminal value based on the Perpetuity
Growth Model. The five-year forecast and related assumptions are derived from the most recent annual financial forecast for
which the planning process commenced in our fourth quarter. The discount rate applied to our forecasts of future cash flows is
based on our estimated weighted average cost of capital and includes factors such as the risk-free rate of return and the return
an outside investor would expect to earn based on the overall level of inherent risk. The determination of expected returns
includes consideration of the beta (a measure of risk) of traded securities of comparable companies. Changes in these estimates
and assumptions could materially affect the determination of fair value and/or goodwill impairment for each reporting unit.
We evaluate goodwill for impairment by comparing the estimated fair value of a reporting unit to its carrying
value, including goodwill. If the carrying value exceeds the estimated fair value, we measure impairment by comparing the
derived fair value of goodwill to its carrying value, and any impairment determined is recorded in the current period. For each
of the three years ended December 31, 2016, no material impairment of goodwill was identified. (See Item 18. Financial
Statements - Note 2(Q) for additional information.)
Useful Lives of Long-Lived Assets
Identifiable intangible assets and property, plant and equipment are amortized over their estimated useful lives.
Determining the useful lives of such assets involves the use of estimates and judgments. In determining the useful lives we take
into account various factors such as the expected use of the assets, effects of obsolescence, including technological
developments, competition, demand and changes in business, acquisitions and other economic factors. If we experience
changes and the useful lives of such assets increase or decrease, it will affect our results of operations. (See above “Impairment
of Long-Lived Assets and Goodwill” for further discussion of the effects of changes in useful lives.)
Income Taxes
We record income taxes using the asset and liability approach, whereby deferred tax assets and liability account
balances are determined based on differences between financial reporting and tax bases of assets and liabilities and of operating
losses and credit carry-forwards, and are measured using the enacted tax rates and laws that will be in effect when the
differences are expected to reverse. We record a valuation allowance, if necessary, to reduce deferred tax assets to amounts that
are more likely than not to be realized. We have considered future taxable income on a jurisdiction by jurisdiction basis and
used prudent and feasible tax planning strategies and other available evidence in determining the need for a valuation
allowance. In the event we were to determine that we would be able to realize these deferred income tax assets in the future, we
would adjust the valuation allowance, which would reduce the provision for income taxes.
We establish reserves for tax-related uncertainties based on estimates of whether, and the extent to which,
additional taxes will be due. These reserves are established when we believe that certain positions might be challenged despite
our belief that our tax return positions are in accordance with applicable tax laws. As part of the determination of our tax
liability, management exercises considerable judgment in evaluating tax positions taken by us in determining the income tax
provision and establishes reserves for tax contingencies in accordance with ASC 740 "Income Taxes" guidelines. We adjust
these reserves in light of changing facts and circumstances, such as the closing of a tax audit, new tax legislation or the change
of an estimate based on new information. To the extent that the final tax outcome of these matters is different from the amounts
recorded, such differences will affect the provision for income taxes in the period in which such determination is made. During
2014, 2015 and 2016, certain of our subsidiaries settled certain income tax matters pertaining to multiple years in Israel and
Europe. Elbit Systems and certain of our Israeli subsidiaries are currently undergoing tax audits by the Israeli Tax Authority.
The provision for income taxes includes the effect of reserve provisions and changes to reserves that are considered appropriate,
as well as the related interest and penalties.
30
Management’s judgment is required in determining our provision for income taxes in each of the jurisdictions in
which we operate. The provision for income tax is calculated based on our assumptions as to our entitlement to various benefits
under the applicable tax laws in the jurisdictions in which we operate. The entitlement to such benefits depends upon our
compliance with the terms and conditions set out in these laws. Although we believe that our estimates are reasonable and that
we have considered future taxable income and ongoing prudent and feasible tax strategies in estimating our tax outcome, there
is no assurance that the final tax outcomes will not be different than those which are reflected in our historical income tax
provisions and accruals. Such differences could have a material effect on our income tax provision, net income and cash
balances in the period in which such determination is made. (See Item 18. Financial Statements - Notes 2(W) and 18.)
Stock-Based Compensation Expense
We account for equity based compensation in accordance with ASC 718 “Compensation - Stock Based Compensation”
(ASC 718), which requires the measurement and recognition of compensation expense for all share-based payment awards made to
our employees and directors, including employee stock options, cash-based awards linked to the share price and our Phantom Bonus
Retention Plan, based on estimated fair values. (See Item 18. Financial Statements - Notes 2(Z) and 21.)
Governmental Policies
Governmental policies and regulations applicable to defense contractors, such as cost accounting and audit, export
control, procurement solicitation and anti-bribery rules and regulations, could have a material impact on our operations. (See
Item 3. Risk Factors – General Risks Related to Our Business and Market and Item 4. Information on the Company –
Governmental Regulation.) According to Section 404 of the U.S. Sarbanes-Oxley Act of 2002, we are required to include in our
annual report on Form 20-F an assessment, as of the end of the fiscal year, of the effectiveness of our internal controls over
financial reporting. (See Item 15. Controls and Procedures – Management’s Annual Report on Internal Control Over Financial
Reporting.)
Recent Accounting Pronouncements
See Item 18. Financial Statements – Note 2(AE).
Long-Term Arrangements and Commitments
Government Funding of Development. Elbit Systems and certain Israeli subsidiaries partially finance our
research and development expenditures under programs sponsored by the Israel Innovation Authority (IIA) in the Ministry of
Economy and Industry (formerly the Office of the Chief Scientist) for the support of research and development activities
conducted in Israel. At the time the funds are received, successful development of the funded projects is not assured. In
exchange for the funds, Elbit Systems and the subsidiaries pay 2% – 5% of total sales of the products developed under these
programs. The obligation to pay these royalties is contingent on actual future sales of the products. Elbit Systems and some of
our subsidiaries may also be obligated to pay certain amounts to the IMOD and others on certain sales including sales resulting
from the development of some of the technologies developed with such respective entity’s funds. (See Item 4. Information on
the Company – Conditions in Israel – Israel Innovation Authority and Investment Center Funding.)
Lease Commitments. The future minimum lease commitments of the Company under various non-cancelable
operating lease agreements for property, motor vehicles and office equipment as of December 31, 2016 were as follows: $47.5
million for 2017, $35.9 million for 2018, $27.2 million for 2019, $19.4 million for 2020 and $100.6 million for 2021 and
thereafter. (See below “Contractual Obligations”.)
Bank Covenants. In connection with bank credits and loans, including performance guarantees issued by banks
and bank guarantees in order to secure certain advances from customers, Elbit Systems and certain subsidiaries are obligated to
meet certain financial covenants. (See below – “Liquidity and Capital Resources – Financial Resources”.) Such covenants
include requirements for shareholders’ equity, current ratio, operating profit margin, tangible net worth, EBITDA, interest
coverage ratio and total leverage. (See Item 18. Financial Statements – Note 20(F).) As of December 31, 2015 and 2016, the
Company met all financial covenants.
Bank and Other Financial Institution Guarantees. As of December 31, 2016 and 2015, guarantees in the
aggregate amount of approximately $1,219 million and $1,211 million, respectively, were issued by banks and other financial
institutions on behalf of several Company entities primarily in order to secure certain advances from customers and
performance bonds.
31
Purchase Commitments. As of December 31, 2016 and 2015, we had purchase commitments of approximately
$1,313 million and $1,292 million, respectively. These purchase orders and subcontracts are typically in standard formats
proposed by us. These subcontracts and purchase orders also reflect provisions from the applicable prime contract that apply to
subcontractors and vendors. The terms typically included in these purchase orders and subcontracts are consistent with Uniform
Commercial Code provisions in the United States for sales of goods, as well as with specific terms requested by our customers
in international contracts. These terms include our right to terminate the purchase order or subcontract in the event of the
vendor’s or subcontractor’s default, as well as our right to terminate the order or subcontract for our convenience (or if our
prime contractor has so terminated the prime contract). Such purchase orders and subcontracts typically are not subject to
variable price provisions.
Acquisitions During 2016
See Item 4. Information on the Company – Mergers, Acquisitions and Divestitures.
Backlog of Orders
Our backlog includes firm commitments received from customers for systems, products, services and projects that
have yet to be completed. Our policy is to include orders in our backlog only when specific conditions are met. Examples of
these conditions may include, among others, receipt of a letter of commitment, program funding, advances, letters of credit,
guarantees and/or other commitments from customers. As a result, from time to time we could have unrecorded orders in excess
of the level of backlog.
We reduce backlog when revenues for a specific contract are recognized, such as when delivery or acceptance
occurs or when contract milestones or engineering progress under long-term contracts are recognized as achieved, or when
revenues are recognized based on costs incurred. In the unusual event of a contract cancellation, we reduce our backlog
accordingly. The method of backlog recognition used may differ depending on the particular contract. Orders in currencies
other than U.S. dollars are translated periodically into U.S. dollars and recorded accordingly.
Our backlog of orders as of December 31, 2016 was $6,909 million, of which 68% was for orders outside Israel.
Our backlog of orders as of December 31, 2015 was $6,564 million, of which 68% was for orders outside Israel.
Approximately 69% of our backlog as of December 31, 2016 is scheduled to be performed during 2017 and 2018. The majority
of the 31% balance is scheduled to be performed in 2019 and 2020. Backlog information and any comparison of backlog as of
different dates may not necessarily represent an indication of future sales.
Trends
Trends in the defense and homeland security areas in which we operate have been impacted by the nature of
recent conflicts and terrorism activities throughout the world, increasing the focus of defense forces on low intensity conflicts,
homeland security and cyber warfare. The defense market has also been impacted by the withdrawal of most of the allied forces
from Iraq and a reduction of allied forces in Afghanistan, as well as by the recent conflicts in Ukraine and Syria and various
conflicts with ISIS and other terrorist organizations. There has also been a trend of many armed forces to focus more on
airborne, naval and intelligence forces and less on traditional ground forces activities.
In the defense and homeland security markets, there is an increasing demand for products and systems in the areas
of airborne systems, C4ISR and unmanned vehicles. Accordingly, while we continue to perform platform upgrades, in recent
years more emphasis is being placed on airborne systems, C4ISR, information systems, intelligence gathering, situational
awareness, precision guidance, all weather and day/night operations, border and perimeter security, UAS, other unmanned
vehicles, cyber-defense systems, training and simulation, space and satellite-based defense capabilities and homeland security
systems. Many governments are increasing their budgets in the homeland security and cyber-defense areas. We believe that
our core technologies and abilities will enable us to take advantage of many of these emerging trends.
In recent years consolidation in the defense and homeland security industries has affected competition. This
consolidation has decreased the number but increased the relative size and resources of our competitors. We adapt to evolving
market conditions by adjusting our business strategy. Our business strategy also anticipates increased competition in the defense
and homeland security markets due to declining budgets in certain countries such as a number of countries in Latin America.
However, there have been recent indications of enhanced defense and homeland security budgets in the U.S. and in certain
European countries. We believe in our ability to compete on the basis of our systems development, technological expertise,
operationally-proven performance and policy of offering customers overall solutions to technological, operational and financial
needs and at the same time enhancing the industrial capabilities in certain of our customers’ countries.
32
Our future success is dependent on our ability to meet our customers’ expectations and anticipate emerging
customer needs. We must continue to successfully perform on existing programs, as past performance is an important selection
criterion for new competitive awards. We also must anticipate customer needs so as to be able to develop working prototypes in
advance of program solicitations. This requires us to anticipate future technological and operational trends in our marketplace
and efficiently engage in relevant research and development efforts.
Summary of Operating Results
The following table sets forth our consolidated statements of operations for each of the three years ended
December 31, 2016.
Year ended December 31,
(in thousands of U.S. dollars except per share data)
2016
2015
2014
$
$ 3,260,219
2,300,636
959,583
$
%
100.0 $ 3,107,581
2,210,528
70.6
897,053
29.4
$
%
100.0 $ 2,958,248
2,133,151
71.1
825,097
28.9
%
100.0
72.1
27.9
291,749
(35,957 )
255,792
271,037
151,353
(17,575 )
660,607
298,976
(23,742 )
3,967
279,201
45,617
233,584
8.9
(1.1 )
7.8
8.3
4.6
(0.5 )
20.3
9.2
(0.7 )
0.1
8.6
1.4
7.2
277,837
(34,421 )
243,416
239,366
145,693
—
628,475
268,578
(20,240 )
216
248,554
46,235
202,319
8.9
(1.1 )
7.8
7.7
4.7
—
20.2
8.6
(0.7 )
—
8.0
1.5
6.5
267,691
(39,680 )
228,011
216,537
139,634
(5,951 )
578,231
246,866
(47,498 )
120
199,488
25,624
173,864
5,224
238,808
$
0.2
7.4 $
4,542
206,861
0.1
6.6 $
5,549
179,413
9.0
(1.3 )
7.7
7.3
4.7
(0.2 )
19.5
8.3
(1.6 )
—
6.7
0.9
5.9
0.2
6.1
(1,899 )
(0.1 )
(4,352 )
(0.1 )
(8,433 )
(0.3 )
$
236,909
7.3
$
202,509
6.5
$
170,980
5.8
Total revenues
Cost of revenues
Gross profit
Research and development (R&D)
expenses
Less – participation
R&D expenses, net
Marketing and selling expenses
General and administrative expenses
Other operating income, net
Operating income
Financial expenses, net
Other income, net
Income before taxes on income
Taxes on income
Equity in net earnings of affiliated
companies and partnerships
Net income
Less – net loss (income) attributable to
non-controlling interests
Net income attributable to the
Company’s shareholders
Diluted net earnings per share:
$
5.54
$
4.74
$
4.01
33
2016 Compared to 2015
Revenues
Our sales are primarily to governmental entities and prime contractors under government defense and homeland
security programs. Accordingly, the level of our revenues is subject to governmental budgetary constraints.
The following table sets forth our revenue distribution by areas of operation:
Airborne systems
C4ISR systems
Land systems
Electro-optic systems
Other (mainly non-defense engineering and production services)
Total
Year ended December 31,
2016
2015
$ millions
%
$ millions
1,242.3
1,220.9
408.0
276.0
113.0
3,260.2
38.1
37.4
12.5
8.5
3.5
100.0
1,225.7
995.2
558.7
231.9
96.1
3,107.6
%
39.4
32.0
18.0
7.5
3.1
100.0
Our consolidated revenues in 2016 were the $3,260.2 million, as compared to $3,107.6 million in 2015.
The leading contributors to our revenues were the airborne systems and C4ISR systems areas of operations. The
increase in the C4ISR area of operation was primarily due to an increase in sales of command and control systems and radio
systems in Europe, Asia-Pacific and Israel. Revenues from land systems decreased due primarily to a decline in sales of tank
fire control systems to Asia-Pacific.
The following table sets forth our distribution of revenues by geographical regions:
Israel
North America
Europe
Asia-Pacific
Latin America
Other
Total
Year ended December 31,
2016
2015
$ millions
%
$ millions
%
709.5
825.7
640.8
801.6
212.8
69.8
3,260.2
21.8
25.3
19.7
24.6
6.5
2.1
100.0
616.6
838.9
497.6
800.3
325.4
28.8
3,107.6
19.8
27.0
16.0
25.8
10.5
0.9
100.0
The decrease in Latin America was mainly a result of lower sales of command and control systems for homeland
security applications.
Cost of Revenues and Gross Profit
Cost of revenues in 2016 was $2,300.6 million (70.6% of revenues), as compared to $2,210.5 million (71.1% of
revenues) in 2015.
34
Our major components of cost of revenues are (i) wages and related benefits costs, (ii) subcontractors and material
consumed and (iii) manufacturing and other expenses (including depreciation and amortization). The amounts and percentage
of those components in 2016 and 2015 were as follows:
Wages and related benefits costs in 2016 constituted 38% of cost of revenues, as compared to 39% of cost of
revenues in 2015. The total cost of wages and related benefits in 2016 was approximately $874 million, as compared to $852
million in 2015.
Subcontractors and material consumed costs in 2016 constituted 47% of cost of revenues, as compared to 48% in
2015. The total amount of subcontractors and material consumed costs in 2016 was approximately $1.1 billion, similar to that
in 2015.
Manufacturing and other expenses in 2016 constituted 14% of cost of revenues, as compared to 13% in 2015. The
total cost of manufacturing and other expenses in 2016 was approximately $320 million, as compared to approximately $300
million in 2015.
In 2016, our cost of revenues included a decrease in inventories of approximately $60 million in work-in-progress
and finished goods inventories, as compared to a decrease of approximately $30 million in work-in-progress and finished goods
inventories in 2015.
Changes from 2015 to 2016 in our cost of revenues and cost of revenues components were not material. We did
not identify any developing trends in cost of revenues that we believe would have a material impact on our future operations
other than the continued changes in the NIS against the U.S. dollar, which could have an impact mainly on our labor costs.
Gross profit for the year ended December 31, 2016 was $959.6 million (29.4% of revenues), as compared to
$897.1 million (28.9% of revenues) in the year ended December 31, 2015. The increase in the gross profit rate in 2016 was
mainly due to the mix of programs sold.
Research and Development (R&D) Expenses
We continually invest in R&D in order to maintain and further advance our technologies, in accordance with our
long-term plans, based on our estimate of future market needs. Our R&D costs, net of participation grants, include costs
incurred for independent research and development and bid and proposal efforts and are expensed as incurred.
Gross R&D expenses in 2016 totaled $291.7 million (8.9% of revenues), as compared to $277.8 million (8.9% of
revenues), in 2015.
Net R&D expenses (after deduction of third party participation) in 2016 totaled $255.8 million (7.8% of
revenues), as compared to $243.4 million (7.8% of revenues) in 2015.
Marketing and Selling Expenses
We are active in developing new markets and pursue at any given time various business opportunities according to
our plans.
Marketing and selling expenses in 2016 were $271.0 million (8.3% of revenues), as compared to $239.4 million
(7.7% of revenues) in 2015. The increase in marketing and selling expenses in 2016 was mainly related to the mix of countries
and types of marketing activities for projects in which we invested our marketing efforts.
General and Administration (G&A) Expenses
G&A expenses in 2016 were $151.4 million (4.6% of revenues), as compared to $145.7 million (4.7% of
revenues) in 2015.
35
Other Operating Income (Net)
Other operating income, net for the year ended December 31, 2016 amounted to $17.6 million. The amount
reflects net gains related to the valuation of shares in two of our Israeli subsidiaries in the energy and automotive areas due to
third party investments.
Operating Income
Our operating income in 2016 was $299.0 million (9.2% of revenues), as compared to $268.6 million (8.6% of
revenues) in 2015. The main reason for the improvement in the operating income was the increase in the gross profit in 2016 as
compared to 2015.
Financial Expense (Net)
Net financing expenses in 2016 were $23.7 million, as compared to $20.2 million in 2015. Financial expenses in
2015 were relatively low mainly due to gains from exchange rate differences.
Other Income (Net)
Other Income, net in 2016 amounted to $4 million. This was due to a capital gain related to the sale of real estate
acquired in prior years.
Taxes on Income
Our effective tax rate represents a weighted average of the tax rates to which our various entities are subject.
Taxes on income in 2016 were $45.6 million (effective tax rate of 16.3%), as compared to $46.2 million (effective
tax rate of 18.6%) in 2015. The effective tax rates in 2016 and 2015 were affected by prior years adjustments of $18.6 million
and $1.4 million, respectively. The adjustments in 2016 were mainly related to tax settlements. The change in the effective tax
rate was also affected by the mix of the tax rates in the various jurisdictions in which the Company’s entities generate taxable
income. We continued to enjoy a lower effective Israeli tax rate and the benefits of an “Approved and Privileged Enterprise”,
which resulted in savings of $16.1 million and $20.8 million, respectively, in 2016 and 2015, significantly influencing our
effective tax rates.
Company’s Share in Earnings of Affiliated Entities
The entities, in which we hold 50% or less in shares or voting rights (affiliates) and are therefore not consolidated
in our financial statements, operate in complementary areas to our core business activities, including electro-optics and airborne
systems.
In 2016, we had income of $5.2 million from our share in earnings of affiliates, as compared to income of $4.5
million in 2015.
Net Income and Earning Per Share (EPS)
As a result of the above, net income in 2016 was $236.9 million (7.3% of revenues), as compared to net income of
$202.5 million (6.5% of revenues) in 2015. The diluted EPS was $5.54 in 2016, as compared to $4.74 in 2015.
The number of shares used for computation of diluted EPS in the year ended December 31, 2016 was 42,752,000
shares, as compared to 42,733,000 shares in the year ended December 31, 2015.
36
2015 Compared to 2014
Revenues
The following table sets forth our revenue distribution by areas of operation:
Airborne systems
C4ISR systems
Land systems
Electro-optic systems
Other (mainly non-defense engineering and production services)
Total
Year ended December 31,
2015
2014
$ millions
%
$ millions
1,225.7
995.2
558.7
231.9
96.1
3,107.6
39.4
32.0
18.0
7.5
3.1
100.0
1,197.9
1,118.5
274.9
265.1
101.8
2,958.2
%
40.5
37.8
9.3
9.0
3.4
100.0
Our consolidated revenues in 2015 were the $3,107.6 million, as compared to $2,958.2 million in 2014.
The leading contributors to our revenues were the airborne systems and C4ISR systems areas of operations. The
increases in the land systems area of operation were primarily due to increased revenues from tank fire control systems and
electro-optic night vision systems sold to Asia-Pacific. Revenues from C4ISR systems in Latin America decreased slightly, due
to decline in sales of command and control systems mainly for homeland security applications.
The following table sets forth our distribution of revenues by geographical regions:
Israel
North America
Europe
Asia-Pacific
Latin America
Other
Total
Year ended December 31,
2015
2014
$ millions
%
$ millions
%
616.6
838.9
497.6
800.3
325.4
28.8
3,107.6
19.8
27.0
16.0
25.8
10.5
0.9
100.0
638.9
826.8
460.9
528.8
454.5
48.4
2,958.2
21.6
27.9
15.6
17.9
15.4
1.6
100.0
The increase in revenues in Asia-Pacific was mainly due to increased sales of tank fire control systems and
electro-optic night vision systems to this region. The decrease in Latin America was a result of lower sales of command and
control systems mainly for homeland security applications.
Cost of Revenues and Gross Profit
Cost of revenues in 2015 was $2,210.5 million (71.1% of revenues), as compared to $2,133.2 million (72.1% of
revenues) in 2014.
37
Our major components of cost of revenues are (i) wages and related benefits costs, (ii) subcontractors and material
consumed and (iii) manufacturing and other expenses (including depreciation and amortization). The amounts and percentage
of those components in 2015 and 2014 were as follows:
Wages and related benefits costs in 2015 constituted 39% of cost of revenues, as compared to 40% of cost of
revenues in 2014. The total cost of wages and related benefits in 2015 was approximately $852 million, which was similar to
those in 2014.
Subcontractors and material consumed costs in 2015 constituted 48% of cost of revenues, as compared to 52% in
2014. The total amount of subcontractors and material consumed costs in 2015 was approximately $1.1 billion, similar to that
in 2014.
Manufacturing and other expenses in 2015 constituted 13% of cost of revenues, similar to that in 2014. The total
cost of manufacturing expenses in 2015 was approximately $300 million, similar to that in 2014.
In 2015, our cost of revenues increased due to a decrease of approximately $30 million in our work-in-progress
and finished goods inventories, as compared to a reduction in our cost of revenues in 2014 as a result of an increase of
approximately $110 million in work-in-progress and finished goods inventories. Also, in 2014, a wholly-owned subsidiary in
the U.S. sold certain assets related to a high speed machinery product line. As a result of the sale we recorded in cost of
revenues an operating loss of approximately $5 million (see Item 18. Financial Statements - Note 1(D)).
Changes from 2014 to 2015 in our cost of revenues and cost of revenues components were not material We did
not identify any developing trends in cost of revenues that we believe would have a material impact on our future operations
other than the continued changes in the NIS against the U.S. dollar, which could have an impact mainly on our labor costs.
Gross profit for the year ended December 31, 2015 was $897.1 million (28.9% of revenues), as compared to
$825.1 million (27.9% of revenues) in the year ended December 31, 2014. The increase in the gross profit rate in 2015 was
mainly due to the mix of programs sold.
Research and Development (R&D) Expenses
Gross R&D expenses in 2015 totaled $277.8 million (8.9% of revenues), as compared to $267.7 million (9.0% of
revenues), in 2014.
Net R&D expenses (after deduction of third party participation) in 2015 totaled $243.4 million (7.8% of
revenues), as compared to $228.0 million (7.7% of revenues) in 2014.
Marketing and Selling Expenses
Marketing and selling expenses in 2015 were $239.4 million (7.7% of revenues), as compared to $216.5 million
(7.3% of revenues) in 2014. The increase in marketing and selling expenses in 2015 was mainly related to the mix of countries
and types of marketing activities for projects in which we invested our marketing efforts.
General and Administration (G&A) Expenses
G&A expenses in 2015 were $145.7 million (4.7% of revenues), as compared to $139.6 million in 2014 (4.7% of
revenues). The main increase was due to the cost of the phantom bonus retention plan, which is included within G&A expenses.
See Item 18. Financial Statements - Note 21(D).
38
Other Operating Income (Net)
Other operating income, net for the year ended December 31, 2014 amounted to $6.0 million. The amount reflects
a net gain related to the revaluation of a previously held investment in the shares of an Israeli subsidiary at the acquisition date
due to its accounting treatment as a business combination achieved in stages. As a result of this acquisition, the Company
increased its holdings in the subsidiary from 49% to 90%.
Operating Income
Our operating income in 2015 was $268.6 million (8.6% of revenues), as compared to $246.9 million (8.3% of
revenues) in 2014. The main reason for the improvement in the operating income was the increase in the gross profit between
2015 and 2014.
Financial Expense (Net)
Net financing expenses in 2015 were $20.2 million, as compared to $47.5 million in 2014. Financing expenses,
net, in 2014 were comparatively high, mainly as a result of the accelerated devaluation of the NIS in the third quarter of 2014
and its effect on the Company's U.S. dollar derivative activities, as well as fluctuation of the U.S. dollar against other foreign
currencies, such as the Australian dollar and the Brazilian real, during the year.
Taxes on Income
Taxes on income in 2015 were $46.2 million (effective tax rate of 18.6%), as compared to $25.6 million (effective
tax rate of 12.8%) in 2014. The effective tax rates in 2015 and 2014 were affected by prior years adjustments of $1.4 million
and $7.7 million, respectively, mainly related to tax settlements. The change in the effective tax rate was also affected by the
mix of the tax rates in the various jurisdictions in which the Company’s entities generate taxable income. We continued to enjoy
a lower effective Israeli tax rate and the benefits of an “Approved and Privileged Enterprise”, which resulted in savings of $24.9
million and $21.8 million, respectively, in 2015 and 2014, significantly influencing our effective tax rates.
Company’s Share in Earnings of Affiliated Entities
In 2015, we had income of $4.5 million from our share in earnings of affiliates, as compared to income of $5.5
million in 2014.
Net Income and Earning Per Share (EPS)
As a result of the above, net income in 2015 was $202.5 million (6.5% of revenues), as compared to net income of
$171.0 million (5.8% of revenues) in 2014. The diluted EPS was $4.74 in 2015, as compared to $4.01 in 2014.
The number of shares used for computation of diluted EPS in the year ended December 31, 2015 was 42,733,000
shares, as compared to 42,677,000 shares in the year ended December 31, 2014.
Israeli Debt Offering
In June 2010, Elbit Systems completed a public offering in Israel on the TASE of NIS 1.1 billion (approximately
$283 million) Series A Notes (the Series A Notes). The Series A Notes were offered and sold pursuant to a shelf prospectus filed
in May 2010 with the Israeli Securities Authority and the TASE. The shelf prospectus expired in 2012. In March and May 2012,
respectively, under the framework of the shelf prospectus, Elbit Systems completed both an additional public offering on the
TASE and a private placement in Israel to Israeli institutional investors, of new Series A Notes, for an aggregate consideration
of approximately NIS 926 million (approximately $249 million). All Series A Notes formed a single series.
We account for the outstanding principal amount of our Series A Notes as long-term liability, in accordance with
ASC 470, “Debt”, with current maturities classified as short-term liabilities. Debt issuance costs are capitalized and reported as
deferred financing costs, which are amortized over the life of the Series A Notes using the effective interest rate method. As of
December 31, 2016, the value of the Series A Notes was $219.8 million, less $63.6 million in current maturities and a fair value
adjustment of $15.8 million from cross-currency interest rate swaps.
39
The Series A Notes are payable in ten equal annual installments on June 30 of each of the years 2011 through
2020. The Series A Notes bear a fixed interest rate of 4.84% per annum, payable on June 30 and December 30 of each of the
years through 2020 (the first interest payment was made on December 30, 2010, and the last interest payment will be made on
June 30, 2020). (See Item 8. Financial Statements – Note 16.)
The Series A Notes (principal and interest) are in NIS and are not linked to any currency or index. The Series A
Notes are unsecured, non-convertible and do not restrict our ability to issue additional notes of any class or distribute dividends
in the future. There are no covenants on the Series A Notes.
The Series A Notes are listed for trading on the TASE. However, the Series A Notes are not registered under
the U.S. Securities Act of 1933, as amended (the Securities Act), and may not be offered or sold in the United States or to
U.S. Persons (as defined in Regulation “S” promulgated under the Securities Act) without registration under the
Securities Act or an exemption from the registration requirements of the Securities Act.
We also entered into ten-year cross currency interest rate swap transactions in order to effectively hedge the effect
of interest and exchange rate differences resulting from the NIS Series A Notes that were issued in 2010 and the additional
Series A Notes that were issued in 2012. Under the cross currency interest rate swaps, we receive fixed NIS at a rate of 4.84%
on NIS 2 billion and pay floating six-month USD LIBOR plus an average spread of 1.84% on $450 million, which reflects the
U.S. dollar value of the Series A Notes on the specific dates the transactions were consummated. Both the debt and the swap
instruments pay semi-annual interest on June 30 and December 31. The purpose of these swap transactions was to convert the
NIS fixed rate Series A Notes into USD LIBOR (6 months) floating rate obligations. As a result of these agreements, we are
currently paying an effective interest rate of six-month LIBOR (1.32% at December 31, 2016) plus an average of 1.84% on the
principal amount, as compared to the original 4.84% fixed rate. The above transactions qualify for fair value hedge accounting.
(See also Item 11. Quantitative and Qualitative Disclosures about Market Risk.)
Cash Flows
Our operating cash flow is affected by the cumulative cash flow generated from our various projects in the
reported periods. Project cash flows are affected by the timing of the receipt of advances and the collection of accounts
receivable from customers, as well as the timing of payments made by us in connection with the performance of the project.
The receipt of payments usually relates to specific events during the project, while expenses are ongoing. As a result, our cash
flow may vary from one period to another. Our policy is to invest our cash surplus mainly in interest bearing deposits, in
accordance with our projected needs.
In general, subsidiaries are able to transfer cash dividends, loans or advances to Elbit Systems and among
themselves, subject to corporate policy and tax considerations in their applicable jurisdiction and subject to management
commitment not to distribute tax exempt earnings. Such tax considerations have not had in the past, and are not anticipated to
have, a material impact on our ability to meet our obligations.
2016
Our net cash flow generated from operating activities in 2016 was approximately $208 million, resulting mainly
from our net income and an increase in non-cash operating items of $104 million and an increase in trade and other payables of
approximately $253 million, offset by an increase in short and long-term trade receivables of approximately $297 million and a
decrease in advances received from customers of approximately $83 million.
Net cash flow used in investment activities in 2016 was approximately $118 million, which was used mainly for
the purchase of property, plant and equipment in the amount of $124 million, investments in affiliated companies in the amount
of $19 million and offset by proceeds from the net sale of short-term deposits and marketable securities in the amount of $12
million and sale of real estate in the amount of $16 million.
Net cash flow used for financing activities in 2016 was approximately $167 million, which was used mainly for
repayment of Series A Notes in the amount of $56 million, payments of dividends in the amount of $68 million and repayment
of long-term loans in the amount of $48 million.
40
2015
Our net cash flow generated from operating activities in 2015 was approximately $435 million, resulting mainly
from our net income and an increase in non-cash operating items of $159 million, an increase in advances received from
customers of approximately $71 million, a decrease in trade receivables of approximately $32 million and a decrease in
inventories of approximately $40 million, offset partly by a decrease in trade payables in the amount of $74 million.
Net cash flow used in investment activities in 2015 was approximately $182 million, which was used mainly to
acquire subsidiaries and business operations in the amount of approximately $165 million and to purchase property, plant and
equipment in the amount of approximately $99 million, offset by net proceeds from the sale of marketable securities of $71
million.
Net cash flow used for financing activities in 2015 was approximately $154 million, which was used mainly for
repayment of Series A Notes in the amount of approximately $56 million, payment of dividends to shareholders in the amount
of approximately $70 million (of which $8 million was paid by a subsidiary to non-controlling interests) and net repayment of
long-term loans of $2.3 million.
2014
Our net cash flow generated from operating activities in 2014 was approximately $178 million, resulting mainly
from our net income and the increase in trade and other payables of approximately $82 million, offset partly by the increase in
trade receivables in the amount of $67 million and the increase in inventories of approximately $113 million.
Net cash flow used in investment activities in 2014 was approximately $80 million, which was used mainly to
purchase property, plant and equipment in the amount of approximately $71 million.
Net cash flow used for financing activities in 2014 was approximately $89 million, which was used mainly for
repayment of Series A Notes in the amount of approximately $56 million and payment of dividends to shareholders in the
amount of approximately $68 million (of which $14.5 million was paid by a subsidiary to non-controlling interests).
Financial Resources
The financial resources available to us include profits, collection of accounts receivable, advances from customers
and government of Israel and other third parties’ programs such as the Israel Innovation Authority and development grants. In
addition, we have access to bank credit lines and financing in Israel and abroad based on our capital, assets and activities.
Elbit Systems and some subsidiaries are obligated to meet various financial covenants set forth in our respective
loan and credit agreements. Such covenants include requirements for shareholders’ equity, current ratio, operating profit margin,
tangible net worth, EBITDA, interest coverage ratio and total leverage. As of December 31, 2015 and 2016, the Company met
all financial covenants.
On December 31, 2016, we had total borrowings from banks and public institutions in the amount of $166 million
in long-term loans, of which most of the loans mature in 2017, and $1,219 million in guarantees issued on our behalf by banks
and other financial institutions, mainly in respect of advance payment and performance guarantees provided in the regular
course of business. In addition, at December 31, 2016, we had $218 million in outstanding debt under our Series A Notes,
including $56 million maturing in 2017. On December 31, 2016, we had a cash balance amounting to $223 million. We also
have the ability to raise funds on the capital market and through expansion of our credit lines. (See above “Israeli Debt
Offering”.)
As of December 31, 2016, we had working capital of $527 million and a current ratio of 1.27. We believe that our
working capital and cash flow from operations are sufficient to support our current requirements and financial covenants.
We believe that our current cash balances, cash generated from operations, lines of credit and financing
arrangements will provide sufficient resources to meet our operational needs for at least the next fiscal year. However, our
ability to borrow funds from the banking system may be impacted by the global financial and liquidity situation. See Item 3.
Risk Factors – General Risk Related to Our Business and Market.
41
For further information on the level, maturity and terms of our borrowings, see Item 18. Financial Statements –
Notes 12, 15 and 16.
We believe our cash balance, amounts available under lines of credits, cash flows from operating activities and our
ability to access external capital resources should be sufficient to satisfy existing short-term and long-term commitments and
plans, and also to provide adequate financial flexibility to take advantage of potential strategic business opportunities should
they arise within the next year.
Pensions and Other Post-Retirement Benefits. We account for pensions and other post-employment arrangements in
accordance with ASC 715 “Compensation – Retirement Benefits”. Accounting for pensions and other post-retirement benefits
involves judgment about uncertain events, including estimated retirement dates, salary levels at retirement, mortality rates, rates
of return on plan assets, determination of discount rates for measuring plan obligations, healthcare cost trend rates and rates of
utilization of healthcare services by retirees. These assumptions are based on the environment in each country. (For our pension
and other post-retirement benefit assumptions at December 31, 2016 and 2015, see Item 18. Financial Statements – Note 17.) At
December 31, 2016, our employee benefit liabilities were $376 million, of which we had severance funds of $264 million set
aside to satisfy potential obligations.
Material Commitments for Capital Expenditures.We believe that we have adequate sources of funds to meet our material
commitments for capital expenditures for the fiscal year ending December 31, 2016 and the subsequent fiscal year (see above
“Financial Resources”). Our anticipated capital expenditures (which include mainly the purchase of equipment, buildings and
an enhancement to our Enterprise Resource Planning (ERP) system) as of December 31, 2016 are somewhat higher than those
as of December 31, 2015, due to an anticipated increase in expenditures for buildings, ERP enhancements and certain other
expenses. We plan to pay for such anticipated capital expenditures using cash from operations. (See also Item 18. Financial
Statements – Consolidated Statements of Cash Flows and Note 10.)
Impact of Inflation and Exchange Rates
Functional Currency. Our reporting currency is the U.S. dollar, which is also the functional currency for most of our
consolidated operations. A majority of our sales are made outside of Israel in non-Israeli currency, mainly U.S. dollars, as well
as a majority of our purchases of materials and components. A significant portion of our expenses, mainly labor costs, are in
NIS. Some of our subsidiaries have functional currencies in Euro, GBP, Brazilian reals, Australian dollars and other currencies.
Transactions and balances originally denominated in U.S. dollars are presented in their original amounts. Transactions and
balances in currencies other than the U.S. dollar are remeasured in U.S. dollars according to the principles set forth in ASC 830
“Foreign Currency Matters”. Exchange gains and losses arising from remeasurement are reflected in financial expenses, net, in
the consolidated statements of income.
Market Risks and Variable Interest Rates
Market risks relating to our operations result mainly from changes in interest rates and exchange rates. We use
derivative instruments to limit exposure to changes in exchange rates in certain cases. We also typically enter into forward
contracts in connection with transactions where long-term contracts have been signed and that are denominated in currencies
other than U.S. dollars or NIS. We also enter from time to time into forward contracts and other hedging instruments related to
NIS based on market conditions.
We use financial instruments and derivatives in order to limit our exposure to risks arising from changes in
exchange rates and to mitigate our exposure to effects of changes in foreign currency rates and interest rates. The use of such
instruments does not expose us to additional exchange rate risks since the derivatives are held against an asset (for example,
excess assets in Euros). Our policy in utilizing these financial instruments is to protect the dollar value of our cash and cash
equivalent assets rather than to serve as a source of income.
In the context of our overall treasury policy specific objectives apply to the management of financial risks. These
objectives are disclosed under the headings below “NIS/U.S. Dollar Exchange Rates”, “Inflation and Currency Exchange
Rates” and “Foreign Currency Derivatives and Hedging”.
On December 31, 2016, our liquid assets were comprised of bank deposits and short and long-term investments.
Our deposits and investments earn interest based on variable interest rates, and their value as of December 31, 2016 was
therefore exposed to changes in interest rates. Should interest rates either increase or decrease, such change may affect our
results of operations due to changes in the cost of the liabilities and the return on the assets that are based on variable rates.
42
NIS/U.S. Dollar Exchange Rates. We attempt to manage our financial activities in order to reduce material financial losses in
U.S. dollars resulting from the impact of inflation and exchange rate fluctuations on our non-U.S. dollar assets and liabilities.
Our income and expenses in Israeli currency are translated into U.S. dollars at the prevailing exchange rates as of the date of the
transaction. Consequently, we are affected by changes in the NIS/U.S. dollar exchange rates. We entered into other derivative
instruments to limit our exposure to exchange rate fluctuations, related mainly to payroll expenses incurred in NIS. (See Item
11. Quantitative and Qualitative Disclosure of Market Risks.) The amount of our exposure to the changes in the NIS/U.S. dollar
exchange rate may vary from time to time. (See Item 3. Key Information – Risk Factors – Risks Relating to Our Israeli
Operations.)
Inflation and Currency Exchange Rates
The U.S. dollar cost of our operations in Israel is influenced by any increase in the rate of inflation in Israel that is
not fully offset by the devaluation of the NIS in relation to the U.S. dollar. Unless inflation in Israel is offset by a devaluation of
the NIS, such inflation may have a negative effect on the profitability of contracts where Elbit Systems or any of our Israeli
subsidiaries receives payment in U.S. dollars, NIS linked to U.S. dollars or other foreign currencies, but incurs expenses in NIS
linked to the CPI. Inflation in Israel and currency fluctuations may also have a negative effect on the profitability of fixed-price
contracts where we receive payments in NIS.
In the past, our profitability was negatively affected when inflation in Israel (measured by the change in the CPI
from the beginning to the end of the calendar year) exceeded the devaluation of the NIS against the U.S. dollar and at the same
time we experienced corresponding increases in the U.S. dollar cost of our operations in Israel. For example, in 2014, inflation
decreased by approximately 0.2%, and the NIS depreciated against the U.S. dollar by approximately 12%. In 2015, the inflation
rate decreased by approximately 0.2%, and the NIS depreciated against the U.S. dollar by approximately 0.3%. In 2016, the
inflation rate decreased by approximately 0.2%, and the NIS strengthened against the U.S. dollar by approximately 1.5%. There
can be no assurance that we will not be materially adversely affected in the future if inflation in Israel exceeds the devaluation
of the NIS against the U.S. dollar or if the timing of such devaluation lags behind increases in inflation in Israel.
A devaluation of the NIS in relation to the U.S. dollar also has the effect of decreasing the dollar value of any of
our assets that consist of NIS or accounts receivable denominated in NIS, unless such assets or accounts receivable are linked to
the U.S. dollar. Such a devaluation also has the effect of reducing the U.S. dollar amount of any of our liabilities that are
payable in NIS, unless such payables are linked to the U.S. dollar. On the other hand, any increase in the value of the NIS in
relation to the U.S. dollar will have the effect of increasing the U.S. dollar value of any unlinked NIS assets as well as the U.S.
dollar amount of any unlinked NIS liabilities and expenses.
Foreign Currency, Derivatives and Hedging
While our functional currency is the U.S. dollar, we also have some non-U.S. dollar or non-U.S. dollar linked
exposure to currencies other than NIS. These are mainly non-U.S. dollar customer debts, payments to suppliers and
subcontractors as well as obligations in other currencies, assets or undertakings. Some subcontractors are paid in local currency
under prime contracts where we are paid in U.S. dollars. The exposure on these transactions has not been in amounts that are
material to us. However, when we view it economically advantageous, due to anticipated uncertainty in the applicable foreign
exchange rates, we seek to minimize our foreign currency exposure by entering into hedging arrangements, obtaining periodic
payments upon the completion of milestones, obtaining guarantees and security from customers and sharing currency risks with
subcontractors.
A significant part of our future cash flows that will be denominated in currencies other than the NIS and the U.S.
dollar were covered as of December 31, 2016 by forward contracts. On December 31, 2016, we had forward contracts for the
sale and purchase of Euro, GBP and various other currencies totaling approximately $207 million ($127 million in Euros, $36
million in GBP and the balance of $44 million in other currencies).
We also use forward exchange hedging contracts and options strategies in order to limit our exposure to exchange
rate fluctuation associated with payroll expenses, mainly incurred in NIS. These include forward contracts with notional
amount of approximately $647 million to purchase NIS maturing in 2016. (See also Item 11. Quantitative and Qualitative
Disclosure of Market Risks.) As of December 31, 2016, an unrealized net loss of approximately $19 million was included in
accumulated other comprehensive income. As of December 31, 2016, all of the forward contracts are expected to mature during
the years 2017 – 2021.
Regarding the measures taken to reduce the foreign currency exchange rate impact on our Series A Notes see
above “Liquidity and Capital Resources – Israeli Debt Offering.”
43
The table below presents the balance of the derivative instruments held in order to limit the exposure to exchange
rate fluctuations as of December 31, 2016 and is presented in millions of U.S. dollar equivalent terms:
Forward
Buy US$ and Sell:
Euro
GBP
NIS
Other various currencies
Forward
Sell US$ and Buy:
Euro
GBP
NIS
Other various currencies
*
Notional amount information is based on the foreign exchange rate at year end.
Notional
Amount*
Unrealized
Gain (Loss)
89.8
31.5
—
19.3
6.5
3.0
—
0.1
Notional
Amount*
Unrealized
Gain (Loss)
37.1
4.8
646.5
25.1
(1.6 )
(0.7 )
3.1
—
44
Contractual Obligations
1. Long-Term Debt Obligations(1)
2. Series A Notes(1)
3. Interest payment(2)
4. Operating Lease Obligations(3)
5. Purchase Obligations(3)
6. Other Long-Term Liabilities Reflected on the Company’s Balance
Sheet under U.S. GAAP(4)
7. Other Long-Term Liabilities(5)
Total
Up to
1 year
165
56
9
47
972
—
—
1,249
2-3 years
4-5 years
(U.S. dollars in millions)
1
56
1
36
45
—
112
7
63
192
—
—
374
—
—
139
More than
5 years
—
—
—
—
104
—
—
104
(1)
(2)
(3)
(4)
The above includes derivative instruments defined as hedge accounting - see Item 18. Financial Statements - Note
2(Y).
All our long-term debt borrowings and Series A Notes bear interest at variable rates, which are indexed to LIBOR
(plus a fixed spread). For long-term fixed rate borrowings (mainly Series A Notes) we use variable interest rate
swaps, effectively converting our long-term fixed rate borrowings to long-term variable rate borrowings indexed
to LIBOR. (See also Item 18. Financial Statements - Notes 15 and 16.) To estimate the scheduled interest
payments related to Series A Notes, we applied the future expected interest rates that were used for calculating the
fair value of our interest rate swap at the balance sheet date. To estimate the scheduled interest payments related to
our other long-term debt obligations we used the LIBOR (plus a fixed spread) interest rates that were effective at
the balance sheet date. The majority of our long-term debt obligations are scheduled to be repaid within a period
of two - three years.
For further description of the Purchase Obligations see above “Long-Term Arrangements and Commitments –
Purchase Commitments” and see Item 18. Financial Statements – Notes 20(D) and 20(G).
The obligation amount does not include an amount of $376 million of pension and employee termination
liabilities. See Item 18. Financial Statements – Notes 2(R) and 17. The obligation amount also does not include an
amount of $47 million of tax reserve related to uncertain tax positions. See Item 18. Financial Statements – Note
18.
(5)
See below “Off-Balance Sheet Transactions.”
Off-Balance Sheet Transactions
Buy-Back
In connection with projects in certain countries, Elbit Systems and some of our subsidiaries have entered and may
enter in the future into “buy-back” or “offset” agreements, required by a number of our customers as a condition to our
obtaining orders for our products and services. These agreements are customary in our industry and are designed to facilitate
economic flow back (buy-back) and/or technology transfer to businesses or government agencies in the applicable country.
These commitments may be satisfied by our placement of direct work or vendor orders for supplies and/or
services, transfer of technology, investments or other forms of assistance in the applicable country. The buy-back rules and
regulations, as well as the underlying contracts, may differ from one country to another. The ability to fulfill the buy-back
obligations may depend, among other things, on the availability of local suppliers with sufficient capability to meet our
requirements and which are competitive in cost, quality and schedule. In certain cases, our commitments may also be satisfied
through transactions conducted by other parties.
45
We do not commit to buy-back agreements until orders for our products or services are definitive, but in some
cases the orders for our products or services may become effective only after our corresponding buy-back commitments
become effective. Buy-back programs generally extend at least over the relevant commercial contract period and may provide
for penalties in the event we fail to perform in accordance with buy-back requirements. In some cases we provide guarantees in
connection with the performance of our buy-back obligations.
Should we be unable to meet such obligations we may be subject to contractual penalties, our guarantees may be
drawn upon and our chances of receiving additional business from the applicable customers could be reduced or, in certain
cases, eliminated. (See Item 3. Risk Factors – General Risks Related to Our Business and Market.)
At December 31, 2016, we had outstanding buy-back obligations totaling approximately $1.1 billion that extend
through 2024.
Non-GAAP Financial Data
The following non-GAAP financial data is presented to enable investors to have additional information on our
business performance as well as a further basis for periodical comparisons and trends relating to our financial results. We
believe such data provides useful information to investors by facilitating more meaningful comparisons of our financial results
over time. Such non-GAAP information is used by our management to make strategic decisions, forecast future results and
evaluate our current performance. However, investors are cautioned that, unlike financial measures prepared in accordance with
GAAP, non-GAAP measures may not be comparable with the calculation of similar measures for other companies.
The non-GAAP financial data below includes reconciliation adjustments regarding non-GAAP gross profit,
operating income, net income and diluted EPS. In arriving at non-GAAP presentations, companies generally factor out items
such as those that have a non-recurring impact on the income statements, various non-cash items, significant effects of
retroactive tax legislation and changes in accounting guidance and other items which, in management’s judgment, are items that
are considered to be outside the review of core operating results. In our non-GAAP presentation, we made certain adjustments
as indicated in the table below.
These non-GAAP measures are not based on any comprehensive set of accounting rules or principles. We believe
that non-GAAP measures have limitations in that they do not reflect all of the amounts associated with our results of operations,
as determined in accordance with GAAP, and that these measures should only be used to evaluate our results of operations in
conjunction with the corresponding GAAP measures. Investors should consider non-GAAP financial measures in addition to,
and not as replacements for or superior to, measures of financial performance prepared in accordance with GAAP.
46
Reconciliation of GAAP (Audited) to
Non-GAAP (Unaudited) Supplemental Financial Data
(U.S. dollars in millions, except for per share amounts)
GAAP gross profit
Adjustments:
Amortization of purchased intangible assets
Non-GAAP gross profit
Percent of revenues
GAAP operating income
Adjustments:
Amortization of purchased intangible assets
Gain from change in holdings
Non-GAAP operating income
Percent of revenues
GAAP net income attributable to Elbit Systems’ shareholders
Adjustments:
Amortization of purchased intangible assets
Impairment of investment
Capital gain
Gain from changes in holdings
Related tax benefits
Non-GAAP net income attributable to Elbit Systems’ shareholders
Percent of revenues
GAAP diluted net EPS
Adjustments, net
Non-GAAP diluted net EPS
Years Ended December 31,
2016
2015
2014
959.6
897.1
825.1
31.2
990.8
29.9
927.0
21.6
846.7
30.4 %
29.8 %
28.6 %
299.0
268.6
246.9
41.2
(17.6 )
322.6
9.9 %
48.1
—
316.7
43.1
(6.0 )
284.0
10.2 %
9.6 %
236.9
202.5
171.0
41.2
2.5
(3.9 )
(16.4 )
(6.1 )
254.2
7.8 %
5.54
0.41
5.95
48.1
—
—
—
(8.2 )
242.4
7.8 %
4.74
0.93
5.67
43.1
—
—
(6.0 )
(6.9 )
201.2
6.8 %
4.01
0.70
4.71
47
Item 6.
Directors, Senior Management and Employees.
Directors and Executive Officers
Board of Directors (Board)
Our directors as of March 15, 2017 are as follows:
Name
Michael Federmann (Chair)
Rina Baum
Yoram Ben-Zeev
David Federmann (Vice Chair)
Dr. Yehoshua Gleitman (External Director)
Dov Ninveh
Professor Ehood (Udi) Nisan
Dalia Rabin (External Director)
Professor Yuli Tamir
__________________
* was not a member of the Board from April - October 2013
Age
Director
Since
73
71
72
42
67
69
49
66
63
2000
2001
2014
2007
2010
2000*
2016
2010
2015
The term of office of each director, other than the External Directors, expires at the annual general
shareholders meeting to be held during 2017. The term of office for Yehoshua Gleitman as an External Director expires in
March 2019, and the term of office for Dalia Rabin as an External Director expires in November 2019.
Michael Federmann. Michael Federmann has served as chair of the Board since 2000. Since 2002 he has
served as chair and CEO of Federmann Enterprises Ltd. (FEL), a privately-owned Israeli company in which Mr.
Federmann has held managerial positions since 1969. FEL, directly and through subsidiaries, holds a diversified
portfolio of investments, including ownership of approximately 46% of the Company’s outstanding ordinary shares. FEL
also has ownership interests in Dan Hotels Ltd. (Dan Hotels), an Israeli hotel chain, in Freiberger Compound Materials
GmbH (Freiberger), a German company engaged in the supply of materials for the semi-conductor industry, as well as in
several financial, real estate and venture capital investments. Mr. Federmann serves as chair of the board of directors of
Dan Hotels and is chair of the board of governors of the Hebrew University of Jerusalem (the Hebrew University). He
serves as the president of the Israel - Germany Chamber of Industry and Commerce and is an Honorary Commander of
the Order of the British Empire (CBE). Mr. Federmann holds a bachelor’s degree in economics and political science from
the Hebrew University, which has also awarded him an honorary doctorate in philosophy.
Rina Baum. Rina Baum is vice president for investments of FEL and since 1986 has served as a director and
as general manager of Unico Investment Company Ltd. She serves as a director of Dan Hotels and Etanit Building
Products Ltd. (Etanit), and holds other managerial positions with investee companies of FEL. She also serves as a director
of Harel-PIA Mutual Funds Management Company Ltd. Mrs. Baum holds an L.L.B. degree in law from the Hebrew
University.
Yoram Ben-Zeev. Yoram Ben-Zeev serves as a director of Kardan Ltd., an Israel-based publicly-traded
company, operating mainly in the fields of real estate, property sales and rentals, leasing of vehicles as well as investments
in the communication and technology sectors. Mr. Ben-Zeev also serves on the board of several non-profit organizations
in Israel and is a member of the Israel Ministry of Foreign Affairs’ (MFA) Nomination Committee. He served as Israel's
ambassador to the Federal Republic of Germany from 2007 until 2012. Prior to that, he served for 26 years in various
senior positions in the MFA, including as deputy general director, head of the North America Division and senior member
of the directorate. Among other positions held during his service in the MFA, Mr. Ben-Zeev served as Israel's consul
general to the West Coast in the United States, political advisor to the president of the State of Israel, special coordinator
to the Middle East peace process, advisor to prime minister Ehud Barak for the Camp David Peace Conference and chair
of the MFA’s Steering Committee - Foreign Service Strategic and Functional Planning and of the Israel-Canada Annual
Strategic Forum. Mr. Ben-Zeev has been the recipient of special awards for his diplomatic service from both the U.S.
House of Representatives and the president of the Federal Republic of Germany. Mr. Ben-Zeev holds a bachelor's degree
in Middle Eastern studies, political science and international relations from the Hebrew University and a master's degree
48
in Middle Eastern studies from the Tel-Aviv University. Mr. Ben Zeev serves as the chair of the Corporate Governance
and Nominating Committee of the Board and as a member of the Audit Committee, the Financial Statements Review
Committee and the Compensation Committee of the Board.
David Federmann. David Federmann has served as vice chair of the Board since 2015. He has served in
various management capacities in FEL since 2000. He currently serves as chair of the board of Freiberger and as a
member of the boards of directors of Dan Hotels and BGN Technologies (the technology transfer company of Ben-Gurion
University). David Federmann is the son of Michael Federmann, chair of the Board. Mr. Federmann holds a bachelor’s
degree in mathematics and philosophy from New York University.
Dr. Yehoshua Gleitman (External Director). Dr. Yehoshua (Shuki) Gleitman has served since 2001 as the
managing partner of Platinum VC, a venture capital firm. He currently serves as the chair of the board of directors of
Capital Point Ltd. and and of GIBF - Guangzhou Israel Bio Tech Fund, and is a director of Teuza - A Fairchild
Technology Venture Ltd. From 2000 until 2005, he was the chief executive officer and a director of SFKT Ltd. From 1997
until 1999, Dr. Gleitman was the chief executive officer of Ampal-American Israel Corporation. Prior to that he served in
various senior management positions in the Israeli government and in Israeli industry, including as director general and
chief scientist of the Israel Ministry of Industry and Trade, chair of the U.S.-Israel Industrial R&D Foundation, joint chair
of the U.S.-Israel Science and Technology Commission, managing director of AIMS Ltd., vice president and general
manager of Elop Electro-Optic Industries Ltd.’s (Elop) marine and aerial operations and head of the Laser Branch of the
Israel Ministry of Defense. Dr. Gleitman serves as the honorary consul general of Singapore to Israel. Dr. Gleitman holds
bachelor of science, master of science and PhD degrees in physical chemistry from the Hebrew University. Dr. Gleitman
serves as the chair of the Audit Committee and the Financial Statements Review Committee of the Board and as a member
of the Compensation Committee and the Corporate Governance and Nominating Committee of the Board. He is
considered by the Board to have accounting and financial expertise under the Companies Law.
Dov Ninveh. Dov Ninveh has served as chief financial officer and a manager in FEL since 1994 and as
general manager of Heris Aktiengesellschaft since 2012. He serves as a director of Dan Hotels and Etanit, and as a
member of the board of Freiberger. Mr. Ninveh served as a director of Elop from 1996 until 2000. From 1989 to 1994, he
served as deputy general manager of Etanit Building Products Ltd. Mr. Ninveh holds a bachelor of science degree in
economics and management from the Israel Institute of Technology (the Technion).
Professor Ehood (Udi) Nisan. Prof. Ehood (Udi) Nisan is a professor in the School of Public Policy and
Government of the Hebrew University. He serves as chair of the board of directors of Midreshet Sde Boker Banegev Ltd., an
Israeli government company, is a member of the board of Bezalel Academy of Art and chair of its finance committee, and an
External Director of Solgreen (Israel) Ltd. and of Rekah Pharmaceutical Industry Ltd. From 2013 to 2016, he was the chair of
the board of directors of Delek, The Israel Fuel Corporation Ltd. From 2009 to 2011, Prof. Nisan was the director of the
budgets department of the Israeli Ministry of Finance, and from 2007 to 2009 he served as the director of the Government
Companies Authority. Prior to that he served in various executive positions in the Israeli Ministry of Finance and served as a
member and chair of several government and public committees, including from 1999 until 2002 as the CEO of the Jerusalem
Development Authority. Prof. Nisan holds bachelor’s and master's degrees in economics and business administration, and a
PhD in economics and public policy from the Hebrew University. Prof. Nisan serves as a member of the Audit Committee and
the Financial Statements Review Committee of the Board. He is considered by the Board to have accounting and financial
expertise under the Companies Law.
Dalia Rabin (External Director). Dalia Rabin is the chair of the Yitzhak Rabin Center, a national institute
dedicated to ensuring that the legacy of former Prime Minister and Minister of Defense Yitzhak Rabin continues to impact
Israeli society through experiential educational programming, a national archive and a museum. Before that, Mrs. Rabin
was a member of the Israeli Government from 1999 until 2002. She is the president of the Center for Arbitration and
Dispute Resolution and a member of the board of directors of Peilim Investment Portfolio Management Company Ltd.
Mrs. Rabin was elected to the Knesset on the Center Party Ticket in 1999 and acted as chair of the Ethics Committee. She
also served on the Constitution, Law and Justice Committee; the Committee for the Advancement of the Status of Women;
the State Control Committee; and the Committee for the Advancement of the Status of the Child. In 2001, Mrs. Rabin was
appointed Deputy Minister of Defense. She resigned in 2002 to head the Rabin Center. Prior to her election to the
Knesset, Mrs. Rabin served as the legal advisor of the professional associations of the General Federation of Labor (the
Histadrut). She also served for fourteen years in the Tel-Aviv District Attorney's Office in the Civil Division, specializing
in labor law. Mrs. Dalia Rabin holds an L.L.B degree from Tel-Aviv University. Mrs. Rabin serves as the chair of the
Compensation Committee of the Board and as a member of the Audit Committee, the Financial Statements Review
Committee and the Corporate Governance and Nominating Committee.
49
Professor Yuli Tamir. Prof. Yuli Tamir has served since 2010 as the President of Shenkar College, a public
college in Ramat-Gan, Israel. Before that, from 2006 until 2009, she served as Israel’s Minister of Education. Prof. Tamir
also served as the Minister of Immigration from 1999 until 2001. She was a deputy speaker of the Knesset and a member
of the Finance Committee, the Education Committee and the Security and Foreign Affairs Committee. Prof. Tamir is a
founding member of the Israeli peace movement "Peace Now". She served as the chair of the Association of Civil Rights
in Israel and was a member of the political committee of the Women’s Lobby. She was a professor at Tel-Aviv University
and a scholar-in-residence at Princeton University, Harvard University, the University of Pennsylvania, the European
University in Florence, the Central European University in Budapest and the Blavatnik School of Government in Oxford.
Prof. Tamir is the recipient of numerous academic awards. Prof. Tamir holds a bachelor of science degree in biology and a
master's degree in political science from the Hebrew University and a PhD in political philosophy from Oxford
University. Prof. Tamir serves as a member of the Audit Committee and the Financial Statements Review Committee of
the Board.
50
Executive Officers
Our executive officers, the President and CEO and the Executive Vice Presidents who report to the President and
CEO) as of March 15, 2017 are as follows:
Name
Age
Position
Bezhalel Machlis
Elad Aharonson
Jonathan Ariel
David Block Temin
Adi Dar
Joseph Gaspar
Zeev Gofer
Shelly Gordon
Ran Kril
Edgar Maimon
Avi Mizrachi
Ilan Pacholder
Yuval Ramon
Gideon Sheffer
Yoram Shmuely
Yehuda Vered
Yehoshua Yehuda
54
43
60
61
45
68
64
56
46
61
59
62
51
68
56
59
49
President and Chief Executive Officer
Executive Vice President and General Manager – ISTAR Division
Executive Vice President and Chief Legal Officer
Executive Vice President, Chief Compliance Officer and Senior Counsel
Executive Vice President and General Manager – CYBERBIT
Executive Vice President and Chief Financial Officer
Executive Vice President – Strategic and Business Development - North
America
Executive Vice President – Human Resources
Executive Vice President - International Marketing and Business
Development
Executive Vice President and General Manager – EW and SIGINT Elisra
Division
Executive Vice President - Business Development - Israel and Southeast Asia
Executive Vice President – Mergers and Acquisitions and Financing
Executive Vice President and Chief Operating Officer
Executive Vice President – Strategic Planning
Executive Vice President and General Manager – Aerospace Division
Executive Vice President and General Manager – Land and C4I Division
Executive Vice President - Chief Technology Officer
Bezhalel Machlis. Bezhalel Machlis has served as the Company’s President and CEO since 2013. From
2008 until 2012, he served as executive vice president and general manager – land and C4I division, after serving as
corporate vice president and general manager – land systems and C4I since 2004. In 2003, he served as corporate vice
president and general manager – ground, C4I and battlefield systems. From 2000 until 2002, he served as vice president –
battlefield and information systems. Mr. Machlis joined Elbit Ltd. in 1991 and held various management positions in the
battlefield and information systems area. Prior to that, he served as an artillery officer in the IDF, where he holds the rank
of colonel (reserves). Mr. Machlis holds a bachelor of science degree in mechanical engineering and a bachelor of arts
degree in computer science from the Technion and an MBA from Tel-Aviv University. He is a graduate of Harvard
University Business School's Advanced Management Program.
Elad Aharonson. Elad Aharonson has served as Executive Vice President and General Manager - ISTAR
Division since 2015. From 2011 until his current appointment, he served as executive vice president and general manager
- UAS Division, after serving as vice president - UAV systems since 2009. He joined Elbit Systems in 2004 and held
various senior program management positions relating to UAS. Prior to that, Mr. Aharonson served as an officer in the
IDF holding command positions in the Artillery Branch and in the Ground Forces’ UAV unit. Mr. Aharonson holds an
L.L.B. degree in law and a bachelor’s degree in business administration from the Hebrew University.
51
Jonathan Ariel. Jonathan Ariel has served as Executive Vice President and Chief Legal Officer since 2012,
after serving as senior vice president and general counsel since 2008. He joined Elbit Systems in 1996 and has held
several positions within the legal department, including vice president and general counsel of Elop. Prior to joining Elbit
Systems, Mr. Ariel served as a legal advisor both in-house and in private law firms in Israel and the U.S. Mr. Ariel holds
an L.L.B degree in law from Tel-Aviv University and is admitted to the Israeli Bar.
David Block Temin. David Block Temin has served as Executive Vice President, Chief Compliance Officer
and Senior Counsel since 2012, after serving as executive vice president, chief legal officer and chief compliance officer
since 2008. Prior to that he served as corporate vice president and general counsel since 2000 and as general counsel
since 1996. From 1987 to 1996, he was a legal advisor to Elbit Ltd. Prior to that, Mr. Block Temin was an attorney with
law firms in New York City. Mr. Block Temin received a juris doctor degree as well as a master of arts degree in
international relations from Stanford University and holds a bachelor of arts degree in political science from the
University of Maryland. He is admitted to the Israeli bar.
Adi Dar. Adi Dar was appointed as Executive Vice President and General Manager - CYBERBIT in 2015.
From 2009 until his current appointment, he served as executive vice president and general manager - Electro-optics -
Elop Division. From 2006 until 2009, he served as Elop’s vice president for business development. Prior to that he served
in a number of management positions in Elbit Systems, which he joined in 2002. From 1999 until 2002, he was vice
president for business development and marketing at Elron Telesoft Ltd. Mr. Dar holds a bachelor's degree in industrial
engineering from the Technion and an MBA from Tel-Aviv University.
Joseph Gaspar. Joseph Gaspar was appointed as an Executive Vice President in 2008 and has served as
Chief Financial Officer since 2001. He was appointed as a corporate vice president in 2000 and served as corporate vice
president – strategy, technology and subsidiaries from 2000 until 2001. From 1996 until 2000, he held the position of
corporate vice president, marketing and business development of Elop. Mr. Gaspar joined Elop in 1975 and held several
management positions, including vice president and general manager of Elop’s optronics product division and co-manager
of an Elop subsidiary in the United States. Mr. Gaspar holds a bachelor of science degree from the Technion in electronic
engineering with advanced studies in digital signal processing and communication.
Zeev Gofer. Zeev Gofer has served as Executive Vice President – Strategic and Business Development –
North America since 2009. From 2008 until his current appointment he was executive vice president – business
development and marketing, after serving as corporate vice president – business development and marketing since 2003.
He previously served as corporate vice president and as co-general manager – aircraft and helicopter upgrades and
systems from 2000 until 2003. From 1999 until 2000, he was vice president – aircraft upgrades and airborne systems
division, having served as division manager since 1996. He joined Elbit Ltd. in 1982 and held various management
positions, including director of the aircraft upgrade division, director of a major aircraft upgrade program, director of
avionics system engineering and technical manager of the Lavi aircraft avionics program. Mr. Gofer holds bachelor's and
master of science degrees in electronic engineering from the Technion and a master of science of management degree
from the Polytechnic University of New York.
Shelly Gordon. Shelly Gordon was appointed as Executive Vice President - Human Resources shortly after
joining Elbit Systems in 2015. From 2012 until joining Elbit Systems, she headed executive education at the
Interdisciplinary Center Herzilya. From 2005 until 2012, Dr. Gordon served as vice president - organizational
development and talent management at Amdocs Limited and served as vice president - human resources at Elite
Confectionary Ltd. from 2000 until 2005. Prior to that, she worked as an independent consultant with management teams
and senior managers, leading major transformations in varied organizations and industries. Dr. Gordon received a
bachelor’s degree in education and art from the Hebrew University, a bachelor’s degree in psychology from Tel-Aviv
University and a doctorate in management studies from the University of Hertfordshire in the U.K.
Ran Kril. Ran Kril was appointed as Executive Vice President - International Marketing and Business
Development in 2015. From 2013 until his current appointment, he served as vice president for marketing and sales in the
aerospace division, after serving as the aerospace division’s vice president for sales and contracts since 2007. He joined
Elbit Systems in 1997 and held various senior positions in the marketing, sales and finance departments of the aerospace
division. Mr. Kril holds a bachelor of science degree in economics and management from the Technion and a master of
science of management degree from the Polytechnic University of New York.
52
Edgar Maimon. Edgar Maimon has served as Executive Vice President and General Manager – EW and
SIGINT Elisra Division since 2013. From 2005 until his current appointment Mr. Maimon served as vice president of
marketing and business development at Elbit Systems EW and SIGINT – Elisra Ltd. (Elisra). He joined Elisra in 2004.
Prior to that Mr. Maimon served for 26 years in the IAF, where he retired with the rank of colonel. He served as the head
of the IAF’s C4I systems engineering department and held several additional senior positions in the IAF. Mr. Maimon
holds a bachelor of science degree in electronic engineering from Ben Gurion University.
Avi Mizrachi. Avi Mizrachi was appointed Executive Vice President - Business Development - Israel and
Southeast Asia in January 2017, after serving as executive vice president - business development - Southeast Asia since
2014. He joined Elbit Systems in 2013 as a senior vice president in the corporate marketing department. Prior to that, Mr.
Mizrachi completed 33 years of service in the IDF, retiring with the rank of major general. From 2009 to 2012, he served
as the commander of the IDF’s Central Command. Prior to that he held a number of senior command positions including
head of the Technology and Logistics Branch and commander of the IDF’s Ground Forces. Mr. Mizrachi holds a bachelor
of arts degree in computer science and business administration from Pace University in New York and is a graduate of the
Harvard University Business School’s Advanced Management Program.
Ilan Pacholder. Ilan Pacholder has served as Executive Vice President – Mergers and Acquisitions since
2009, in addition to his position as Executive Vice President – Financing to which he was appointed in 2008. From 2008
until 2015, he also served as executive vice president - offset. During 2007, he served as vice president and chief
financial officer of Tadiran Communications Ltd. Mr. Pacholder served as corporate secretary and vice president – finance
and capital markets of Elbit Systems from 2003 until 2006. From 2001 until 2003, he served as vice president – finance.
Mr. Pacholder joined Elbit Ltd. in 1994 and held various senior positions in the finance department. Prior to joining Elbit
Ltd. he served as the chief financial officer for Sanyo Industries in New York. Before that Mr. Pacholder worked for Bank
Leumi in New York and held the position of vice president in the international and domestic lending departments. Mr.
Pacholder holds a bachelor of arts degree in accounting and economics from Queens College in New York and an MBA in
finance and investments from Adelphi University.
Yuval Ramon. Yuval Ramon was appointed Executive Vice President and Chief Operating Officer in 2015.
From 2014 until his current appointment, he served as vice president - corporate operations. Prior to that, from 1998 -
2013, he served in a number of management positions in Elbit Systems of America, including as senior vice president of
operations, site lead at the Merrimack operations and director of sales and contracts for the Fort Worth operations. He
joined Elbit Systems in 1994 as a sales and contract manager. Mr. Ramon holds a bachelor of science degree in industrial
engineering and economics from the Technion.
Gideon Sheffer. Gideon Sheffer has served as Executive Vice President – Strategic Planning since January
2017, after serving as executive vice president - strategic planning and business development – Israel since 2009. From
2008 until 2009 he served as executive vice president – strategic planning, after serving as corporate vice president –
strategic planning since 2001. Prior to that he served as acting head of Israel’s National Security Council and as national
security advisor to former prime minister Ehud Barak. In 1998, he completed 32 years of service in the IDF, retiring with
the rank of major general. From 1995 to 1998, he served on the general staff as head of the IDF’s human resources branch.
Before that, he served as deputy commander of the IAF. Mr. Sheffer held a number of command positions in the IAF after
serving as a fighter aircraft and helicopter pilot. Mr. Sheffer holds a bachelor’s degree in Israel studies from Bar Ilan
University and is a graduate of the Harvard University Business School’s Advanced Management Program.
Yoram Shmuely. Yoram Shmuely has served as Executive Vice President and General Manager – Aerospace
Division since 2013, after serving as executive vice president and co-general manager of the aerospace division since
2008. Mr. Shmuely served as corporate vice president and co-general manager – airborne and helmet systems since 2003.
He served as corporate vice president and general manager – helmet mounted systems from 2000 until 2003. From 1998
until 2000, he was vice president – helmet mounted systems division. From 1996 until 1998, he served as president of a
U.S. subsidiary of Elbit Systems. Mr. Shmuely joined Elbit Ltd. in 1990 and served as director of Elbit Ltd.’s helmet
mounted display business. He served as a fighter aircraft pilot in the IAF. Mr. Shmuely holds a bachelor of science degree
in electronic engineering from the Technion.
53
Yehuda Vered. Yehuda (Udi) Vered has served Executive Vice President and General Manager – Land and
C4I Division since 2013. From 2009 until his current appointment Mr. Vered served as executive vice president – service
solutions as well as vice president – marketing for the land and C4I division. Prior to that, since 2004 he served as chief
financial officer and vice president for contracts and sales of the land and C4I division. Mr. Vered joined Elbit Systems in
2003 as vice president for contracts and sales and chief financial officer – ground, C4I and battlefield systems. Before
that, he served as an aircrew officer in the IAF, where he holds the rank of colonel (reserves). Mr. Vered holds a bachelor
of arts degree in management and economics from Tel-Aviv University, an MBA from Ben Gurion University and is a
graduate of the Harvard University Business School’s Advanced Management Program.
Yehoshua Yehuda. Yehoshua (Shuki) Yehuda was appointed as Executive Vice President and Chief
Technology Officer in January 2016. From 2008 until his current appointment, he served as Elisra’s vice president and
chief technology officer as well as general manager - radar solutions business unit. Prior to that he served in a number of
management positions in Elisra, which he joined in 2000. Prior to joining Elisra, Mr. Yehuda served as an officer in the
IDF, holding command positions in the Intelligence Corps. Mr. Yehuda holds a bachelor of science degree in electrical
engineering from Tel-Aviv University and a master of science degree in neural computation from the Hebrew University.
He is a graduate of Harvard University Business School's Advanced Management Program.
President and CEO of Elbit Systems of America
Elbit Systems of America’s President and CEO reports to the board of directors of Elbit Systems of America
in accordance with the provisions of the Special Security Agreement with the U.S. Department of Defense. (See Item 4.
Information on the Company – U.S. Subsidiaries.) Raanan Horowitz has served as President and CEO of Elbit Systems of
America since 2007. He served as executive vice president and general manager of EFW from 2001 until his current
appointment. From 1991 until 2001, Mr. Horowitz held various management positions with EFW and other U.S.
subsidiaries of the Company. From 1989 to 1991, he served as a senior program manager for Elbit Ltd. Mr. Horowitz
serves on the executive committee of the board of governors of the Aerospace Industries Association and is a member of
the executive committee of the national board of directors of the Leukemia and Lymphoma Society. Mr. Horowitz holds
an MBA from the Seidman School of Business of Grand Valley State University in Allendale, Michigan. He also holds a
master of science degree in electrical engineering and a bachelor of science degree in mechanical engineering from Tel-
Aviv University.
Compensation of Directors and Executive Officers
Compensation Policy
Pursuant to the Companies Law, a public company such as Elbit Systems is required to adopt a
compensation policy regarding the terms of office and employment of its Office Holders (as defined in the Companies
Law) (generally Elbit Systems' directors and executive officers), including compensation, equity-based awards, releases
from liability, indemnification and insurance, severance and all other employment benefits (Employment Terms). In
accordance with the Companies Law, in 2014 our shareholders, following a favorable recommendation of the
Compensation Committee of the Board and the approval of the Board as a whole, approved a compensation policy (the
Compensation Policy) applicable to Employment Terms arrangements with our Office Holders. The Company
contemplates proposing a new compensation policy which will be submitted for the consideration of the Compensation
Committee and approval by the Board and the Company's shareholders, in accordance with the requirements of the
Companies Law.
The Companies Law requires that we obtain the approval of the Compensation Committee and the Board as
a whole for each Employment Terms arrangement with an Office Holder. In addition, the Companies Law requires that
we also obtain the approval of our shareholders for any Employment Terms arrangement with our CEO or a director, or
with any other Office Holder where the terms are not consistent with an approved compensation policy. With respect to
such arrangement with our CEO or in connection with such arrangement with an Office Holder that is not consistent with
an approved compensation policy, such shareholder approval requires that (a) a majority of the Applicable Shareholders
(as defined below) vote to approve the arrangement and (b) Applicable Shareholders who vote against approval do not
represent more than 2% of our total voting rights. For these purposes, “Applicable Shareholders” means shareholders
who are not controlling shareholders and do not have a Personal Interest (as defined in the Companies' Law) in the
arrangement to be approved and who participate in the voting, in person, by proxy or by written ballot (excluding
abstentions).
54
Under certain circumstances described in the Companies Law, if the Employment Terms of an Office Holder
who is not a director or a controlling shareholder that requires the approval of the shareholders as described above, are not
approved by shareholders by the required minority, the Compensation Committee and the Board may nonetheless approve
such arrangement.
In addition, pursuant to the Companies Law, changes determined by the Compensation Committee not to be
material to the existing Employment Terms of an Office Holder who is not a director, require only the approval of the
Compensation Committee.
In accordance with the requirements of the Companies’ Law, at the Shareholders’ Extraordinary General
Meeting held on March 8, 2016, the Company’s shareholders, following the recommendations of the Compensation
Committee and the Board, approved, by the required majority, the Employment Terms of our CEO, Mr. Bezhalel
Machlis, with effect as of April 1, 2016.
For further information see below "Board Practices - Compensation Committee", Item 10 - Additional
Information - General Provisions of Israeli Law and Related Provisions of Articles of Association - Office Holders; and
Item 10 - Additional Information - Approval of Certain Transactions - Approval of Employment Terms of Office Holders.
Compensation of Directors and Executive Officers
Aggregate Compensation to Directors and Executive Officers
The following table sets forth the aggregate compensation costs for all of our directors and executive officers
as a group for the fiscal year ended December 31, 2016:
All directors (consisting of 10 persons)
All executive officers (consisting of 20 persons)
$
$
Salaries,
Directors’
Fees
Commissions
and Bonuses
Pension,
Retirement
and
Similar
Benefits
(U.S. dollars in thousands)
485 (1) $
23,149 (2)(3) $
—
1,702
(1) Directors Fees
In accordance with the Compensation Policy and with the Israeli Companies Regulations (Relief from Related Parties'
Transactions), 5760-2000, in meetings held in October 2016, the Compensation Committee and the Board as a whole
approved payment to the Company's directors, including to Michael Federmann and David Federmann (who each may
be considered a direct or indirect controlling shareholder of the Company), in accordance with maximum regulatory
rates payable to External Directors under Israeli law for companies similarly classified based on their shareholding
equity, which is also paid to the Company's External Directors. As a result, each of the Company's directors is and will
be entitled to an annual fee of NIS 111,345 (equal to approximately $29,057) and a per meeting fee of NIS 4,285
(equal to approximately $1,118), which reflect the above mentioned fee levels, linked to the Israeli consumer price
index.
(2) Phantom Bonus Retention Plan
(i) In 2012, our Board approved a “Phantom” Bonus Retention Plan for Senior Officers (the Phantom Plan). The
purpose of the Phantom Plan is to provide an incentive to retain applicable senior officers of Elbit Systems and
certain of our subsidiaries by strengthening the alignment of the Phantom Plan recipients’ financial interests with
those of the Company and our shareholders. Under the Phantom Plan, phantom bonus units were granted to
executive officers within the framework of three consecutive yearly tranches, each such tranche comprised of an
equal number of units which entitle the recipient the right to receive the financial benefit (Unit Benefits) deriving
from increases in the value of the Company’s shares during the applicable periods, subject to certain restrictions.
Unit Benefits are calculated separately for each tranche. The Unit Benefits accrual period for each tranche is three
years from the respective grant date of the applicable bonus units.
55
(ii) At the end of each year during the Unit Benefits accrual period for each tranche, the Company calculates the value
of each Unit Benefit for such year (the Unit Benefits Value). The Unit Benefits Value is the difference between:
(i) the basic value for that year - i.e. the average closing price on the TASE of the Company’s shares for the thirty
(30) trading days preceding the beginning of the respective year, and (ii) the year-end value for said year - i.e. the
average closing price on the TASE of the Company’s shares for the thirty (30) trading days preceding the end of
the relevant year.
(iii) The accrued Unit Benefits Value for each yearly tranche is the sum of the first year Unit Benefits Value, the
second year Unit Benefits Value and the third year Unit Benefits value for that tranche. Because of certain
conditions in the Phantom Plan, the Unit Benefits Value for a particular year of a tranche may be zero or only part
of the calculated Unit Benefits Value for that year. The aggregate maximum Unit Benefits Value of a unit granted
for the full three years of a tranche may not exceed 100% of the basic value determined for that tranche for its first
year. Except in certain circumstances described in the Phantom Plan, the accrued Unit Benefits Value of a tranche
is paid to the recipient at the end of the third year of the respective tranche.
(iv) Except as otherwise provided in the Phantom Plan, entitlement to receipt of benefits is conditioned on the
recipient remaining an employee of the Company. The benefits received under the Phantom Plan are subject to tax
at the regular personal income tax rates.
(v) We recorded amounts of approximately $15.1 million and $14.7 million in 2015 and 2016, respectively, as
compensation costs related to grants to our executive officers under the Phantom Plan. See Item 18. Financial
Statements – Note 21(D).
(3) Other Compensation
In addition to payment of monthly salary and annual bonus, our executive officers are entitled to reimbursement of
travel and certain other expenses in a manner similar to other employees.
Office Holders of the Company, including our directors and executive officers, are covered by our D&O liability
insurance policy and are entitled to indemnification in accordance with our Articles of Association and pursuant to an
indemnification letter as approved by our shareholders. (See Item 10. "Additional Information - Exemption, Insurance and
Indemnification of Directors and Officers - Exemption, Insurance and Indemnification Under the Companies Law".)
Compensation of Five Most Highly Compensated Office Holders
The following describes the compensation of our five most highly compensated Office Holders with respect to
the year ended December 31, 2016. All amounts specified are in terms of cost to the Company as recorded in our financial
statements. Each of the mentioned Office Holders was employed on a full-time basis in 2016.
Compensation for each of the specified executive officers is indicated in terms of the following types of
compensation costs:
(1) Salary Costs. Salary Costs include gross salary and social benefits. Salary Costs also include, if and to the
extent applicable to a respective Office Holders, vacation days, sick days, convalescence pay, monthly remuneration for a
study fund, contributions made by the Company on behalf of the Office Holders to an insurance policy or a pension fund,
contributions by the Company on behalf of the Office Holders towards work disability insurance, benefit for company car
and benefit for communication costs. U.S. dollar amounts indicated for Salary Costs are based on the exchange rate of
3.832, which represents the average weighted U.S. dollar - NIS exchange rate for the date of payments for each of the
months during 2016 (Average Exchange Rate).
(2) Bonus Costs. Bonus Costs represent bonuses (annual, managerial evaluation and/or special, as the case may
be) to the Office Holders with respect to the year ended December 31, 2016. U.S. dollar amounts indicated for Bonus
Costs are based on the Average Exchange Rate .
(3) Phantom Bonus Costs. Phantom Bonus Costs are costs recorded with respect to the year ended December
31, 2016 related to the value of benefits under tranches of phantom bonus units granted to the Office Holders under our
Phantom Bonus Retention Plan (see above "Aggregate Compensation to Directors and Officers - Table - Note (2)" and
Item 18. Financial Statements - Note 21(D).) Benefits under the Phantom Plan cover tranches payable over three years.
56
(4) Stock Option Costs. Stock Option Costs are costs recorded with respect to the year ended December 31,
2016 related to stock options in start-up entities or similar ventures established by the Company (whether by allocation of
options by the start-up entities themselves or by allocation of shares or options to purchase shares of such start-up entities
which are held by the Company).
(5) Other Costs. Other Costs are one-time contributions made by the Company on behalf of the Office Holder
to an insurance policy or a pension fund and/or towards employee disability insurance, as well as accrued vacation
benefits, which contributions are required under Israeli law and agreed employment terms in the event the monthly salary
is increased. These contributions take into account, among other factors, retroactive contributions on the basis of the
actual years of employment with the Company.
The five most highly compensated Office Holders in 2016 were as follows (U.S. dollar amounts in thousands):
(1) Bezhalel Machlis - President and CEO. Compensation costs recorded for Mr. Machlis in 2016 included: $808 in
Salary Costs, $800 in Bonus Costs, $1,927 in Phantom Bonus Costs and $509 in Other Costs.
(2) Joseph Gaspar - Executive Vice President and Chief Financial Officer. Compensation costs recorded for Mr.
Gaspar in 2016 included: $528 in Salary Costs, $148 in Bonus Costs, $1,012 in Phantom Bonus Costs, $7 in
Stock Option Costs and $148 in Other Costs.
(3) Yoram Shmuely - Executive Vice President and General Manager - Aerospace Division. Compensation costs
recorded for Mr. Shmuely in 2016 included: $575 in Salary Costs, $128 in Bonus Costs, $1,012 in Phantom
Bonus Costs, $2 in Stock Option Costs and $108 in Other Costs.
(4) Itzhak Dvir - Corporate Executive Lead One ERP (former Executive Vice President - Special Matters).
Compensation costs recorded for Mr. Dvir in 2016 included: $484 in Salary Costs, $109 in Bonus Costs, $1,012
in Phantom Bonus Costs and $11 in Other Costs.
(5) Gideon Sheffer - Executive Vice President - Strategic Planning. Compensation costs recorded for Mr. Sheffer in
2016 included: $449 in Salary Costs, $141 in Bonus Costs, $1,012 in Phantom Bonus Costs and $9 in Other
Costs.
Board Practices
Appointment of Directors
Our directors who are not External Directors are elected by the shareholders at the annual general
shareholders meeting. They hold office until the next annual general shareholders meeting, which is held at least once
every calendar year but not more than 15 months after the previous general shareholders meeting. Between annual general
shareholders meetings our Board may appoint new directors to fill vacancies. The External Directors are elected at a
general shareholders meeting as described under “External Directors” below. Our Articles of Association authorize a
maximum of 17 directors, a minimum of five directors and, unless otherwise approved by our shareholders, the number of
directors will be nine.
The Companies Law requires the board of directors of a public company, after considering the company’s
type and size and the scope and complexity of its activities, to determine the minimum number of directors on the board
having “financial and accounting expertise” as defined in the Companies Law. Our Board has adopted a policy pursuant to
which it will include a minimum of two directors having financial and accounting expertise as defined under the
Companies Law. Currently our Board has two directors who are considered by the Board to have financial and accounting
expertise: Dr. Gleitman and Prof. Nisan. In addition, the Companies Law provides that a person will not be elected and
will not serve as a director in a public company if he or she does not have the required qualifications and the ability to
dedicate an appropriate amount of time for the performance of his or her director position in the company, taking into
consideration, among other factors, the special needs and size of the company. A general shareholders meeting of a
company whose shares are publicly traded, at which the election of a director is to be considered, will not be held unless
the nominee has declared to the company that he or she complies with the above-mentioned requirements, and the details
of his or her applicable qualifications are provided, and in case such nominee is an "Independent Director" as defined in
the Companies Law (see below), that such nominee has also declared that he or she complies with the independence
criteria under the Companies Law. Each of our elected directors has declared to our Board that he or she complies with the
required qualifications under the Companies Law for appointment as a member of our Board, detailing his or her
57
applicable qualifications, and that he or she is capable of dedicating the appropriate amount of time for the performance of
his or her role as a member of our Board. In addition, Mr. Ben-Zeev, Prof. Nisan and Prof. Tamir also each have declared
that he or she complies with the criteria of an Independent Director under the Companies Law.
In addition to the External Directors, under the Companies Law and regulations thereunder, a director in a
company such as Elbit Systems, who qualifies as an independent director under the relevant non-Israeli rules relating to
independence standards, such as the Nasdaq director independence criteria, may be considered an Independent Director
pursuant to the Companies Law if such director meets certain conditions listed therein, and provided such director has
been designated as such by the audit committee. The Audit Committee has designated Mr. Ben-Zeev, Prof. Nisan and
Prof. Tamir as Independent Directors under the Companies Law.
The current External Directors on our Board were each appointed at a general meeting of shareholders, for a
three-year term, with their terms expiring as described under “External Directors” below. The other seven current
directors were appointed at the annual general meeting of shareholders held in November 2016. There are no service
contracts or similar arrangements with any director that provide for benefits upon termination of directorship.
Nasdaq’s director independence and related rules applicable to boards of directors apply to Elbit Systems.
Under these rules, our Board is required to meet the Nasdaq director independence criteria. Also applicable are certain
other rules regarding independent directors serving on a director nomination committee and the manner for approving the
compensation to Elbit Systems’ CEO. Directors on our Board are recommended for appointment or election by the
Board’s Corporate Governance and Nominating Committee. (See below “Corporate Governance and Nominating
Committee.”)
Substitute Directors. The Articles of Association provide that any director may appoint another person to
serve as a substitute director. A substitute director must be qualified under the Companies Law to serve as a substitute of
the relevant director, and, under the Companies Law, in case the substituted director is an Independent Director as defined
in the Companies Law, the substitute director must also comply with the requirements of the Companies Law for
Independent Directors. If his or her appointment is for more than one meeting it will be subject to the approval of the
Board. Such person may not act as a substitute director for more than one director at the same time. In addition, a Board
committee member may not substitute for another Board committee member in meetings of the applicable committee. The
same rules, including compensation, will apply to a substitute director as to the director who appointed him or her, and the
substitute director may participate in Board and Board committee meetings in the same manner as the appointing director
(subject to any applicable independence criteria). Subject to the Companies Law, a director who has appointed a substitute
director may revoke the appointment at any time. In addition, the office of a substitute director will be vacated at any time
that the office of the director who appointed the substitute is vacated for any reason. Any appointment or revocation of the
appointment of a substitute director will be made by notice in writing to the substitute director and Elbit Systems. The
appointment or revocation, as the case may be, will become effective on the later of the date of receipt of the above notice
or the date fixed in the notice. Appointing a substitute director will not release the appointing director from his/her
liabilities, taking into account the applicable circumstances.
External Directors
Under the Companies Law publicly held Israeli companies are required to appoint at least two “External
Directors.” Among other requirements, for each publicly held company such as Elbit Systems that is considered to have a
controlling shareholder, a person may serve as an External Director:
(A) if that person is not a relative of the controlling shareholder of that company, or if that person (and each
of that person’s relatives, partners and employers), or any person to whom he or she is subordinated
(directly or indirectly), or any entity controlled by that person, did not have, at any time during the two
years preceding that person’s appointment as an External Director, any affiliation (as defined in the
Companies Law) with any of:
(1) the applicable company;
(2) the controlling shareholder of the applicable company or any of his or her relatives on the date of
appointment; or
(3) any entity controlled, on the date of such appointment or at any time within the preceding two years,
by the applicable company or by the controlling shareholder of the applicable company; and
58
(B) if and so long as:
(1) no conflict of interest exists or may exist between that person's responsibilities as a member of the
board of directors of the respective company and that person's other positions or business activities;
or
(2) such position or business activities does not impair that person's ability to serve as a director; and
(C) if and so long as:
(1) that person and each of that person’s relatives, partners and employers, or any person to whom he or
she is subordinated directly or indirectly or any entity controlled by that person has no business or
professional relationships with any of the persons or entities mentioned in (A) above, even if such
relationship is not on a regular basis other than a negligible relationship; and
(2) no other consideration except as permitted under the Companies Law is paid to that person in
connection with that person's position as a director in the relevant company; and
(D) if that person serves also as a member of the board of directors of another company, none of the external
directors of that other company serves at the same time as a member of the board of directors of the
respective company; and
(E) if that person is not an employee of a securities authority or a stock exchange in Israel.
In general, at least one External Director must have “financial and accounting expertise”, and the other
External Director(s) must have “professional competence” as described below. However, in companies such as Elbit
Systems that are “dual listed” (for example traded on a stock exchange in both Israel and the U.S.) if one or more other
directors who meet the independence criteria applicable to members of the audit committee under the foreign applicable
law (including stock exchange rules) have been determined by the board of directors to have “financial and accounting
expertise” then it is permissible for any or all of the External Directors to have only “professional competence” as
described below. Under the relevant regulations of the Companies Law, a director has “financial and accounting
expertise” if he or she, based on his or her education, experience and qualifications, is highly skilled in respect of, and
understands, business and accounting matters and financial statements, in a manner that enables him or her to have an in-
depth understanding of the company’s financial statements and to stimulate discussion with respect to the manner in
which the financial data is presented.
The evaluation of the “financial and accounting expertise” of a director is to be made by the board of
directors taking into account the parameters specified in the relevant regulations of the Companies Law. A director has
“professional competence” if he or she (1) has an academic degree in either economics, business administration,
accounting, law or public administration or an academic degree in an area relevant to the company’s business, or (2) has at
least five years experience in a senior position in the business management of any corporate entity with a substantial
scope of business, in a senior position in public service or in the field of the applicable company’s business. The
evaluation of the professional competence of a director is to be made by the board of directors.
According to the Companies Law and our Articles of Association, our External Directors serve for a three-
year term following which they may stand for up to two additional terms of three years each. Re-election of an External
Director for each additional period beyond the first period requires that he or she: (i) is recommended for re-election by
one or more shareholders holding at least 1% of all voting rights of the relevant company; or (ii) is recommended for re-
election by the board of directors of the relevant company; or (iii) proposes his or her nomination, and, in each case the
nomination is approved by the general meeting of shareholders of the relevant company with the applicable majority
requirements as provided by the Companies Law.
In addition, External Directors in companies such as Elbit Systems that are “dual listed” may stand for re-
election to additional terms of up to three years each beyond the first three terms, subject to meeting the following
conditions:
59
(1) the audit committee and the board both determine that based upon the expertise and the unique
contribution of the External Director to the work of the board and its committees, his or her re-election
for an additional term is for the benefit of the company;
(2) his or her re-election is recommended by the board or by one or more shareholders holding at least 1%
of all voting rights of the relevant company, or if such External Director offered to continue to serve as
such for an additional term;
(3) his or her re-election is approved at a general shareholders meeting by the special majority required for
nomination of External Directors under the Companies Law; and
(4) his or her terms of service as an External Director and the considerations of the audit committee and the
board regarding his or her re-election were presented to the general meeting of shareholders prior to the
vote on such approval.
Our Articles of Association allow the External Directors of the Company to be elected to more than three
terms of service. According to the Companies Law, any committee of the Board must include at least one External
Director, and all External Directors must be members of the Audit Committee and the Compensation Committee.
Dr. Gleitman and Mrs. Rabin currently serve as our Board’s External Directors. Dr. Gleitman’s term of office
ends in March 2019, and the term of office of Mrs. Rabin ends in November 2019. Dr. Gleitman was determined by the
Board to have “financial and accounting expertise” under Israeli law, and Mrs. Rabin was determined by the Board to
have the applicable “professional competence” to serve as an External Director.
Audit Committee. Dr. Gleitman (chair), Mr. Ben-Zeev, Prof. Nisan, Mrs. Rabin and Prof. Tamir are members
of the Audit Committee. In accordance with the Companies Law, an audit committee must consist of at least three
directors qualified to serve as members of an audit committee under the Companies Law, including all External Directors,
and must be comprised of a majority of directors meeting certain independence criteria of the Companies Law. The chair
of the audit committee must be an External Director. In accordance with the applicable Nasdaq rules and those of the
SEC, Elbit Systems Audit Committee must be comprised solely of independent directors, as defined by said rules. The
Audit Committee operates in accordance with an Audit Committee Charter that provides the framework for its oversight
functions consistent with Israeli and U.S. legal and regulatory requirements. All of the members of the Audit Committee
meet the independent criteria of the Companies Law and have been determined to be independent as defined by the
applicable Nasdaq rules and those of the SEC. The Audit Committee meets from time to time in executive sessions and
also conducts annual assessments of the sufficiency of its Charter and of the Committee’s compliance with its obligations.
(See Item 16A. Audit Committee – Financial Expert and Item 16D. Exemptions from the Listing Standards for Audit
Committees.)
Financial Statements Review Committee. Dr. Gleitman (chair), Mr. Ben-Zeev, Prof. Nisan, Mrs. Rabin and
Prof. Tamir are members of the Board’s Financial Statements Review Committee. Pursuant to the Israeli Companies
Regulations the financial reports of a public company such as Elbit Systems may be brought for discussion and approval
of the board only after such committee has discussed and formulated recommendations to the board in connection with:
(1) the valuations and estimates used in connection with the financial statements; (2) the internal controls related to
financial reporting; (3) the completeness and appropriateness of disclosure in the financial statements; (4) the accounting
policy adopted and accounting treatment applied in the material matters of the company; and (5) valuations, including the
assumptions and estimates underlying them, on which data in the financial statements is provided. The Financial
Statements Review Committee must consist of at least three members, the chair of the committee must be an External
Director, and the majority of its members must be directors who meet certain independence requirements of the
Companies Law, and, among other criteria, all of its members must be able to read and understand financial statements,
with at least one of the members having “financial and accounting expertise” (as defined above). Dr. Gleitman and Prof.
Nisan have been determined by the Board to have “financial and accounting expertise”.
60
Compensation Committee
Mrs. Rabin (chair), Mr. Ben Zeev and Dr. Gleitman are members of the Board’s Compensation Committee.
Pursuant to the Companies Law (see above "Compensation to Directors and Executive Officers - Compensation Policy"),
the compensation committee of a public company, such as Elbit Systems, is required to consist of at least three members,
and all of the external directors must be members of the committee (one of which to be appointed as the chairperson) and
constitute the majority thereof. The remaining members must be directors who qualify to serve as members of the audit
committee as defined in the Companies Law and whose compensation is in accordance with the compensation
requirements applicable to the External Directors. All of our Compensation Committee members have been determined to
be eligible to be members of a compensation committee in accordance with the Companies Law and also have been
determined to be independent as defined by the applicable Nasdaq rules and those of the SEC.
In addition to its other roles, under the Companies Law the compensation committee of a public company
such as Elbit Systems is required:
(1) to recommend to the board of directors the compensation policy for the company's Office Holders to be
adopted by the company and to recommend to the board of directors, once every three years, regarding
any extension or modifications of the current compensation policy that had been approved for a period
of more than three years;
(2) from time to time to recommend to the board of directors any updates required to the compensation
policy and examine the implementation thereof;
(3) to determine, with respect to the company's Office Holders, whether to approve their Employment
Terms; and
(4) in certain situations described in the Companies Law, to determine whether to exempt the approval of
Employment Terms of a candidate for the position of CEO of the company from the requirement to
obtain shareholder approval.
According to the Companies Law, Employment Terms of a public company’s Office Holders must be
approved also by the board as a whole and, with respect to Employment Terms of the CEO or a director, also by the
company's shareholders in accordance with the majority requirements of the Companies Law. (For further information see
above "Compensation of Directors and Executive and Executive Officers - Compensation Policy"; Item 10. Additional
Information – General Provisions of Israeli Law and Related Provisions of Articles of Association – Office Holders; and
Item 10 - Additional Information - Approval of Certain Transactions - Approval of Employment Terms of Office Holders).
Our Compensation Committee operates in accordance with a Compensation Committee Charter that
provides the framework for its oversight functions consistent with Israeli and U.S. legal and regulatory requirements,
including with the amended compensation committee listing rules of the Nasdaq.
Corporate Governance and Nominating Committee. Mr. Ben Zeev (chair), Dr. Gleitman and Mrs. Rabin
are members of the Board’s Corporate Governance and Nominating Committee. This Committee operates in accordance
with a Corporate Governance and Nominating Committee Charter that specifies its oversight functions consistent with
Israeli and U.S. legal and regulatory requirements. The role of the Corporate Governance and Nominating Committee is to
assist the Board in fulfilling its responsibilities with respect to the qualification of candidates to become Board members
and to monitor compliance with corporate governance requirements applicable to Board members. All of the members of
the Corporate Governance and Nominating Committee have been determined to be independent as defined by the
applicable Nasdaq rules and those of the SEC. A nominee to our Board must have such experience in business or financial
matters as would make such nominee an asset to the Board. In recommending director candidates, our Corporate
Governance and Nominating Committee takes into consideration such factors as it deems appropriate based on our current
needs. These factors may include: professional and personal ethics and integrity; business, professional and industry
knowledge, sophistication and contacts; the ability to make informed and independent judgments on a wide range of
issues; relevant skills and experience demonstrated through business, professional, charitable or civic affairs; and the
candidate’s ability to devote the required time and effort to serve on our Board. (See Item 16.G. Corporate Governance.)
61
Board Committee Membership
Audit Committee:
Yehoshua Gleitman
(chair)
Yoram Ben-Zeev
Ehood Nisan
Dalia Rabin
Yuli Tamir
Financial Statements
Review Committee:
Yehoshua Gleitman
(chair)
Yoram Ben-Zeev
Ehood Nisan
Dalia Rabin
Yuli Tamir
Board and Committee Meetings
Corporate Governance
and Nominating
Committee:
Compensation
Committee:
Yoram Ben Zeev
(chair)
Yehoshua Gleitman
Dalia Rabin
Dalia Rabin
(chair)
Yoram Ben Zeev
Yehoshua Gleitman
The Board meets quarterly and at other times during the year as necessary to conduct its activities. The Audit
Committee and Financial Statement Review Committee each meet at least quarterly, and the Compensation Committee
and Corporate Government and Nominating Committee each meet at least annually. Each of the committees also meets at
additional times during the year as may be necessary to carry out its functions. The Financial Statement Review
Committee meets at least quarterly in executive sessions, and the Board and the other committees meet in executive
sessions periodically. During 2016, the average attendance for Board members at Board and committee meetings was
93.3%.
Employees
Number of Employees. Most of our employees are based in Israel, and we have a significant number of
employees in the United States. The total number of employees worldwide and the number of employees in the U.S. at the
end of 2014, 2015 and 2016 were as follows:
2016
2015
2014
Total
Employees
12,470
12,134
11,851
U.S.
Employees
1,425
1,426
1,505
Employment Contracts. The majority of our Israeli employees have individual employment contracts.
However, by law some employees receive rights under a number of general collective bargaining agreements and under
Israeli employment laws. See Item 4. Information on the Company – Conditions in Israel – Israeli Labor Laws. We
believe our overall relationship with our employees is satisfactory.
Collective Bargaining Agreements. In Israel, several of our wholly-owned subsidiaries are each parties to
collective bargaining agreements covering a portion of their employees. A total of approximately 2,380 employees in
Israel are covered by such agreements that extend for various periods through 2017, with certain elements of those
agreements extending for longer periods. Approximately 125 of the employees at Elbit Systems of America’s operations
are covered by collective bargaining agreements in effect through various periods through May 2017.
62
Item 7.
Major Shareholders and Related Party Transactions.
Major Shareholders
Percentages
As of March 15, 2017, we had 42,747,884 ordinary shares outstanding. The following table sets forth specific
information as of March 15, 2017, to the best of our knowledge, concerning:
• beneficial ownership of more than 5% of our outstanding ordinary shares; and
•
the number of ordinary shares beneficially owned by all of our executive officers and directors as a group.
Name of Beneficial Owner
Federmann Enterprises Ltd.
99 Hayarkon Street
Tel-Aviv, Israel(2)
Amount Owned
Percent of
Ordinary
Shares(1)
19,580,342
(3)
45.8 %
Heris Aktiengesellschaft
c/o 99 Hayarkon Street
Tel-Aviv, Israel
All executive officers and directors as a group (26 persons)
3,836,458
(3)
4,899 (4)
8.97 %
0.01 %
(1) Based on 42,747,884 ordinary shares outstanding as of March 15, 2017, which excludes 1,408,921 ordinary
shares held by us as treasury shares.
(2) Federmann Enterprises Ltd. (FEL) owns our ordinary shares directly and indirectly through Heris
Aktiengesellschaft (Heris), which is controlled by FEL. FEL is controlled by Beit Federmann Ltd. (BFL).
BFL is controlled by Beit Bella Ltd. (BBL) and Beit Yekutiel Ltd. (BYL). Michael Federmann is the
controlling shareholder of BBL and BYL. He is also the chair of Elbit Systems’ Board and the chair of the
board and the chief executive officer of FEL. Therefore, Mr. Federmann controls, directly and indirectly, the
vote of ordinary shares owned by Heris and FEL.
In connection with FEL’s purchase of our ordinary shares in 2004 and 2006, FEL obtained loans from two
Israeli banks. As security for the loans, FEL pledged an aggregate of 4,300,000 of our ordinary shares to the
banks.
(3) The 19,580,342 shares held by FEL includes the 3,836,458 shares held by Heris.
(4) This amount does not include any ordinary shares that may be deemed to be beneficially owned by Michael
Federmann as described in footnote (2) above.
Rights in Shares, Significant Changes in Shareholders and Controlling Shareholders
Our controlling shareholders have the same rights as other holders of our ordinary shares. (See also Item 10.
Additional Information – Provisions Relating to Major Shareholders. With respect to the Company’s repurchase of our ordinary
shares see Item 16.E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers.)
63
The only changes in shareholdings by our controlling shareholders in the last three years were those relating to
FEL as follows:
March 15, 2017
March 15, 2016
February 28, 2015
February 28, 2014
Shares
Owned
% of
Shares
Owned
Shares
Owned
% of
Shares
Owned
Shares
Owned
% of
Shares
Owned
Shares
Owned
% of
Shares
Owned
FEL
19,580,342 45.80%
19,580,342
45.82% 19,580,342
45.87%
19,580,342
45.94%
As of March 15, 2017, approximately 9.75% of our outstanding ordinary shares were held in the United States
by approximately 171 shareholders of record registered on the books of our transfer agent.
We are not aware of any arrangement which may result in a change in control of the Company.
Related Party Transactions
Transactions with Affiliated Companies. In the ordinary course of business, some of our subsidiaries and
affiliates engage in business activities with each other. The purchases among our related parties are made at prices and on terms
equivalent to those used in transacting business with unrelated parties under similar conditions. The sales among our related
parties in respect to government defense contracts are made on the basis of costs incurred. (See Item 10. Additional Information
– General Provisions of Israeli Law and Related Provisions of Articles of Association – Approval of Certain Transactions.)
Transactions with Office Holders. See below – Item 10. Additional Information – General Provisions of Israeli
Law and Related Provisions of Articles of Association - Office Holders; Item 10. Additional Information – General Provisions
of Israeli Law and Related Provisions of Articles of Association - Approval of Certain Transactions - Approval of Transactions;
and Item 10. Additional Information – General Provisions of Israeli Law and Related Provisions of Articles of Association -
Approval of Certain Transactions - Approval of Employment Terms of Office Holders. See also Item 18. Financial Statements -
Note 26.
Item 8.
Financial Information.
Consolidated Statements and Other Financial Information
See Item 18. Financial Statements.
Export Sales
Export sales constitute a significant portion of our sales. In 2016, export sales were approximately $2.55 billion,
constituting approximately 78% of our total sales. (For further information regarding the allocation of our revenues by
geographic region see Item 5. Operating and Financial Review and Prospects – 2016 Compared to 2015 – Revenues.)
Legal Proceedings
The Company is involved in various legal proceedings from time to time. For a discussion of our significant legal
proceedings see Item 18. Financial Statements - Note 20(C).
Dividend Distributions
We do not have an established dividend policy. (Regarding declarations of dividends out of certain tax-exempt
income see below Item 10. Additional Information – Taxation – Investment Law.) Our Articles of Association provide that the
Board may approve dividend payments to shareholders out of surplus earnings as permitted by applicable law. We have
consistently paid a quarterly dividend to our shareholders.
64
Our aggregate quarterly dividend payments for the last three full fiscal years were as follows:
2014
2015
2016
$
$
$
1.28 per share
1.44 per share
1.60 per share
Other than any significant event that may be described in this annual report, there have not been any significant
changes since December 31, 2016.
Item 9.
The Offer and Listing.
Share Listings and Trading Prices
Our ordinary shares are listed on the TASE and are quoted on Nasdaq under the symbol "ESLT".
The high and low sale prices for our ordinary shares for the five most recent fiscal years are:
2012
2013
2014
2015
2016
Nasdaq
TASE(*)
High
Low
High
Low
$
$
$
$
$
42.09 $
61.08 $
64.66 $
89.87 $
104.70 $
29.59 $
37.08 $
54.36 $
58.63 $
80.24 $
39.87 $
61.20 $
64.26 $
90.22 $
104.53 $
29.02
37.06
53.19
59.04
80.25
The high and low quarterly sale prices for our ordinary shares for the two most recent full financial years and the
next subsequent quarter are:
2015
First Quarter
Second Quarter
Third Quarter
Fourth Quarter
2016
First Quarter
Second Quarter
Third Quarter
Fourth Quarter
2017
First Quarter (through March 15, 2017)
Nasdaq
TASE(*)
High
Low
High
Low
$
$
$
$
$
$
$
$
$
71.91 $
81.90 $
84.68 $
89.87 $
99.50 $
101.85 $
103.11 $
104.70 $
58.63 $
71.69 $
71.87 $
73.83 $
80.24 $
88.78 $
90.58 $
94.71 $
71.55 $
81.38 $
84.96 $
90.22 $
96.43 $
102.60 $
102.97 $
104.53 $
59.04
72.08
72.39
74.44
80.25
87.98
89.96
94.91
120.75 $
110.00 $
119.68 $
109.14
65
The monthly high and low sale prices of our ordinary shares for the most recent six months are:
September 2016
October 2016
November 2016
December 2016
January 2017
February 2017
Nasdaq
TASE(*)
High
Low
High
Low
$
$
$
$
$
$
99.44 $
98.80 $
104.70 $
104.17 $
110.00 $
118.55 $
91.51 $
94.71 $
95.37 $
98.82 $
101.87 $
110.00 $
99.79 $
98.73 $
104.53 $
104.44 $
109.98 $
118.20 $
91.52
94.91
95.05
99.14
101.50
109.14
(*) The closing prices of our ordinary shares on the TASE have been translated into U.S. dollars using the daily representative rate
of exchange of the NIS to the U.S. dollar as published by the Bank of Israel for the applicable day of the high/low amount in the
specified period.
Item 10.
Additional Information.
General Provisions of Israeli Law and Related Provisions of Articles of Association
Israeli Companies Registrar. We are registered with the Israeli Companies Registrar. The registration number
issued to us by the Companies Registrar is 52-004302-7.
The Companies Law and Restated Articles of Association. The Companies Law is the basic corporation law
governing Israeli publicly and privately held companies. The Companies Law mandates that specific provisions be included in
an Israeli company’s articles of association, which are included in Elbit Systems' Restated Articles of Association (the Articles
of Association).
Purpose. Elbit Systems’ purpose, as described in Article 3 of the Articles of Association, includes any objectives
permitted by law.
Appointment and Removal of Directors. See Item 6. Directors, Senior Management and Employees – Directors
and Executive Officers – Board of Directors.
Internal Auditor. Publicly held Israeli companies are required to appoint an internal auditor. The main role of the
internal auditor is to examine whether the company’s activities are conducted in accordance with the law, with integrity and
pursuant to orderly business procedures. The internal auditor operates in accordance with the internal audit provisions of a
written audit committee charter that provides the framework for the committee's oversight of the internal auditor's functions,
consistent with applicable Israeli and U.S. laws and regulations.
Office Holders
The Companies Law specifies the duty of care and fiduciary duties that an “Office Holder” owes to a company.
An Office Holder is defined as a director, general manager, chief business manager, deputy general manager, vice general
manager, any other person who fulfills these functions without regard to that person’s title and any other manager directly
subordinate to the general manager. Under the Companies Law, the general manager of a corporation has authority equivalent
to that of a president or chief executive officer of a U.S. corporation. For such purposes, our general manager is Bezhalel
Machlis, our President and Chief Executive Officer. Each person listed as a director or executive officer in Item 6. Directors -
Senior Management and Employees - Directors and Executive Officers, is an Office Holder of Elbit Systems.
Under the Companies Law, an Office Holder’s fiduciary duty includes the general duty to act in good faith and for
the benefit of the company, avoiding any conflict of interest between the Officer Holder’s position in the company and his or
her personal affairs. The fiduciary duty also includes avoiding any competition with the company and any exploitation of a
business opportunity of the company in order to receive personal advantage for the Office Holder or others. Also, the Office
Holder is required to disclose to the company any information or documents relating to the company’s affairs that the Office
Holder has received due to his or her position as an Office Holder. Under the Companies Law voting agreements among
66
directors or a director’s failure to exercise independent judgment while voting are each considered a breach of fiduciary duty.
The duty of care requires an Office Holder to act in a way that a reasonable Office Holder would act in the same position and
under similar circumstances. This includes the duty to utilize reasonable means to obtain information regarding the advisability
of a given action submitted for his or her approval or performed by virtue of his or her position and all other relevant
information.
Some members of our Board are also directors of FEL or companies controlled by FEL. Therefore, in the event of
an issue or transaction between Elbit Systems and any of those companies, those individuals who are affiliated with both of the
applicable companies will be excluded from any decisions concerning such issue or transaction. In addition, an issue or
transaction with any of such companies also requires authorization in accordance with the requirements of the Companies Law.
(See below "Approval of Certain Transactions" and "Provisions Relating to Major Shareholders".)
Arrangements in connection with the Employment Terms (see Item 6 - Directors, Senior Management and
Employees - Compensation of Executive Officers and Directors - Compensation Policy) of Elbit Systems' Office Holders
require special authorizations. (See below "Approval of Certain Transactions - Approval of Employment Terms of Office
Holders".)
Other transactions with Office Holders and affiliates may also require authorization in accordance with the
requirements of the Companies Law. (See below "Approval of Certain Transactions".)
Approval of Certain Transactions
Approval Procedures. The Companies Law requires that certain transactions, actions and arrangements, mainly
with related parties including Office Holders, be approved as provided for in the Companies Law and in a company’s articles of
association and in many cases by the audit committee or the compensation committee and by the board of directors. In some
cases shareholder approval is also required.
Personal Interest and Extraordinary Transactions. The Companies Law requires that an Office Holder or a
controlling shareholder (see “Provisions Relating to Major Shareholders” below) of a publicly traded company immediately
disclose (and no later than the first board meeting at which the transaction is discussed) any “Personal Interest” that he or she
may have and all related material information known to him or her, in connection with any existing or proposed transaction of
the company. A person with a Personal Interest in any such transaction that is brought for approval of the audit committee or
board of directors may not be present at the meeting where the transaction is being deliberated or approved (unless the chair of
the audit committee or the board, as the case may be, determines that such person’s presence at the meeting is required for
presentation of the relevant transaction) and, in case such person is a director, he or she may not vote on the matter, unless a
majority of the members of the audit committee or of the board of directors (as the case may be) have a Personal Interest in the
approval of the relevant transaction, in which case the directors having such Personal Interest may be present and may
participate in the vote. In the event that the majority of the members of the board of directors have a Personal Interest in the
relevant transaction, the approval of the shareholders is also required. Personal Interest also includes any interest held by the
Office Holder’s spouse, siblings, parents, grandparents, descendants, spouse’s descendants, spouse’s siblings and parents and
the spouses of any of them. It also includes an interest by any entity in which the Office Holder or his or her relative is a 5% or
greater shareholder, director or general manager or in which he or she has the right to appoint at least one director or the general
manager. An “extraordinary transaction” is a transaction other than in the ordinary course of business, other than on market
terms or likely to have a material impact on the company’s profitability, assets or liabilities.
Approval of Transactions
In accordance with the Companies Law the transactions specified below require the following approvals, provided
always that such transaction is for the benefit of the company:
(1) approval of the board of directors - a transaction with an Office Holder, other than arrangements in
connection with Employment Terms, or a transaction in which an Office Holder has a Personal Interest,
where the audit committee has determined that such transaction is not an extraordinary transaction, unless the
company's articles of association provide otherwise;
(2) approval of both the audit committee and the board of directors:
67
(i)
a transaction with an Office Holder, other than arrangements in connection with Employment Terms,
or a transaction in which an Office Holder has a Personal Interest, where the audit committee has
determined such transaction to be an extraordinary transaction;
(ii)
for material actions or arrangements that may otherwise be considered a breach of fiduciary duty of an
Office Holder; or
(iii)
for extraordinary transactions of a public company with its controlling shareholder or with another
person in which the controlling shareholder has a Personal Interest, including a private offering in
which the controlling shareholder has a Personal Interest, as well as an agreement of a public company
with its controlling shareholder or his or her relatives, directly or indirectly, including through a
company controlled by him or her, regarding the grant of services to the applicable company or
regarding the terms of service and/or employment of the controlling shareholder or his or her relatives,
as the case may be; or
(3) approval of both the compensation committee and the board of directors - with respect to arrangements
regarding Employment Terms of an Office Holder or of a controlling shareholder or his or her relatives as
Office Holders or employees of the company.
Except for certain exemptions specified under the Companies Law, the transactions and arrangements described
above may also require shareholder approval, including, where applicable, by a specified percentage of non-interested
shareholders. In addition, the Companies Law requires re-approval every three years with respect to some of the matters
referred to above. Re-approval when applicable is required by the audit committee or the compensation committee, as the case
may be, the board of directors and, except for certain specific exemptions, by the shareholders. (See also Item 10 - Provisions
Relating to Major Shareholders.)
Under the Companies Law, the audit committee of a publicly held company such as Elbit Systems, is also
required to determine whether to carry out competitive procedures or other procedures before any engagement in a transaction
with a controlling shareholder or in which a controlling shareholder has a Personal Interest.
Approval of Employment Terms of Office Holders
In accordance with the Companies Law (see Item 6. Directors, Senior Managers and Employees - Compensation
of Directors and Executive Officers - Compensation Policy), approval by both the compensation committee and the board of
directors is required for all arrangements regarding Employment Terms of an Office Holder. In addition, the Companies Law
requires that we also obtain the approval of our shareholders for any Employment Terms arrangement with our CEO or a
director, or with any other Office Holder where the terms are not consistent with an approved compensation policy. With
respect to such agreement with our CEO, an Office Holder who is a controlling shareholder (or his/her relative) or with an
Office Holder that is not consistent with an approved compensation policy, such shareholder approval requires that (a) a
majority of the Applicable Shareholders (as defined below) vote to approve the arrangement and (b) Applicable Shareholders
who vote against approval do not represent more than 2% of our total voting rights. For these purposes, “Applicable
Shareholders” means shareholders who are not controlling shareholders and do not have a Personal Interest (as defined in the
Companies' Law) in the arrangement to be approved and who participate in the voting, in person, by proxy or by written ballot
(excluding abstentions).
In accordance with the Companies Law, the compensation committee may determine that an arrangement in
connection with Employment Terms of a candidate for the position of the CEO of a public company is exempt from the
approval by the shareholders of the company, provided that: (i) the CEO candidate is "independent" based on criteria set forth
in the Companies Law; (ii) the compensation committee determines, based on detailed reasons, that bringing the arrangement to
the approval of the shareholders may compromise completing the arrangement; and (iii) the Employment Terms are consistent
with the company's approved compensation policy.
In addition, pursuant to the Companies Law, the compensation committee and the board of directors may approve
Employment Terms of an Office Holder (other than a director) that are not in accordance with the company's approved
compensation policy, even if the shareholders do not approve such terms, provided that:
(1) both the compensation committee and the board of directors re-discussed the relevant Employment Terms
and decided to approve them despite the shareholders' objection, based on detailed reasons; and
68
(2) the company is not a "Public Pyramid Held Company". For this purpose, a "Public Pyramid Held Company"
is a public company that is controlled by another public company (including by a company that only issued
debentures to the public), which is also controlled by another public company (including a company that only
issued debentures to the public) that has a controlling shareholder.
Changes of the terms of a current arrangement regarding Employment Terms of an Office Holder (other than a
director) require only the approval of the compensation committee, if the compensation committee has determined that such
changes are not material.
For further information see above "General Provisions of Israeli Law and Related Provisions of Articles of
Association - Office Holders" and Item 6. Directors, Senior Management and Employees - Compensation of Executive Officers
and Directors - Compensation Policy.
Exemption, Insurance and Indemnification of Directors and Officers
Exemption, Insurance and Indemnification under the Companies Law
Under the Companies Law, an Israeli company may not exempt an Office Holder from liability with respect to a
breach of his or her duty of loyalty, but may exempt in advance an Office Holder from his or her liability to the company, in
whole or in part, with respect to a breach of his or her duty of care, provided that a relevant provision is included in the
company’s articles of association. However, a company may not exempt in advance a director from his or her liability to the
company with respect to a breach of duty of care in connection with a distribution made by the company.
The Companies Law permits a company to obtain an insurance policy covering liabilities of Office Holders
resulting from a breach of the Office Holder’s duty of care to the company or to another person. Insurance may also be obtained
to cover liabilities from the breach of his or her fiduciary duty to the company, to the extent that the Office Holder acted in
good faith and had reasonable cause to believe that the act would not prejudice the interests of the company. Such insurance
may also cover monetary liabilities charged against an Office Holder while serving the company, provided that relevant
provisions are included in the company's articles of association. In addition, the Israeli Securities Law – 1968 (Securities Law)
permits that such insurance policy will cover a payment which an Office Holder is obligated to pay to an injured party as set
forth in the relevant sections of the Securities Law as well as expenses incurred by an Office Holder in connection with certain
proceedings that are specified in the Securities Law, including reasonable litigation expenses (including attorneys' fees),
provided that a relevant provision is included in the company's articles of association.
Under the Companies Law, a company may indemnify an Office Holder against any monetary liability incurred in
his or her capacity as an Office Holder whether imposed on him or her in favor of another person pursuant to a judgment, a
settlement or an arbitrator’s award approved by a court. A company may also indemnify an Office Holder against: (i)
reasonable litigation expenses, including attorneys’ fees, incurred by him or her in his or her capacity as an Office Holder, in an
investigation or proceeding by an authority authorized to conduct such investigation or proceeding in which no indictment was
filed and no monetary payments in lieu of criminal proceedings were imposed against the Office Holder, or (ii) monetary
payments in lieu of criminal proceedings that were imposed on him or her provided that the alleged criminal offense does not
require proof of criminal intent. In addition, a company may also indemnify an Office Holder against reasonable litigation
expenses, including attorneys’ fees, incurred by him or her in his or her capacity as an Office Holder, in a proceeding instituted
against him or her by the company, on its behalf or by a third party, or in connection with criminal proceedings in which the
Office Holder was acquitted, or as a result of a conviction for a crime that does not require proof of criminal intent or in which
an indictment was not brought against the Office Holder. In addition, a company may indemnify an Office Holder in respect of
payments that the Office Holder is obligated to pay to an injured party as set forth in the relevant sections of the Securities Law,
including reasonable litigation expenses (including attorneys' fees). These indemnifications are subject to the inclusion of
relevant provisions in the company’s articles of association.
Under the Companies Law, a company may indemnify an Office Holder in respect of certain liabilities, either in
advance of an event or following an event. If a company undertakes to indemnify an Office Holder in advance of an event, the
indemnification, other than reasonable litigation expenses, must be limited to foreseeable events in light of the company’s
actual activities at the time the company undertook such indemnification and also limited to reasonable amounts or criteria
under the circumstances, as determined by the board of directors, and the undertaking to indemnity will specify any such
events, amounts or criteria.
69
A company may not indemnify an Office Holder or enter into an insurance contract that would provide coverage
for any monetary liability incurred or exempt an Office Holder from liability to the company with respect to and of the
following:
(1) a breach of fiduciary duty, except indemnification or insurance that provides coverage for a breach of a
fiduciary duty to the company while acting in good faith and having reasonable cause to assume that such act
would not prejudice the interests of the company;
(2) a willful breach of the duty of care or reckless disregard for the circumstances or to the consequences of a
breach of the duty of care other than mere negligence;
(3) an act done with the intent to unlawfully realize a personal gain;
(4) a fine or monetary penalty imposed upon such Office Holder; or
(5) certain monetary liabilities that are set forth in the Securities Law.
Insurance and Indemnification of Directors and Officers under the Articles of Association
In accordance with and subject to the provisions of the Companies Law and the Securities Law, Elbit Systems’
Articles of Association allow for directors and officers liability insurance, in respect of a liability or payment imposed on a
director or officer as a result of an act carried out by such person in his or her capacity as a director or officer. This insurance
may cover:
(1) a breach of his or her duty of care to Elbit Systems or to another person;
(2) a breach of his or her fiduciary duty to Elbit Systems, provided that the director or officer acted in good faith
and had reasonable cause to assume that his or her act would not harm the interests of Elbit Systems;
(3) a financial obligation imposed on him or her in favor of another person;
(4) a payment that he or she is obligated to pay to an injured party as set forth in the relevant sections of the
Securities Law;
(5) expenses incurred by him or her in connection with certain administrative proceedings specified in the
Securities Law, including reasonable litigation expenses (including attorneys' fees); or
(6) any other event for which insurance of a director or officer is or may be permitted.
In addition, in accordance with and subject to the Companies Law and the Securities Law, Elbit Systems’ Articles
of Association permit indemnification, retroactively or in advance, of a director or officer against liability, payment or expense
imposed on or incurred by him or her as a result of an act carried out in his or her capacity as a director or officer, that may
include:
(1) a monetary liability imposed on the director or officer or paid by him or her in favor of a third party under a
judgment, including a judgment by way of compromise or a judgment of an arbitrator approved by a court;
provided however, that in case such undertaking is granted in advance it will be limited to events which, in
the Board’s opinion, are foreseeable in light of the Elbit Systems’ actual activities at the time of granting the
obligation to indemnify, and to a sum or under criteria as the Board deems reasonable under the
circumstances, and the undertaking to indemnify will specify the aforementioned events and sum or criteria;
(2) a payment imposed on him or her in favor of an injured party in the circumstances specified in the Securities
Law;
70
(3) reasonable litigation expenses (including attorneys' fees), incurred by a director or officer as a result of an
investigation or proceeding conducted against him or her by an authority authorized to conduct such
investigation or procedure, provided that such investigation or procedure: (i) concludes without the filing of
an indictment against the director or officer and without imposition of monetary payment in lieu of criminal
proceedings; or (ii) concludes with imposing on the director or officer monetary payment in lieu of criminal
proceedings, provided that the alleged criminal offense in question does not require proof of criminal intent
or was incurred by the director or officer in connection with a monetary sanction imposed by the Companies
Law or the Securities Law;
(4) expenses incurred by a director or a officer in connection with certain administrative proceedings set forth in
the Securities Law, including reasonable litigation expenses (including attorneys' fees);
(5) reasonable litigation expenses (including attorneys' fees), expended by the director or officer or imposed on
him or her by the court for:
(i)
proceedings issued against him or her by or on Elbit Systems’ behalf or by a third party;
(ii)
criminal proceedings from which the director or officer was acquitted; or
(iii)
criminal proceedings in which he or she was convicted of an offense that does not require proof of
criminal intent; or
(6) any other liability or expense for which it is or may be permissible to indemnify a director or an officer.
The Articles of Association permit the grant of similar indemnification to any person acting on behalf or at the
request of Elbit Systems as a director or officer of another company in which Elbit Systems is directly or indirectly a
shareholder or has any other interest. However, any indemnification so granted by Elbit Systems may not exceed 25% of Elbit
Systems’ consolidated shareholders equity as reflected in our most recent consolidated financial statements published prior to
the date of the indemnification payment.
In November 2011, Elbit Systems’ Audit Committee, Board and shareholders approved the grant to members of
our Board, including to Michael Federmann and to David Federmann, who may each be considered a direct or indirect
controlling shareholder of the Company, of indemnification letters reflecting the above conditions and limitations. Similar
letters were also approved by the Audit Committee and the Board for indemnification of Office Holders of Elbit Systems who
are not directors.
According to the Companies Law, the granting by a public company, such as Elbit Systems, of an indemnification
letter to an Office Holder who may be considered as a direct or indirect controlling shareholder of that company, requires re-
approval every three years by the company's compensation committee, the board of directors and the company's shareholders.
On March 31, 2015, at an Extraordinary General Meeting of Shareholders, our shareholders re-approved, following the re-
approval by our Compensation Committee and the Board in meetings held in February 2015, the granting of the
indemnification letters originally granted by the Company in November 2011 to Michael Federmann and David Federmann,
who may be considered as direct or indirect controlling shareholders of the Company, for an additional period of three years
commencing as of December 1, 2014.
Elbit Systems' Compensation Policy allowed Elbit Systems to purchase, from time to time during the term of the
Compensation Policy, directors and officers (D&O) liability insurance on terms and for premiums that reflect current market
conditions with respect to the Company and the nature of its operations; provided that the coverage limit shall not exceed $150
million and the annual premium to be paid by Elbit Systems shall not exceed $1 million for each such insurance policy. In
accordance with the Companies Law, our Compensation Committee and the Board respectively approved, in meetings held in
November 2016, the purchase of D&O liability insurance which complies with the requirements of the Compensation Policy. In
their November 2016 meetings, our Audit Committee and Board also approved, in accordance with the Israeli Companies
Regulations (Relief from Related Parties’ Transactions), 5760-2000, the inclusion of Michael Federmann and David Federmann
(who may be considered direct or indirect controlling shareholders of the Company) and of Bezhalel Machlis, our President and
CEO, in the D&O liability insurance policy to be purchased by the Company for the Company’s other directors and officers. As
of March 15, 2017, the D&O policy’s limit of liability was $70 million and the annual premium was $300,000.
71
Rights, Preferences and Restrictions of Shares
Elbit Systems currently has one type of share, this being ordinary shares. The share capital of Elbit Systems is NIS
80,000,000 divided into 80,000,000 ordinary shares of NIS 1 nominal (par) value each, of which 42,747,884 ordinary shares
were issued and outstanding as of March 15, 2017. All issued and outstanding ordinary shares are fully paid and non-
assessable.
Each ordinary share entitles its owner to receive notices of, to attend and to cast one vote at, a general meeting of
shareholders.
Our Articles of Association do not grant shareholders any rights to share in our profits other than through
dividends. Subject to Israeli law, dividends may be declared by our Board and paid to the shareholders according to their
respective rights. In the event that we were to go into liquidation, any surplus remaining after the payment of liabilities would
be distributed to the shareholders in proportion to the amount paid by each on account of the nominal value of the shares paid.
No account is taken of any premiums paid in excess of the nominal value.
Our Board may make calls upon shareholders in respect of sums unpaid on their shares. Our Articles of
Association contain no provisions which discriminate against any existing or future shareholder as a result of the number of
shares such shareholder holds.
A change of Elbit Systems’ share capital, by way of increasing the share capital, creation of new shares or
cancellation of unissued registered shares (if there is no undertaking to allot such shares), requires a change to our Articles of
Association and as such requires the vote of a special majority of the shareholders participating in a general meeting of
shareholders (see “General Meetings of Shareholders” below.)
If at any time our share capital is divided into different classes of shares, we may change the rights of shareholders
by way of a resolution at a general meeting of shareholders, subject to the consent of the shareholders of the class whose rights
are being impaired by the proposed change or subject to the adoption of a resolution by a special majority of the general
meeting of the shareholders of such class, all of which would be subject to other terms if and as provided by the terms of
issuance of a particular class of shares.
Our ordinary shares do not have pre-emptive rights.
General Meetings of Shareholders
An annual general meeting of our shareholders must be held once in each year and not later than 15 months after
the preceding annual general meeting.
Any general meeting that is not an annual general meeting is defined as an extraordinary general meeting. All
shareholders are entitled to attend any annual or extraordinary general meeting and vote at general meetings in person, by proxy
or through the Israeli Securities Authority's electronic voting system. Notice of an annual or extraordinary general meeting may
be sent by us by personal delivery or by sending it by prepaid registered mail. Such notice may be sent by cablegram, telex,
facsimile or other electronic means provided confirmation is made by registered mail as stated above and should be sent to
shareholders at the address in our records.
Our Board may convene an extraordinary general meeting when and as it sees fit. In addition the Board must,
according to statute, convene an extraordinary general meeting if it receives a demand to do so from either: (i) at least two
directors; (ii) at least one quarter of the members of the Board; or (iii) one or more shareholders who hold: (A) an aggregate of
at least 5% of our issued share capital and at least 1% of all voting rights; or (B) at least 5% of all voting rights, and in such
case the extraordinary meeting must be held not more than 56 days from the submission date of such request to the Board and
not later than 35 days from the applicable notice to shareholders described below. Any demand by a person or persons, as
described in (i), (ii) and/or (iii) of this paragraph, who demands that an extraordinary general meeting be convened, must be
made in writing and sent to our registered office.
72
Subject to the provisions of our Articles of Association, as well as applicable law and regulations, including
applicable laws and regulations of any stock market on which our shares are listed, notice of an annual general meeting and of
an extraordinary general meeting must be sent at least 21 days (and in some cases at least 35 days) in advance to all
shareholders recorded in our shareholders registry. Such notice must include the place, date and hour of the meeting, the agenda
for the meeting, the proposed resolutions and instructions for proxy voting.
The quorum required for a meeting of shareholders, except in the case of certain extraordinary meetings convened
in special circumstances, consists of at least two shareholders present in person or by proxy or other voting instrument and
holding or representing between them at least one-third of the voting power. The chair of our Board generally presides at our
shareholders’ meetings. A meeting adjourned for lack of a quorum will be adjourned to the same day in the following week, at
the same time and place, or to the day, time and place that the Board determines, with notice to the shareholders. At the
reconvened meeting, if a quorum is not present within one-half hour from the time appointed for holding the adjourned
meeting, the required quorum then is two shareholders, present in person or by proxy or other voting instrument, representing at
least 10% of the voting power. Nasdaq Listing Rule 5620(c) provides that a company listed on the Nasdaq Global Select
Market should have a quorum requirement for shareholder meetings of at least one-third of the company’s outstanding common
voting stock. As described above, our general quorum requirement is consistent with the Nasdaq Listing Rule. However, in the
case of an adjourned meeting, our Articles of Association, consistent with what is permissible under the Companies Law,
provide for a 10% quorum requirement.
In general, subject to the Companies Law, ordinary resolutions in a general meeting require approval of a majority of
the votes cast at the general meeting, whether in person or by proxy. (For information as to the required majority for the
approval of related party transactions, see “Provisions Relating to Major Shareholders” below. For information as to the
required majority for the approval of certain transactions with Office Holders of a public company, see "Approval of Certain
Transactions - Approval of Transactions" and "Approval of Employment Terms" above). However, under our Articles of
Association, certain resolutions require a special majority of at least 67% of all votes properly cast at a general meeting,
without taking into account abstentions.
Limitations on Non-Israeli Shareholders
No limitations exist or are imposed by Israeli law or our constituent documents with regard to the rights of non-
Israeli shareholders or shareholders not resident in Israel to hold or exercise voting rights except for shareholders who are
subjects of countries that are enemies of the State of Israel. (For a description of Israeli regulations relating to acquisitions of a
controlling interest in Israeli "defense entities" see Item 4. Information on the Company – Governmental Regulation – Approval
of Israeli Defense Acquisitions.)
Change of Control
Subject to certain exceptions, the Companies Law provides that a merger requires approval both by the board of
directors and by the shareholders of each of the merging companies. In approving a merger, the board of directors must
determine that there is no reasonable expectation that, as a result of the merger, the merged company will not be able to meet its
obligations to its creditors. Creditors may seek a court order to enjoin or delay the merger if there is an expectation that the
merged company will not be able to meet its obligations to its creditors. A court may also issue other instructions for the
protection of the creditors’ rights in connection with a merger.
Under the Companies Law, an acquisition of shares in a public company must be made by means of a tender offer
to all shareholders if, as a result of the acquisition, the purchaser would hold 25% or more of the company’s voting rights
(where no other shareholder holds 25% or more) or 45% or more of the company’s voting rights (where no other shareholder
holds 45% or more). This rule does not apply to a purchase of shares by way of a “private offering” in certain circumstances
provided under the Companies Law. (For information regarding Israeli law applicable to acquisition of Israeli “defense entities”
see Item 4. Information on the Company – Governmental Regulations – Approval of Israeli Defense Acquisitions.)
Provisions Relating to Major Shareholders
We are required by law to maintain a separate registry of shareholders that hold 5% or more of either our issued
shares or voting rights.
73
Under the Companies Law, the disclosure requirements with respect to the disclosure of a Personal Interest that
apply to an Office Holder also apply to a controlling shareholder of a public company. A controlling shareholder is a
shareholder who has the ability to direct the activities of a company, including a shareholder that holds 25% or more of the
voting rights if no other shareholder owns more than 50% of the voting rights in the company, but excluding a shareholder
whose power derives solely from his or her position as a director of the company or any other position with the company.
Except for certain specified exemptions under the Companies Law, audit committee approval is required for
extraordinary transactions, as defined by criteria established by the audit committee, with a controlling shareholder or in which
a controlling shareholder has a Personal Interest, including a private offering in which the controlling shareholder has a
Personal Interest, and an engagement of a public company with a controlling shareholder or his or her relative, directly or
indirectly, including through a company controlled by such person, regarding the grant of services to the applicable company
(and regarding his or her Employment Terms if the controlling shareholder is an employee of the company but he or she is not
an Office Holder). If the controlling shareholder is an Office Holder, his or her Employment Terms must be approved by the
compensation committee, the board of directors and the shareholders of the company, in that order. Such shareholder approval
requires that (a) a majority of the Applicable Shareholders (as defined below) vote to approve the arrangement and (b)
Applicable Shareholders who vote against approval do not represent more than 2% of our total voting rights. For these
purposes, “Applicable Shareholders” means shareholders who are not controlling shareholders and do not have a Personal
Interest (as defined in the Companies' Law) in the arrangement to be approved and who participate in the voting, in person, by
proxy or by written ballot (excluding abstentions).
In addition, the Companies Law requires that, except for certain exemptions, transactions with a controlling
shareholder whose terms are for a period of more than three years must be re-approved in same manner for every three-year
period.
Also, under the Companies Law, each shareholder has a duty to act in good faith in exercising his or her rights and
fulfilling his or her obligations toward the company and other shareholders and to refrain from abusing his or her power in the
company, such as in certain shareholder votes. In addition, specified shareholders have a duty of fairness toward the company.
These shareholders include any controlling shareholder, any shareholder who knows that it possesses the power to determine
the outcome of a shareholder vote and any shareholder who, pursuant to the provisions of the articles of association, has the
power to appoint or to prevent the appointment of an Office Holder or has any other power, beyond that of other shareholders,
with respect to the company.
Borrowing Power
Our Articles of Association grant broad powers to the Board to have us borrow, repay borrowings, make
guarantees and grant security interests in borrowings.
Exchange Controls and Other Limitations Affecting Security Holders
Non-residents of Israel may freely hold and trade our ordinary shares under general and specific permits issued
under the Israeli Currency Control Law, 1978 (the Currency Control Law). Our Memorandum of Association and Articles of
Association do not restrict the ownership of ordinary shares by non-residents of Israel. Neither the Memorandum of Association
and Articles of Association nor Israeli law restrict the voting rights of non-residents.
Under the general permit given pursuant to the Currency Control Law, non-residents of Israel who buy our
ordinary shares inside or outside of Israel with any foreign currency are able to receive a number of types of distributions in
freely repatriable U.S. dollars or specified other currencies. These distributions include dividends, proceeds from the sale of
shares and any amounts payable in the event of the dissolution, liquidation or winding-up of Elbit Systems.
Taxation
General
The following is a summary of some aspects of the current tax law applicable to companies in Israel, with special
reference to its effect on Elbit Systems and our Israeli subsidiaries, and government programs from which Elbit Systems and
some of our Israeli subsidiaries benefit.
74
The following also contains a discussion of specified Israeli and U.S. tax consequences to our shareholders. It also
contains a discussion of the Israeli tax consequences to holders of our Series A Notes. See Item 5. Operating and Financial
Review and Prospects – Liquidity and Capital Resources – Israeli Debt Offering. The Series A Notes are not registered for
trading in the U.S. and may not be sold in the U.S. without registration or compliance with Regulation “S” under the Securities
Act. Therefore, we have not included a discussion of U.S. tax consequences to holders of the Series A Notes. To the extent that
the discussion is based on tax legislation that has not been subject to judicial or administrative interpretation, there can be no
assurance that the views expressed in the discussion will be accepted by the tax authorities in question. The discussion is not
intended, and should not be construed, as legal or professional tax advice and is not exhaustive of all possible tax
considerations.
Elbit Systems’ income tax liability in Israel is based on our unconsolidated earnings and such earnings of our
Israeli-based subsidiaries. It is determined in NIS and not in U.S. dollars. Tax liability of non-Israeli subsidiaries is determined
according to the laws of their respective countries of residence. As a result, the tax provision in Elbit Systems’ consolidated
financial statements does not directly relate to income reported on these statements.
General Corporate Tax in Israel
Generally, Israeli companies were subject to corporate tax on taxable income and capital gains at the rate of 25%
for the 2016 tax year. The corporate income tax rates for each of the year 2015 and 2014 tax years was 26.5% .
In December 2016, the Knesset approved a reduction of the corporate tax rate to 24%, effective as of January 1,
2017 and 23% effective as of January 1, 2018.
Under the Israeli Tax Ordinance, 1961 (the Ordinance) transfer pricing rules require that cross-border transactions
between related parties be carried out implementing an arm’s-length principle and reported and taxed accordingly.
A portion of our Israeli operations have been granted “Approved Enterprise”, “Privileged Enterprise” and
“Preferred Enterprise” status, as described under “Investment Law” below. These operations are subject to taxation at reduced
rates applicable to those types of enterprises. We cannot assure that Elbit Systems or our Israeli subsidiaries will continue to
qualify for such benefits, or benefits under the Law for Encouragement of Industry, in the future. We also cannot assure that we
will continue to qualify as an Approved Enterprise, Privileged Enterprise or Preferred Enterprise, or that the benefits described
above will be available in the future.
Industry Encouragement. Under the Law for the Encouragement of Industry (Taxes), 1969, a company qualifies
as an “Industrial Company” if it is resident in Israel and at least 90% of its income (determined in Israeli currency) in a given
tax year, with some exceptions, comes from “Industrial Enterprises” owned by that company. An Industrial Enterprise is
defined as an enterprise whose primary activity in a particular tax year is industrial manufacturing activity. We believe Elbit
Systems qualifies as an Industrial Company. See further Item 18. Financial Statements - Note 18(A)(2).
Investment Law. The Israeli Law for the Encouragement of Capital Investments, 1959 (the Investment Law)
provides tax benefits to companies that make capital investments in eligible fixed assets. Under the Investment Law, subject to
applicable conditions, companies could apply to receive “Approved Enterprise”, “Privileged Enterprise” or "Preferred
Enterprise" status, each of which provides various tax benefits. See Item 18. Financial Statements - Note 18(A)(3).
Capital Gains to a Shareholder
Capital gains to Israeli residents. Starting January 1, 2012, the tax rate on capital gains to a “non-principal”
individual shareholder (those persons holding less than 10% of our ordinary shares) is 25%, and 30% to an individual
“principal” shareholder. As of January 1, 2013, the capital gains tax rate increased by 2% in the event the individual's taxable
income in any tax year exceeds NIS 810,720 (approximately $210,000) (linked to the CPI each year) including capital gains
from marketable securities, dividends and interest income. Dealers in securities in Israel are taxed at regular tax rates
applicable to business income. Companies resident in Israel are taxed at rates applicable to capital gains.
Capital gains to non-residents of Israel. Gains on the sale of ordinary shares traded on the TASE and on Nasdaq
held by non-Israeli resident investors for tax purposes will generally be exempt from Israeli capital gains tax, subject to the
provisions of the Israeli tax legislation. However, non-Israeli corporations will not be entitled to such exemption if an Israeli
resident (i) has a controlling interest of 25% or more in such non-Israeli corporation, or (ii) is the beneficiary or is entitled to
25% or more of the revenues or profits of such non-Israeli corporation, whether directly or indirectly. In addition, the United
States - Israel tax treaty exempts United States residents who hold less than 10% of our voting rights, and who held less than
75
10% of our voting rights during the twelve months prior to a sale of their shares, from Israeli capital gains tax in connection
with such sales under certain circumstances.
Capital Gains to a Holder of Series A Notes
Capital gains to Israeli residents. A capital gain for an individual derived from the sale of a debenture that is not
linked to an index, such as our Series A Notes, will be taxable at a rate not to exceed 15% in case of a “non-principal”
individual note holder, or 20% in the case of a “principal” individual note holder. Tax payers claiming a deduction of real
interest expenses and linkage differences on debentures such as the Series A Notes will be taxed at a rate of 30% on their real
capital gains. Dealers in securities in Israel are taxed at regular tax rates applicable to business income. Companies resident in
Israel are taxed at rates applicable to capital gains.
Capital gains to non-residents of Israel. Gains on the sale of securities traded on the TASE, such as our Series A
Notes, held by non-Israeli resident investors for tax purposes will generally be exempt from Israeli capital gains tax, subject to
the provisions of the Israeli tax legislation. However, non-Israeli corporations will not be entitled to such exemption if an Israeli
resident: (i) has a controlling interest of 25% or more in such non-Israeli corporation; or (ii) is the beneficiary or is entitled to
25% or more of the revenues or profits of such non-Israeli corporation, whether directly or indirectly.
Taxation on Dividends Paid to a Shareholder
Income tax for individual Israeli residents. Residents of Israel are subject to income tax on distributions of
dividends other than bonus shares (stock dividends). Effective January 1, 2012, the tax rate on dividend income to a “non-
principal” individual shareholder is 25% and 30% to an individual “principal” shareholder. The paying company withholds at
source income tax at the rate of 25% or 30% in the case of a “principal shareholder”. A company whose stock is traded on a
stock exchange withholds tax at the rate of 25% from dividends paid to a “principal” shareholder for shares registered and held
by a registration company. Dividends distributed from "Preferred Income" under Preferred Enterprise status (see above
"Investment Law") are subject to a withholding tax rate of 20%. These rates are the final tax on dividends.
Income tax for non-residents of Israel. Non-residents of Israel are subject to income tax on distributions of
dividends other than bonus shares (stock dividends). Effective January 1, 2012, the tax rate on dividend income to a "non-
principal" non-resident of Israel shareholder is 25% and 30% to a "principal" shareholder (including a foreign company as
opposed to an Israeli company). The paying company withholds at source income tax at the rate of 25% for a “non-principal”
shareholder, or 30% for a "principal" shareholder. A company whose stock is traded on a stock exchange will withhold tax at
the rate of 25% from dividends paid to a "principal" shareholder for shares registered and held by a registration company,
unless a lower rate is applicable under a double taxation treaty. Accordingly, Elbit Systems withholds income tax at the source.
Generally, dividends distributed from taxable income accrued during the period of benefit of an Approved Enterprise,
Privileged Enterprise or Preferred Enterprise are taxable at the rate of 15% if the dividend is distributed during the tax benefit
period under the Investment Law or within 12 years after the period (this limitation does not apply if the company qualifies as a
foreign investors’ company according to the Investment Law). Following the enactment of the National Priorities Law,
effective January 1, 2014, dividends distributed from "Preferred Income" under a Preferred Enterprise status are subject to a
withholding tax rate of 20% (unless a lower treaty rate applies). These rates are the final taxes in Israel on dividends for
individual and corporate non-residents of Israel. Foreign residents who have Israeli derived income for which tax was withheld
at the source are generally exempt from the duty to file tax returns in Israel for such income. This includes income from Israeli
derived interest, dividends and royalties.
Taxation of Interest Income of Holders of Series A Notes
Income tax for Israeli residents. Israeli resident individuals are tax exempt on the linkage differences derived
from the debenture principal, under certain conditions. An individual is taxable at a rate of 15% on interest or discount fees
originating from debentures which are not linked to the index, whether in whole or in part, such as the Series A Notes. Effective
January 1, 2012, the tax rate on interest income or discount fees originating from fully index-linked debentures, including
debentures linked to a foreign currency, is 25% in case of a "non-principal" note holder. These tax rates will not apply if any of
the following conditions are met: (1) the interest represents income from a “business” or is recorded in the individual’s books of
account or is required to be so recorded; (2) the individual has claimed deduction of linkage differences and interest expenses
on the debentures; (3) the individual is a “principal” individual note holder; or (4) the individual is employed by a corporation
that paid the interest, is a supplier of goods or services to the corporation or has other special relations with the corporation,
unless the tax assessing officer is satisfied that the interest rate has been established in good faith and regardless of the
existence of any such relations between the individual and the corporation. In these cases, the individual will be taxed at the
marginal tax rate. The paying company will deduct tax at a rate of 15% on interest in respect of unlinked debentures, such as
76
the Series A Notes, and at a rate of 25% in the case of linked debentures. The maximum tax rate will apply in the case of an
individual who is a "principal" individual note holder, an individual employed by the interest-paying-corporation or a supplier
of goods or services to the corporation. The tax rate applicable to interest income (including linkage differences) or discount
fees of an Israeli resident corporation is the corporate tax rate. The paying company will deduct tax at the corporate tax rate.
Income tax for foreign residents. Interest, discount fees or linkage differences paid to a foreign resident on
debentures listed on the TASE and issued by an Israeli resident corporation, such as our Series A Notes, are typically exempt
from Israeli tax, provided that the income is not produced by the foreign resident’s permanent establishment in Israel. The tax
exemption will not apply in the following circumstances: (1) the foreign resident is a “principal” shareholder or note holder of
the issuing company; (2) the foreign resident is a relative, as defined in the Ordinance, of the issuing company; (3) the foreign
resident is an employee, a supplier of goods or services or has special relations with respect to the issuing company (unless it is
demonstrated that the interest rate or discount fees have been determined in good faith and regardless of the existence of any
special relations); or (4) the foreign resident company is held by Israeli residents. If the tax exemption does not apply as above,
the tax rate applicable to interest income received by foreign residents (individuals and corporations) originating from securities
will be established in accordance with the provisions of the Ordinance, or in accordance with the provisions of the relevant
treaty for the avoidance of double taxation signed between the State of Israel and the foreign resident’s country of residence. In
such case, the paying company will withhold tax according to the rates prescribed in the Ordinance as above, and this rate may
be reduced subject to the relevant treaty for the avoidance of double taxation. As indicated above, the Series A Notes are not
registered under the Securities Act and may not be offered or sold in the United States or to U.S. Persons (as defined in
Regulation “S” under the Securities Act) without registration under the Securities Act or an exception from the registration
requirements of the Securities Act.
Israeli Tax on United States Shareholders
Dividends paid by Elbit Systems to an individual shareholder resident in the United States are generally subject to
withholding tax deducted at source in Israel. Israel and the United States are parties to a tax treaty. Under the treaty, the
withholding tax rate on a dividend is normally 25%, or 15% in connection with an Approved Enterprise, Privileged Enterprise
or Preferred Enterprise. (See above “Investment Law.”)
A U.S. corporation would have a reduced withholding tax rate of 15% on dividends if it were to own 10% or more
of Elbit Systems’ voting shares under specified conditions. The reduced withholding tax rate on the dividend would be 12.5%.
The U.S. corporation must own at least 10% of the voting shares during a portion of Elbit Systems’ tax year in which the
payment of the dividend occurs but prior to the payment date and during the entire prior tax year. The reduced rate is also
subject to two other conditions. First, not more than 25% of Elbit Systems’ gross income for the prior tax year may consist of
interest, other than interest received from banking, financing or similar businesses or from certain subsidiaries. Second, the
dividend may not be derived from income during any period for which Elbit Systems is entitled to the reduced tax rate
applicable to an Approved Enterprise / Privileged Enterprise.
Under the terms of the tax treaty, Israel may tax capital gains realized by shareholders resident in the United
States on a sale of ordinary shares of Elbit Systems if certain conditions exist, however, such right is subject to the following
exemption. Since Elbit Systems’ ordinary shares are traded on the TASE and on Nasdaq, gains on the sale of ordinary shares
held by non-Israeli resident investors for tax purposes generally will be exempt from Israeli capital gains tax, subject to the
provisions of the Israeli tax legislation.
Subject to certain conditions and limitations, any Israeli tax withheld or paid with respect to dividends on ordinary
shares generally will be eligible for credit against a U.S. shareholder’s U.S. federal income tax liability at such U.S.
shareholder’s election. The U.S. Internal Revenue Code of 1986, as amended, (the Code) provides limitations on the amount of
foreign tax credits that a U.S. shareholder may claim, including extensive separate computation rules under which foreign tax
credits allowable with respect to specific categories of income cannot exceed the U.S. federal income taxes otherwise payable
with respect to each such category of income. U.S. shareholders that do not elect to claim a foreign tax credit may instead claim
a deduction for Israeli income tax withheld or paid, but only for a year in which these U.S. shareholders elect to do so for all
foreign income taxes. Dividends with respect to the ordinary shares will generally be classified as foreign source “passive
income” for the purpose of computing a U.S. shareholder’s foreign tax credit limitations for U.S. foreign tax credit purposes.
The rules relating to foreign tax credits are complex, and each U.S. holder of our ordinary shares should consult his or her tax
advisor to determine whether and if he or she would be entitled to this credit.
77
This summary of Israeli taxation is based on existing treaties, laws, regulations and judicial and
administrative interpretations thereof. There can be no assurance that any of these may not be amended or repealed,
possibly with retroactive effect, or that a tax authority may take a contrary position. Also, this summary does not
address the tax consequences that may be applicable to specific persons based on their individual circumstances. It also
does not address any local or other foreign tax consequences. A shareholder or holder of Series A Notes should consult
his or her own tax advisor as to the specific tax consequences of purchasing, holding or transferring shares or Series A
Notes of Elbit Systems.
United States Federal Income Tax Considerations
General
The following is a summary of material U.S. federal income tax considerations regarding the acquisition,
ownership and disposition of Elbit Systems’ ordinary shares by a “U.S. Shareholder”, which, for these purposes, means a
beneficial owner of an ordinary share who is, for U.S. federal income tax purposes:
(1)
a citizen or individual resident of the United States for U.S. federal income tax purposes;
(2)
a corporation (or an entity taxable as a corporation for U.S. federal income tax purposes) created or
organized in or under the laws of the United States or any political subdivision thereof (including the
District of Columbia);
(3)
an estate whose income is subject to U.S. federal income taxation regardless of its source; or
(4)
a trust if (A) a U.S. court is able to exercise primary supervision over the trust’s administration and (B) one
or more U.S. persons have the authority to control all of the trust’s substantial decisions or if it has a valid
election in place to be treated as a U.S. person.
If a partnership or other entity treated as a partnership for U.S. federal income tax purposes holds ordinary shares
of Elbit Systems, the tax treatment of a partner generally will depend upon the status of the partner and the activities of the
partnership. A partner in a partnership that holds our ordinary shares is urged to consult its own tax advisor regarding the
specific tax consequences of owning and disposing of our ordinary shares.
This summary is based on provisions of the Code, existing and proposed U.S. Treasury regulations, administrative
pronouncements, rulings and judicial decisions in effect as of the date of this annual report. These authorities and their
interpretation are subject to change, possibly with retroactive effect. In addition, this summary does not discuss all aspects of
U.S. federal income taxation that may be applicable to investors in light of their particular circumstances or to investors who
are subject to special treatment under U.S. federal income tax law, including U.S. expatriates, insurance companies, banks,
regulated investment companies, securities broker-dealers, financial institutions, tax-exempt organizations, persons holding
ordinary shares as part of a straddle, hedging or conversion transaction, persons subject to the alternative minimum tax, persons
who acquired their Elbit Systems’ ordinary shares pursuant to the exercise of employee stock options or otherwise as
compensation, persons having a functional currency other than the U.S. dollar, persons owning (directly, indirectly or by
attribution) 10% or more of our outstanding voting shares and persons not holding ordinary shares as capital assets.
Dividends
A U.S. Shareholder generally will be required to include in gross income, as ordinary income, the amount of any
distributions paid on ordinary shares of Elbit Systems to the extent of Elbit Systems’ earnings and profits out of current or
accumulated earnings and profits, including the amount of any Israeli taxes withheld in respect of such dividend. Dividends
paid by Elbit Systems do not qualify for the dividends-received deduction applicable in certain cases to U.S. corporations.
The amount of any distribution paid in NIS, including the amount of any Israeli withholding tax thereon, will be
included in the gross income of a U.S. Shareholder of ordinary shares in an amount equal to the U.S. dollar value of the NIS
calculated by reference to the spot rate of exchange in effect on the date the distribution is received by the U.S. Shareholder. If a
U.S. Shareholder converts dividends paid in NIS into U.S. dollars on the day Elbit Systems distributes the dividends, the U.S.
Shareholder generally should not be required to recognize foreign currency gain or loss with respect to such conversion. If the
NIS received in the distribution are not converted into U.S. dollars on the date of receipt, any foreign currency gain or loss
recognized upon a subsequent conversion or other disposition of the NIS will be treated as U.S. source ordinary income or loss.
Special rules govern and special elections are available to accrual method taxpayers to determine the U.S. dollar amount that
78
should be included in income in the case of taxes withheld in a foreign currency. Accrual basis taxpayers are urged to consult
their own tax advisors regarding the requirements and the elections applicable in this regard.
Dividends paid by us to a U.S. Shareholder on our ordinary shares will be treated as foreign source income and
will generally be categorized as “passive category income” for U.S. foreign tax credit purposes. Subject to the limitations in the
Code, as modified by the applicable tax treaty, a U.S. Shareholder may elect to claim a foreign tax credit against its U.S. federal
income tax liability for Israeli income tax withheld from dividends received in respect of ordinary shares. U.S. Shareholders
who do not elect to claim the foreign tax credit may instead claim a deduction for Israeli income tax withheld, but only for a
year in which the U.S. Shareholder elects to do so with respect to all foreign income taxes. A deduction does not reduce U.S.
tax on a dollar-for-dollar basis as it does for a tax credit. The deduction, however, is not subject to the limitations applicable to
foreign tax credits. The rules relating to the determination of the foreign tax credit are complex. Accordingly, if you are a U.S.
Shareholder of ordinary shares, you should consult your own tax advisor to determine whether and to what extent you would be
entitled to the credit.
Certain U.S. Shareholders (including individuals) are eligible for reduced U.S. federal income tax rates in respect
of “qualified dividend income.” Subject to applicable limitations, qualified dividend income included in income after December
31, 2012 is generally subject to U.S. federal taxation at a maximum rate of 15%, or 20% in the case of taxpayers with annual
taxable income that exceeds certain thresholds. For this purpose, qualified dividend income generally includes dividends paid
by a non-U.S. corporation if, among other things, the U.S. Shareholder meets certain minimum holding periods and the non-
U.S. corporation satisfies certain requirements, including that either: (i) the shares with respect to which the dividend has been
paid are readily tradeable on an established securities market in the United States; or (ii) the non-U.S. corporation is eligible for
the benefits of a comprehensive U.S. income tax treaty , which provides for the exchange of information. We currently believe
that dividends paid with respect to our ordinary shares should constitute qualified dividend income for U.S. federal income tax
purposes. Each individual U.S. Shareholder of ordinary shares is urged to consult his or her own tax advisor regarding the
availability to him of the reduced dividend tax rate in light of his or her own particular situation and regarding the computations
of his or her foreign tax credit limitation with respect to any qualified dividend income paid by us, as applicable.
Medicare Tax
Non-corporate U.S. Shareholders may be subject to an additional 3.8% Medicare surtax on all or a portion of "net
investment income", which generally may include dividends on, or capital gains recognized from the disposition of, our
ordinary shares. U.S. Shareholders are urged to consult their own tax advisors regarding the applicability of the Medicare tax
to their investment in our shares.
Sale, exchange or other disposition
Upon the sale, exchange or other disposition of ordinary shares, a U.S. Shareholder generally will recognize
capital gain or loss equal to the difference between the U.S. dollar value of the amount realized on the sale, exchange or other
disposition and the U.S. Shareholder’s adjusted tax basis, determined in U.S. dollars, of the ordinary shares. Any gain or loss
recognized upon the sale, exchange or other disposition of the ordinary shares will be treated as long-term capital gain or loss
if, at the time of the sale, exchange or other disposition, the holding period of the ordinary shares exceeds one year. In the case
of individual U.S. Shareholders, capital gains generally are subject to U.S. federal income tax at preferential rates if specified
minimum holding periods are met. The deductibility of capital losses by a U.S. Shareholder is subject to significant limitations.
U.S. Shareholders should consult their own tax advisors in this regard.
In general, gain or loss recognized by a U.S. Shareholder on the sale, exchange or other disposition of ordinary
shares will be U.S. source income or loss for U.S. foreign tax credit purposes. Pursuant to the applicable tax treaty, however,
gain from the sale or other disposition of ordinary shares by a holder who is a U.S. resident, for purposes of the applicable tax
treaty, and who sells the ordinary shares within Israel, may be treated as foreign source income for U.S. foreign tax credit
purposes.
U.S. Shareholders who hold ordinary shares through an Israeli stockbroker or other Israeli intermediary may be
subject to Israeli withholding tax on any capital gains recognized if the U.S. Shareholder does not obtain approval of an
exemption from the Israeli Tax Authorities. U.S. Shareholders are advised that any Israeli tax paid under circumstances in
which an exemption from such tax was available generally will not give rise to a deduction or credit for foreign taxes paid for
U.S. federal income tax purposes. U.S. Shareholders are advised to consult their Israeli stockbroker or intermediary regarding
the procedures for obtaining an exemption.
79
If a U.S. Shareholder receives NIS upon the sale of ordinary shares, that U.S. Shareholder may recognize ordinary
income or loss as a result of currency fluctuations between the date of the sale of the ordinary shares and the date the sales
proceeds are converted into U.S. dollars.
Passive Foreign Investment Company rules
A non-U.S. corporation will be classified as a Passive Foreign Investment Company (a PFIC) for any taxable year
if at least 75% of its gross income consists of passive income (such as dividends, interest, rents, royalties - other than rents or
royalties derived in the active conduct of a trade or business and received from an unrelated person - or gains on the disposition
of certain minority interests), or at least 50% of the average value of its assets consists of assets that produce, or are held for the
production of, passive income. We currently believe that we were not a PFIC for the year ended December 31, 2016. However,
this conclusion is a factual determination that must be made at the close of each year and is based on, among other things, a
valuation of our ordinary shares and assets, which will likely change from time to time. If we were characterized as a PFIC for
any taxable year, a U.S. Shareholder would suffer adverse tax consequences. These consequences may include having gains
realized on the disposition of ordinary shares treated as ordinary income rather than capital gains and being subject to punitive
interest charges on certain dividends and on the proceeds of the sale or other disposition of the ordinary shares. Furthermore,
dividends paid by a PFIC are not eligible to be treated as “qualified dividend income” (as discussed above).
The PFIC rules are complex. U.S. Shareholders should consult their own tax advisors regarding the potential
application of the PFIC rules to the ownership of our ordinary shares.
Informational reporting and backup withholding
Dividend payments with respect to ordinary shares and proceeds from the sale, exchange or other disposition of
ordinary shares may be subject to informational reporting to the Internal Revenue Service (the IRS) and possible U.S. backup
withholding at a current rate of 28%. Backup withholding will not apply, however, to a holder who timely furnishes a correct
taxpayer identification number or certificate of foreign status and makes any other required certification or who is otherwise
exempt from backup withholding. U.S. persons who are required to establish their exempt status generally must provide IRS
Form W-9 (Request for Taxpayer Identification Number and Certification). Non-U.S. Shareholders generally will not be
subject to U.S. informational reporting or backup withholding. However, such holders may be required to provide certification
of non-U.S. status (generally on IRS Form W-8BEN) in connection with payments received in the United States or through
certain U.S.-related financial intermediaries.
Backup withholding is not an additional tax. Amounts withheld as backup withholding may be credited against a
holder’s U.S. federal income tax liability, and a holder may obtain a refund of any excess amounts withheld by timely filing the
appropriate claim for refund with the IRS and furnishing any required information.
Holders of our ordinary shares should consult their own tax advisors concerning the specific U.S. federal,
state and local tax consequences of the ownership and disposition of the ordinary shares in light of their particular
situations as well as any consequences arising under the laws of any other taxing jurisdiction. In particular, U.S.
Shareholders are urged to consult their own tax advisors concerning whether they will be eligible for benefits under the
above-mentioned tax treaty.
Documents on Display
We are subject to the informational requirements of the Securities Exchange Act of 1934, as amended. In
accordance with these requirements, we file reports and other information with the SEC. These materials, including this annual
report and its exhibits, may be inspected and copied at the SEC’s Public Reference Room (the Public Reference Room) at 100 F
Street, N.E., Washington, D.C. 20549, and copies of the materials may be obtained from the Public Reference Room at
prescribed rates. The public may obtain information on the operation of the Public Reference Room by calling the SEC in the
United States at 1-800-SEC-0330.
80
Item 11.
Quantitative and Qualitative Disclosures About Market Risk.
General
Market risks relating to our operations result primarily from changes in exchange rates and interest rates. We take
various measures to compensate for the effects and fluctuation in both exchange rates and interest rates. We use financial
instruments and derivatives in order to limit the exposure to risks deriving from changes in exchange rates and interest rates.
No derivatives instruments are entered into for trading purposes.
Exchange Rate Risk Management
General
While our functional currency is the U.S. dollar, we also have some non-U.S. dollar or non-U.S. dollar linked
currency exposures. These exposures are mainly derived from our revenues and expenses denominated in foreign currencies
and non-U.S. dollar accounts receivable, payments to suppliers and subcontractors, obligations in other currencies and payroll
related expenses incurred, mainly in NIS. Some subcontractors are paid in local currency under prime contracts where we are
paid in U.S. dollars.
We take various measures to compensate for the effects of fluctuations in exchange rates. These measures include
currency hedging transactions in which we purchase foreign exchange contracts to reduce the volatility of cash flows associated
with project related revenues and expenses denominated in certain foreign currencies (mainly Euro and GBP) and attempts to
maintain a balance between monetary assets and liabilities in our functional currencies. We also attempt to share currency risks
with subcontractors on a “back-to-back” basis, by having the subcontractor assume a proportional amount of the exchange risk.
We use currency hedging contracts and other derivatives instruments to limit our exposure to exchange rate
fluctuations related to payroll expenses incurred in NIS. The objective of the foreign exchange contracts is to better ensure that
the U.S. dollar-equivalent cash flows are not adversely affected by changes in U.S. dollar/foreign currency exchange rates. In
accordance with ASC 815, “Derivatives and Hedging”, these contracts are designated as cash flow hedges. The gain on the
effective portion of a cash flow hedge is initially reported as a component of accumulated other comprehensive income and
subsequently reclassified into revenues and to contract expenses when the hedged exposure affects revenues or contract
expenses, or as financial expenses, if the hedged transaction becomes probable of not occurring. Any gain or loss after a hedge
is de-designated, because the hedged transaction is no longer probable of occurring or related to an ineffective portion of a
hedge, is recognized in “financial expenses, net” in our consolidated statements of income.
As of December 31, 2015 and December 31, 2016, the notional amount of our outstanding forward contracts was
$937.2 million and $853.9 million, respectively. Most of these contracts met the requirements of hedge accounting.
The table below provides information regarding our derivatives instruments held in order to limit the exposure to
exchange rate fluctuation as of December 31, 2016. The table does not include information regarding the cross currency interest
rate swap transactions in order to effectively hedge the effect of interest and exchange rate differences resulting from the NIS
Series A Notes.
Maturity Date - Notional Amount
( US dollars in millions)
2017
2018
2019
2020
2021
onwards
Total
Fair Value at
December
31, 2016
66.9
29.7
10.1
106.7
15.7
1.5
4.3
21.5
4.4
0.2
3.3
7.9
1.3
—
1.6
2.9
1.5
—
—
1.5
89.8
31.4
19.3
140.5
6.5
3.0
0.1
9.6
Buy US$ and sell:
EUR
GBP
Other currencies
Total
81
Maturity Date - Notional Amount
( US dollars in millions)
2017
2018
2019
2020
2021
onwards
Total
Fair Value at
December
31, 2016
34.0
4.8
646.5
16.2
701.5
1.9
—
—
7.1
9.0
1.2
—
—
1.7
2.9
—
—
—
—
—
—
—
—
—
—
37.1
4.8
646.5
25.0
713.4
(1.6 )
(0.7 )
3.1
0.1
0.9
Sell US$ and buy:
EUR
GBP
NIS
Other currencies
Total
At December 31, 2016, a 5% and 10% strengthening of the U.S. dollar relative to the currencies in which our
derivative instruments were denominated would have resulted in unrealized losses of $26.2 and $49.6 million, respectively, and
a 5% and 10% weakening in the value of the U.S. dollar relative to the currencies in which our derivative instruments were
denominated would have resulted in unrealized gains of $29.3 and $62.2 million, respectively. This calculation assumes that
each exchange rate would have changed in the same direction relative to the U.S. dollar. Consistent with the use of these
contracts to neutralize the effect of exchange rate fluctuations, most of such unrealized losses or gains would be offset by
corresponding gains or losses, respectively, in the remeasurement of the underlying transactions being hedged. When taken
together, these forward currency contracts and the offsetting underlying commitments did not create material market risk.
Interest Rate Risk Management
On December 31, 2016, our liquid assets and obligations were comprised of cash and cash equivalents, bank
deposits, short and long-term loans and Series A Notes. Our deposits are mainly in U.S. dollars.
In June 2010, we issued NIS 1.1 billion (approximately $283 million) of Senior A Notes in a public offering on
the TASE, These Senior A Notes are payable in ten equal annual installments on June 30 of each of the years 2011 through
2020 and bear a fixed interest rate of 4.84% per annum, payable semi-annually on June 30 and December 30 of each of the
years 2010 through 2020. In March 2012, we issued through a public offering on the TASE additional Series A Notes in the
aggregate principal amount of NIS 807 million (approximately $217 million), and in May 2012, we issued additional Series A
Notes in an aggregate principal amount of NIS 92 million (approximately $24 million) through a private placement to Israeli
institutional investors. As of December 31, 2015 and December 31, 2016, the total principal amount of the Series A Notes was
$269 million and $218.5 million, respectively.
We also entered into ten-year cross currency interest rate swap transactions in order to effectively hedge the effect
of interest and exchange rate differences resulting from the NIS Series A Notes (including the additional Series A Notes that
were issued in March and May 2012). Under the cross currency interest rate swaps, the Company received fixed NIS at a rate
of 4.84% on NIS 2 billion and pays floating six-month USD LIBOR + an average spread of 1.84% on $524 million, which
reflects the U.S. dollar value of the Series A Notes on the specific dates the transactions were entered. (See above Item 5.
Operating and Financial Review and Prospects – Israeli Debt Offering.)
The remaining debt is mainly in loans in NIS at fixed interest rates, and loans in U.S. dollars at floating interest
rates. In order to hedge the effect of the interest and exchange rate differences resulting from the NIS loans, we entered into a
cross currency interest rate transaction. The majority of our borrowings (net of the effect of the cross currency interest rate
swap transaction) are usually linked to the relevant LIBOR plus a spread of 1.15% - 1.35%, and therefore are exposed to
changes in interest rates. Most of our loans will mature within the next year.
Should interest rates either increase or decrease, such change may affect our results of operations due to changes
in the cost of the liabilities and the return on the assets that are based on variable rates. At December 31, 2016, a hypothetical
1% (100 basis points) increase in the then current interest rates would not have had a material impact on our financial results.
82
Item 12.
Description of Securities Other than Equity Securities.
Not applicable.
Item 13.
Defaults, Dividend Arrearages and Delinquencies.
Not applicable.
Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds.
Not applicable.
Item 15.
Controls and Procedures.
Disclosure Controls and Procedures. We maintain disclosure controls and procedures designed to ensure
that information required to be disclosed in our periodic filings with the SEC is recorded, processed, summarized and reported
within the time periods specified in the SEC’s rules and forms. These controls and procedures also provide that such
information is accumulated and communicated to our management, including our Chief Executive Officer (CEO) and Chief
Financial Officer (CFO), as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating
the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed
and operated, can provide only reasonable assurance of achieving the desired control objectives. Also, management necessarily
was required to use its judgment in evaluating the cost to benefit relationship of possible disclosure controls and procedures. As
of December 31, 2016, we performed an evaluation of the effectiveness of the design and operation of our disclosure controls
and procedures. The evaluation was performed with the participation of senior management of major business areas and key
corporate functions, and under the supervision of the CEO and CFO. Based on the evaluation, our management, including the
CEO and CFO, concluded that our disclosure controls and procedures were effective. There have been no significant changes in
our internal controls or in other factors that could significantly affect internal controls after the date we completed the
evaluation.
Management’s Annual Report on Internal Control Over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial
reporting. Internal control over financial reporting is defined in Rules 13a-15(f) under the Securities Exchange Act of 1934, as
amended, as a process designed to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with generally accepted accounting principles and
includes those policies and procedures that:
(1) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect our transactions
and dispositions of assets;
(2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting principles, and that our receipts and
expenditures are being made in accordance with authorizations of our management and directors; and
(3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or
disposition of our assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect
misstatements including the possibility of human error and the circumvention or overriding of sound control procedures.
Projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate
because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Our management, including our CEO and CFO, assessed the effectiveness of our internal control over
financial reporting as of December 31, 2016. In making this assessment, management used the criteria set forth by the
Committee of Sponsoring Organizations of the Treadway Commission (COSO) in “Internal Control – Integrated Framework
(2013 Framework).” Based on this assessment, management believes that, as of December 31, 2016, our internal control over
financial reporting is effective.
83
The effectiveness of our internal control over financial reporting as of December 31, 2016 has been audited
by Kost Forer Gabbay & Kasierer (Kost), an independent registered public accounting firm in Israel and a member of Ernst &
Young Global (EY), as stated in their report included in Item 18. Financial Statements.
Changes in Internal Control over Financial Reporting. During the period covered by this annual report,
there have not been any changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and
15d-15(f) under the Securities Exchange Act of 1934, as amended) that have materially affected, or are reasonably likely to
materially affect, our internal control over financial reporting.
Item 16A. Audit Committee Financial Expert.
Dr. Gleitman and Prof. Nisan, members of our Audit Committee, each meets the criteria of an “Audit Committee
Financial Expert” under the applicable rules and regulations of the SEC, and each of their designations as an Audit Committee
Financial Expert has been ratified by the Board. They are each “independent”, as that term is defined in the Nasdaq listing
standards.
Item 16B. Code of Ethics.
We have adopted a code of business conduct and ethics that is applicable to all our directors, officers and
employees including our principal executive, financial and accounting officers and persons performing similar functions. The
code of ethics was approved by our Board and covers areas of professional and business conduct. It is intended to promote
honest and ethical behavior, including fair dealing and the ethical handling of conflicts of interest. The code of ethics includes a
“whistleblower” process to encourage reports of violations. We provide training on our code of ethics to all of our employees.
Our code of ethics is posted on our website: www.elbitsystems.com.
Item 16C. Principal Accountant Fees and Services.
At the annual general shareholders meeting held in November 2016, our shareholders reappointed Kost to serve as our
independent auditors. Kost and other EY affiliates billed the Company the following fees for professional services in each of the last
two fiscal years:
Audit Fees
Tax Fees
Other Fees
Total
Year Ended December 31
2016
2015
(U.S. dollars in
thousands)
2,839 $
318
137
3,294 $
2,784
263
222
3,269
$
$
“Audit Fees” are the aggregate fees for the audit of our consolidated annual financial statements. This category also
includes services generally provided by the independent auditor, such as consents and assistance with and review of documents filed
with the SEC, as well as with documentation related to Sarbanes-Oxley Act implementation. It also includes fees billed for
accounting consultations regarding the accounting treatment of matters that occur in the regular course of business, implications of
new accounting pronouncements and other accounting issues that occur from time to time.
“Tax Fees” are the aggregate fees billed for professional services rendered for tax compliance and tax advice,
other than in connection with the audit. Tax compliance involves preparation of original and amended tax returns, tax planning
and tax advice.
“Other Fees” are fees billed for services related to assessment of finance software.
Kost and other EY affiliates did not bill the Company for services other than the Audit Fees, Tax Fees and Other
Fees described above for fiscal year 2016 or fiscal year 2015.
84
Our Audit Committee has adopted a pre-approval policy for the engagement of our independent accountant to
perform permitted audit and non-audit services. Under this policy, which is designed to assure that such engagements do not
impair the independence of our auditors, the Audit Committee pre-approves annually a range of specific audit and non-audit
services in the categories of Audit Services, Audit-Related Services, Tax Services and other services that may be performed by
our independent accountants, and the maximum pre-approved fees that may be paid as compensation for each pre-approved
service in those categories. The Audit Committee is notified periodically and before commencement of any work in these
categories. Any proposed services exceeding the pre-approved fees or which includes other scope of work requires specific pre-
approval by the Audit Committee. Accordingly, all of the above-mentioned independent auditor fees were pre-approved by our
Audit Committee.
Item 16D. Exemptions from the Listing Standards for Audit Committees.
Not applicable.
Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers.
Reference is made to the disclosure relating to changes in shareholdings of major shareholders in Item 7 of this
annual report on Form 20-F.
No shares were repurchased by Elbit Systems during 2016.
Item 16F. Changes in Registrant’s Certifying Accountant.
Not Applicable.
Item 16G. Corporate Governance.
We follow corporate governance standards applicable to us under Israeli and U.S. laws and regulations and
Nasdaq listing standards.
Item 16H. Mine Safety Disclosure.
Not applicable.
Item 17.
Financial Statements.
Not applicable.
Item 18.
Financial Statements.
See Consolidated Financial Statements attached to this annual report on Form 20-F.
85
Item 19.
Exhibits.
(a) Index to Financial Statements
Report of Independent Registered Public Accounting Firm
Report of Independent Registered Public Accounting Firm on Internal Control over Financial Reporting
Consolidated Balance Sheets
Consolidated Statements of Income
Consolidated Statements of Comprehensive Income
Consolidated Statements of Changes in Equity
Consolidated Statements of Cash Flows
Notes to Consolidated Financial Statements
Schedule II – Valuation and Qualifying Accounts
Page
F-2
F-3
F-4
F-6
F-7
F-8
F-12
F-14
S-1
1.1
1.2
4.1
8
12.1
(b) Exhibits
Elbit Systems’ Memorandum of Association(1)
Elbit Systems’ Restated Articles of Association(2)
Description of the Terms of Office and Employment of the Company's President and Chief Executive Officer(3)
Major Operating Subsidiaries of Elbit Systems
Certification of Chief Executive Officer of the Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of
2002
12.2
Certification of Chief Financial Officer of the Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
13.1
Certification of Chief Executive Officer of the Registrant pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
13.2
Certification of Chief Financial Officer of the Registrant pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
15.1
Consent of Kost Forer Gabbay & Kasierer
(1)
(2)
(3)
Filed as an exhibit to Elbit Systems’ Annual Report on Form 20-F (File No. 0-28998) for the year ended
December 31, 2000, which was filed with the SEC on April 5, 2001, and incorporated herein by reference.
Filed as Exhibit 2 to Elbit Systems’ Report on Form 6-K filed by Elbit Systems with the SEC on March 26, 2008,
and incorporated herein by reference; as amended by that certain amendment filed as Annex A to Exhibit 1 to
Elbit Systems' Report on Form 6-K filed by Elbit Systems with the SEC on October 25, 2011, and incorporated
herein by reference.
Filed as Exhibit 4.2 to Elbit Systems' Annual Report on Form 20-F filed by Elbit Systems with the SEC on March
22, 2016 and incorporated herein by reference.
86
SIGNATURES
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant certifies that it
meets all of the requirements for filing on Form 20-F and has duly caused this annual report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Date: March 21, 2017
ELBIT SYSTEMS LTD.
By:
/s/ BEZHALEL MACHLIS
Name:
Title:
Bezhalel Machlis
President and Chief Executive Officer
(Principal Executive Officer)
87
ELBIT SYSTEMS LTD. AND
SUBSIDIARIES
CONSOLIDATED FINANCIAL STATEMENTS
as of and for the year ended December 31, 2016
ELBIT SYSTEMS LTD. AND
SUBSIDIARIES
CONSOLIDATED FINANCIAL STATEMENTS
as of and for the year ended December 31, 2016
in thousands of U.S. dollars
C O N T E N T S
REPORTS OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
CONSOLIDATED FINANCIAL STATEMENTS:
Consolidated Balance Sheets
Consolidated Statements of Income
Consolidated Statements of Comprehensive Income
Statements of Changes in Equity
Consolidated Statements of Cash Flows
Notes to the Consolidated Financial Statements
Page
2 - 3
4 - F - 5
6
7
8 - F - 10
11 - F - 12
13 - F - 66
F - 1
Kost Forer Gabbay & Kasierer
3 Aminadav St.
Tel-Aviv 6706703, Israel
Tel: +972-3-6232525
Fax: +972-3-5622555
ey.com
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Directors of
Elbit Systems Ltd.
We have audited the accompanying consolidated balance sheets of Elbit Systems Ltd. (“Elbit Systems”) and subsidiaries as of
December 31, 2016 and 2015, and the related consolidated statements of income, comprehensive income, changes in equity and
cash flows for each of the three years in the period ended December 31, 2016. Our audits also included the financial statement
schedule listed in the index at Item 19. These consolidated financial statements and schedule are the responsibility of Elbit Systems’
management. Our responsibility is to express an opinion on these consolidated financial statements and schedule based on our
audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States).
Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the
financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management,
as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our
opinion.
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated
financial position of Elbit Systems and subsidiaries as of December 31, 2016 and 2015, and the consolidated results of their
operations and their cash flows for each of the three years in the period ended December 31, 2016, in conformity with U.S.
generally accepted accounting principles. Also, in our opinion, the related financial statement schedule, when considered in relation
to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), Elbit
Systems and subsidiaries’ internal control over financial reporting as of December 31, 2016, based on criteria established in Internal
Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013
framework), and our report dated March 21, 2017, expressed an unqualified opinion thereon.
Kost Forer Gabbay & Kasierer
A member of Ernst & Young Global
Tel Aviv, Israel
March 21, 2017
F - 2
Kost Forer Gabbay & Kasierer
3 Aminadav St.
Tel-Aviv 6706703, Israel
Tel: +972-3-6232525
Fax: +972-3-5622555
ey.com
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
ON INTERNAL CONTROL OVER FINANCIAL REPORTING
To the Shareholders and Board of Directors of
Elbit Systems Ltd.
We have audited Elbit Systems Ltd.’s (“Elbit Systems”) and subsidiaries internal control over financial reporting as of December 31, 2016,
based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the
Treadway Commission (2013 framework) (the “COSO criteria”). Elbit Systems’ management is responsible for maintaining effective
internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in
the accompanying Management’s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion
on Elbit Systems and subsidiaries' internal control over financial reporting based on our audit.
We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial
reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting,
assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on
the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit
provides a reasonable basis for our opinion.
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting
principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance
of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide
reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally
accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations
of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of
any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in
conditions, or that the degree of compliance with the policies or procedures may deteriorate.
In our opinion, Elbit Systems and subsidiaries maintained, in all material respects, effective internal control over financial reporting as of
December 31, 2016, based on the COSO criteria.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the
consolidated balance sheets of Elbit Systems and subsidiaries as of December 31, 2016 and 2015, and the related consolidated statements
of income, comprehensive income, changes in equity and cash flows for each of the three years in the period ended December 31, 2016,
and our report dated March 21, 2017, expressed an unqualified opinion thereon.
Kost Forer Gabbay & Kasierer
A member of Ernst & Young Global
Tel Aviv, Israel
March 21, 2017
F - 3
CONSOLIDATED BALANCE SHEETS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
CURRENT ASSETS:
Cash and cash equivalents
Short-term bank deposits
Available-for-sale marketable securities
Trade and unbilled receivables, net
Other receivables and prepaid expenses
Inventories, net of customer advances
Total current assets
LONG-TERM INVESTMENTS AND RECEIVABLES:
Investments in affiliated companies, partnerships and other companies
Long-term trade and unbilled receivables
Long-term bank deposits and other receivables
Deferred income taxes, net
Severance pay fund
PROPERTY, PLANT AND EQUIPMENT, NET
GOODWILL
OTHER INTANGIBLE ASSETS, NET
Total assets
December 31,
Note
2016
2015
(9)
(3)
(4)
(5)
(6)
(7)
(8)
(18F)
(2R)
(10)
(11)
(11)
$
222,810 $
8,882
13,370
1,232,591
135,315
840,266
2,453,234
299,322
20,266
12,836
941,913
171,359
837,111
2,282,807
180,962
189,688
15,917
47,303
264,253
698,123
129,758
152,463
15,765
52,619
270,151
620,756
474,109
449,759
616,997
622,654
109,401
147,622
$ 4,351,864 $ 4,123,598
The accompanying notes are an integral part of the consolidated financial statements.
F - 4
CONSOLIDATED BALANCE SHEETS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
CURRENT LIABILITIES:
Short-term bank credit and loans
Current maturities of long-term loans and Series A Notes
Trade payables
Other payables and accrued expenses
Customer advances in excess of costs incurred on contracts in progress
Total current liabilities
LONG-TERM LIABILITIES:
Long-term loans, net of current maturities
Series A Notes, net of current maturities
Employee benefit liabilities
Deferred income taxes and tax liabilities, net
Customer advances in excess of costs incurred on contracts in progress
Other long-term liabilities
Total long-term liabilities
COMMITMENTS AND CONTINGENT LIABILITIES
EQUITY:
Elbit Systems Ltd. equity:
Share capital:
Ordinary shares of 1 New Israeli Shekels (“NIS”) par value each; Authorized –
80,000,000 shares as of December 31, 2016 and 2015; Issued 44,154,737 and
44,138,989 shares as of December 31, 2016 and 2015, respectively; Outstanding
42,745,816 and 42,730,068 shares as of December 31, 2016 and 2015,
respectively
Additional paid-in capital
Treasury shares – 1,408,921 as of December 31, 2016 and 2015.
Accumulated other comprehensive loss
Retained earnings
Total Elbit Systems Ltd. equity
Non-controlling interests
Total equity
Total liabilities and equity
December 31,
Note
2016
2015
(12)
(15,16)
(13)
(14)
$
5,027 $
228,956
514,106
830,516
347,393
1,925,998
—
113,359
347,366
739,867
437,202
1,637,794
475
171,066
376,115
58,298
174,529
78,142
858,625
165,971
226,758
381,641
44,738
167,601
99,668
1,086,377
(15)
(16)
(2R)
(18F)
(14)
(20)
(21)
12,345
261,992
(40,428 )
(72,181 )
1,398,112
1,559,840
7,401
1,567,241
12,341
261,421
(40,428 )
(71,610 )
1,229,650
1,391,374
8,053
1,399,427
$ 4,351,864 $ 4,123,598
The accompanying notes are an integral part of the consolidated financial statements.
F - 5
CONSOLIDATED STATEMENTS OF INCOME
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Year ended December 31,
Revenues
Cost of revenues
Gross profit
Operating expenses:
Research and development, net
Marketing and selling, net
General and administrative, net
Other operating income, net
Total operating expenses
Operating income
Financial expenses, net
Other income, net
Income before income taxes
Income taxes
Note
(22)
(23)
(1D)
(24)
(25)
(18D)
Equity in net earnings of affiliated companies and partnerships
(6B)
Net income
Less: net income attributable to non-controlling interests
Net income attributable to Elbit Systems Ltd.’s shareholders
$
$
2016
2015
$ 3,260,219 $ 3,107,581 $ 2,958,248
2,133,151
825,097
2,210,528
897,053
2,300,636
959,583
2014
255,792
271,037
151,353
(17,575 )
660,607
298,976
(23,742 )
3,967
279,201
(45,617 )
233,584
5,224
238,808 $
(1,899 )
236,909 $
243,416
239,366
145,693
—
628,475
268,578
(20,240 )
216
248,554
(46,235 )
202,319
4,542
206,861 $
(4,352 )
202,509 $
228,011
216,537
139,634
(5,951 )
578,231
246,866
(47,498 )
120
199,488
(25,624 )
173,864
5,549
179,413
(8,433 )
170,980
4.01
4.01
Basic net earnings per share attributable to Elbit Systems Ltd.’s
shareholders
Diluted net earnings per share attributable to Elbit Systems
Ltd.’s shareholders
(21)
$
5.54
$
4.74
$
$
5.54
$
4.74
$
Weighted average number of shares used in computation of
basic net earnings per share
Weighted average number of shares used in computation of
diluted net earnings per share
42,742
42,711
42,654
42,752
42,733
42,677
The accompanying notes are an integral part of the consolidated financial statements.
F - 6
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Net income
Other comprehensive income (loss), net of tax (benefits) expenses in the amounts
of $1,904, $9,209 and $20,471 for the years 2016, 2015 and 2014, respectively:
Foreign currency translation differences
Unrealized gains (losses) on derivative instruments, net of tax
Pension and other post-retirement benefit plans, net of tax
Unrealized losses on available-for-sale marketable securities, net of tax
Total comprehensive income
Less: comprehensive income attributable to non-controlling interest
Comprehensive income attributable to Elbit Systems Ltd.'s shareholders
$
Year ended December 31,
2016
238,808 $
2015
206,861 $
2014
179,413
$
(8,471 )
6,741
(56 )
(11 )
(1,797 )
237,011
(673 )
236,338 $
(13,917 )
30,632
7,892
(59 )
24,548
231,409
(3,927 )
227,482 $
(22,155 )
(20,582 )
(29,210 )
(200 )
(72,147 )
107,266
(7,650 )
99,616
The accompanying notes are an integral part of the consolidated financial statements.
F - 7
STATEMENTS OF CHANGES IN EQUITY
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Number of
outstanding
shares
Share
capital
Additional
paid–in
capital
Accumulated
other
comprehensive
income (loss)
Retained
earnings
Treasury
shares
Non–
controlling
interest
Total
equity
Balance as of January 1, 2014
42,587,499
$
12,302
$
255,841
$
(25,219 ) $
971,556
$
(40,428 ) $
17,157
$
1,191,209
Exercise of options
97,996
Stock-based compensation
Dividends paid
Purchase of subsidiaries shares
from non-controlling interest, net
Other comprehensive loss, net of
tax benefit of $20,471
Net income attributable to non-
controlling interests
Net income attributable to Elbit
Systems Ltd.'s shareholders
—
—
—
—
—
—
28
—
—
—
—
—
—
3,514
322
—
—
—
—
—
—
—
—
—
(71,364 )
—
—
—
—
(53,825 )
—
—
—
170,980
—
—
—
—
—
—
—
—
—
3,542
322
(14,452 )
(68,277 )
1,873
1,873
(783 )
(72,147 )
8,433
8,433
—
170,980
Balance as of December 31, 2014
42,685,495
$
12,330
$
259,677
$
(96,583 ) $
1,088,711
$
(40,428 ) $
12,228
$
1,235,935
The accompanying notes are an integral part of the consolidated financial statements.
F - 8
STATEMENTS OF CHANGES IN EQUITY
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Number of
outstanding
shares
Share
capital
Additional
paid–in
capital
Accumulated
other
comprehensive
income (loss)
Retained
earnings
Treasury
shares
Non–
controlling
interest
Total
equity
Balance as of January 1, 2015
42,685,495
$
12,330
$
259,677
$
(96,583 ) $
1,088,711
$
(40,428 ) $
12,228
$
1,235,935
Exercise of options
44,573
Stock-based compensation
Purchase of subsidiaries shares, net
Dividends paid
Other comprehensive income, net
of tax expense of $9,209
Net income attributable to non-
controlling interests
Net income attributable to Elbit
Systems Ltd.'s shareholders
—
—
—
—
—
—
11
—
—
—
—
—
—
1,605
139
—
—
—
—
—
—
—
—
—
24,973
—
—
—
—
—
(61,570 )
—
—
202,509
—
—
—
—
—
—
—
—
—
120
1,616
139
120
(8,222 )
(69,792 )
(425 )
24,548
4,352
4,352
—
202,509
Balance as of December 31, 2015
42,730,068
$
12,341
$
261,421
$
(71,610 ) $
1,229,650
$
(40,428 ) $
8,053
$
1,399,427
The accompanying notes are an integral part of the consolidated financial statements.
F - 9
STATEMENTS OF CHANGES IN EQUITY
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Number of
outstanding
shares
Share
capital
Additional
paid–in
capital
Accumulated
other
comprehensive
income (loss)
Retained
earnings
Treasury
shares
Non–
controlling
interest
Total
equity
Balance as of January 1, 2016
42,730,068
$
12,341
$
261,421
$
(71,610 ) $
1,229,650
$
(40,428 ) $
8,053
$
1,399,427
Exercise of options
15,748
Stock-based compensation
Dividends paid
Purchase of minority interest
shares, net
—
—
—
4
—
—
—
Other comprehensive loss, net of
tax expense of $1,904
—
—
Net income attributable to non-
controlling interests
—
—
Net income attributable to Elbit
Systems Ltd.'s shareholders
—
—
501
70
—
—
—
—
—
—
—
—
—
—
—
(68,447 )
—
—
—
—
—
—
—
—
505
70
(68,447 )
(1,325 )
(1,325 )
(571 )
—
—
(1,226 )
(1,797 )
—
—
—
1,899
1,899
—
236,909
—
—
236,909
Balance as of December 31, 2016
42,745,816
$
12,345
$
261,992
$
(72,181 ) $
1,398,112
$
(40,428 ) $
7,401
$
1,567,241
The accompanying notes are an integral part of the consolidated financial statements.
F - 10
CONSOLIDATED STATEMENTS OF CASH FLOWS
U.S. dollars (In thousands, except per share data )
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
CASH FLOWS FROM OPERATING ACTIVITIES
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
Write-off impairment on marketable securities
Stock-based compensation
Amortization of Series A Notes discount (premium) and related issuance costs, net
Deferred income taxes and reserve, net
Loss (gain) on sale of property, plant and equipment
Loss (gain) on sale of investments and deconsolidation of subsidiary
Equity in net (earnings) losses of affiliated companies and partnerships, net of dividend
received(*)
Changes in operating assets and liabilities, net of amounts acquired:
Decrease (increase) in short and long-term trade receivables, and prepaid expenses
Decrease (increase) in inventories, net
Increase (decrease) in trade payables, other payables and accrued expenses
Severance, pension and termination indemnities, net
Increase (decrease) in advances received from customers
Net cash provided by operating activities
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment and other assets
Acquisitions of subsidiaries and business operations (Schedule A)
Investments in affiliated companies and other companies
Deconsolidation of subsidiary(**)
Proceeds from sale of property, plant and equipment
Proceeds from sale of investments
Investment in long-term deposits
Proceeds from sale of long-term deposits
Investment in short-term deposits and available-for-sale marketable securities
Proceeds from sale of short-term deposits and available-for-sale marketable securities
Net cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercise of options
Repayment of long-term loans
Proceeds from long-term loans
Repayment of Series A Notes
Dividends paid (***)
Change in short-term bank credit and loans, net
Net cash used in financing activities
Year ended December 31,
2015
2014
2016
$
238,808 $
206,861 $
179,413
122,888
86
70
(92 )
2,683
(3,347 )
(16,734 )
122,354
—
139
(92 )
15,928
1,742
33
122,408
—
322
(91 )
(47,456 )
(3,266 )
(4,957 )
(1,728 )
19,999
7,449
(297,439 )
(8,040 )
253,413
315
(82,881 )
208,002
(124,221 )
—
(19,277 )
(1,538 )
15,745
—
(417 )
894
(25,622 )
36,619
(117,817 )
505
(48,250 )
—
(55,532 )
(68,447 )
5,027
(166,697 )
31,860
39,801
(74,280 )
(799 )
71,282
434,828
(99,175 )
(141,436 )
(23,852 )
—
11,563
—
(396 )
721
(57,175 )
128,187
(181,563 )
1,616
(226,635 )
196,550
(55,532 )
(69,792 )
(557 )
(154,350 )
(67,177 )
(112,747 )
81,687
6,282
15,970
177,837
(71,211 )
787
(4,620 )
—
24,969
110
(796 )
790
(89,521 )
59,374
(80,118 )
3,542
(345,839 )
376,500
(55,532 )
(68,277 )
557
(89,049 )
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE YEAR
CASH AND CASH EQUIVALENTS AT THE END OF THE YEAR
(*) Dividends received from affiliated companies and partnerships
(76,512 )
299,322 $
222,810 $
98,915
200,407 $
299,322 $
8,670
191,737
200,407
3,496 $
24,541 $
12,998
$
$
$
(**) During 2016, an Israeli subsidiary was deconsolidated. See Note 1D and Note 6(b)(7).
(***) Dividends paid in 2015 and 2014 included approximately $8,222 and $14,452, respectively, in dividends paid by a subsidiary to non-
controlling interests.
The accompanying notes are an integral part of the consolidated financial statements.
F - 11
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
U.S. dollars (In thousands, except per share data )
SUPPLEMENTAL CASH FLOW ACTIVITIES:
Cash paid during the year for:
Income taxes, net
Interest
Schedule A: Acquisitions of subsidiaries and business operations
Estimated net fair value of assets acquired and liabilities assumed at the date of
acquisition was as follows:
Working capital, net (excluding cash and cash equivalents)
Property, plant and equipment
Other long-term assets
Goodwill and other intangible assets
Deferred income taxes
Long-term liabilities
Non-controlling interest
Year ended December 31,
2016
2015
2014
28,603 $
37,410 $
17,347
6,254 $
3,631 $
5,078
Year ended December 31,
2016
2015
2014
— $
—
—
—
—
—
—
— $
(7,210 ) $
3,368
(250 )
183,718
2,606
(40,796 )
—
141,436 $
(1,143 )
213
(9,791 )
12,422
(1,001 )
—
(1,487 )
(787 )
$
$
$
$
The accompanying notes are an integral part of the consolidated financial statements.
F - 12
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 1 -
GENERAL
A. GENERAL DESCRIPTION
Elbit Systems Ltd. (“Elbit Systems” or the "Company") is an Israeli corporation that is 45.80% owned by the
Federmann Group. Elbit Systems’ shares are traded on the Nasdaq National Market in the United States
(“Nasdaq”) and on the Tel-Aviv Stock Exchange (“TASE”). Elbit Systems and its subsidiaries (collectively the
“Company”) are engaged mainly in the fields of defense, homeland security and commercial aviation. Elbit
Systems’ major wholly-owned subsidiaries are the Elbit Systems of America, LLC (“ESA”) companies, Elbit
Systems Electro-Optics Elop Ltd. (“Elop”), Elbit Systems Land and C4I Ltd. (“ESLC”), Elbit Systems EW and
SIGINT - Elisra Ltd. (“Elisra”) and CYBERBIT Ltd. (“CYBERBIT”).
B. SALES TO GOVERNMENTAL AGENCIES
The Company derives a majority of its revenues from direct or indirect sales to governments or governmental
agencies. As a result, these sales are subject to the special risks associated with sales to governments or
governmental agencies. These risks include, among others, dependence on the resources allocated by governments
to defense programs, changes in governmental priorities, changes in governmental regulations and changes in
governmental approvals regarding export licenses required for the Company’s products and for its suppliers. As
for major customers, refer to Note 22(C).
C. SALE OF CERTAIN ASSETS
In 2014, the Company's wholly-owned subsidiary, ESA, sold certain assets related to a high-speed machinery
product line. As a result of the sale, the Company recorded an operating pre-tax loss of $4,600, which was
included in cost of revenues.
D. ACQUISITIONS AND INVESTMENTS
In the first quarter of 2016, an Israeli subsidiary was deconsolidated following an investment by a third party,
which included certain substantial participating rights. As a result, the Company recognized in other operating
income a net gain related to the revaluation of the investment of approximately $7,000.
In the second quarter of 2016, the Company invested approximately $13,400 in a U.K. company that is a joint
venture held 50% by a wholly-owned U.K. subsidiary of the Company and 50% by Kellogg Brown & Root
Limited ("KBR"). The joint venture is engaged in the area of flight training systems.
In the third quarter of 2016, a third party invested in a newly established Israeli subsidiary acting in the area of
energy technology solutions for civilian transportation applications. The third party investor holds certain
substantial participation rights. As a result, the Company recognized in other operating income a net gain of
approximately $10,500 related to valuation of the shares.
In April 2015, the Company completed the acquisition of a 100% interest in an Israeli company for a purchase
price of approximately $24,000. Based on a purchase price allocation ("PPA") performed by an independent
adviser, the purchase price was attributed mainly to goodwill (approximately $8,300) and to other intangible
assets (approximately $9,300). The results of operation of the acquired company were consolidated in the
Company's financial statements commencing on the date of acquisition.The effect on consolidated revenues and
net income were immaterial. Pro-forma information was not provided due to immateriality.
F - 13
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 1 -
GENERAL (Cont.)
D. ACQUISITIONS AND INVESTMENTS (Cont.)
In 2015, the Company acquired a division from an Israeli based company (the "Seller"), for a total consideration
of approximately $154,000, of which approximately $40,000 is contingent consideration, which may become
payable on the occurrence of certain future events.
Based on a PPA performed by an independent adviser, the purchase price was attributed to the fair value of assets
acquired and liabilities assumed from the seller as follows:
Net tangible assets and liabilities assumed (current and non-current)
Technology
IPR&D
Customer relationships
Backlog
Goodwill
Expected useful
lives
7.5 years
2.5 years
8.5 years
5.5 years
Fair value
$
(10,287 )
31,997
714
9,127
11,689
111,142
$ 154,382
The results of operation of the acquired business were consolidated in the Company's financial statements
commencing on the date of acquisition. The effects on consolidated revenues and net income were immaterial. Pro-
forma information was not provided due to immateriality.
In December 2016, following certain claims and allegations demanding indemnification pursuant to the asset purchase
agreement, the Company signed a settlement agreement with the Seller, in which the parties agreed on certain cash
payments and a reduction of up to $4,000 from any contingent consideration payment to Seller (the reduction in the
contingent consideration offset general and administrative expenses).
In 2010, the Company acquired a 49% interest in an Israeli company ("Subsidiary B"). On March 30, 2014, the
Company, through another wholly-owned Israeli subsidiary, increased its holdings in Subsidiary B to 90% and, as a
result, the Company recognized a gain of approximately $6,000, included in "other operating income, net", based on
the re-measurement of the fair-value of its previously held 49% equity interest in Subsidiary B. The acquisition was
accounted for using the purchase method as a business combination achieved in stages. The results of Subsidiary B
were consolidated in the Company's consolidated financial statements commencing on the date of acquisition.
Revenues and earnings from the acquisition date through December 31, 2014, were immaterial to the consolidated
results of the Company. In 2016, the Company acquired the additional 10% non-controlling interest in Subsidiary B
for a consideration of $1,300.
In 2010, a wholly-owned Israeli subsidiary completed an acquisition of a 100% interest in another wholly-owned
Israeli subsidiary ("Subsidiary C") and recorded a contingent consideration payable subject to the occurrence of certain
future events during a period of four years (the "period"). Following the lapse of the period in 2014, and as a result of
the non-occurrence of certain events, the Company de-recognized the contingent consideration of approximately
$5,000, recorded in other operating income, net.
F - 14
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 2 -
SIGNIFICANT ACCOUNTING POLICIES
The consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting
principles (“U.S. GAAP”).
A. USE OF ESTIMATES
The preparation of financial statements in conformity with generally accepted accounting principles requires
management to make estimates and assumptions that affect the amounts reported in the financial statements and
accompanying notes. The most significant assumptions are employed in estimates used in determining values of
intangible assets, warranty and contract loss accruals, legal contingencies, tax assets and tax liabilities, stock-
based compensation costs, retirement and post-retirement benefits (including the actuarial assumptions), financial
instruments with no observable market quotes, as well as in estimates used in applying the Company's revenue
recognition policies. Actual results may differ from estimated results.
B. FUNCTIONAL CURRENCY
The Company’s revenues are generated mainly in U.S. dollars. In addition, most of the Company’s costs are
incurred in U.S. dollars. The Company’s management believes that the U.S. dollar is the primary currency of the
economic environment in which the Company operates. Thus, the functional and reporting currency of the
Company is the U.S. dollar.
Transactions and balances of the Company and certain subsidiaries that are denominated in other currencies have
been remeasured into U.S. dollars in accordance with principles set forth in ASC 830, “Foreign Currency
Matters”. All exchange gains and losses from the remeasurement mentioned above are reflected in the statement
of income as financial expenses or income, as appropriate.
For those foreign subsidiaries and investees whose functional currency has been determined to be other than the
U.S. dollar, assets and liabilities are translated at year-end exchange rates, and statement of income items are
translated at average exchange rates prevailing during the year. Resulting translation differences are recorded as a
separate component of accumulated other comprehensive income in equity.
C. PRINCIPLES OF CONSOLIDATION
The consolidated financial statements include the accounts of Elbit Systems and its wholly and majority-owned
subsidiaries and variable interests entities that are required to be consolidated.
Intercompany transactions and balances, including profit from intercompany sales not yet realized outside the
Company, have been eliminated upon consolidation.
F - 15
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)
D.
COMPREHENSIVE INCOME
The Company accounts for comprehensive income in accordance with ASC 220, "Comprehensive Income". This
statement establishes standards for the reporting and display of comprehensive income and its components.
Comprehensive income generally represents all changes in shareholders' equity during the period except those
resulting from investments by, or distributions to, shareholders. Accordingly, the Company presents a separate
statement of consolidated comprehensive income.
The following table displays the changes in accumulated other comprehensive income (loss), net of taxes, in the
amount of $571 and $24,973, for the years ended December 31, 2016 and December 31, 2015, respectively, by
components:
Unrealized
gains (losses)
on derivative
instruments
Unrealized
gains (losses)
on available-
for-sale
marketable
securities
Pension and
post-
retirement
benefit plans
Foreign
currency
translation
differences
Total
Balance as of December 31, 2015
$
8,520 $
28 $
(46,751 ) $
(33,407 ) $ (71,610 )
Other comprehensive income (loss) before
reclassifications
Amount reclassified from accumulated other
comprehensive income (loss)
18,619
(11,878 )
Net current-period other comprehensive
income (loss)
Balance as of December 31, 2016
6,741
15,261 $
$
—
(11 )
(11 )
17 $
(3,642 )
(7,245 )
7,732
3,586
—
(8,303 )
(56 )
(7,245 )
(571 )
(46,807 ) $
(40,652 ) $ (72,181 )
Unrealized
gains (losses)
on derivative
instruments
Unrealized
gains (losses)
on available-
for-sale
marketable
securities
Pension and
post-
retirement
benefit plans
Foreign
currency
translation
differences
Total
Balance as of December 31, 2014
$
(22,112 ) $
87 $
(54,643 ) $
(19,915 ) $ (96,583 )
Other comprehensive income (loss)
before reclassifications
Amount reclassified from accumulated other
comprehensive income (loss)
Net current-period other comprehensive
income (loss)
Balance as of December 31, 2015
$
7,309
23,323
30,632
8,520 $
2
(61 )
(59 )
28 $
4,063
(13,492 )
(2,118 )
3,829
—
27,091
7,892
(13,492 )
24,973
(46,751 ) $
(33,407 ) $ (71,610 )
F - 16
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)
E. BUSINESS COMBINATIONS
The Company applies ASC 805, “Business Combinations”. ASC 805 requires recognition of assets acquired,
liabilities assumed, and non-controlling interest in the acquired entity at the acquisition date, measured at their fair
values as of that date. This ASC also requires the fair value of acquired in-process research and development
(“IPR&D”) to be recorded as intangibles with indefinite lives, contingent consideration to be recorded on the
acquisition date, and restructuring and acquisition-related deal costs to be expensed as incurred. Any excess of the
fair value of net assets acquired over purchase price and any subsequent changes in estimated contingencies are to
be recorded in earnings. In addition, changes in valuation allowance related to acquired deferred tax assets and in
acquired income tax position are to be recognized in earnings.
F. CASH AND CASH EQUIVALENTS
Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original
maturities of three months or less, when purchased.
G. SHORT-TERM BANK DEPOSITS
Short-term bank deposits are deposits with original maturities of more than three months but less than one year.
The short-term bank deposits are presented at their cost, which approximates fair value.
H. AVAILABLE-FOR-SALE MARKETABLE SECURITIES
The Company accounts for its investments in debt securities, and marketable equity securities of entities in which
it does not have significant influence, in accordance with ASC 320, “Investments - Debt and Equity Securities”.
The Company classifies all debt securities and marketable equity securities as “available-for-sale”. All of the
Company’s investments in available-for-sale securities are reported at fair value. Unrealized gains and losses are
comprised of the difference between fair value and the cost of such securities and are recognized, net of tax, in
accumulated other comprehensive income (“OCI”).
The amortized cost of debt securities reflects amortization of premiums and accretion of discounts to maturity.
Such amortization and accretion together with interest and dividends on securities are included in "financial
expenses, net".
The Company recognizes an impairment charge when a decline in the fair value of its investments in debt
securities below the amortized cost basis of such securities is judged to be other-than-temporary impairment
(“OTTI”). Factors considered in making such a determination include the duration and severity of the impairment,
the reason for the decline in value, the potential recovery period and if the entity has the intent to sell the debt
security, or if it is more likely than not that it will be required to sell the debt security before recovery of its
amortized cost basis. However, if an entity does not expect to sell a debt security, it will still need to evaluate
expected cash flows to be received and determine if a credit loss exists. In the event of a credit loss, only the
amount of impairment associated with the credit loss is recognized in earnings. Amounts relating to factors other
than credit losses are recorded in OCI.
F - 17
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)
I.
INVENTORIES
Inventories are stated at the lower of cost or market value. Inventory write-offs are provided to cover risks arising
from slow-moving items or technological obsolescence for which recoverability is not probable.
Cost is determined as follows:
Raw materials using the average or FIFO cost method.
•
• Work in progress:
•
•
Costs incurred on long-term contracts in progress include direct labor, material, subcontractors,
other direct costs and an allocation of overheads, which represent recoverable costs incurred for
production, allocable operating overhead cost and, where appropriate, research and development
costs (See Note 2(V)).
Labor overhead is generally included on the basis of updated hourly rates and is allocated to each
project according to the amount of hours expended. Material overhead is generally allocated to
each project based on the value of direct material that is charged to the project.
Advances from customers are allocated to the applicable contract inventories and are deducted from the inventory
balance. Advances in excess of related inventories are classified as liabilities.
Pre-contract costs are generally expensed, but can be deferred and included in inventory, only when such costs
can be directly associated with a specific anticipated contract and if their recoverability from the specific
anticipated contract is probable according to the guidelines of ASC 605-35.
J.
INVESTMENT IN AFFILIATED COMPANIES, PARTNERSHIPS AND OTHER COMPANIES
Investments in affiliated companies and partnerships that are not controlled but over which the Company can
exercise significant influence (generally, entities in which the Company holds approximately between 20% to
50% of the voting rights of the investee) are presented using the equity method of accounting. Profits on
intercompany sales, not realized outside the Company, are eliminated. The Company discontinues applying the
equity method when its investment (including advances and loans) is reduced to zero and the Company has not
guaranteed obligations of the affiliate or otherwise committed to provide further financial support to the affiliate.
Investments in preferred shares, which are not in substance common stock, are recorded on a cost basis according
to ASC 323-10-15-13, “Investments - Equity Method and Joint Ventures - In-substance Common Stock” and ASC
323-10-40-1, "Investment -Equity Method and Joint Ventures - Investee Capital Transactions".
A change in the Company’s proportionate share of an investee’s equity, resulting from issuance of common or in-
substance common shares by the investee to third parties, is recorded as a gain or loss in the consolidated income
statements in accordance with ASC 323-10-40-1.
Investments in non-marketable equity securities of entities in which the Company does not have control or the
ability to exercise significant influence over their operation and financial policies, are recorded at cost (generally
when the Company holds less than 20% of the voting rights).
Management evaluates investments in affiliated companies, partnerships and other non-marketable equity
securities for evidence of other-than-temporary declines in value. Such evaluation is dependent on the specific
facts and circumstances. Accordingly, in determining whether other-than-temporary declines exist, management
evaluates various indicators for other-than-temporary declines and evaluates financial information (e.g. budgets,
business plans, financial statements, etc.). During 2016 the Company recorded an impairment of approximately
$2,500 on one of its affiliated companies. During 2015 and 2014, no material impairment was recognized.
F - 18
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)
K. VARIABLE INTEREST ENTITIES
ASC 810-10, “Consolidation”, provides a framework for identifying variable interest entities (“VIEs”) and
determining when a company should include the assets, liabilities, non-controlling interests and results of
activities of a VIE in its consolidated financial statements. According to ASC 810-10, the Company consolidates a
VIE when it has both (1) the power to direct the economically significant activities of the entity and (2) the
obligation to absorb losses of, or the right to receive benefits from, the entity that could potentially be significant
to the variable interest entity. The determination about whether the Company should consolidate a VIE is
evaluated continuously as existing relationships change or future transactions occur.
The Company’s assessment of whether an entity is a VIE and the determination of the primary beneficiary is
judgmental in nature and involves the use of significant estimates and assumptions. Those include, among others,
forecasted cash flows, their respective probabilities and the economic value of certain preference rights. In
addition, such assessment also involves estimates of whether an entity can finance its current activities, until it
reaches profitability, without additional subordinated financial support.
Also according to ASC 810, a non-controlling interest in a subsidiary is an ownership interest in the consolidated
entity that should be reported as a separate component of equity in the consolidated financial statements. As such,
changes in the parent’s ownership interest with no change of control are treated as equity transactions, rather than
acquisitions achieved in stages or dilution gains or losses. Losses of partially owned consolidated subsidiaries
shall continue to be allocated to the non-controlling interests even when their investment was already reduced to
zero.
A 51%-held subsidiary in the U.K. ("Subsidiary "D") is considered to be a VIE. As Elbit Systems is the primary
beneficiary and has both the power to direct its activities and absorb the majority of its losses or the right to the
majority of its earnings based upon holding the 51% economic interest, Subsidiary D is consolidated in the
Company’s financial statements.
Subsidiary E is an Israeli limited partnership and considered to be a VIE. As the Company holds 50% of the
contractual rights in Subsidiary E and is the primary beneficiary, Subsidiary E is consolidated in the Company’s
financial statements.
L. LONG-TERM RECEIVABLES
Long-term trade, unbilled and other receivables, with payment terms in excess of one year which are considered
collectible, are recorded at their estimated present values (determined based on the market interest rates at the date
of initial recognition).
M. LONG-TERM BANK DEPOSITS
Long-term bank deposits are deposits with maturities of more than one year. These deposits are presented at cost
and earn interest at market rates. Accumulated interest to be received over the next year is recorded as a current
asset. The deposits and accumulated interest approximate fair value.
F - 19
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
F - 20
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)
N. PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment are stated at cost, net of accumulated depreciation and investment grants. For
equipment produced for the Company’s own use, cost includes materials, labor and overhead (including interest
costs, when applicable) but not in excess of the fair value of the equipment.
Depreciation is calculated by the straight-line method over the estimated useful life of the assets at the following
annual rates:
Buildings and leasehold improvements (*)
Instruments, machinery and equipment
Office furniture and other
Motor vehicles
%
2-20
3-33
4-33
12-33
(Mainly 15%)
(*)
Prepayments for operating leases and leasehold improvements are amortized generally over the term
of the lease or the useful life of the assets, whichever is shorter.
O. OTHER INTANGIBLE ASSETS
Other identifiable intangible assets mainly consist of purchased technology, customer relations and trademarks.
These intangible assets are stated at cost net of accumulated amortization and impairments, and are amortized
over their useful life using the straight-line method, or the accelerated method, whichever better reflects the
applicable expected utilization pattern.
P.
IMPAIRMENT OF LONG-LIVED ASSETS
The Company’s long-lived assets and finite-lived intangible assets are reviewed for impairment in accordance
with ASC 360-10-35 “Property, Plant and Equipment – Subsequent Measurement” whenever events or changes in
circumstances indicate that the carrying amount of an asset may not be recoverable.
Recoverability of assets (or assets group) to be held and used is determined by a comparison of the carrying
amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If the carrying
amount is higher, an asset is deemed to be impaired and the impairment to be recognized is measured by the
amount by which the carrying amount of the asset exceeds its fair value. For the years ended December 31, 2016,
2015 and 2014, no impairment was identified.
As required by ASC 820, “Fair Value Measurements”, the Company applies assumptions that marketplace
participants would consider in determining the fair value of long-lived assets (or assets groups).
F - 21
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)
Q. GOODWILL IMPAIRMENT
Goodwill is subject to an impairment test at the reporting unit level on an annual basis (or more frequently if
impairment indicators arise).
The Company identified several reporting units based on the guidance of ASC 350, “Intangibles – Goodwill and
Other”.
ASC 350 prescribes a two-phase process for impairment testing of goodwill. The first phase screens for
impairment, while the second phase (if necessary) measures impairment.
Goodwill impairment is deemed to exist if the net book value of a reporting unit exceeds its estimated fair value.
In such case, the second phase is then performed, and the Company measures impairment by comparing the
carrying amount of the reporting unit’s goodwill to the implied fair value of that goodwill. An impairment loss is
recognized in an amount equal to the excess. For each of the three years in the period ended December 31, 2016,
no impairment losses were identified.
As required by ASC 820, “Fair Value Measurement”, the Company applies assumptions that market place
participants would consider in determining the fair value of each reporting unit.
R. SEVERANCE PAY
Elbit Systems’ and its Israeli subsidiaries’ obligations for severance pay are calculated pursuant to Israel’s
Severance Pay Law based on the most recent salary of the employees multiplied by the number of years of
employment as of the balance sheet date, and are presented on an undiscounted basis (the “Shut Down Method”).
Subject to certain conditions, employees are entitled to one month’s salary for each year of employment or a
portion thereof. The obligation is funded by monthly deposits through insurance policies and by an accrual. The
value of these policies is recorded as an asset on the Company’s balance sheet. The deposited funds may be
withdrawn only upon the fulfillment of the obligation, pursuant to the Severance Pay Law or labor agreements.
The value of the deposited funds is based on the cash surrender value of these policies and includes profits (or
losses) accumulated to the balance sheet date.
Elbit Systems and its Israeli subsidiaries have entered into an agreement with some of its employees
implementing Section 14 of the Severance Pay Law and the General Approval of the Labor Minister dated June
30, 1998, issued in accordance with such Section 14. The agreement mandates that upon termination of such
employees’ employment, all the amounts accrued in their insurance policies shall be released to them. The
severance pay liabilities and deposits covered by these plans are not reflected in the balance sheet as the
severance pay risks have been irrevocably transferred to the severance funds.
Severance pay expenses for the years ended December 31, 2016, 2015 and 2014 amounted to approximately
$55,294, $47,407 and $49,243, respectively.
S. PENSION AND OTHER POSTRETIREMENT BENEFITS
The Company accounts for its obligations for pension and other post-retirement benefits in accordance with ASC
715, “Compensation – Retirement Benefits” (see Note 17).
F - 22
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)
T. REVENUE RECOGNITION
The Company generates revenues principally from long-term contracts involving the design, development,
manufacture and integration of defense systems and products. In addition, to a lesser extent, the Company
provides non-defense systems and products as well as support and services for the Company's systems and
products.
Revenues from long-term contracts are recognized primarily using ASC 605-35, “Revenue Recognition -
Construction-Type and Production-Type Contracts”, according to which revenues are recognized on the
percentage-of-completion ("POC") basis.
Sales under long-term fixed-price contracts which provide for a substantial level of development efforts in
relation to total contract efforts are recorded using the cost-to-cost method of accounting as the basis to measure
progress toward completing the contract and to recognize revenues using the POC basis. According to this
method, sales and profits are recorded based on the ratio of costs incurred to estimated total costs at completion.
When measuring progress toward completion, the Company may consider other factors, such as contracts'
performance obligations or the achievement of milestones.
Sales and anticipated profit under long-term fixed-price contracts which provide for a substantial level of
production effort are recorded on a POC basis, using the units-of-delivery method as the basis to measure progress
of the contracts' performance toward completing the contract and recognizing revenues. In certain circumstances,
which involve long-term fixed-price production type contracts for non-homogeneous units or small quantities of
units, or when the achievement of performance milestones provides a more reliable and objective measure of the
extent of progress toward completion, revenue is recognized based on the achievement of performance
milestones.
Sales and anticipated profit under long-term fixed-price contracts that involve both development and production
efforts are recorded using the cost-to-cost method and units-of-delivery method or the achievement of
performance milestones as applicable to each phase of the contract, as the basis to measure progress toward
completion. In addition, when measuring progress toward completion under the development portion of the
contract, the Company may consider other factors, such as its progress on certain performance obligations or the
achievement of milestones.
The POC method of accounting requires management to estimate the cost and gross profit margin for each
individual contract. Estimated gross profit or loss from long-term contracts may change due to differences
between actual performance and original estimated forecasts.
Sales under cost-reimbursement-type contracts are recorded as costs are incurred. Applicable estimated profits are
included in earnings in the proportion that incurred costs bear to total estimated costs.
Amounts representing contract change orders, claims or other items are included in sales only when they can be
reliably estimated and realization is probable. Penalties and awards applicable to performance on contracts are
considered in estimating sales and profit margins and are recorded when they are probable and there is sufficient
information to assess anticipated contract performance.
Under the POC method, changes in estimated revenues and/or estimated project costs are recorded in the period
the change is reasonably determinable, with the full amount of the inception-to-date effect of such changes
recorded in such period on a “cumulative catch-up” basis. The cumulative catch-up basis amounts in the contract
estimated total costs are charged to cost of revenues ("COR") and are reflected in the reported gross profit in the
consolidated financial statements. Any changes in performance costs estimates that result in an anticipated loss on
F - 23
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
contracts are charged to COR when they are probable and reasonably determinable by management. The
Company reviews the actual costs and the estimated costs to complete long-term contracts on a quarterly basis. In
addition, the Company periodically monitors the impact of changes in estimated contract performance costs that
result from cumulative catch-up cost adjustments on COR.
F - 24
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)
T. REVENUE RECOGNITION (Cont.)
The nature of the Company's numerous contracts is such that refinements of the estimated performance costs or
revenues for a project may occur for various reasons, including: change orders, contract price adjustments,
significant technical and development matters encountered during performance and provision for loss and contract
costs changes that may occur in a situation where: (a) identified contract risks cannot be resolved within the cost
estimates included in a contract estimated costs at completion ("EAC"); or (b) new or unforeseen risks or changes
in the performance cost estimates must be incorporated into the contract EAC. In addition, anticipated losses on
contracts are recognized when determined to be probable.
These adjustments may result from positive program performance in which case they would be reflected as a
decrease in COR during the period. Likewise, these adjustments may result in an increase in COR if the Company
determines it will not be successful in mitigating these risks or realizing related opportunities.
The Company believes that the use of the POC method is appropriate as the Company has the ability to make
reasonably dependable estimates of the extent of progress towards completion and contract costs. In addition,
contracts executed include provisions that clearly specify the enforceable rights regarding services to be provided
and received by the parties to the contracts, the consideration to be exchanged and the manner and terms of
settlement. In all cases, revenue is recognized when the Company expects to perform its contractual obligations
and its customers are expected to satisfy their obligations under the contract.
Management reviews periodically the estimates of progress towards completion and project costs. These estimates
are determined based on engineering estimates and past experience, by personnel having the appropriate authority
and expertise to make reasonable estimates of the related costs. Such engineering estimates are reviewed for each
specific contract by professional personnel from various disciplines within the organization. These estimates take
into consideration the probability of achievement of certain milestones, as well as other factors that might impact
the contract’s completion and projected cost.
A number of internal and external factors affect the Company's cost estimates, including labor rates, estimated
future prices of material, revised estimates of uncompleted work, efficiency variances, linkage to indices and
exchange rates, customer specifications and testing requirement changes. If any of the above factors were to
change, or if different assumptions were used in estimating progress cost and measuring progress towards
completion, it is possible that materially different amounts would be reported in the Company’s consolidated
financial statements.
The Company's COR included net EAC adjustments resulting from changes in performance cost estimates of
approximately $33,700 (1.47% of COR and 3.52% of gross profit), $2,600 (0.12% of COR and 0.29% of gross
profit) and $26,900 (1.26% of COR and 3.26% of gross profit) for the years ended December 31, 2016, 2015 and
2014, respectively. Accordingly, during the above mentioned periods there were no material net EAC adjustments
to COR.
These adjustments changed our net income by approximately $28,200 ($0.66 per diluted share), $2,100 ($0.05 per
diluted share) and $23,400 ($0.55 per diluted share) for the years ended December 31, 2016, 2015 and 2014,
respectively.
In certain circumstances, sales under short-term fixed-price production type contracts or sales of products are
accounted for in accordance with Securities and Exchange Commission Staff Accounting Bulletin No. 104,
“Revenue Recognition in Financial Statements” (“SAB 104”), and recognized when all the following criteria are
met: persuasive evidence of an arrangement exists, delivery has occurred, the seller’s price to the buyer is fixed or
determinable, no further obligation exists and collectability is reasonably assured.
F - 25
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
F - 26
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)
T. REVENUE RECOGNITION (Cont.)
In cases where the contract involves the delivery of products and performance of services, or other obligations
such as buy-back (see Note 20(B)), the Company follows the guidelines specified in ASC 605-25, “Revenue
Recognition – Multiple-Element Arrangements” in order to allocate the contract consideration between the
identified different elements using the relative selling price method. The selling price for each element would be
allocated by using a hierarchy of: (1) Vendor Specific Objective Evidence (“VSOE”); (2) Third-Party Evidence
(“TPE”) of the selling price for that element; or (3) Estimated Selling Price (“ESP”), for individual elements of an
arrangement when VSOE or TPE of the selling price are unavailable.
The Company determines ESP for the purposes of allocating the consideration to individual elements of an
arrangement by considering several external and internal factors including, but not limited to, pricing practices,
margin objectives, geographies in which the Company offers products and services and internal costs. The
determination of ESP is judgmental and is made through consultation with and approval by management.
Service revenues include contracts primarily for rendering of services not associated with design, development or
manufacturing and production activities. Such revenues may be derived from a stand-alone service contract or a
service element which was separated from the design, development or production contract according to the
criteria established in ASC 605-25. Service contracts primarily include operation contracts, outsourcing-type
arrangements, maintenance contracts, training, installation services and similar items. Revenues from services
were less than 10% of consolidated revenues in each of the years ended December 31, 2016, 2015 and 2014.
Such service revenues are usually recognized in accordance with SAB 104 ratably over the service period, and
when all other revenue recognition criteria are met. Buy-back obligations are recognized upon fulfillment,
generally when the related products have been delivered or services have been rendered. In addition, where
applicable, the Company recognizes service revenues upon achievement of related performance milestones.
As for research and development costs accounted for as contract costs refer to Note 2(V).
U. WARRANTY
The Company estimates the costs that may be incurred under its basic warranty. Such costs are estimated as part
of the total contract’s cost and are recorded as a liability at the time revenue for delivered products is recognized.
The specific terms and conditions of those warranties vary depending upon the product sold and the country in
which the Company does business. Factors that affect the Company’s warranty cost include the number of
delivered products, engineering estimates and anticipated rates of warranty claims. The Company periodically
assesses the adequacy of its recorded warranty cost and adjusts the amount as necessary.
Changes in the Company’s provision for warranty, which is included mainly in other payables and accrued
expenses in the Balance Sheet, are as follows:
Balance, at January 1
Warranties issued during the year
Reduction due to warranties expired or claimed during the year
Additions resulting from acquisitions
Balance, at December 31
F - 27
$
2016
191,948 $
111,835
(58,055 )
—
$
245,728 $
2015
197,463
78,344
(90,531 )
6,672
191,948
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)
V. RESEARCH AND DEVELOPMENT COSTS
Research and development costs, net of participation grants, include costs incurred for independent research and
development and bid and proposal efforts and are expensed as incurred unless the costs are related to certain
contractual arrangements which are recorded as part of cost of revenues, over the period that revenue is
recognized, consistent with the Company’s revenue recognition accounting policy. The Company does not
perform significant stand-alone research and development for others.
The Company has certain research and development contractual arrangements that meet the requirements for best
efforts research and development accounting. Accordingly, the amounts funded by the customer are recognized as
an offset to its research and development expenses rather than as contract revenues.
Elbit Systems and certain Israeli subsidiaries receive grants (mainly royalty-bearing) from the Israeli Innovation
Authority in the Ministry of Economy and Industry (formerly the Office of Chief Scientist's) and from other
sources for the purpose of partially funding approved research and development projects. The grants are not to be
repaid, but instead Elbit Systems and certain Israeli subsidiaries are obliged to pay royalties as a percentage of
future sales if and when sales from the funded projects are generated. These grants are recognized as a deduction
from research and development costs at the time the applicable entity is entitled to such grants on the basis of the
research and development costs incurred. Since the payment of royalties is not probable when the grants are
received, the Company records a liability in the amount of the estimated royalties for each individual contract,
when the related revenues are recognized, as part of COR. For more information regarding such royalties’
commitments see Note 20(A). For more information regarding grants and participation received, see Note 23.
W. INCOME TAXES
The Company accounts for income taxes and uncertain tax positions in accordance with ASC 740, “Income
Taxes”. This guidance prescribes the use of the liability method whereby deferred tax asset and liability account
balances are determined based on differences between financial reporting and tax bases of assets and liabilities
and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to
reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to amounts that
are more likely than not to be realized.
The Company establishes reserves for uncertain tax positions based on an evaluation of whether the tax position is
“more likely than not” to be sustained upon examination. The Company records interest and penalties pertaining
to its uncertain tax positions in the financial statements as income tax expense.
X. CONCENTRATION OF CREDIT RISKS
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of
cash and cash equivalents, short and long-term deposits, marketable securities and trade receivables.
The majority of the Company’s cash and cash equivalents and short and long-term deposits are invested with
major banks mainly in Israel and the United States. Deposits in the U.S. may be in excess of insured limits and are
not insured in other jurisdictions. Management believes that the financial institutions that hold the Company’s
investments have a high credit rating.
F - 28
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)
X. CONCENTRATION OF CREDIT RISKS (Cont.)
The Company's marketable securities include investments in corporate debentures, U.S. Treasury Bills, U.S.
government agency debentures and Israeli Treasury Bills. The Company's investment policy limits the amount
that the Company may invest in any one type of investment or issuer, thereby reducing credit risk concentrations.
The Company’s trade receivables are derived primarily from sales to large and stable customers and governments
located mainly in Israel, the United States, Europe and Asia-Pacific. The Company performs ongoing credit
evaluations of its customers and has not experienced in recent years any unexpected material losses. An allowance
for doubtful accounts is recognized with respect to those amounts that the Company has determined to be doubtful
of collection.
The Company entered into foreign exchange forward contracts and cross currency interest rate swaps (together
“derivative instruments”) intended to protect against the increase in the dollar equivalent value of forecasted non-
dollar currency cash flows and interest as applicable. These derivative instruments are designed to effectively
hedge the Company’s non-dollar currency and interest rates exposures (see Note 2(AA)).
Y. DERIVATIVE FINANCIAL INSTRUMENTS
The Company accounts for derivatives and hedging based on ASC 815, “Derivatives and Hedging”, which
requires the Company to recognize all derivatives on the balance sheet at fair value. If a derivative meets the
definition of a cash flow hedge and is so designated, changes in the fair value of the derivative will be recognized
in other comprehensive income until the hedged item is recognized in earnings. The ineffective portion of a
derivative’s change in fair value is recognized immediately in earnings. If a derivative does not meet the definition
of a hedge, the changes in the fair value are included immediately in earnings in “Financial income (expenses),
net”, in each reporting period (see Note 24).
As part of its hedging strategy, the Company enters into forward exchange contracts in order to protect the
Company from the risk that the eventual dollar cash flows from the sale to international customers and purchase
of products from international vendors will be adversely affected by changes in exchange rates.
The Company also enters into forward exchange contracts and options strategies in order to limit the exposure to
exchange rate fluctuation associated with payroll expenses mainly incurred in NIS.
In connection with the issuance of Series A Notes in 2010 and in 2012 on the Tel Aviv Stock Exchange (see Note
16), the Company entered into cross-currency interest rate swap transactions with a notional principal of the NIS
1.1 billion and NIS 0.9 billion, respectively, to effectively hedge the effect of interest and exchange rate difference
from the NIS Series A Notes. The cross-currency interest rate swap instruments effectively convert the fixed
interest rate of the debt to a floating interest rate. The terms of the swap agreements substantially match the terms
of the debt. Under the terms of the swap agreements, the Company receives interest payments semi-annually in
NIS at an annual rate of 4.84% on the notional principal and pays interest semi-annually in U.S. dollars at an
annual weighted rate of six-month LIBOR plus 1.84% on the notional principal.
In addition, in connection with a NIS loan received from a financial institution at a fixed interest rate of 3% in
2013, the Company entered into cross-currency interest rate swap transactions with a notional principal of NIS
440 million to effectively hedge the effect of interest and exchange rate differences from the NIS loan. Under the
terms of the cross currency interest rate swap, the Company receives fixed NIS at a rate of 3% and pays interest
semi-annually in USD LIBOR plus 1.35% on the notional principal.
F - 29
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
The swap agreements are designated as a fair value hedge. The gains and losses related to changes in the fair
value of the cross-currency interest rate swap transactions are included in interest expense and substantially offset
changes in the fair value of the hedged portion of the underlying hedged Series A Notes and NIS loan.
F - 30
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)
Z.
STOCK-BASED COMPENSATION
The Company accounts for share-based arrangements under ASC 718, “Compensation – Stock Compensation”,
which requires all share-based payments, including grants of employee stock options and grants under the
Company's Phantom Bonus Retention Plan, to be recognized in the income statement based on their fair values.
AA. FAIR VALUE OF FINANCIAL INSTRUMENTS
The carrying amounts of cash and cash equivalents, short-term bank deposits, trade receivables, short-term bank
credit and loans and trade payables approximate their fair values due to the short-term maturities of such
instruments.
The fair value of long-term loans is estimated by discounting the future cash flows using current interest rates for
loans of similar terms and maturities. The carrying amount of the long-term loans approximates their fair value.
As of December 31, 2016, the fair value of the Series A Notes, based on quoted market price on the Tel-Aviv
Stock Exchange, was approximately $235,287.
The Company accounts for certain assets and liabilities at fair value under ASC 820, “Fair Value Measurement”.
Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a
liability in an orderly transaction between market participants. As such, fair value is a market-based measurement
that should be determined based on assumptions that market participants would use in pricing an asset or a
liability.
The hierarchy below lists three levels of fair value based on the extent to which inputs used in measuring fair
value are observable in the market. The Company categorizes each of its fair value measurements in one of these
three levels based on the lowest level input that is significant to the fair value measurement in its entirety.
The three levels of inputs that may be used to measure fair value are as follows:
Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active
markets;
Level 2 - Includes other inputs that are directly or indirectly observable in the marketplace, other than quoted
prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices
for identical or similar assets or liabilities in markets with insufficient volume or infrequent transactions, or other
inputs that are observable (model-derived valuations in which significant inputs are observable), or can be derived
principally from or corroborated by observable market data; and
Level 3 - Unobservable inputs which are supported by little or no market activity.
The availability of observable inputs can vary from instrument to instrument and is affected by a wide variety of
factors, including, for example, the type of instrument, the liquidity of markets and other characteristics particular
to the transaction. To the extent that valuation is based on models or inputs that are less observable or
unobservable in the market, the determination of fair value requires more judgment and the instruments are
categorized as Level 3.
F - 31
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)
AA. FAIR VALUE OF FINANCIAL INSTRUMENTS (Cont.)
The Company’s cross-currency interest rate swaps are valued under an income approach using industry-standard
models that consider various assumptions, including time value, volatility factors, current market and contractual
prices for the underlying, and counterparty non-performance risk. Substantially all of these assumptions are
observable in the marketplace throughout the full term of the instruments, can be derived from observable data or
are supported by observable levels at which transactions are executed in the marketplace, and accordingly such
instruments are categorized as Level 2.
The Company measures its marketable equity securities, debt securities and foreign currency derivative
instruments at fair value. Government debt securities are classified within Level 1. The Company's corporate debt
marketable securities trade in markets that are not considered to be active, but are valued based on quoted market
prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency and
accordingly are categorized as Level 2.
The Company’s foreign currency derivative instruments are classified within Level 2 as valuation inputs are based
on quoted prices and market observable data of similar instruments.
F - 32
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)
AA. FAIR VALUE OF FINANCIAL INSTRUMENTS (Cont.)
Assets and liabilities measured at fair value on a recurring basis are summarized below:
Fair value measurement at
December 31, 2016 using
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
$
$
1,051 $
—
—
—
—
—
1,051 $
— $
12,319
14,218
10,339
(3,636 )
(1,798 )
31,442 $
—
—
—
—
—
—
—
Fair value measurement at
December 31, 2015 using
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
$
$
880 $
—
—
—
—
—
880 $
— $
11,956
16,679
10,858
(8,289 )
(2,266 )
28,938 $
—
—
—
—
—
—
—
Description of Assets
Available-for-sale marketable securities:
Government bonds
Corporate bonds
Foreign currency derivatives and option contracts
Cross-currency interest rate swap
Liabilities
Foreign currency derivative and option contracts
Cross-currency interest rate swap
Total
Description of Assets
Available-for-sale marketable securities:
Government bonds
Corporate bonds
Foreign currency derivatives and option contracts
Cross-currency interest rate swap
Liabilities
Foreign currency derivative and option contracts
Cross-currency interest rate swap
Total
F - 33
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)
AB. TRANSFERS OF FINANCIAL ASSETS
ASC 860, "Transfers and Servicing", establishes a standard for determining when a transfer of financial assets
should be accounted for as a sale. The Company's arrangements are such that the underlying conditions are met
for the transfer of financial assets to qualify for accounting as a sale. The transfers of financial assets are typically
performed by the factoring of receivables to an Israeli financial institution. In 2015, the Company sold rights to
receive payments from the Israeli Ministry of Defense ("IMOD") to an Israeli financial institution in a total
amount of $42,631. Control and risk of these rights were fully transferred in accordance with ASC 860.
The Company's agreement pursuant to which the Company sells its trade receivables, is structured such that the
Company (i) transfers the proprietary rights in the receivable from the Company to the financial institution;
(ii) legally isolates the receivable from the Company's other assets, and presumptively puts the receivable beyond
the lawful reach of the Company and its creditors, even in bankruptcy or other receivership; (iii) confers on the
financial institution the right to pledge or exchange the receivable; and (iv) eliminates the Company's effective
control over the receivable, in the sense that the Company is not entitled and shall not be obligated to repurchase
the receivable other than in case of failure by the Company to fulfill its commercial obligation.
AC. BASIC AND DILUTED NET EARNINGS PER SHARE
Basic earnings per share are computed based on the weighted average number of outstanding ordinary shares
during each year. Diluted earnings per share are computed based on the weighted average number of outstanding
ordinary shares during each year, plus dilutive potential ordinary shares outstanding during the year. Outstanding
stock options are excluded from the calculation of the diluted earnings per share when their effect is anti-dilutive.
The weighted average number of shares related to outstanding anti-dilutive stock options excluded from the
calculations of diluted net earnings per share was not material for the last three years ended December 31, 2016.
AD. TREASURY SHARES
Elbit Systems’ shares held by the Company are recognized at cost and presented as a reduction of shareholders’
equity.
AE. RECENT ACCOUNTING PRONOUNCEMENTS
ASU 2014-15 - Presentation of Financial Statements - Going Concern (Subtopic 205-40):
In August 2014, the FASB issued guidance on disclosure of Uncertainties about an Entity’s Ability to Continue as
a Going Concern (ASU 2014-15), which defines management’s responsibility to evaluate whether there is
substantial doubt about a company’s ability to continue as a going concern. ASU 2014-15 also provide principles
and definitions that are intended to reduce diversity in the timing and content of disclosures in the financial
statement footnotes. This guidance is effective for the annual period ending after December 15, 2016, and for
annual periods and interim periods thereafter. The Company adopted the provisions of ASU 2014-15 for the year
ended December 31, 2016. The adoption of ASU 2014-15 did not have a material impact on the consolidated
financial statements.
ASU 2015-16 - Business Combinations (Topic 805):
In September 2015, the FASB issued guidance on current accounting for measurement-period adjustments. The
guidance requires entities to recognize adjustments to provisional amounts that are identified during the
measurement period in the reporting period in which the adjustment amounts are determined. Measurement period
adjustments were previously required to be retrospectively adjusted as of the acquisition date. The provisions of
this update are effective for fiscal years, and interim periods within those fiscal years, beginning after
December 15, 2015, and should be applied prospectively. The adoption of ASU 2015-16 did not have a material
impact on the consolidated financial statements.
F - 34
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)
AE. RECENT ACCOUNTING PRONOUNCEMENTS (Cont.)
ASU 2016-18 - Statement of Cash Flows (Topic 230):
In November 2016, the FASB issued Accounting Standards Update No. 2016-18, Statement of Cash Flows (Topic
230): Restricted Cash. The ASU requires that the Consolidated Statement of Cash Flows explain the change in
total cash and equivalents and amounts generally described as restricted cash or restricted cash equivalents when
reconciling the beginning-of-period and end-of-period total amounts. The ASU also requires a reconciliation
between the total of cash and equivalents and restricted cash presented on the Consolidated Statement of Cash
Flows and the cash and equivalents balance presented on the Consolidated Balance Sheet. ASU 2016-18 is
effective retrospectively on January 1, 2018, with early adoption permitted. The Company is currently evaluating
the potential effect of the guidance on its consolidated financial statements.
ASU 2015-17 - Income Taxes (Topic 740):
In November 2015, the FASB issued guidance on balance sheet classification of deferred taxes. The new guidance
requires entities to present all deferred tax assets and liabilities, along with any related valuation allowance, as
non-current on the balance sheet. The guidance is effective for interim and annual periods beginning after
December 15, 2016 (early adoption is permitted). The Company does not expect this guidance to have a material
effect on its consolidated financial statements at the time of adoption of this standard.
ASU 2016-02 - Leases (Topic 842):
In February 2016, the FASB issued guidance on the recognition, measurement, presentation and disclosure of
leases for both parties to a contract (i.e, lessees and lessors). The new standard requires lessees to apply a dual
approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease
is effectively a financed purchase by the lessee. This classification will determine whether lease expense is
recognized based on an effective interest method or on a straight-line basis over the term of the lease, respectively.
A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than
12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for in a
manner similar to the accounting under existing guidance for operating leases today. The new standard requires
lessors to account for leases using an approach that is substantially equivalent to existing guidance for sales-type
leases, direct financing leases and operating leases. Topic 842 supersedes the previous leases standard, ASC 840,
"Leases". The guidance is effective for the interim and annual periods beginning on or after December 15, 2018
(early adoption is permitted). The Company is currently evaluating the potential effect of the guidance on its
consolidated financial statements.
ASU 2015-11 - Inventory (Topic 330):
In July 2015, the FASB issued guidance on current accounting for inventory measurement. The new guidance
requires entities to measure inventory at the lower of cost or net realizable value. Net realizable value is defined
by the guidance as the estimated selling prices in the ordinary course of business, less reasonably predictable costs
of completion, disposal and transportation. The guidance is effective for the interim and annual periods beginning
on or after December 15, 2016 (early adoption is permitted). The Company does not expect this guidance to have
a material effect on its consolidated financial statements at the time of adoption of this standard.
F - 35
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)
AE. RECENT ACCOUNTING PRONOUNCEMENTS (Cont.)
ASU 2014-09 - Revenue from Contracts with Customers (Topic 606):
In May 2014, the FASB issued ASU 2014-09, "Revenue from Contracts with Customers" (Topic 606), which will
replace existing requirements in U.S. GAAP, including industry-specific requirements, significantly expand the
disclosure requirements and provide companies with a single revenue recognition model for recognizing revenue
from contracts with customers. ASU 2014-09 also provides for additional disclosure requirements. The FASB has
recently issued several amendments to the new standard, including clarification on accounting for licenses of
intellectual property and identifying performance obligations. The amendments include ASU No. 2016-08,
"Revenue from Contracts with Customers (Topic 606)-Principal versus Agent Considerations", which was issued
in March 2016, and clarifies the implementation guidance for principal versus agent considerations in ASU 2014-
09, and ASU No. 2016-10, "Revenue from Contracts with Customers (Topic 606)-Identifying Performance
Obligations and Licensing", which was issued in April 2016, and amends the guidance in ASU No. 2014-09
related to identifying performance obligations and accounting for licenses of intellectual property.
The new standard permits adoption either by using (i) a full retrospective approach for all periods presented in the
period of adoption or (ii) a modified retrospective approach with the cumulative effect of initially applying the
new standard recognized at the date of initial application and providing certain additional disclosures. While ASU
2014-09 was to be effective for annual periods and interim periods beginning after December 15, 2016, on July 9,
2015, the FASB approved the deferral of the effective date to periods beginning on or after December 15, 2017.
Accordingly, the Company intends to adopt ASU 2014-09 on January 1, 2018 and continues to deliberate the
selection of the transition method. The Company has made progress toward completing the evaluation of the
potential changes from adopting the new standard in its financial reporting and disclosures. The Company has
evaluated the impact of the standard on all of its revenue streams and most of its significant contracts. The
Company expects to predominantly complete the contract evaluation and validate the impact of the accounting
and disclosure changes on its business processes, controls and systems during the first half of 2017, design any
changes to such business processes, controls and systems by the middle of 2017 and implement the changes over
the remainder of 2017.
The adoption of the new standard may primarily impact the Company's contracts where revenue is currently
recognized using the percentage-of-completion units-of-delivery method, with the possible resulting impact being
revenue which may be recognized earlier in the performance period as it incurs costs, as opposed to when units
are delivered. This change may also impact the Company's balance sheet presentation with a possible decrease in
inventories, an increase in contract assets (i.e., unbilled receivables) and a net increase to retained earnings to
primarily reflect the impact of converting units-of-delivery contracts to the cost-to-cost method for recognizing
revenue and profits.
ASU 2016-09 - Compensation - Stock Compensation (Topic 718):
In March 2016, the FASB issued guidance on improvements to Employee Share-Based Payments. The standard
requires among others, that excess tax benefits or deficiencies for share-based payments be recorded as income
tax benefit of expense, rather then within additional paid in capital, in the period the shares vest. Cash flows
related to excess tax benefits will be included in operating activities insted of separately classified as a financing
activity. The new guidance is effective for fiscal years beginning after December 15, 2016. Early adoption is
permitted. The Company does not expect this guidance to have a material effect on its consolidated financial
statements at the time of adoption of this standard.
F - 36
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)
AE. RECENT ACCOUNTING PRONOUNCEMENTS (Cont.)
ASU 2016-13 Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial
Instruments:
In June 2016, the FASB issued guidance on the measurement of credit losses, which significantly changes how
entities will measure credit losses for most financial assets and certain other instruments that aren’t measured at
fair value through net income. The standard will replace today’s incurred loss approach with an expected loss
model for instruments measured at amortized cost. For available-for-sale debt securities, entities will be required
to record allowances rather than reduce the carrying amount, as they do today under the other-than-temporary
impairment model. It also simplifies the accounting model for purchased credit-impaired debt securities and loans.
Topic 326 is effective for annual periods beginning after December 15, 2019, and interim periods therein. Early
adoption is permitted for annual periods beginning after December 15, 2018, and interim periods therein. The
Company is currently evaluating the potential effect of the guidance on its consolidated financial statements.
ASU 2016-15 - Statement of Cash Flows (Topic 230),Classification of Certain Cash Receipts and Cash Payments:
In August 2016, the FASB issued guidance on the classification of Certain Cash Receipts and Cash Payments
which intended to reduce diversity in practice in how certain cash receipts and cash payments are presented and
classified in the Consolidated Statement of Cash Flows by providing guidance on eight specific cash flow issues.
ASU 2016-15 is effective retrospectively on January 1, 2018, with early adoption permitted. The Company is
currently evaluating the potential effect of the guidance on its consolidated cash flow statement.
ASU 2016-01 - Financial Instruments - Overall (Subtopic 825-10):
In January 2016, the FASB issued guidance on Financial Instruments - Recognition and Measurement of Financial
Assets and Financial Liabilities. The pronouncement revises the classification and measurement of investments in
certain equity investments and the presentation of certain fair value changes for certain financial liabilities
measured at fair value. ASU 2016-01 is effective for fiscal years, beginning after December 15, 2017 and interim
periods within those years. The Company is currently evaluating the impact of adopting the new standard on its
consolidated financial statements.
ASU 2016-07 - Investments - Equity Method and Joint Ventures (Topic 323):
In March 2016, the FASB issued guidance on Investments - Equity Method and Joint Ventures. The update
simplifies the equity method of accounting by eliminating the requirement to retrospectively apply the equity
method to an investment that subsequently qualifies for such accounting as a result of an increase in the level of
ownership interest or degree of influence. Consequently, when an investment qualifies for the equity method, the
cost of acquiring the additional interest in the investee would be added to the current basis of the investor’s
previously held interest, and the equity method would be applied subsequent to the date on which the investor
obtains the ability to exercise influence over the investee. The standard is effective for fiscal years beginning after
December 15, 2016, including interim periods within those periods. The Company does not expect this guidance
to have a material effect on its consolidated financial statements.
AF. RECLASSIFICATIONS
Certain financial statement data for prior years has been reclassified to conform to current year financial statement
presentation.
F - 37
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 3 - TRADE AND UNBILLED RECEIVABLES, NET
Receivables (1)
Unbilled receivables
Less – allowance for doubtful accounts
(1) Includes receivables from affiliated companies
December 31,
$
2016
723,538 $
516,469
(7,416 )
$ 1,232,591 $
2015
562,616
386,035
(6,738 )
941,913
$
84,969 $
76,598
Unbilled receivables on long-term contracts principally represent sales recorded under the percentage-of-completion method of
accounting, when sales or revenues based on performance attainment, though appropriately recognized, cannot be billed yet under
terms of the contract as of the balance sheet date. Accounts receivable include claims on items that the Company believes are earned,
but are subject to uncertainty concerning their ultimate realization. Such amounts were not material as of the balance sheet date.
Trade receivables and unbilled receivables, other than those detailed under Note 7, are expected to be billed and collected during
2017.
Short and long-term receivables and unbilled receivables include amounts related to contracts with the IMOD in the aggregate
amounts of $498,464 and $520,176, as of December 31, 2016 and 2015, respectively.
As for long-term trade and unbilled receivables – see Note 7.
Note 4 - OTHER RECEIVABLES AND PREPAID EXPENSES
Deferred income taxes, net
Prepaid expenses
Government institutions
Derivative instruments
Cross-currency interest rate swap
Other
December 31,
2016
2015
32,336 $
32,254
37,937
14,218
2,275
16,295
135,315 $
36,561
41,216
54,562
16,679
3,234
19,107
171,359
$
$
F - 38
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 5 - INVENTORIES, NET OF CUSTOMER ADVANCES
Cost incurred on long-term contracts in progress
Raw materials
Advances to suppliers and subcontractors
Less -
Cost incurred on contracts in progress deducted from customer advances
Advances received from customers (*)
Provision for losses on long-term contracts
December 31,
$
2016
837,906 $
123,595
52,728
1,014,229
2015
901,775
124,475
40,207
1,066,457
65,032
65,418
43,513
840,266 $
78,623
70,282
80,441
837,111
$
(*) The Company has transferred legal title of inventories to certain customers as collateral for advances received.
Advances are allocated to the relevant inventories on a per-project basis. In cases where advances are in excess of
the inventories, the net amount is presented in customer advances (see Note 14).
Note 6 -
INVESTMENTS IN AFFILIATED COMPANIES, PARTNERSHIPS AND OTHER COMPANIES
A.
INVESTMENT IN AFFILIATED COMPANIES:
Companies accounted for under the equity method
Companies accounted for on a cost basis
December 31,
2016
173,396 $
7,566
180,962 $
2015
126,059
3,699
129,758
$
$
B.
INVESTMENT IN COMPANIES ACCOUNTED FOR UNDER THE EQUITY METHOD:
Company F (1)
Company I (2)
Company J (3)
Company K (4)
Company L (5)
Company M (6)
Company N (7)
Other
December 31,
2016
65,594 $
19,974
11,881
19,120
18,003
25,707
5,107
8,010
173,396 $
2015
61,577
18,847
14,398
20,000
—
—
—
11,237
126,059
$
$
(1) Company F is an Israeli partnership, held 50% by the Company and 50% by Rafael Advanced Defense Systems
Ltd. (“Rafael”). Company F is engaged in the development and production of various thermal detectors and laser
diodes. Company F is jointly controlled and therefore is not consolidated in the Company’s financial statements.
F - 39
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
During 2016 and 2015, the Company received a dividend in the amount of $2,140 and $20,000, respectively from
Company F.
F - 40
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 6 -
INVESTMENTS IN AFFILIATED COMPANIES, PARTNERSHIPS AND OTHER COMPANIES (Cont.)
B.
INVESTMENT IN COMPANIES ACCOUNTED FOR UNDER THE EQUITY METHOD (Cont.):
(2) Company I is an Israeli company owned 50.000001% by the Company and 49.99999% by Rafael. Company I
focuses mainly on commercial applications of thermal imaging and electro-optic technologies. The Company
jointly controls Company I with Rafael, and therefore Company I is not consolidated in the Company’s financial
statements.
(3) Company J is a Romanian company held 40% by the Company. Company J is engaged in the construction of fiber
optic-telecommunication networks in Romania. During 2016, the Company wrote off $2,500 of its investment in
Company J.
(4) Company K is a European company held 33% by the Company. During 2015, the Company, through a wholly-
owned Israeli subsidiary, invested approximately $20,000 in Company K, which is engaged in the area of
composite aerostructure parts manufacturing for commercial aircraft.
(5) Company L is an Israeli company held 80% by the Company. During 2016, the Company established Company L,
based on its in-house developed energy technology for transportation, that is engaged in developing energy
solutions for civilian transportation applications. In July 2016, an international strategic investor invested €16,000
(approximately $18,000) in exchange for 20% of Company L's ownership interest (in preferred shares) and was
granted rights in several of Company L's energy related technologies. The investor has certain participating rights
in the day-to-day operations of Company L. As a result, the Company deconsolidated Company L and reevaluated
its remaining holdings, recognizing a gain of approximately $10,500, which was included in "other operating
income, net"
(6) Company M is a U.K. joint venture held 50% by a wholly-owned U.K. subsidiary of the Company and 50% by
Kellogg Brown & Root Limited. During 2016, the Company invested in company M approximately$13,400.
Company M is engaged in the area of flight training systems. (See Note 1(D).)
(7) Company N is an Israeli company held 71% by the Company. During 2016, due to an external investment in
Company N in which a third party investor acquired substantial participation rights, Company N ceased to be
consolidated in the Company's financial results.
Equity in net earnings (losses) of affiliated companies and partnerships is as follows:
Company F
Company I
Company M
Other (*)
Year ended December 31,
2016
2015
2014
$
$
6,157 $
2,047
4,253
(7,233 )
5,224 $
3,948 $
2,284
—
(1,690 )
4,542 $
2,758
1,982
—
809
5,549
(*)
Includes write-off impairment in Company J in the amount of approximately $2,500 in 2016.
F - 41
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 6 -
INVESTMENTS IN AFFILIATED COMPANIES, PARTNERSHIPS AND OTHER COMPANIES (Cont.)
B.
INVESTMENT IN COMPANIES ACCOUNTED FOR UNDER THE EQUITY METHOD (Cont.)
The summarized aggregate financial information of companies accounted for under the equity method is as follows:
Balance Sheet Information:
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Shareholders' equity
Total liabilities and equity
Income Statement Information:
Revenues
Gross profit
Net income
See Note 20(E) for guarantees.
December 31,
2016
452,343 $
145,346
597,689 $
2015
312,585
91,958
404,543
168,352 $
103,656
325,681
597,689 $
142,662
15,049
246,832
404,543
$
$
$
$
Year ended December 31,
2016
424,045 $
83,266 $
21,252 $
2015
250,499 $
67,747 $
13,920 $
2014
260,025
72,631
17,452
$
$
$
Note 7 - LONG-TERM TRADE AND UNBILLED RECEIVABLES
Receivables
Unbilled receivables
December 31,
2016
— $
189,688
189,688 $
2015
96
152,367
152,463
$
$
The majority of the long-term unbilled receivables are expected to be billed and collected during the years 2018 - 2021.
Long-term trade and unbilled receivables are mainly related to contracts with the IMOD.
F - 42
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 8 - LONG-TERM BANK DEPOSITS AND OTHER RECEIVABLES
Restricted deposits with banks (1)
Cross-currency interest rate swap
Deposits with banks and other long-term receivables (2)
December 31,
2016
2015
462 $
8,064
7,391
15,917 $
652
7,624
7,489
15,765
$
$
(1) Restricted deposits in respect of an issued bank guarantee
(2) Includes long-term balances of a non-qualified deferred compensation plan structured under Section 409A of the
U.S. Internal Revenue Code in the amount of $7,106 and $6,790 as of December 31, 2016 and 2015, respectively
(see Note 17)
Note 9 - AVAILABLE-FOR-SALE MARKETABLE SECURITIES
As of December 31, 2016 and 2015, the fair value, amortized cost and gross unrealized holding gains and losses of
available-for-sale marketable securities were as follows:
Government debentures - fixed and floating interest rate
Corporate debentures - fixed and floating interest rate
Government debentures - fixed and floating interest rate
Corporate debentures - fixed and floating interest rate
Amortized
cost
$
$
1,051
12,302
13,353
Amortized
cost
$
$
887
11,921
12,808
December 31, 2016
Gross
unrealized
gains
Gross
unrealized
losses
December 31, 2015
Gross
unrealized
gains
Gross
unrealized
losses
—
17
17
—
99
99
Fair value
1,051
12,319
13,370
— $
—
— $
Fair value
880
11,956
12,836
(7 ) $
(64 )
(71 ) $
The contractual maturities of the available-for-sale marketable securities in future years are as follows:
2017
2018
2019
2020
2021+ and after
F - 43
December 31,
2016
$
$
1,802
1,753
4,040
2,405
2,864
12,864
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
As of December 31, 2016 and 2015, interest receivable included in other receivables amounted to $147 and $155,
respectively.
F - 44
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 10 -
PROPERTY, PLANT AND EQUIPMENT, NET
Cost (1):
Land, buildings and leasehold improvements (2)
Instruments, machinery and equipment (3)
Office furniture and other
Motor vehicles and airplanes
Accumulated depreciation
Depreciated cost
December 31,
2016
2015
$
$
450,301 $
807,791
83,431
55,457
1,396,980
(922,871 )
474,109 $
434,763
734,731
81,684
63,669
1,314,847
(865,088 )
449,759
Depreciation expenses for the years ended December 31, 2016, 2015 and 2014 amounted to $81,728, $74,239 and
$79,457, respectively.
(1) Net of investment grants received (mainly for instruments, machinery and equipment) in the amounts of $15,023
and $17,591 as of December 31, 2016 and 2015, respectively.
(2) Set forth below is additional information regarding the real estate owned or leased by the Company:
Owned
Leased
Israel(a)
2,161,000 square feet
2,281,000 square feet
U.S.(b)
633,854 square feet
671,200 square feet
Other Countries(c)
891,000 square feet
453,000 square feet
(a) Includes offices, development and engineering facilities, manufacturing facilities, maintenance facilities,
hangar facilities and landing strips in various locations in Israel.
(b) Includes offices, development and engineering facilities, manufacturing facilities and maintenance facilities of
ESA primarily in Texas, New Hampshire, Florida, Alabama and Virginia.
(c) Includes offices, design and engineering facilities and manufacturing facilities, mainly in Europe, Latin
America and Asia-Pacific.
(3) Includes equipment produced by the Company for its own use in the aggregate amount of $114,241 and $111,393
as of December 31, 2016 and 2015, respectively.
As for liens on assets – see Notes 20(H) and 20(I).
F - 45
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 11 - GOODWILL AND OTHER INTANGIBLE ASSETS, NET
A. COMPOSITION OF IDENTIFIABLE INTANGIBLE ASSETS:
Original cost:
Technology
Customer relations
Trademarks and other
Accumulated amortization:
Technology
Customer relations
Trademarks and other
Amortized cost
Weighted
average
useful lives
$
12
12
11
$
December 31,
2016
2015
234,081 $
169,695
161,019
564,795
172,649
157,179
125,566
455,394
109,401 $
234,805
170,692
158,666
564,163
150,516
151,421
114,604
416,541
147,622
B. AMORTIZATION EXPENSES
Amortization expenses amounted to $41,160, $48,115 and $42,951 for the years ended December 31, 2016,
2015 and 2014, respectively.
C. AMORTIZATION EXPENSES FOR FIVE SUCCEEDING YEARS
The estimated aggregate amortization expenses for each of the five succeeding fiscal years and thereafter are as
follows:
2017
2018
2019
2020
2021
and thereafter
D. CHANGES IN GOODWILL
Changes in goodwill during 2016 were as follows:
Balance, at January 1
Reduction related to deconsolidation of a subsidiary (1)
Net translation differences (2)
Balance, at December 31
$
24,545
21,893
21,054
16,755
25,154
109,401
2016
622,654
(1,206 )
(4,451 )
616,997
$
$
(1) See Note 6(B)(5).
(2) Foreign currency translation differences resulting from goodwill allocated to reporting units, whose functional
currency has been determined to be other than the U.S. dollar.
F - 46
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 12 -
SHORT-TERM BANK CREDIT AND LOANS
Short-term bank credit and loans
Note 13 - OTHER PAYABLES AND ACCRUED EXPENSES
Interest %
December 31,
Libor + 1.3%
$
$
2016
2015
5,027 $
5,027 $
—
—
Payroll and related expenses
Provision for warranty
Provision for vendors on accrued expenses
Provision for vacation pay (1)
Provision for losses on long-term contracts (2)
Provision for income tax, net of advances
Provision for royalties
Other income tax liabilities
Value added tax (“VAT”) payable
Derivative instruments
Deferred income tax, net
Other (3)
December 31,
2016
187,051 $
250,212
55,379
46,878
39,835
33,541
34,330
9,762
6,433
5,429
1,800
159,866
830,516 $
2015
160,413
199,449
64,708
44,477
36,511
27,842
36,105
31,435
13,651
8,289
545
116,442
739,867
$
$
(1) Long-term provision for vacation pay as of December 31, 2016 and 2015 was $27,969 and $26,166, respectively,
included in other long-term liabilities.
(2) Includes a provision of $4,586 and $4,949 as of December 31, 2016 and 2015, respectively, related to the
cessation of a program with a foreign customer. During 2016, the Company recorded a reversal of reserves which
offset COR by approximately $20,000, primarily related to reserves for potential liabilities recorded in 2011
related to the cessation of a program and a legal settlement with a Seller as part of an asset purchase agreement.
(3) Includes provisions for estimated future costs in respect of (1) penalties and the probable loss from claims (legal
or unasserted) in the ordinary course of business (e.g. damages caused by the items sold and claims as to the
specific products ordered), and (2) unbilled services of service providers.
F - 47
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 14 - CUSTOMER ADVANCES IN EXCESS OF COSTS INCURRED ON CONTRACTS IN PROGRESS
Advances received
Less -
Advances presented under long-term liabilities
Advances deducted from inventories
Less -
Costs incurred on contracts in progress (See Note 5)
As for guarantees and liens, see Notes 20(E), 20(H) and 20(I).
Note 15 - LONG-TERM LOANS, NET OF CURRENT MATURITIES
December 31,
2016
652,372 $
2015
753,708
$
174,529
65,418
412,425
167,601
70,282
515,825
65,032
347,393 $
78,623
437,202
$
December 31,
Long-term loans (*)
Less: current maturities
Currency
USD
NIS (**)
Other
Interest %
Libor + 1.15%
2.56% - Libor + 1.35%
Years of
maturity
1
mainly 1
$
2016
118,550 $
47,317
—
165,867
165,392
$
475 $
2015
118,550
94,790
709
214,049
48,078
165,971
(*)
(**)
For covenants see Note 20(F).
Includes derivative instrument defined as hedge accounting. See Note 2(Y) and Note 2(AA).
As of December 31, 2016, the LIBOR semi-annual rate for long-term loans denominated in U.S. dollars was 1.317%.
The maturities of these loans for periods after December 31, 2016, are as follows:
2017 - current maturities
2018
2019
2020 and after
$
$
165,392
—
—
475
165,867
F - 48
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 16 -
SERIES A NOTES, NET OF CURRENT MATURITIES
Series A Notes
Less – Current maturities
Carrying amount adjustments on Series A Notes (*)
Premium on Series A Notes, net
December 31,
2016
218,466 $
(63,564 )
15,843
321
171,066 $
2015
269,037
(65,281 )
22,589
413
226,758
$
$
(*) As a result of fair value hedge accounting, described below and in Notes 2(Y) and 2(AA). The carrying value
of the Series A Notes is adjusted for changes in the interest rates.
In June 2010, the Company issued Series A Notes in the aggregate principal amount of NIS 1.1 billion (approximately
$283,000), payable in 10 equal annual installments on June 30 of each of the years 2011 through 2020. The Series A
Notes bear a fixed interest rate of 4.84% per annum, payable on June 30 and December 30 of each of the years 2010
through 2020 (the first interest payment was made on December 30, 2010, and the last interest payment will be made on
June 30, 2020). Debt issuance costs were approximately $2,530, of which $2,164 was allocated to the Series A Notes
discount, and $366 was allocated to deferred issuance costs and are amortized as financial expenses over the term of the
Series A Notes due in 2020.
In March 2012, the Company issued additional Series A Notes in the aggregate principal amount of NIS 807 million
(approximately $217,420). The immediate gross proceeds received by the Company for the issuance of the March 2012
Series A Notes were approximately NIS 831 million (approximately $224,000). Debt issuance costs were approximately
$2,010, of which $1,795 was allocated to the Series A Notes discount, and $215 was allocated to deferred issuance costs
and are amortized as financial expenses over the term of the Series A Notes due in 2020. Premium was approximately
$3,675 and is amortized as financial income over the term of the Series A Notes due in December 2020.
In May 2012, the Company issued additional Series A Notes in an aggregate principal amount of NIS 92 million
(approximately $24,407) through a private placement to Israeli institutional investors. The immediate gross proceeds
received by the Company for the issuance of the May 2012 Series A Notes were approximately NIS 95 million
(approximately $24,900). Debt issuance costs were approximately $94. These costs were allocated to deferred issuance
costs and are amortized as financial expenses over the term of the Series A Notes due in 2020. The premium was
approximately $260 and is amortized as financial income over the term of the Series A Notes due in December 2020.
The 2010 Series A Notes together with the 2012 Series A Notes form one single series with the same terms and
conditions.
The Series A Notes (principal and interest) are not linked to any currency or index. The Series A Notes are unsecured,
non convertible and do not restrict the Company’s ability to issue additional notes of any class or distribute dividends in
the future. There are no covenants on the Series A Notes. The Series A Notes are listed for trading on the Tel-Aviv Stock
Exchange.
During the years ended December 31, 2016, 2015 and 2014, the Company recorded $6,565, $6,812 and $7,954,
respectively, as interest expenses and $92, $92 and $91, respectively, as amortization of debt issuance costs and
premium, net, on the Series A Notes.
F - 49
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 16 -SERIES A NOTES, NET OF CURRENT MATURITIES (Cont.)
The Company also entered into 10-year cross currency interest rate swap transactions in order to effectively hedge the
effect of interest and exchange rate differences resulting from the 2010 NIS Series A Notes. Under the cross currency
interest rate swaps, the Company receives fixed NIS at a rate of 4.84% on NIS 1.1 billion and pays floating six-month
USD LIBOR + an average spread of 1.65% on $287,000, which reflects the U.S. dollar value of the Series A Notes on
the specific dates the transactions were consummated. Both the debt and the swap instruments pay semi-annual interest
on June 30 and December 31. The purpose of these transactions was to convert the NIS fixed rate Series A Notes into
USD LIBOR (6 months) floating rate obligations. As a result of these agreements, the Company is currently paying an
effective interest rate of six-month LIBOR (1.32% at December 31, 2016) plus an average of 1.65% on the principal
amount, as compared to the original 4.84% fixed rate. The above transactions qualify for fair value hedge accounting.
In April 2012 and May 2012, the Company entered into cross currency interest rate swap transactions in order to
effectively hedge the effect of interest and exchange rate differences resulting from the 2012 issuance of Series A Notes.
Under these cross currency interest rate swaps, the Company receives fixed NIS at a rate of 4.84% on NIS 807 million
and NIS 92 million and pays floating six-month USD LIBOR + an average spread of 2.02% on $217,300 and 2.285% on
$24,100, respectively, which reflects the U.S. dollar value of the 2012 issued Series A Notes on the specific dates the
transactions were consummated. Both the debt and the swap instruments pay semi-annual interest on June 30 and
December 31. The purpose of these transactions was to convert the NIS fixed rate Series A Notes into USD LIBOR (6
months) floating rate obligations. As a result of these agreements, the Company is currently paying an effective interest
rate of six-month LIBOR (1.32% at December 31, 2016) plus an average of 2.05% on the 2012 principal amounts, as
compared to the original 4.84% fixed rate. The above transactions qualify for fair value hedge accounting.
Future principal payments for the Series A Notes, including the effect of the cross-currency interest rate swap
transactions are as follows:
current maturities
2017
2018
2019
2020
December 31,
2016
$
55,533
55,533
55,533
55,533
F - 50
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 17 - BENEFIT PLANS AND OBLIGATIONS FOR TERMINATION INDEMNITY
The Company’s subsidiaries ESA, a German subsidiary (the "German Subsidiary") and a Belgian subsidiary (the
"Belgian Subsidiary") sponsor benefit plans for their employees in the U.S., Germany and Belgium, respectively, as
follows:
1. Defined Benefit Retirement Plan based on Employer’s Contributions
a) ESA has three defined benefit pension plans (the “Plans”) which cover the employees of ESA’s two largest
subsidiaries. Monthly benefits are based on years of benefit service and annual compensation. Annual
contributions to the Plans are determined using the unit credit actuarial cost method and are equal to or exceed the
minimum required by law. Pension fund assets of the Plans are invested primarily in stocks, bonds and cash
through a financial institution, as the investment manager of the Plans’ assets. Pension expense is allocated
between cost of sales and general and administrative expenses, depending on the responsibilities of the employee.
The measurement date for ESA subsidiaries' benefit obligation is December 31.
Participation in ESA’s qualified defined benefit plans was frozen as of January 1, 2010, for non-represented
employees. Current participants continue to accrue benefits; however no new non-represented employees were
allowed to enter the plan.
b) The German Subsidiary, which is wholly-owned by the Company, has mainly one defined benefit pension plan
(the “P3-plan”) which covers all employees. The P3-plan provides for yearly cash balance credits equal to a
percentage of a participant’s compensation, which accumulate together with the respective interest credits on the
employee’s cash balance accounts. In case of an insured event (retirement, death or disability) the benefits can be
paid as a lump sum, in installments or as a life-long annuity. The P3-plan is an unfunded plan.
c) The Belgian Subsidiary, which is wholly-owned by the Company, has a defined benefit pension plan, which is
divided into two categories:
1) Normal retirement benefit plan, with eligibility at age 65. The lump sum is based on employee contributions
of 2% of the final pensionable salary up to a certain breakpoint, plus 6% exceeding the breakpoint at a
maximum of 5% of pensionable salary, and the employer contributions, with a maximum of 40 years. The
vested benefit is equal to the retirement benefit calculated with the pensionable salary and pensionable
service observed at the date of leaving service.
2) Pre-retirement death benefit to employees.
The plan is funded and includes profit sharing.
F - 51
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 17 - BENEFIT PLANS AND OBLIGATIONS FOR TERMINATION INDEMNITY (Cont.)
The following table sets forth the Plans’ funded status and amounts recognized in the consolidated financial statements
for the years ended December 31, 2016 and 2015:
$
$
$
December 31,
2016
2015
219,360 $
7,768
8,929
(669 )
6,861
(7,003 )
235,246 $
127,455
10,035
9,753
(7,003 )
140,240 $
(95,003 )
71,839
206
225,668
8,921
8,372
(2,847 )
(15,612 )
(5,142 )
219,360
126,489
(2,225 )
8,333
(5,142 )
127,455
(91,905 )
72,411
(271 )
$
(22,958 ) $
(19,765 )
(1,254 )
(93,749 )
72,045
$
(22,958 ) $
(725 )
(91,179 )
72,139
(19,765 )
Changes in benefit obligation:
Benefit obligation at beginning of year
Service cost
Interest cost
Exchange rate differences
Actuarial losses (gain)
Benefits paid
Benefit obligation at end of year
Changes in the Plans’ assets:
Fair value of Plans’ assets at beginning of year
Actual return on Plans’ assets (net of expenses)
Employer contribution
Benefits paid
Fair value of Plans’ assets at end of year
Accrued benefit cost, end of year:
Funded status
Unrecognized net actuarial loss
Unrecognized prior service cost
Amount recognized in the statement of financial position:
Accrued benefit liability, current
Accrued benefit liability, non-current
Accumulated other comprehensive income, pre-tax
Net amount recognized
F - 52
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Components of the Plans’ net periodic pension cost:
Service cost
Interest cost
Expected return on Plans’ assets
Amortization of prior service cost
Amortization of transition amount
Amortization of net actuarial loss
Total net periodic benefit cost
Additional information
Accumulated benefit obligation
Year ended December 31,
2016
2015
2014
$
$
$
7,768 $
8,929
(9,057 )
65
—
5,765
13,470 $
8,921 $
8,372
(8,970 )
(62 )
46
6,295
14,602 $
7,762
7,833
(8,221 )
(125 )
121
2,108
9,478
227,799 $
213,675 $
215,276
Note 17 - BENEFIT PLANS AND OBLIGATIONS FOR TERMINATION INDEMNITY (Cont.)
Weighted average assumptions:
Discount rate as of December 31
Expected long-term rate of return on Plans’ assets
Rate of compensation increase
Asset allocation by category as of December 31:
Asset Category:
Equity Securities
Debt Securities
Other
Total
December 31,
2016
2015
4.3 %
7.3 %
2.4 %
4.3 %
7.3 %
2.4 %
2016
2015
66.3 %
33.1 %
0.6 %
66.0 %
34.0 %
— %
100.0 %
100.0 %
The investment policy of ESA is directed toward a broad range of securities. The diversified portfolio seeks to
maximize investment return while minimizing the risk levels associated with investing. The investment policy is
structured to consider the retirement plan’s obligations and the expected timing of benefit payments. The target asset
allocation for the Plan years presented is as follows:
Asset Category:
Equity Securities
Debt Securities
Other
Total
2016
2015
65.0 %
35.0 %
— %
50.0 %
40.0 %
10.0 %
100.0 %
100.0 %
The fair value of the asset values by category at December 31, 2016 was as follows:
F - 53
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Asset Category
Cash
Cash Equivalents:
Money Market Funds (a)
Fixed Income Securities:
Mutual Funds (b)
Equity Securities:
International Companies (c)
Mutual Funds (d)
Total
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
Significant
Observable
Inputs
(Level 2)
Significant
Unobservab
le Inputs
(Level 3)
Total
$
553 $
553 $
— $
335
335
45,409
45,409
3,953
89,990
140,240 $
$
3,953
89,990
140,240 $
—
—
—
—
— $
—
—
—
—
—
—
F - 54
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 17 - BENEFIT PLANS AND OBLIGATIONS FOR TERMINATION INDEMNITY (Cont.)
(a)
(b)
(c)
(d)
This category includes highly liquid daily traded cash-like vehicles.
This category invests in highly liquid mutual funds representing a diverse offering of debt issuance.
This category represents common stocks of companies domiciled outside of the U.S.; they can be
represented by ordinary shares or ADRs.
This category represents highly liquid diverse equity mutual funds of varying asset classes and
styles.
In developing the overall expected long-term rate of return on assets assumption, ESA used a building block approach
in which rates of return in excess of inflation were considered separately for equity securities, debt securities, real
estate and all other assets. The excess returns were weighted by the representative target allocation and added along
with an approximate rate of inflation to develop the overall expected long-term rate of return. It is the policy of ESA to
meet the ERISA minimum contribution requirements for a Plan year. The minimum contribution requirements for the
2016 Plan year have been satisfied as of December 31, 2016. Benefit payments over the next five years are expected to
be $6,255 in 2017, $7,077 in 2018, $7,791 in 2019, $8,599 in 2020 and $9,468 in 2021.
2. Retiree Medical Plan
ESA offers retiree medical benefits to a limited number of retirees, The measurement date for ESA's benefit obligation
is December 31. The following table sets forth the retiree medical plans’ funded status and amounts recognized in the
consolidated financial statements for the years ended December 31, 2016 and 2015:
Change in Benefit Obligation:
Benefit obligation at beginning of period
Service cost
Interest cost
Actuarial (gain) loss
Employee contribution
Benefits paid
Benefit obligation at end of period
Change in Plan Assets:
Employer contribution
Employee contribution
Benefits paid
Fair value of Plan assets at end of period
December 31,
2016
2015
1,791 $
71
60
233
33
(135 )
2,053 $
102 $
33
(135 )
— $
1,953
102
63
(237 )
27
(117 )
1,791
90
27
(117 )
—
$
$
$
$
F - 55
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
F - 56
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 17 - BENEFIT PLANS AND OBLIGATIONS FOR TERMINATION INDEMNITY (Cont.)
Accrued benefit cost, end of period:
Funded status
Unrecognized net actuarial (gain) loss
Accrued benefit cost, end of period
Amounts recognized in the statement of financial position:
Accrued benefit liability, current
Accrued benefit liability, non-current
Accumulated other comprehensive gain, pretax
Net amount recognized
Components of net periodic pension cost (for period):
Service cost
Interest cost
Amortization of net actuarial gain
Total net periodic benefit cost
Assumptions as of end of period:
Discount rate
Health care cost trend rate assumed for next year
Ultimate health care cost trend rate
Year ended December 31,
2016
2015
$
$
$
(2,053 ) $
(1,110 )
(3,163 ) $
(180 ) $
(1,873 )
(1,110 )
$
(3,163 ) $
$
$
71 $
60
(179 )
(48 ) $
(1,791 )
(1,522 )
(3,313 )
(153 )
(1,638 )
(1,522 )
(3,313 )
102
63
(143 )
22
3.50 %
6.50 %
3.80 %
3.50 %
6.50 %
3.84 %
The effect of a 1% change in the health care cost trend rate at December 31, 2016 was as follows:
Net periodic benefit cost
Benefit obligation
3. Defined Contribution Plan
1% increase 1% decrease
13 $
141 $
(11 )
(127 )
$
$
The 401(k) savings plan (“401(k) plan”) is a defined contribution retirement plan that covers all eligible ESA
employees, as defined in section 401(k) of the U.S. Internal Revenue Code. Employees may elect to contribute a
percentage of their annual gross compensation to the 401(k) plan. ESA may make discretionary matching contributions
as determined by ESA. Total expense under the 401(k) plan amounted to $5,300, $4,209 and $4,675 for the years
ended December 31, 2016, 2015 and 2014, respectively. Expense for the deferred 401(k) plan is allocated between cost
of sales and general and administrative expenses depending on the responsibilities of the related employees.
F - 57
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 17 - BENEFIT PLANS AND OBLIGATIONS FOR TERMINATION INDEMNITY (Cont.)
4. Non-Qualified Defined Contribution Plan
ESA has two benefit plans for the executives of the organization. The non-qualified, defined contribution plan is
structured under Section 409(A). The plan provides the employees at vice president level and above the opportunity to
defer up to 100% of their salary to the 409(A) plan. ESA provides a match of 50 cents on the dollar up to 10% of the
employees’ total salary and incentive based compensation. The contribution can be made into the 401(k) plan, the
409(A) plan or both plans. The purpose is to provide comparable defined contribution plan benefits for the senior
management across ESA locations. The 409(A) plan funds are contributed to several life insurance policies. Participant
contributions to the plan were $1,194, $1,221 and $181 for the years ended December 31, 2016, 2015 and 2014,
respectively, and the total ESA contribution to the plan was $265 for 2016. The cash and cash surrender value of these
life insurance policies at December 31, 2016 was $4,455. The total liability related to the 409(A) plan was $6,211 at
December 31, 2016.
The second plan implemented is a non-qualified, defined benefit plan for certain executives of ESA. The plan provides
a calculated, guaranteed payment in addition to their regular pension through the company upon retirement. The plan
is funded with several life insurance policies. They are not segregated into a trust or otherwise effectively restricted.
These policies are corporate owned assets that are subject to the claims of general creditors and cannot be considered
as formal plan assets. The defined benefit plan put in place meets the ERISA definition of an unfunded deferred
compensation plan maintained for the benefit of a select group of management or highly compensated employees. The
plan assets of life insurance policies have a cash surrender of $2,651 at December 31, 2016. Related liability for the
pension payments is $4,777 at December 31, 2016. As of December 31, 2016, all executives had partially vested
balances in the plan.
Note 18 - TAXES ON INCOME
A. APPLICABLE TAX LAWS
(1) Israeli Corporate Income Tax Rates
Corporate tax rates and real capital gains tax in Israel were 25% in 2016 and 26.5% in 2015 and 2014.
In December 2016, the Israeli Parliament approved a reduction of the corporate tax rate to 24%, effective as
of January 1, 2017 and 23% effective as of January 1, 2018.
(2) Tax benefits under Israel’s Law for the Encouragement of Industry (Taxes), 1969:
Elbit Systems and most of its subsidiaries in Israel currently qualify as “Industrial Companies”, as defined by
the Law for the Encouragement of Industry (Taxes), 1969, and as such, these companies are entitled to
certain tax benefits, mainly amortization of costs relating to know-how and patents over eight years,
accelerated depreciation, the right to deduct public issuance expenses for tax purposes and an election under
certain conditions to file a consolidated tax return with additional related Israeli Industrial Companies.
In December 2015, Elbit Systems and certain of its Israeli subsidiaries (also industrial companies) submitted
an election notice to the Israel Tax Authority to file a consolidated tax return starting tax year 2015.
F - 58
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 18 - TAXES ON INCOME (Cont.)
A. APPLICABLE TAX LAWS (Cont.)
(3) Tax benefits under Israel’s Law for the Encouragement of Capital Investments, 1959:
Elbit Systems’ and certain of its Israeli subsidiaries’ (“the companies”) operations have been granted
“Approved Enterprise” status under Israel’s Law for the Encouragement of Capital Investments, 1959 (the
“Law”). Accordingly, certain income of the companies derived from the “Approved Enterprise” programs is
tax exempt for two years and subject to reduced tax rates of 25% for five-year to eight-year periods or tax
exempt for a ten-year period, commencing in the first year in which the companies had taxable income
(limited to twelve years from commencement of production or fourteen years from the date of approval,
whichever is earlier).
An Amendment to the Law from 2005 defines the “Privileged Enterprise” status rather than the previous
“Approved Enterprise” status and limits the scope of enterprises which may qualify for “Privileged
Enterprise” status by setting criteria such as that at least 25% of the “Privileged Enterprise” program’s
income be derived from exports. Additionally, the 2005 Amendment enacted major changes in the manner in
which tax benefits are awarded under the Law so that companies no longer require an Investment Center
approval in order to qualify for tax benefits. Similar criteria have been set for the “Preferred Enterprise”
status which was added in an Amendment to the Law in 2011. Companies are not required to receive an
Investment Center approval in order to qualify for the tax benefits under the “Preferred Enterprise”e status,
however, companies which are under an “Approved Enterprise” or “Privileged Enterprise” program must
waive their former benefits to elect the “Preferred Enterprise” benefits.
Tax-exempt income generated by the Company and certain of its Israeli subsidiaries’ “Approved Enterprise”
and “Privileged Enterprise” will be subject to tax upon dividend distribution or complete liquidation. Income
generated under a “Preferred Enterprise” is not subject to additional taxation to the Company or its Israeli
subsidiaries upon distribution or complete liquidation.
The entitlement to the above benefits is subject to the companies’ fulfilling the conditions specified in the
Law, and the regulations promulgated thereunder and the letters of approval for the specific investments in
“Approved Enterprises”. In the event of failure to comply with these conditions, the benefits may be canceled
and the companies may be required to refund the amount of the benefits, in whole or in part, including
interest. As of December 31, 2016, the Company’s management believes that the Company and its Israeli
subsidiaries met all conditions of the Law and letters of approval.
As of December 31, 2016, the tax benefits for the Company’s “Privileged Enterprise” existing programs will
expire within the period 2017 to 2022.
As of December 31, 2016, retained earnings of the Company included approximately $630,000 in tax-exempt
profits earned by the Company’s “Approved Enterprises”. If the retained tax-exempt income is distributed,
with respect to the “Approved Enterprises” it would be taxed at the corporate tax rate applicable to such
profits as if the Company had not elected the alternative tax benefits track (currently 25%), and an income
tax liability would have been incurred of approximately $157,500 as of December 31, 2016.
The boards of directors of the Company and its applicable Israeli subsidiaries have decided that their policy
is not to declare dividends out of such tax-exempt income. Accordingly, no deferred income taxes have been
provided on exempt income attributable to the companies’ “Approved Enterprises” and “Privileged
Enterprise”, as such retained earnings are essentially permanent in duration.
In Israel, income from sources other than the “Approved Enterprise”, “Privileged Enterprise” and “Preferred
Enterprise” during the benefit period will be subject to tax at the regular corporate tax rate.
F - 59
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 18 - TAXES ON INCOME (Cont.)
A. APPLICABLE TAX LAWS (Cont.)
In December 2016, the Knesset (Israeli Parliament) approved amendments to the Law that introduce an
innovation box regime for intellectual property (IP) based companies, enhance tax incentives for certain
industrial companies and reduce the standard corporate tax rate and certain withholding rates starting in 2017.
Innovation Box Regime
The new regime was tailored by the Israeli government to a post-base erosion and profit shifting ("BEPS")
world, encouraging multinationals to consolidate IP ownership and profits in Israel along with existing Israeli
research and development ("R&D") functions. Tax benefits created to achieve this goal include a reduced
corporate income tax rate of 6% on IP-based income and on capital gains from future sale of IP.
The 6% rate would apply to qualifying Israeli companies that are part of a group with global consolidated
revenue of over NIS 10 billion (approximately US$2.6 billion). Other qualifying companies with global
consolidated revenue below NIS 10 billion would be subject to a 12% tax rate. However, if the Israeli
company is located in Jerusalem or in certain northern or southern parts of Israel, the tax rate is further
reduced to 7.5%. Additionally, withholding tax on dividends would be subject to a reduced rate of 4% for all
qualifying companies (unless further reduced by a treaty).
Entering into the regime is not conditioned on making additional investments in Israel, and a company could
qualify if it invested at least 7% of the last three years’ revenue in R&D (or NIS 75 milion R&D expense per
year) and met one of the following three conditions:
1. Have at least 20% R&D employees engaged in R&D (or more than 200 R&D employees);
2. Venture capital investment of NIS 8 million was previously made in the company; or
3. Average annual growth over three years of 25% in sales or employees.
Companies not meeting the above conditions may still be considered as a qualified company at the discretion
of the Israeli Innovation Authority in the Ministry of Economy and Industry (formerly the "Office of the
Chief Scientist"). Companies wishing to exit from the regime in the future will not be subject to clawback of
tax benefits. The Knesset also approved a stability clause in order to encourage multinationals to invest in
Israel. Accordingly, companies will be able to confirm the applicability of tax incentives for a 10-year period
under a pre-ruling process. Further, in line with the new Organization for Economic Co-operation and
Development ("OECD") Nexus Approach, the Finance Minister will promulgate regulations to ensure
companies are benefiting from the regime to the extent qualifying R&D expenditures are incurred. The
regulations were set to be finalized by March 31, 2017. The new amendments to the Law will come into
effect after the regulations have been finalized. Accordingly, the new law was not considered enacted at
December 31, 2016.
Enhancement of Current Tax Incentives Regime
Tax incentives in Israel are also available to certain Israeli industrial companies and to R&D centers
(operating on a cost plus basis) under two tracks: (i) a Preferred Enterprise and (ii) a Special Preferred
Enterprise, aimed at large enterprises that meet certain investment requirements. Accordingly, a Preferred
Enterprise is eligible for a reduced corporate income tax rate of 16%. However, if the company is located in
Jerusalem or in certain northern or southern parts of Israel, the tax rate was further reduced to 9%. On 15
December 2016, the Finance Committee approved a further 1.5% reduction in the tax rate for such locations,
from 9% to 7.5%.
F - 60
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 18 - TAXES ON INCOME (Cont.)
A. APPLICABLE TAX LAWS (Cont.)
Since the Company and its Israeli subsidiaries are operating under more than one program, and since part of
their taxable income is not entitled to tax benefits under the Law and is taxed at the regular tax rates, the
effective tax rate is the result of a weighted combination of the various applicable rates and tax exemptions,
and the computation is made for income derived from each program on the basis of formulas specified in the
law.
The Knesset enacted a reform to the Law, effective January 2011. According to the reform a flat rate tax
applies to companies eligible for the “Preferred Enterprise” status. In order to be eligible for a “Preferred
Enterprise” status, a company must meet minimum requirements to establish that it contributes to the
country’s economic growth and is a competitive factor for the Gross Domestic Product (a competitive
enterprise).
Israeli companies which currently benefit from an “Approved Enterprise” or “Privileged Enterprise” status
and meet the criteria for qualification as a “Preferred Enterprise” can elect to apply the “Preferred Enterprise”
benefits by waiving their benefits under the Approved and “Privileged Enterprise” status. The Company and
several of its Israeli subsidiaries have elected the “Preferred Enterprise” status.
Benefits granted to a “Preferred Enterprise” include reduced and gradually decreasing tax rates. In peripheral
regions (Development Area A) the reduced tax rate was 10% in 2012 and 7% in 2013. In other regions the tax
rate was 15% in 2012, and 12.5% in 2013. Following the enactment of the National Priorities Law, effective
January 1, 2014, the reduced tax rate is 9% in the Development Area A regions and 16% in other regions.
“Preferred Enterprises” in peripheral regions are eligible for Investment Center grants, as well as the
applicable reduced tax rates.
A distribution from a “Preferred Enterprise” out of the “Preferred Income” through December 31, 2013, was
subject to 15% withholding tax for Israeli-resident individuals and non-Israeli residents (subject to applicable
treaty rates) and effective January 1, 2014, is subject to 20% withholding tax for Israeli-resident individuals
and non-Israeli residents (subject to applicable treaty rates).
B. NON-ISRAELI SUBSIDIARIES
Non-Israeli subsidiaries are generally taxed based upon tax laws applicable in their countries of residence.
F - 61
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 18 - TAXES ON INCOME (Cont.)
C. INCOME FROM CONTINUING OPERATIONS BEFORE TAXES ON INCOME
Income before taxes on income:
Domestic
Foreign
D. TAXES ON INCOME
Current taxes:
Domestic
Foreign
Adjustment for previous years:
Domestic
Foreign
Deferred income taxes:
Domestic
Foreign
Total taxes on income
Total:
Domestic
Foreign
Total taxes on income
Year ended December 31,
2016
2015
2014
$
$
234,643 $
44,558
279,201 $
189,228 $
59,326
248,554 $
141,532
57,956
199,488
Year ended December 31,
2016
2015
2014
$
44,095 $
14,454
58,549
34,693 $
10,246
44,939
24,348
13,254
37,602
(18,630 )
8
(18,622 )
(903 )
(455 )
(1,358 )
4,605
1,085
5,690
45,617 $
1,842
812
2,654
46,235 $
(5,753 )
(1,905 )
(7,658 )
(3,831 )
(489 )
(4,320 )
25,624
30,070 $
15,547
45,617 $
35,632 $
10,603
46,235 $
14,764
10,860
25,624
$
$
$
F - 62
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 18 - TAXES ON INCOME (Cont.)
E. UNCERTAIN TAX POSITIONS
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
Balance at the beginning of the year
Additions related to interest and currency translation
Additions based on tax positions taken during a prior period
Reductions related to tax positions taken during a prior period
Reductions related to settlement of tax matters
Additions based on tax positions taken during the current period
Reductions related to a lapse of applicable statute of limitation
Balance at the end of the year
2016
2015
$
$
49,813 $
613
14,353
(19,797 )
(12,222 )
14,597
(510 )
46,847 $
46,158
(111 )
373
(1,925 )
(1,128 )
8,920
(2,474 )
49,813
At December 31, 2016 and 2015, the Company had a liability for unrecognized tax benefits of $46,847
and$49,813, respectively, including an accrual of $1,157 and $3,952 for the payment of related interest and
penalties, respectively. The Company recognizes interest and penalties related to unrecognized tax benefits in the
provision for income taxes.
During 2016 and 2015, the Company and certain of its subsidiaries settled certain income tax matters pertaining
to multiple years in Israel and Europe. As a result of the settlement of the tax matters, the Company recorded tax
benefits of approximately $12,200 and $400 during the years 2016 and 2015, respectively, in the statements of
income in “taxes on income”. Following the examination by the Israeli Tax Authority, the Company has applied
some of the items for which settlement was reached to subsequent outstanding years.
The Company operates in multiple jurisdictions throughout the world, and its tax returns are periodically audited
or subject to review by both domestic and foreign authorities. Certain Israeli subsidiaries of the company are
currently undergoing tax audits by the Israeli Tax Authority.
As a result of ongoing examinations, tax proceedings in certain countries and additions to unrecognized tax
benefits for positions taken and interest and penalties, if any, arising in 2016, it is not possible to estimate the
potential net increase or decrease to the Company’s unrecognized tax benefits during the next twelve months.
F - 63
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 18 - TAXES ON INCOME (Cont.)
F. DEFERRED INCOME TAXES
Significant components of net deferred tax assets and liabilities are based on separate tax jurisdictions as follows:
As of December 31, 2016
Deferred tax assets:
Reserves and allowances
Inventory allowances
Property, plant and equipment
Other
Net operating loss carry-forwards
Valuation allowance
Net deferred tax assets
Deferred tax liabilities:
Intangible assets
Property, plant and equipment
Reserves and allowances
Net deferred tax assets
As of December 31, 2015
Deferred tax assets:
Reserves and allowances
Inventory allowances
Property, plant and equipment
Other
Net operating loss carry-forwards
Valuation allowance
Net deferred tax assets
Deferred tax liabilities:
Intangible assets
Property, plant and equipment
Reserves and allowances
Net deferred tax assets
Deferred
Tax Asset (Liability)
Total
Current
Non-
current
$
$
$
38,441 $
3,730
(2,621 )
32,553
14,141
86,244
(6,605 )
79,639
(6,538 )
(11,775 )
(4,701 )
(23,014 )
56,625 $
50,716 $
3,267
(6,859 )
32,704
15,892
95,720
(6,540 )
89,180
(5,753 )
(14,577 )
(6,575 )
13,496 $
3,730
276
13,132
1,893
32,527
(191 )
32,336
—
(19 )
(1,781 )
(1,800 )
30,536 $
14,070 $
3,267
158
16,012
3,950
37,457
(896 )
36,561
—
(6 )
(539 )
(26,905 )
62,275 $
(545 )
36,016 $
$
24,945
—
(2,897 )
19,421
12,248
53,717
(6,414 )
47,303
(6,538 )
(11,756 )
(2,920 )
(21,214 )
26,089
36,646
—
(7,017 )
16,692
11,942
58,263
(5,644 )
52,619
(5,753 )
(14,571 )
(6,036 )
(26,360 )
26,259
F - 64
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 18 - TAXES ON INCOME (Cont.)
F. DEFERRED INCOME TAXES (Cont.)
The deferred taxes, net, are reflected in the balance sheet as follows:
Current deferred income tax assets (Note 4)
Current deferred income tax liabilities (Note 13)
Non-current deferred income tax assets
Non-current deferred income tax liabilities
G. CARRY-FORWARD TAX LOSSES
December 31,
2016
2015
$
$
$
$
32,336 $
1,800 $
47,303 $
21,214 $
36,561
545
52,619
26,360
As of December 31, 2016, Elbit Systems’ Israeli subsidiaries had estimated total available carry-forward tax
losses of approximately $108,781, and its non-Israeli subsidiaries had estimated available carry-forward tax
losses of approximately $40,330. The Company had also carry-forward capital losses of approximately
$37,867 for which a full valuation allowance was provided.
H. RECONCILIATION
Reconciliation of the actual tax expense as reported in the statements of operations to the amount computed
by applying the Israeli statutory tax rate is as follows:
Income before taxes as reported in the consolidated statements of income
Statutory tax rate
Theoretical tax expense
Tax benefit arising from reduced rate as an “Approved, Privileged and Preferred
Enterprise” and other tax benefits (*)
Tax adjustment in respect of different tax rates for foreign subsidiaries
Changes in carry-forward losses and valuation allowances
Taxes resulting from non-deductible expenses
Difference in basis of measurement for financial reporting and tax return purposes
Taxes in respect of prior years (See E above)
Other differences, net
Actual tax expenses
Effective tax rate
Year ended December 31,
2016
$ 279,201
2015
2014
$ 248,554
$ 199,488
25.0 %
26.5 %
26.5 %
$
69,800
$
65,867
$
52,864
(16,072 )
3,597
5,290
3,144
135
(18,622 )
(20,818 )
2,433
3,851
776
(849 )
(21,781 )
1,563
1,779
2,244
(310 )
(1,358 )
(7,658 )
$
(1,655 )
45,617
16.34 %
$
(3,667 )
46,235
18.60 %
$
(3,077 )
25,624
12.84 %
(*) Net earnings per share – amounts of the benefit resulting from the Approved, Privileged and Preferred Enterprises
Basic
Diluted
$
$
0.38
0.38
$
$
0.49
0.49
$
$
0.51
0.51
I. FINAL TAX ASSESSMENTS
F - 65
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Final tax assessments have been received by the Company up to and including the tax year 2014 and by
certain subsidiaries up to 2013.
F - 66
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 19 - DERIVATIVE FINANCIAL INSTRUMENTS
A. FAIR VALUE OF DERIVATIVE INSTRUMENTS
Derivative financial instruments are presented as other assets or other payables. For asset derivatives and liability
derivatives, the fair value of the Company’s outstanding derivative instruments as of December 31, 2016 and
December 31, 2015 is summarized below:
Derivatives designated as hedging instruments
Foreign exchange contracts
Cross-currency interest rate swaps
Derivatives not designated as hedging instruments
Foreign exchange contracts
Asset Derivatives (*)
Liability Derivatives (**)
December 31,
2016
December 31,
2015
December 31,
2016
December 31,
2015
13,719
10,339
24,058 $
499
499 $
16,475
10,858
27,333 $
204
204 $
$
$
2,926
1,798
4,724 $
710
710 $
7,802
2,266
10,068
487
487
(*) Presented as part of other receivables and long-term other receivables.
(**) Presented as part of other payables and long-term other payables.
B. EFFECT ON CASH FLOW HEDGING
The effect of derivative instruments on cash flow hedging and the relationship between income and other
comprehensive income for the years ended December 31, 2016 and December 31, 2015, is summarized below:
Gain (Loss) Recognized
in Other Comprehensive
Income on Effective-
Portion of Derivative, net
December 31,
December 31,
2015
2016
Gain (loss) on Effective
Portion
of Derivative Reclassified
from Accumulated Other
Comprehensive Income (*)
December 31,
December 31,
2015
2016
Ineffective Portion of Gain
(loss) of Derivative and
Amount Excluded from
Effectiveness Testing
Recognized in Income (**)
December 31,
December 31,
2015
2016
$
21,891 $
8,487 $
13,653 $
28,177 $
— $
1,522
$
—
$
—
$
—
$
—
$
1,592
$
4,186
Derivatives designated as
hedging instruments:
Foreign exchange contracts
Derivatives not designated as
hedging instruments:
Foreign exchange contracts
and other derivatives
instruments
(*) Presented as part of revenues/cost of revenue.
(**) Presented as part of financial income (expenses), net
F - 67
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 19 - DERIVATIVE FINANCIAL INSTRUMENTS (Cont.)
C. NET EFFECT OF CROSS-CURRENCY SWAPS
The annual net effect on earnings from the cross-currency swaps was a gain of approximately $12,740, of which
approximately $7,567 was offset against exchange rate difference related to Series A Notes and approximately
$5,173 was offset against interest expenses.
D. FORWARD CONTRACTS
The notional amounts of outstanding foreign exchange forward contracts at December 31, 2016 and
December 31, 2015, is summarized below:
Euro
GBP
NIS
Other
Forward contracts
Buy
Sell
December 31,
December 31,
2016
2015
2016
$
$
37,054 $
4,777
646,500
25,078
713,409 $
46,094 $
10,820
697,467
7,417
761,798 $
89,764 $
31,450
—
19,260
140,474 $
2015
132,220
35,460
5,500
2,245
175,425
Note 20 - COMMITMENTS AND CONTINGENT LIABILITIES
A. ROYALTY COMMITMENTS
Elbit Systems and certain Israeli subsidiaries partially finance their research and development expenditures under
grant programs sponsored by the Israel Innovation Authority ("IIA") in the Ministry of Economy and Industry
(formerly Office of Chief Scientist) for the support of research and development activities conducted in Israel. At
the time the grants were received from the IIA, successful development of the related projects was not assured.
In exchange for participation in the programs by the IIA, Elbit Systems and the subsidiaries agreed to pay 2% -
5% of total sales of products developed within the framework of these programs. The royalties will be paid up to a
maximum amount equaling 100% to 150% of the grants provided by the IIA, linked to the dollar bearing annual
interest at a rate based on LIBOR. The obligation to pay these royalties is contingent on actual sales of the
products, and in the absence of such sales payment of royalties is not required.
In some cases, the Government of Israel’s participation (through the IIA) is subject to export sales or other
conditions. The maximum amount of royalties is increased in the event of production outside of Israel.
Elbit Systems and certain of its subsidiaries may also be obligated to pay certain amounts to the IMOD and others
on certain sales including sales resulting from the development of certain technologies.
Royalties expenses amounted to $4,460, $7,811 and $7,362 in 2016, 2015 and 2014, respectively.
F - 68
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 20 - COMMITMENTS AND CONTINGENT LIABILITIES (Cont.)
B. COMMITMENTS IN RESPECT OF LONG-TERM PROJECTS
In connection with projects in certain countries, Elbit Systems and some of its subsidiaries have entered and may
enter in the future into “buy-back” or “offset” agreements, required by a number of the Company’s customers for
these projects as a condition to the Company obtaining orders for its products and services. These agreements are
customary in the Company’s industry and are designed to facilitate economic flow back (buy-back) and/or
technology transfer to businesses or government agencies in the applicable country.
These commitments may be satisfied by the Company’s placement of direct work or vendor orders for supplies
and/or services, transfer of technology, investments or other forms of assistance in the applicable country. The
buy-back rules and regulations, as well as the underlying contracts, may differ from one country to another. The
ability to fulfill the buy-back obligations may depend, among other things, on the availability of local suppliers
with sufficient capability to meet our requirements and which are competitive in cost, quality and schedule. In
certain cases, the Company’s commitments may also be satisfied through transactions conducted by other parties.
The Company does not commit to buy-back agreements until orders for its products or services are definitive, but
in some cases the orders for the Company’s products or services may become effective only after the Company’s
corresponding buy-back commitments are in effect.
Buy-back programs generally extend at least over the relevant commercial contract period and may provide for
penalties in the event the Company fails to perform in accordance with buy-back requirements. In some cases the
Company provides guarantees in connection with the performance of its buy-back obligations.
Should the Company be unable to meet such obligations it may be subject to contractual penalties, our guarantees
may be drawn upon and our chances of receiving additional business from the applicable customers could be
reduced or, in certain cases, eliminated.
At December 31, 2016, the Company had outstanding buy-back obligations totaling approximately $1,104,000
that extend through 2024.
C. LEGAL CLAIMS
Elbit Systems and its subsidiaries are involved in legal claims arising in the ordinary course of business. The
Company’s management, based on the opinion of its legal counsel, believes that any financial impact from the
settlement of such claims in excess of the accruals recorded in the financial statements will not have a material
adverse effect on the financial position or results of operations of the Company. The following is a description of
significant legal proceedings.
In 2015, Elbit Systems of America, LLC and Elbit Systems Land & C4I Ltd. filed a claim for patent infringement
in the U.S. District Court for the Eastern District of Texas against Hughes Network Systems, LLC, Black Elk
Energy Offshore Operations, LLC, Blue Tide Communications, Inc. and Helms Hotels Group (collectively the
defendants). The claim alleges that the defendants infringed the Company's patents relating to "Reverse Link for
a Satellite Communications Network" and "Infrastructure for Telephony Network". The claim does not yet
specify the amount of damages resulting from the patent infringement and is currently in the discovery stage. A
trial date has been set for July 2017.
F - 69
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 20 - COMMITMENTS AND CONTINGENT LIABILITIES (Cont.)
D. LEASE COMMITMENTS
The future minimum lease commitments of the Company under various non-cancelable operating lease
agreements in respect of premises, motor vehicles and office equipment as of December 31, 2016, are as follows:
2017
2018
2019
2020
2021 and thereafter
$
$
47,479
35,907
27,174
19,360
100,637
230,557
Lease expenses for the years ended December 31, 2016, 2015 and 2014 amounted to $44,614, $37,169 and
$35,099, respectively.
E. GUARANTEES
(1) As of December 31, 2016, guarantees in the amount of approximately $1,219,451 were issued by banks and
other financial institutions on behalf of the Company and certain of its subsidiaries mainly in order to secure
certain advances from customers and performance bonds.
(2) Elbit Systems has provided, on a basis proportional to its ownership interest, guarantees for one of its
investees in respect of credit lines granted to them by banks in the aggregate amount of $4,207 as of
December 31, 2016 (2015 - $6,274). The guarantees will exist as long as the credit lines are in effect. Elbit
Systems would be liable under the guarantee for any debt for which the investees would be in default under
the terms of the credit lines. The fair value of such guarantees, as of December 31, 2016 and 2015, were not
material.
F. COVENANTS
In connection with bank credits and loans, including performance guarantees issued by banks and bank guarantees
in order to secure certain advances from customers, the Company and certain subsidiaries are obligated to meet
certain financial covenants. Such covenants include requirements for shareholders’ equity, current ratio, operating
profit margin, tangible net worth, EBITDA, interest coverage ratio and total leverage.
As of December 31, 2016, the Company met all financial covenants.
F - 70
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 20 - COMMITMENTS AND CONTINGENT LIABILITIES (Cont.)
G. CONTRACTUAL OBLIGATIONS
Substantially all of the Company’s purchase commitments relate to obligations under purchase orders and
subcontracts entered into by the Company. These purchase orders and subcontracts are typically in standard
formats proposed by the Company, with the subcontracts and purchase orders also reflecting provisions from the
Company’s applicable prime contract that apply on a flow down basis to subcontractors and vendors. The terms
typically included in these purchase orders and subcontracts are consistent with Uniform Commercial Code
provisions in the United States for sales of goods, as well as with specific terms called for by its customers in
various countries. These terms include the Company’s right to terminate the purchase order or subcontract in the
event of the vendor’s or subcontractor’s default, as well as the Company’s right to terminate the order or
subcontract for the Company’s convenience (or if the Company’s prime contractor has so terminated the prime
contract). Such purchase orders and subcontracts typically are not subject to variable price provisions. As of
December 31, 2016 and 2015, the purchase commitments were $1,313,000 and $1,292,000, respectively.
H. FIXED LIENS
In order to secure bank loans and bank and other financial institutions guarantees in the amount of approximately
$1,219,451 as of December 31, 2016, certain Company entities recorded fixed liens on most of their machinery
and equipment, mortgages on most of their real estate and floating charges on most of their assets.
I. LIEN ON APPROVED ENTERPRISES
A lien on the Company’s Approved Enterprises has been registered in favor of the State of Israel (see Note
18(A)(3)).
Note 21 -
SHAREHOLDERS’ EQUITY
A. SHARE CAPITAL
Ordinary shares confer upon their holders voting rights and the right to receive dividends.
B. 2007 STOCK OPTION PLAN
In 2007 Elbit Systems' shareholders approved an employee Stock Option Plan (the "2007 Stock Option Plan").
As of December 31, 2016, there were 13,000 options remaining unexercised under the 2007 Stock Option Plan.
Compensation expenses related to the 2007 Option Plan amounting to $70, $139 and $322 were recognized
during the years ended December 31, 2016, 2015 and 2014, respectively.
F - 71
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 21 -
SHAREHOLDERS’ EQUITY (Cont.)
C. COMPUTATION OF EARNINGS PER SHARE
Computation of basic and diluted net earnings per share:
Year ended December 31, 2016
Year ended December 31, 2015
Year ended December 31, 2014
Net income
to
shareholders
of ordinary
shares
Weighted
average
number
of
shares (*)
Net income
to
shareholders
of ordinary
shares
Per
Share
amount
Weighted
average
number of
shares (*)
Per
Share
amount
Net income
to
shareholders
of ordinary
shares
Weighted
average
number
of
shares (*)
Per
Share
amount
$
236,909
42,742
$
5.54
$
202,509
42,711
$
4.74
$
170,980
42,654
$
4.01
—
10
—
22
—
23
$
236,909
42,752
$
5.54
$
202,509
42,733
$
4.74
$
170,980
42,677
$
4.01
Basic net
earnings
Effect of
dilutive
securities:
Employee
stock options
Diluted net
earnings
(*) In thousands
D.
2012 PHANTOM BONUS RETENTION PLAN
In August 2012, the Company’s Board of Directors approved a “Phantom Bonus Retention Plan” for Senior
Officers (the “Plan”). In August 2013, the Plan was extended to include other officers of the Company.
The Plan provides for phantom bonus units which entitle the recipients to receive payment in cash of an amount
reflecting the “benefit factor”, which is linked to the performance of Elbit Systems’ stock price over the applicable
periods (tranches) under the Plan. As of December 31, 2016, 2,296,847 phantom bonus units of the Plan were
granted with a weighted average basic price per unit, as defined in the Plan, of $55.78.
The benefit earned for each year of a tranche is the difference between the basic price and the closing price of the
Company’s share for that year, as defined in the Plan, not to exceed an increase of 100% in the Company's share
price from the basic price of the first year of a tranche.
The Company recorded an amount of approximately $32,065, $25,893 and $10,402 in the years ended
December 31, 2016, 2015 and 2014, respectively, as compensation costs related to the phantom bonus units
granted under the Plan, as follows:
Cost of revenues
General and administration expenses
Marketing and selling
E. DIVIDEND POLICY
F - 72
Year ended December 31,
2016
2015
2014
$
$
10,056 $
18,024
3,985
32,065 $
5,859 $
17,864
2,170
25,893 $
1,176
8,804
422
10,402
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Dividends declared by Elbit Systems are paid subject to statutory limitations. Elbit Systems’ Board of Directors
has determined not to declare dividends out of tax exempt earnings.
F - 73
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 22 - MAJOR CUSTOMER AND GEOGRAPHIC INFORMATION
The Company operates in one reportable segment (see Note 1 for a brief description of the Company’s business).
A.
REVENUES ARE ATTRIBUTED TO GEOGRAPHIC AREAS BASED ON LOCATION OF THE END
CUSTOMERS AS FOLLOWS:
Year ended December 31,
North America
Asia-Pacific
Israel
Europe
Latin America
Other
$
2016
825,665 $
801,639
709,562
640,763
212,773
69,817
2014
826,815
528,802
638,858
460,884
454,502
48,387
$ 3,260,219 $ 3,107,581 $ 2,958,248
2015
838,893 $
800,333
616,611
497,559
325,371
28,814
B. REVENUES ARE GENERATED BY THE FOLLOWING AREAS OF OPERATIONS:
Year ended December 31,
Airborne systems
C4ISR systems
Land systems
Electro-optic systems
Other (*)
2016
2014
2015
$ 1,242,286 $ 1,225,678 $ 1,197,942
1,118,487
274,896
265,143
101,780
$ 3,260,219 $ 3,107,581 $ 2,958,248
1,220,917
408,003
276,029
112,984
995,200
558,658
231,939
96,106
(*) Mainly non-defense engineering and production services.
C. MAJOR CUSTOMER DATA AS A PERCENTAGE OF TOTAL REVENUES:
D. LONG-LIVED ASSETS BY GEOGRAPHIC AREAS:
Year ended December 31,
2016
18%
2015
17%
2014
18%
Year ended December 31,
$
2016
943,381 $
149,581
107,545
2014
783,290
167,572
128,205
$ 1,200,507 $ 1,220,035 $ 1,079,067
2015
946,870 $
157,835
115,330
IMOD
Israel
U.S.
Other
F - 74
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 23 - RESEARCH AND DEVELOPMENT EXPENSES, NET
Total expenses
Less - grants and participations
Note 24 -
FINANCIAL EXPENSES, NET
Expenses:
Interest on long-term bank debt
Interest on Series A Notes, net
Interest on short-term bank credit and loans
Loss from exchange rate differences, net
Other
Income:
Interest on cash, cash equivalents and bank deposits
Other
Note 25 - OTHER INCOME, NET
Capital gain (*)
Other
Year ended December 31,
2016
291,749 $
(35,957 )
255,792 $
2015
277,837 $
(34,421 )
243,416 $
2014
267,691
(39,680 )
228,011
$
$
Year ended December 31,
2016
2015
2014
$
(1,489 ) $
(2,365 ) $
(6,565 )
(5,457 )
(2,224 )
(9,495 )
(6,812 )
(2,604 )
(6,341 )
(4,144 )
(25,230 )
(22,266 )
933
555
1,488
(23,742 ) $
850
1,176
2,026
(20,240 ) $
(2,828 )
(7,954 )
(2,787 )
(12,516 )
(24,098 )
(50,183 )
1,404
1,281
2,685
(47,498 )
Year ended December 31,
2016
2015
2014
3,868 $
99
3,967 $
133 $
83
216 $
—
120
120
$
$
$
(*) During 2016, the company recognized a gain from the sale of land and property.
F - 75
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars (In thousands, except per share data)
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Note 26 - RELATED PARTIES' TRANSACTIONS AND BALANCES
Transactions:
Income -
Sales to related-party companies (*)
Participation in expenses
Cost and expenses -
Supplies from related parties (**)
Balances:
Trade receivables and other receivables (*)
Trade payables and advances (**)
Year ended December 31,
2016
2015
2014
$
$
$
176,429 $
2,502 $
150,999 $
2,257 $
138,380
1,911
20,224 $
14,890 $
15,184
December 31,
2016
2015
$
$
88,876 $
16,110 $
79,988
13,663
The sales to the Company’s related parties in respect of U.S. government defense contracts are made on the basis of cost.
(*)
(**)
The significant sales and balances include sales of helmet mounted cueing systems purchased from the Company by
50%-owned subsidiaries of ESA.
Includes mainly electro-optics components and sensors, purchased by the Company from a 50%-owned Israeli
partnership, and electro-optics products purchased by the Company from another 50%-owned Israeli subsidiary.
F - 76
ELBIT SYSTEMS LTD. AND SUBSIDIARIES
Schedule II – Valuation and Qualifying Accounts
(In thousands of U.S. dollars)
Column A
Column B
Column C
Column D Column E
Balance at
Beginning of
Period
Additions
(Charged to
Costs and
Expenses)
Deductions
(Write-Offs
and Actual
Losses
Incurred)
Additions
Resulting
from
Acquisitions
Balance at
End of
Period
Description
Year ended December 31, 2016:
Provisions for Losses on Long-Term
Contracts (*)
Provisions for Claims and Potential
Contractual Penalties and Others
Allowance for Doubtful Accounts
Valuation Allowance on Deferred Taxes
Year ended December 31, 2015:
Provisions for Losses on Long-Term
Contracts (*)
Provisions for Claims and Potential
Contractual Penalties and Others
Allowance for Doubtful Accounts
Valuation Allowance on Deferred Taxes
Year ended December 31, 2014:
Provisions for Losses on Long-Term
Contracts (*)
Provisions for Claims and Potential
Contractual Penalties and Others
Allowance for Doubtful Accounts
Valuation Allowance on Deferred Taxes
130,274
20,775
67,701
7,501
6,738
6,540
158
1,554
2,641
3,175
876
2,576
—
—
—
—
83,348
4,484
7,416
6,605
135,548
20,588
31,961
6,099
130,274
7,557
7,445
5,424
1,860
1,330
3,770
1,916
2,037
2,654
140,259
37,124
41,835
9,208
7,117
9,358
820
1,125
675
2,471
797
4,609
—
—
—
—
—
—
—
7,501
6,738
6,540
135,548
7,557
7,445
5,424
(*)
An amount of $43,513, $80,464 and $72,045 as of December 31, 2016, 2015 and 2014, respectively, is presented as a
deduction from inventories, and an amount of $39,835, $49,810 and $63,503 as of December 31, 2016, 2015 and 2014,
respectively, is presented as part of other payables and accrued expenses.
S-1